Three O
People O
in O
the O
CAR O
Died O
in O
UN O
Helicopter O
Crash B-TERM

Three O
people O
died O
and O
another O
one O
was O
injured O
in O
a O
helicopter O
crash B-TERM
of O
the O
Senegalese O
armed O
forces O
in O
the O
city O
of O
Buar O
in O
the O
west O
of O
the O
CAR O
fulfilling B-TERM
an O
operation O
under O
the O
leadership B-TERM
of O
the O
UN O
Peacekeeping O
Mission O
. O

The O
portal O
DakarActu O
wrote O
about O
this O
on O
Friday O
, O
citing O
the O
Senegalese O
military O
. O

Head B-TERM
of O
Mission O
Mankeur O
Ndiaye O
confirmed O
the O
information B-TERM
about O
the O
crash O
, O
noting O
that O
the O
helicopter O
crash B-TERM
occurred O
during O
landing O
. O

According O
to O
DakarActu O
, O
the O
Mi O
- O
35 O
helicopter O
was O
returning O
from O
an O
operation O
combating O
militant O
groups O
. O

The O
Senegalese O
army O
reported O
that O
it O
is O
in O
contact O
with O
the O
UN O
regarding O
the O
evacuation O
of O
the O
injured O
and O
bodies O
of O
the O
deceased O
. O

The O
coordinator O
of O
Navalny O
's O
Arkhangelsk O
headquarters O
was O
sentenced O
to O
community O
service O

The O
Oktyabrsky O
district O
court O
of O
Arkhangelsk O
delivered O
its O
sentencing O
of O
the O
coordinator O
of O
Alexei O
Navalny O
's O
regional B-TERM
headquarters O
Andrei O
Borovikov O
. O

For O
repeated O
infringements O
of O
the O
rules O
for O
conducting O
public O
gatherings O
( O
art O
. O
212.1 O
of O
the O
Russian O
Criminal O
Code O
) O
the O
court O
sentenced O
him O
to O
400 O
hours O
of O
community O
service O
, O
a O
Kommersant O
correspondent O
reports O
from O
the O
courtroom O
. O

The O
case O
was O
opened O
in O
April O
of O
this O
year O
for O
organizing O
protests O
against O
the O
construction B-TERM
of O
a O
garbage O
disposal O
site O
in O
Arkhangelsk O
region B-TERM
. O

The O
first O
to O
be O
sentenced O
to O
three O
years O
' O
imprisonment O
under O
art O
. O
212.1 O
of O
the O
Russian O
Criminal O
Code O
was O
activist O
Ildar O
Dadin O
in O
2015 O
. O

On O
the O
day O
before O
the O
sentencing O
, O
26 O
September O
, O
the O
parties O
presented O
their O
cases O
in O
court O
. O

The O
prosecution O
insisted O
on O
three O
years O
' O
community O
service O
. O

The O
punishment O
chosen B-TERM
for O
me O
is O
that O
I O
must O
not O
visit O
mass O
public O
gatherings O
and O
must O
not O
communicate O
with O
the O
organizers O
of O
the O
April O
7 O
protest O
. O

" O
All O
this O
time O
I O
wore O
an O
electronic O
bracelet O
and O
transmitter O
. O

That O
is O
how O
they O
tracked O
my O
location O
. O

I O
note O
that O
I O
was O
not O
restricted O
in O
my O
movements B-TERM
. O

Recently O
I O
flew O
from O
Moscow O
where O
I O
was O
studying O
, O
" O
said O
Andrei O
Borovikov O
. O

After O
the O
sentence O
was O
pronounced O
the O
coordinator O
of O
Navalny O
's O
regional B-TERM
headquarters O
said O
that O
he O
would O
serve O
his O
sentence O
in O
Arkhangelsk O
. O

On O
26 O
September O
KPRF O
faction O
deputy O
Sergei O
Shargunov O
submitted O
a O
bill O
to O
the O
State O
Duma O
, O
softening O
art O
. O
212.1 O
of O
the O
Russian O
Criminal O
Code O
. O

KPRF O
, O
LDPR O
and O
SR O
representatives O
told O
Kommersant O
of O
their O
intentions O
to O
support O
the O
initiative O
. O

Pavel O
Mogilevets O
: O
" O
Everybody O
in O
Rubin O
needs O
to O
think O
about O
the O
reasons O
for O
our O
unsuccessful O
games O
. O
" O

Rubin O
halfback O
Pavel O
Mogilevets O
spoke O
of O
the O
reasons O
behind O
the O
team O
's O
unsuccessful O
games O
. O

The O
Kazan O
team O
suffered O
four O
defeats B-TERM
in O
a O
row O
in O
the O
Russian O
championships O
and O
dropped O
out O
of O
the O
Cup O
. O

We O
are O
psyched O
up O
for O
every O
game O
, O
Izvestia O
quoted O
Mogilevets O
as O
saying O
. O

That O
is O
why O
everyone O
needs O
to O
think O
about O
the O
reasons O
for O
our O
unsuccessful O
games O
. O

There O
are O
games O
ahead O
of O
us O
- O
we O
need O
to O
prepare O
for O
them O
and O
fix O
the O
situation B-TERM
. O

How O
? O

If O
we O
knew O
, O
we O
would O
have O
probably O
already O
fixed O
it O
. O

But O
first O
of O
all O
, O
it O
seems B-TERM
to O
me O
, O
we O
need O
to O
up O
such O
aspects O
as O
our O
one O
- O
on O
- O
one O
. O

We O
have O
problems B-TERM
with O
this O
, O
in O
my O
view O
. O

Kremlin O
supports O
smoking O
ban O
on O
residential O
building O
balconies O

The O
Kremlin O
supports O
any O
measures B-TERM
that O
save O
people O
's O
lives O
, O
said O
the O
president O
's O
press O
secretary O
Dmitry O
Peskov O
, O
commenting O
on O
the O
smoking O
ban O
on O
apartment O
balconies O
and O
loggias O
. O

Earlier O
the O
Cabinet O
approved O
changes B-TERM
to O
the O
Fire O
Prevention O
Rules O
, O
according O
to O
which O
it O
is O
forbidden O
to O
use B-TERM
an O
open O
flame O
on O
balconies O
and O
rooms O
of O
residential O
buildings B-TERM
. O

Later O
, O
the O
Emergency O
Situations O
Ministry O
said O
that O
it O
includes O
a O
ban O
on O
smoking O
on O
the O
balconies O
and O
loggias O
of O
apartments O
and O
hotels B-TERM
. O

The O
changes B-TERM
come O
into O
force O
from O
1 O
October O
2019 O
. O

Infringement O
will O
be O
an O
administrative O
offense O
. O

The O
Kremlin O
welcomes O
any O
decision B-TERM
that O
helps B-TERM
save O
human O
life O
. O

" O
We O
know O
how O
many O
fires O
occur O
, O
many O
of O
them O
have O
extremely B-TERM
tragic O
consequences B-TERM
and O
cause O
a O
public O
outcry O
. O

So O
any O
life O
saved O
justifies O
such O
measures O
, O
" O
Peskov O
said O
. O

First O
and O
foremost O
the O
press O
secretary O
approves O
of O
it O
as O
a O
fire O
prevention O
measure B-TERM
, O
and O
not O
as O
a O
way B-TERM
to O
protect B-TERM
neighbors O
from O
tobacco O
smoke O
. O

Peskov O
also B-TERM
noted O
that O
Russian O
President O
Vladimir O
Putin O
does O
not O
approve O
of O
smoking O
and O
is O
a O
healthy O
lifestyle O
proponent B-TERM
. O

Gattuso O
is O
seeking O
work O
at O
one O
of O
Russia O
's O
clubs O

Italian O
football O
trainer O
Gennaro O
Gattuso O
arrived O
in O
Russia O
in O
search O
of O
a O
new O
club O
. O

As O
reported O
by O
Chempionat O
, O
the O
41 O
- O
year O
- O
old O
specialist O
flew O
into O
Moscow O
to O
weigh O
up O
the O
possibility B-TERM
of O
working O
at O
one O
of O
Russia O
's O
clubs O
. O

Gattuso O
's O
previously O
worked O
at O
Milan O
, O
which O
he O
headed O
from O
2017 O
to O
2018 O
and O
under O
his O
supervision O
, O
it O
took O
fifth O
place B-TERM
in O
the O
Italian O
Serie O
A O
standings O
and O
failed O
to O
qualify O
for O
the O
League O
of O
Champions O
. O

He O
also B-TERM
worked O
as O
a O
trainer O
for O
Swiss O
team O
Sion O
, O
Greek O
team O
OFI O
and O
Italian O
teams O
Palermo O
and O
Pisa O
. O

Earlier O
it O
was O
reported O
that O
negotiations O
between O
Pavel O
Mamayev O
and O
Dinamo O
were O
at O
risk O
of O
breaking O
down O
. O

Former O
Milan O
coach O
arrives O
in O
Moscow O
to O
head O
Russian O
club O

Former B-TERM
member O
of O
the O
Italian O
national O
team O
and O
former O
Milan O
head O
coach O
Gennaro O
Gattuso O
has O
arrived O
in O
Moscow O
to O
head O
the O
Russian O
club O
. O

Gattuso O
won O
the O
2006 O
world O
championships O
with O
the O
Italian O
national O
team O
. O

On O
the O
club O
level O
, O
he O
was O
known O
for O
playing O
for O
Milan O
, O
winning O
the O
UEFA O
Champions O
Leage O
with O
them O
twice O
, O
in O
2003 O
and O
2007 O
. O

The O
Italian O
began O
his O
coaching O
career O
with O
Sion O
. O

For O
the O
past O
two B-TERM
seasons O
, O
Gennaro O
led O
Rossoneri O
. O

It O
was O
earlier O
reported O
that O
capital O
CSKA O
player O
Konstantin O
Kuchaev O
spoke O
out O
against O
the O
introduction O
of O
VAR O
( O
Video O
Assistant O
Referee O
) O
. O

Ukraine O
's O
NSDC O
secretary O
resigned O

The O
secretary O
of O
the O
National O
Security O
and O
Defense B-TERM
Council O
( O
NSDC O
) O
of O
Ukraine O
Oleksandr O
Danylyuk O
wrote O
a O
notice O
of O
resignation O
, O
the O
office B-TERM
of O
the O
country O
's O
president O
reports O
. O

This O
was O
done O
before O
the O
start O
of O
Volodymyr O
Zelensky O
's O
working O
visit O
to O
the O
USA O
to O
participate O
in O
the O
74th O
session O
of O
the O
UN O
General O
Assembly O
. O

" O
The O
president O
will O
look O
at O
it O
after O
he O
returns O
to O
Kyiv O
, O
" O
Mr. O
Zelensky O
's O
office B-TERM
said O
. O

The O
president O
of O
Ukraine O
signed O
a O
decree B-TERM
appointing O
former B-TERM
finance O
minister O
Oleksandr O
Danylyuk O
as O
secretary O
of O
the O
NSDC O
at O
the O
end B-TERM
of O
May O
. O

In O
this O
role O
Mr. O
Danylyuk O
replaced O
Oleksandr O
Turchynov O
, O
who O
resigned O
due O
to O
the O
change O
of O
president O
. O

Palkina O
comes O
ninth O
in O
World O
Championship O
qualifications O
. O

Russian O
Sofiya O
Palkina O
took O
ninth O
place B-TERM
in O
the O
qualification O
hammer O
throw O
in O
Group O
A O
at O
the O
World O
Championships O
in O
Doha O
. O

Her O
result B-TERM
was O
68.53 O
meters O
. O

Four O
sportswomen O
who O
exceeded O
72 O
meters O
will O
be O
competing O
in O
the O
finals O
. O

Polish O
athlete O
Joanna O
Fiodorow O
( O
73.39 O
m O
) O
, O
Ukrainian O
Iryna O
Klymets O
( O
72.93 O
m O
) O
, O
Frenchwoman O
Alexandra O
Tavernier O
( O
72.91 O
m O
) O
and O
Belarusian O
Hanna O
Malyshchyk O
( O
72.59 O
m O
) O
. O

The O
final O
will O
see O
the O
12 O
best O
sportswomen O
from O
two B-TERM
groups O
compete O
. O

Palkina O
's O
chances O
for O
participating O
in O
the O
medal O
contention O
will O
become O
clear O
after O
the O
results O
of O
Group O
B O
are O
known O
. O

Kvyat O
's O
car O
breaks O
down O
during O
first O
practice O
in O
Sochi O

Russian O
Toro O
Rosso O
driver O
Daniil O
Kvyat O
had O
to O
finish B-TERM
his O
first O
free B-TERM
Russian O
Formula B-TERM
- O
1 O
Grand O
Prix O
practice O
early O
. O

The O
Russian O
's O
race O
car O
lost O
power O
and O
the O
driver O
couldn O
't O
make O
it O
to O
the O
pits O
. O

Kvyat O
parked O
his O
car B-TERM
in O
one O
of O
the O
safety O
zones O
. O

Before O
leaving O
the O
race O
, O
the O
Toro O
Rosso O
driver O
was O
in O
fifth O
place O
. O

The O
second O
free B-TERM
practice O
is O
expected O
to O
be O
held O
today O
, O
September O
27 O
, O
at O
15 O
: O
00 O
Moscow O
time O
at O
the O
Sochi O
Autodrom O
. O

Earlier O
it O
was O
reported O
that O
Kvyat O
shared O
his O
expectations B-TERM
for O
the O
Sochi O
Grand O
Prix O
. O

China O
is O
strongly O
opposed O
to O
the O
US O
adoption O
of O
Taipei O
legislation O

China O
is O
strongly O
opposed O
to O
the O
US O
adoption O
of O
the O
so O
- O
called B-TERM
Taipei O
legislation O
, O
which O
seriously O
violates O
the O
one O
- O
China O
principle O
and O
the O
principles O
of O
the O
Chinese O
- O
US O
Three O
Communiqu√©s O
. O

Ma O
Xiaoguang O
, O
spokesperson O
for O
China O
's O
Taiwan O
Affairs O
Office O
of O
the O
State O
Council O
, O
said O
on O
Friday O
. O

The O
US O
Senate O
Committee O
on O
Foreign O
Relations O
' O
approval O
of O
the O
legislation O
is O
also B-TERM
a O
serious O
breach O
of O
international O
law O
, O
the O
founding O
principles O
of O
international O
relations O
and O
crude O
interference O
in O
internal O
Chinese O
affairs O
, O
said O
Ma O
Xiaoguang O
. O

According O
to O
him O
, O
Taiwan O
is O
a O
part O
of O
China O
and O
issues O
in O
connection O
with O
this O
are O
an O
internal O
matter O
for O
China O
. O

" O
We O
call O
on O
the O
American O
side O
to O
clarify O
the O
situation B-TERM
, O
immediately B-TERM
cease B-TERM
introducing O
similar O
negative O
legislation O
and O
immediately B-TERM
cease B-TERM
interfering O
in O
the O
Taiwan O
issue O
to O
avoid O
further O
damage B-TERM
to O
Chinese O
- O
US O
relations O
as O
well O
as O
peace O
and O
stability O
in O
the O
Taiwan O
Strait O
, O
" O
he O
said O
. O

China O
should O
and O
will O
be O
reunited O
. O

This O
historic O
trajectory O
cannot O
be O
stopped O
by O
anyone O
or O
any O
force O
, O
said O
Xiaoguang O
. O

TikTok O
is O
hiding B-TERM
undesirable O
videos O
from O
users O

According O
to O
TikTok O
, O
the O
number B-TERM
of O
its O
users O
exceeds O
500 O
million O
worldwide O
, O
40 O
percent O
of O
which O
are O
younger O
than O
18 O
years O
old O
. O

Imagine O
China O
/ O
Reuters O

Chinese O
social O
network O
TikTok O
is O
censoring O
videos O
that O
mention O
Tiananmen O
Square O
, O
Tibetan O
independence B-TERM
or O
the O
forbidden O
Falun O
Gong O
religious O
group O
, O
The O
Guardian O
reported O
. O

Documents O
obtained O
by O
the O
publication O
, O
reveal O
that O
the O
owners B-TERM
of O
TikTok O
( O
ByteDance O
company B-TERM
) O
with O
the O
help O
of O
their O
app O
are O
promoting O
Chinese O
foreign O
policy O
goals B-TERM
overseas O
. O

Most O
of O
the O
violations O
concerning B-TERM
Chinese O
policy O
fall O
under O
" O
inciting O
hatred O
. O
" O

In O
every O
case O
, O
TikTok O
classifies O
the O
undesirable O
posts O
to O
fall O
under O
the O
scope O
of O
general O
rules O
so O
the O
social O
network O
's O
actions O
do O
not O
appear B-TERM
to O
be O
censorship O
. O

For O
example O
, O
a O
ban O
on O
criticizing O
the O
Chinese O
socialist O
system O
falls O
under O
the O
general O
ban O
of O
" O
criticism O
or O
attacks O
on O
the O
politics O
or O
social O
rules O
of O
any O
country O
as O
well O
as O
constitutional O
monarchies O
, O
parliamentary O
systems O
and O
so O
on O
... O
" O

A O
ban O
on O
referring O
to O
the O
events O
of O
Tiananmen O
Square O
or O
the O
genocide O
in O
Cambodia O
falls O
under O
" O
distorting O
the O
history O
of O
China O
or O
other O
countries O
. O
" O

The O
document O
also B-TERM
lists B-TERM
20 O
forbidden O
names B-TERM
of O
" O
foreign B-TERM
leaders B-TERM
or O
politicians O
" O
including O
North O
Korean O
leaders O
Kim O
Jong O
Il O
, O
Kim O
Il O
Sung O
and O
Kim O
Jong O
Un O
, O
Indian O
politician O
Mahatma O
Gandhi O
, O
US O
presidents O
Donald O
Trump O
and O
Barack O
Obama O
, O
Japanese O
Prime O
Minister O
Shinzo O
Abe O
, O
South O
Korean O
President O
Park O
Geun O
- O
hee O
, O
Indonesian O
President O
Joko O
Widodo O
and O
Indian O
Prime O
Minister O
Narendra O
Modi O
. O

The O
document O
states O
that O
banned O
materials B-TERM
fall O
under O
two B-TERM
categories O
. O

Posts O
in O
the O
first O
category O
are O
deleted O
by O
the O
social O
network O
administrators O
and O
can O
lead O
to O
the O
user O
being O
blocked O
. O

Less O
severe O
violations O
are O
included O
in O
the O
second O
category O
: O
such O
posts O
remain O
on O
the O
site O
but O
their O
circulation O
is O
restricted O
by O
the O
TikTok O
algorithm O
. O

ByteDance O
representatives O
told O
The O
Guardian O
that O
these O
rules O
are O
out O
of O
date O
and O
are O
no O
longer O
used O
: O
" O
Now O
we O
use O
a O
local O
approach O
to O
moderating O
as O
well O
as O
drawing O
on O
independent O
local B-TERM
specialists O
. O
" O

TikTok O
has O
no O
specific O
restrictions O
on O
posts O
for O
Russian O
users O
, O
said O
Rustem O
Bogdanov O
, O
founder O
of O
Producer O
Center O
. O

Producer O
Center O
is O
one O
of O
the O
Russian O
media O
companies B-TERM
that O
officially O
works O
with O
TikTok O
. O

All O
the O
advertising O
materials B-TERM
from O
Producer O
Center O
's O
bloggers O
are O
agreed O
with O
the O
social O
network O
's O
representatives O
, O
but O
user O
materials B-TERM
can O
be O
posted O
without O
approval O
, O
said O
Bogdanov O
. O

When O
asked O
about O
whether O
users O
could O
talk O
about O
politics O
or O
Putin O
on O
TikTok O
, O
Bogdanov O
spoke B-TERM
in O
the O
affirmative O
and O
said O
that O
he O
had O
seen B-TERM
such O
posts O
. O

Roman O
Zaripov O
, O
founder O
of O
the O
Our O
Digital O
agency O
, O
agreed O
with O
Bogdanov O
: O
" O
The O
main B-TERM
rules O
for O
TikTok O
users O
are O
listed O
in O
the O
user O
agreement B-TERM
: O
no O
posting O
shocking O
content O
, O
discriminatory O
rhetoric O
and O
so O
on O
. O
" O

However O
, O
any O
content O
disliked O
by O
the O
moderators O
can O
fall O
under O
these O
rules O
, O
noted O
Zaripov O
. O

Zapirov O
's O
agency O
is O
another O
of O
TikTok O
's O
Russian O
partners O
. O

According O
to O
TikTok O
, O
the O
number B-TERM
of O
its O
users O
exceeds O
500 O
million O
worldwide O
, O
40 O
percent O
of O
which O
are O
younger O
than O
18 O
years O
old O
. O

According O
to O
its O
user O
agreement B-TERM
, O
only O
people O
over O
13 O
years O
of O
age O
can O
use B-TERM
TikTok O
. O

The O
social O
network O
's O
administrators O
verify O
ages O
with O
the O
aid O
of O
artificial O
intelligence O
: O
a O
neural O
network O
analyses O
faces B-TERM
and O
determines O
how O
old O
people O
appear B-TERM
, O
said O
Bogdanov O
. O

If O
the O
neural O
network O
decides O
that O
a O
user O
is O
younger O
, O
the O
user O
may O
be O
deleted O
, O
he O
added B-TERM
. O

According O
to O
RBK O
, O
in O
September O
2019 O
, O
ByteDance O
opened O
an O
office B-TERM
in O
Moscow O
on O
the O
territory O
of O
the O
WeWork O
co O
- O
working O
center O
. O

Istanbul O
residents O
spoke O
of O
an O
earthquake O
in O
the O
city O

Powerful B-TERM
earthquake O
caused B-TERM
panic O
in O
Turkey O
's O
largest O
city O

Last O
Thursday O
, O
26 O
September O
, O
a O
5.9 O
- O
magnitude O
earthquake O
took O
place O
in O
Istanbul O
. O

34 O
people O
were O
injured O
, O
ten O
of O
whom O
remain O
in O
hospitals O
. O

Istanbul O
resident O
Melike O
admitted O
she O
had O
a O
panic O
attack O
for O
the O
first O
time O
in O
her O
life O
. O

" O
I O
cried O
a O
lot B-TERM
. O

I O
was O
weeping O
right O
at O
my O
workstation O
. O

Later O
I O
felt O
better O
, O
I O
got O
back O
to O
work O
. O

But O
I O
am O
so O
ashamed O
now O
! O
" O
the O
young O
woman O
told O
the O
" O
360 O
" O
TV O
channel O
. O

" O
In O
Istanbul O
there O
was O
a O
really O
powerful B-TERM
earthquake O
. O

I O
still O
cannot O
go O
back O
! O

But O
overall O
I O
am O
fine O
, O
" O
the O
influential O
political O
analyst O
Ceylan O
Ozgul O
shared O
her O
impressions O
. O

Project B-TERM
manager O
Selin O
noted O
that O
the O
city O
's O
mayor O
is O
keeping O
residents O
informed O
, O
but O
, O
in O
her O
words O
, O
citizens O
still O
feel B-TERM
minor B-TERM
shocks O
of O
3.2 O
or O
3.5 O
magnitude O
. O

She O
also B-TERM
drew O
attention O
to O
communications O
problems B-TERM
after O
the O
earthquake O
. O

The O
young O
woman O
said O
she O
could O
not O
phone O
through O
to O
her O
mother B-TERM
, O
however O
the O
internet O
was O
working O
" O
excellently O
" O
and O
she O
was O
able B-TERM
to O
send O
a O
message B-TERM
via B-TERM
WhatsApp O
. O

As O
the O
site O
kp.ru O
wrote O
, O
after O
the O
earthquake O
all O
kindergartens O
and O
schools O
were O
closed O
, O
and O
all O
pupils O
were O
evacuated O
from O
them O
. O

473 O
buildings B-TERM
were O
damaged O
. O

The O
epicenter O
of O
the O
underground O
shocks O
was O
pinpointed O
68 O
kilometers O
to O
the O
west O
of O
Istanbul O
, O
in O
the O
Sea O
of O
Marmara O
. O

about O
how O
long O
have O
these O
symptoms O
been O
going O
on O
? O

and O
all O
chest O
pain B-TERM
should O
be O
treated O
this O
way O
especially B-TERM
with O
your O
age O

and O
along O
with O
a O
fever O

and O
also B-TERM
needs O
to O
be O
checked O
your O
cholesterol O
blood O
pressure B-TERM

and O
are O
you O
having O
a O
fever O
now O
? O

and O
are O
you O
having O
this O
chest O
pain B-TERM
now O
? O

and O
besides B-TERM
do O
you O
have O
difficulty O
breathing O

and O
can O
you O
tell O
me O
what O
other O
symptoms O
are O
you O
having O
along O
with O
this O
? O

and O
how O
high O
has O
your O
fever O
been O

and O
i O
have O
a O
cough O
too O

and O
i O
have O
a O
little O
cold O
and O
a O
cough O

and O
i O
'm O
really O
having O
some O
bad O
chest O
pain B-TERM
today O

and O
is O
this O
the O
right O
time O
for O
your O
hay O
fever O

and O
it O
get O
the O
chest O
pain B-TERM

and O
i O
think B-TERM
i O
have O
a O
little O
bit O
of O
a O
fever O

and O
i O
want B-TERM
you O
to O
describe O
where O
the O
chest O
pain B-TERM
is O

and O
they O
're O
having O
some O
fevers O
as O
well O

and O
with O
your O
history O
of O
diabetes O

and O
you O
know O
it O
feels O
like B-TERM
my O
chest O
is O
like B-TERM
gonna O
crush O

and O
you O
know O
people O
cough O
on O
me O
all O
the O
time O

and O
you O
're O
having O
chest O
pain B-TERM

and O
you O
said O
this O
is O
a O
pressure B-TERM
in O
your O
chest O

anyone O
in O
the O
family B-TERM
have O
a O
heart B-TERM
problem O
heart B-TERM
disease O
heart O
attack O
high O
cholesterol O
high O
blood O
pressure O

any O
other O
symptoms O
or O
problems B-TERM
that O
you O
notice O
with O
the O
muscle O
aches O
? O

are O
there O
other O
people O
sick O
as O
you O
at O
home O
with O
your O
same O
symptoms O
? O

are O
you O
having O
any O
other O
symptoms O
? O

are O
you O
having O
any O
shortness O
of O
breath O
? O

are O
you O
still O
having O
the O
chest O
pain B-TERM

because O
this O
is O
flu O
season O

but O
also B-TERM
we O
shouldn O
't O
be O
put O
aside O
for O
the O
heart O
cardiac O
origin O
chest O
pain B-TERM

but O
a O
more O
important B-TERM
problem B-TERM
now O
is O
this O
chest O
pain B-TERM

but O
i O
have O
difficulty O
breathing O

but O
i O
know O
lot B-TERM
of O
people O
cough O
on O
me O

but O
we O
need O
to O
treat O
every O
chest O
pain B-TERM
with O
the O
utmost O
seriousness O

but O
you O
're O
breathing O
all O
right O
right O
now O
right O
? O

cause O
of O
this O
chest O
pain B-TERM
i O
totally O
forgot O

does O
it O
feel O
like B-TERM
somebody O
squeezing O
your O
chest O

do O
still O
feel B-TERM
like O
shortness O
of O
breath O

do O
they O
complain B-TERM
of O
being O
sick O
similar O
symptoms O
? O

do O
you O
have O
any O
other O
chronic O
like B-TERM
high O
blood O
pressure O
or O
anything O
like O
that O
? O

do O
you O
have O
any O
other O
diseases B-TERM
chronic O
medical O
problems B-TERM
like B-TERM
diabetes O
? O

do O
you O
have O
any O
shortness O
of O
breath O
with O
that O
chest O
pain B-TERM
? O

do O
you O
have O
high O
blood O
pressure B-TERM
? O

do O
you O
have O
some O
shortness O
of O
breath O
goes O
with O
that O
? O

do O
you O
know O
what O
symptoms O
she O
was O
having O
? O

do O
you O
see B-TERM
the O
image O
? O

drink O
plenty B-TERM
of O
fluids O
today O

however O
i O
take O
tests O
for O
the O
diabetes O

however O
she O
has O
symptoms O
quite O
similar O
to O
mine O

how O
high O
is O
your O
fever O
? O

how O
' O
s O
your O
blood O
pressure B-TERM
? O

if O
you O
continue O
to O
have O
high O
fevers O

if O
you O
have O
a O
fever O
of O
a O
hundred O
and O
two O
or O
higher O

if O
you O
think B-TERM
that O
your O
symptoms O
or O
problems B-TERM
warrant O
a O
better O
look O

i O
got O
a O
fever O
yesterday O

i O
got O
a O
slight O
fever O
too O

i O
had O
a O
fever O
yesterday O

i O
have O
a O
sharp O
pain B-TERM
here O
in O
the O
chest O

i O
have O
some O
difficulty O
breathing O
too O

i O
'll O
send O
you O
an O
image O

i O
'm O
having O
some O
chest O
pain B-TERM
today O

i O
'm O
just O
having O
some O
headaches O
and O
some O
fever O
today O

in O
my O
opinion O
it O
is O
flu O

in O
my O
opinion O
this O
is O
a O
little O
flu O

is O
it O
like B-TERM
some O
heavy O
heavy O
person O
sitting O
on O
your O
chest O
? O

it O
all O
started O
with O
the O
headaches O
and O
with O
the O
fever O
about O
the O
same O
time O

it O
hurts O
in O
the O
middle O
of O
my O
chest O

it O
is O
a O
pressure O
like B-TERM
chest O
pain B-TERM

it O
is O
in O
my O
chest O

it O
is O
in O
the O
center O
of O
my O
chest O

it O
is O
in O
the O
center O
of O
the O
chest O

i O
've O
got O
pain B-TERM
in O
my O
chest O

i O
've O
very O
concerned O
of O
this O
chest O
pain B-TERM

i O
want B-TERM
you O
to O
tell O
me O
in O
describing O
this O
chest O
pain B-TERM

like B-TERM
high O
blood O
pressure B-TERM
or O
diabetes O

like B-TERM
right O
in O
the O
center O
of O
the O
chest O

now O
for O
the O
fever O
you O
can O
take B-TERM
a O
tachipirina O
sweet O

now O
mary O
how O
many O
days O
have O
you O
had O
the O
symptoms O

now O
you O
said O
you O
have O
a O
chest O
pain B-TERM

occasionally O
i O
have O
some O
chest O
pain B-TERM

okay O
are O
you O
having O
any O
other O
symptoms O
along O
with O
this O
other O
than O
just O
the O
pain B-TERM

or O
somebody O
sitting O
on O
your O
chest O
? O

pretty O
much O
the O
same O
with O
the O
fever O
and O
the O
cough O
headache O
and O
muscle O
pains B-TERM

right O
in O
the O
middle O
of O
my O
chest O

show B-TERM
me O
on O
this O
image O
where O
you O
feel B-TERM
the O
pain B-TERM

since O
you O
have O
a O
fever O

so O
do O
you O
think B-TERM
that O
some O
of O
these O
symptoms O
could O
be O
related O
to O
being O
pregnant O
? O

so O
your O
children O
are O
having O
some O
of O
the O
same O
symptoms O
? O

tell O
me O
about O
your O
chest O
pain B-TERM

the O
fever O
increases O
at O
night O

the O
fever O
i O
've O
had O
for O
the O
last O
two B-TERM
days O

the O
fever O
started O
to O
increase O
last O
night O

this O
is O
doctor B-TERM
porter O
in O
the O
emergency O
room O
triage O
center O

well O
can O
you O
tell O
me O
a O
little O
bit O
more O
about O
your O
chest O
pain B-TERM
? O

well O
i O
feel B-TERM
a O
pain B-TERM
in O
the O
front O
of O
my O
body O
here O
in O
my O
chest O

well O
i O
've O
been O
having O
a O
strong B-TERM
pain B-TERM
in O
my O
chest O

well O
when O
i O
have O
that O
pain B-TERM
in O
my O
chest O

what O
kinda O
pain B-TERM
do O
you O
have O
in O
your O
chest O
? O

when O
this O
chest O
pain B-TERM
started O
? O

where O
do O
you O
have O
the O
pain B-TERM
in O
the O
chest O
? O

where O
you O
feel B-TERM
this O
chest O
pain B-TERM
eel O
this O
chest O
t O

you O
feel B-TERM
like O
tightness O
on O
your O
chest O

you O
know O
i O
got O
diabetes O
and O
stuff O

you O
said O
you O
're O
having O
this O
chest O
pain B-TERM

Matthews O
met O
with O
the O
management B-TERM
of O
Toronto O
. O

Toronto O
forward O
Auston O
Matthews O
held O
a O
meeting O
with O
the O
club O
's O
management B-TERM
. O

An O
episode O
in O
which O
Matthews O
is O
accused O
of O
violent O
behavior O
was O
discussed O
during O
the O
meeting O
. O

Everything O
went O
well O
, O
TSN O
reported O
the O
player O
as O
saying O
. O

Of O
course B-TERM
, O
I O
made O
a O
mistake O
. O

And O
I O
take B-TERM
full O
responsibility O
for O
my O
actions O
. O

But O
everyone O
makes O
mistakes O
. O

I O
discussed O
with O
the O
club O
what O
steps O
to O
take O
in O
the O
given O
situation B-TERM
. O

I O
don O
't O
consider B-TERM
our O
relationship O
to O
have O
been O
damaged O
. O

The O
Federal O
Service O
for O
Surveillance O
in O
Healthcare O
released O
the O
results B-TERM
of O
an O
investigation O
into O
the O
amputation O
of O
a O
child O
's O
arm O

A O
Rostov O
region B-TERM
child O
had O
his O
arm O
amputated O
due O
to O
an O
error O
made O
by O
doctors B-TERM
, O
Vzglad O
reported O
, O
citing O
the O
local O
office O
of O
the O
Federal O
Service O
for O
Surveillance O
in O
Healthcare O
's O
site O
. O

The O
11 O
- O
year O
- O
old O
boy B-TERM
broke O
his O
arm O
, O
which O
was O
set O
in O
plaster O
at O
a O
Zernograd O
area B-TERM
hospital O
. O

Some O
point O
after O
that O
, O
the O
child O
developed O
gangrene O
and O
his O
arm O
was O
amputated O
. O

The O
results B-TERM
of O
the O
investigation O
revealed O
that O
errors O
were O
made O
in O
providing O
a O
timely O
and O
correct O
diagnosis O
as O
well O
as O
in O
the O
standard O
and O
level O
of O
treatment O
. O

The O
investigation O
materials B-TERM
were O
given O
to O
the O
regional O
Investigative O
Committee O
's O
office O
of O
criminal O
investigations O
. O

Earlier O
URA.RU O
reported O
that O
the O
head O
doctor O
of O
the O
Yuzhnouralsk O
regional O
hospital O
was O
arrested O
. O

Russians B-TERM
warned O
over O
fake O
phone O
calls O
from O
banks O

In O
Russia O
there O
has O
been O
an O
increase O
in O
the O
number B-TERM
of O
phone O
calls O
from O
swindlers B-TERM
using O
bank O
phone O
numbers B-TERM
. O

Kommersant O
reported O
this O
, O
citing O
Central O
Bank O
information B-TERM
. O

In O
the O
summer O
of O
2019 O
the O
regulator O
provided O
telecommunications O
operators O
with O
information B-TERM
about O
more O
than O
2,500 O
phone O
numbers O
from O
which O
clients B-TERM
of O
various O
financial O
organizations B-TERM
were O
called O
. O

Operators O
detected O
189 O
cases O
of O
number O
substitution O
. O

Another O
218 O
numbers O
were O
blocked O
, O
and O
in O
59 O
cases O
there O
were O
restrictions O
on O
the O
use O
of O
financial O
services O
. O

The O
deputy O
head B-TERM
of O
the O
Central O
Bank O
's O
information O
security O
department O
Artyom O
Sychev O
said O
that O
a O
broad O
spectrum O
of O
Russian O
banks O
had O
encountered O
phone O
number O
substitution O
. O

He O
explained O
that O
operators O
do O
not O
always B-TERM
respond O
to O
Central O
Bank O
warnings B-TERM
about O
fraudulent O
calls O
, O
referring O
to O
the O
lack B-TERM
of O
such O
an O
obligation O
in O
the O
law O
" O
On O
communication O
. O
" O

The O
bank O
Otkritie O
, O
Rosbank O
and O
Alfa O
Bank O
confirmed O
the O
information B-TERM
about O
the O
increased B-TERM
number B-TERM
of O
fraudulent O
phone O
calls O
with O
number O
substitution O
. O

The O
Beeline O
press O
service O
said O
that O
some O
of O
the O
information B-TERM
about O
fraudulent O
phone O
calls O
, O
provided O
by O
the O
Central O
Bank O
, O
was O
incorrect O
: O
the O
list B-TERM
included O
numbers O
that O
are O
actually O
used O
by O
banks O
to O
communicate O
with O
clients B-TERM
. O

Their O
blocking O
would O
cause O
a O
breakdown O
in O
the O
organization B-TERM
's O
work O
. O

Artyom O
Sychev O
said O
that O
the O
Central O
Bank O
plans O
to O
create O
a O
database O
of O
fraudsters O
' O
phone O
numbers O
, O
which O
an O
operator O
will O
refer O
to O
in O
order O
to O
check O
the O
number O
of O
each O
call O
. O

He O
explained O
that O
the O
creation B-TERM
of O
such O
a O
database O
requires O
legislative O
amendments O
. O

b O
'COVID O
- O
19 O
apps O
are O
mobile B-TERM
software O
applications B-TERM
designed O
to O
aid O
contact O
tracing O
in O
response O
to O
the O
2019 O
- O
20 O
coronavirus O
pandemic O
, O
i.e. O
the O
process O
of O
identifying O
persons O
( O
" O
contacts O
" O
) O
who O
may O
have O
been O
in O
contact O
with O
an O
infected O
individual O
. O

Numerous O
applications B-TERM
were O
developed O
or O
proposed O
, O
with O
official O
government O
support O
in O
some O
territories O
and O
jurisdictions O
. O

Several O
frameworks O
for O
building O
contact O
tracing O
apps O
have O
been O
developed O
. O

Privacy O
concerns O
have O
been O
raised O
, O
especially B-TERM
about O
systems O
that O
are O
based O
on O
tracking O
the O
geographical O
location B-TERM
of O
app O
users O
. O

Less O
intrusive O
alternatives O
include O
the O
use O
of O
Bluetooth O
signals O
to O
log O
a O
user O
's O
proximity O
to O
other O
cellphones O
. O

On O
10 O
April O
2020 O
, O
Google O
and O
Apple O
jointly O
announced B-TERM
that O
they O
would O
integrate O
functionality O
to O
support O
such O
Bluetooth O
- O
based O
apps O
directly B-TERM
into O
their O
Android O
and O
iOS O
operating O
systems O
. O

In O
China O
, O
the O
Chinese O
government O
, O
in O
conjunction O
with O
Alipay O
, O
has O
deployed O
an O
app O
that O
allows B-TERM
citizens O
to O
check O
if O
they O
have O
been O
in O
contact O
with O
people O
that O
have O
COVID O
- O
19 O
. O

It O
is O
in O
use O
across O
more O
than O
200 O
Chinese O
cities.In O
Singapore O
, O
an O
app O
called O
TraceTogether O
is O
being O
used O
. O

The O
app O
was O
developed O
by O
local B-TERM
IT O
community O
, O
released O
as O
open B-TERM
source O
and O
will O
be O
handed O
over O
to O
the O
government.North O
Macedonia O
launched O
" O
StopKorona O
! O
, O
" O
a O
Bluetooth O
- O
based O
app O
to O
trace O
exposure O
with O
potentially O
infected O
persons O
and O
provide O
a O
fast O
response O
to O
healthcare O
authorities O
. O

The O
app O
was O
developed O
by O
the O
Ministry O
of O
Communication O
and O
Technology O
and O
Ministry O
of O
Health O
. O

As O
of O
14 O
April O
2020 O
, O
the O
app O
was O
awaiting B-TERM
approval O
by O
the O
Google O
Play O
Store O
and O
Apple O
App O
Store O
. O

On O
12 O
April O
, O
the O
government O
stated O
that O
the O
contact O
tracing O
app O
was O
in O
an O
advanced O
stage B-TERM
of O
development O
, O
and O
would O
be O
available O
for O
deployment O
within O
weeks.A O
similar B-TERM
app O
is O
planned O
in O
Ireland O
, O
and O
in O
France O
( O
" O
StopCovid O
" O
) O
. O

Both O
Australia O
and O
New O
Zealand O
are O
considering B-TERM
apps O
based O
on O
Singapore O
's O
TraceTogether O
app O
and O
BlueTrace O
protocol.Russia O
intends B-TERM
to O
introduce O
a O
geofencing O
app O
for O
patients B-TERM
diagnosed O
with O
COVID O
- O
19 O
living O
in O
Moscow O
, O
designed O
to O
ensure O
they O
do O
not O
leave B-TERM
home B-TERM
. O

Ross O
Anderson O
, O
professor O
of O
security O
engineering O
at O
Cambridge O
University O
, O
listed O
a O
number O
of O
potential O
practical O
problems B-TERM
with O
app O
- O
based O
systems O
, O
including O
false B-TERM
positives O
and O
the O
potential O
lack O
of O
effectiveness O
if O
takeup O
of O
the O
app O
is O
limited O
to O
only O
a O
small B-TERM
fraction B-TERM
of O
the O
population O
. O

Addressing O
concerns O
about O
the O
spread O
of O
misleading O
or O
harmful O
" O
coronavirus O
" O
apps O
, O
Apple O
set O
limits O
on O
which O
types B-TERM
of O
organizations B-TERM
could O
add O
coronavirus O
- O
related O
apps O
to O
its O
App O
Store O
, O
limiting O
them O
to O
only O
" O
official O
" O
or O
otherwise O
reputable O
organizations B-TERM
. O

Google O
and O
Amazon O
have O
implemented O
similar B-TERM
restrictions O
. O

Privacy O
campaigners O
voiced O
their O
concern O
regarding O
the O
implications B-TERM
of O
mass O
surveillance B-TERM
using O
coronavirus O
apps O
, O
in O
particular O
about O
whether O
surveillance B-TERM
infrastructure O
created O
to O
deal O
with O
the O
coronavirus O
pandemic O
will O
be O
dismantled O
once O
the O
threat B-TERM
has O
passed O
. O

Amnesty O
International O
and O
over O
100 O
other O
organizations B-TERM
issued O
a O
statement O
calling O
for O
limits O
on O
this O
kind B-TERM
of O
surveillance B-TERM
. O

The O
organisations B-TERM
declared B-TERM
eight O
conditions B-TERM
on O
governmental O
projects B-TERM
: O

surveillance B-TERM
would O
have O
to O
be O
" O
lawful O
, O
necessary B-TERM
and O
proportionate O
" O
; O

extensions O
of O
monitoring O
and O
surveillance B-TERM
would O
have O
to O
have O
sunset O
clauses O
; O

the O
use O
of O
data B-TERM
would O
have O
to O
be O
limited O
to O
COVID O
- O
19 O
purposes B-TERM
; O

data O
security O
and O
anonymity O
would O
have O
to O
be O
protected B-TERM
and O
shown O
to O
be O
protected O
based O
on O
evidence O
; O

digital O
surveillance B-TERM
would O
have O
to O
avoid O
exacerbating O
discrimination O
and O
marginalisation O
; O

any O
sharing O
of O
data B-TERM
with O
third O
parties O
would O
have O
to O
be O
defined O
in O
law O
; O

there O
would O
have O
to O
be O
safeguards O
against O
abuse O
and O
the O
rights O
of O
citizens O
to O
respond O
to O
abuses O
; O

meaningful B-TERM
participation O
by O
all O
" O
relevant O
stakeholders O
" O
would O
be O
required O
, O
including O
that O
of O
public O
health O
experts B-TERM
and O
marginalised O
groups.The O
German O
Chaos O
Computer O
Club O
( O
CCC O
) O
and O
Reporters O
Without O
Borders O
( O
Reporter O
ohne O
Grenzen O
) O
( O
RSF O
) O
also B-TERM
issued O
checklists B-TERM
. O

The O
proposed O
Google O
/ O
Apple O
plan B-TERM
intends O
to O
address B-TERM
the O
problem B-TERM
of O
persistent O
surveillance B-TERM
by O
removing O
the O
tracing O
mechanism O
from O
their O
device B-TERM
operating O
systems O
once O
it O
is O
no O
longer O
needed O
. O

Some O
countries O
used O
network O
- O
based O
location B-TERM
tracking O
instead O
of O
apps O
, O
eliminating O
both O
the O
need O
to O
download O
an O
app O
and O
the O
ability O
to O
avoid O
tracking O
. O

In O
Israel O
, O
network O
- O
based O
tracking O
was O
approved O
. O

Network O
- O
based O
solutions O
that O
have O
access O
to O
raw O
location B-TERM
data B-TERM
have O
significant O
potential O
privacy O
problems B-TERM
. O

However O
, O
not O
all O
systems O
with O
central O
servers O
need O
to O
have O
access O
to O
personal B-TERM
location B-TERM
data B-TERM
; O
a O
number O
of O
privacy O
- O
preserving O
systems O
have O
been O
created O
that O
use B-TERM
central O
servers O
only O
for O
intercommunication O
( O
see O
section B-TERM
below O
) O
. O

In O
South O
Korea O
, O
a O
non O
- O
app O
- O
based O
system O
was O
used B-TERM
to O
perform O
contact O
tracing O
. O

Instead O
of O
using O
a O
dedicated O
app O
, O
the O
system O
gathered O
tracking O
information O
from O
a O
variety O
of O
sources O
including O
mobile O
device O
tracking O
data B-TERM
and O
card O
transaction O
data O
, O
and O
combined O
these O
to O
generate O
notices O
via O
text O
messages O
to O
potentially O
- O
infected O
individuals O
. O

In O
addition O
to O
using B-TERM
this O
information B-TERM
to O
alert O
potential O
contacts O
, O
the O
government O
has O
also B-TERM
made O
the O
location O
information B-TERM
publicly O
available O
, O
something O
permitted O
because O
of O
far O
- O
reaching O
changes B-TERM
to O
information B-TERM
privacy O
laws O
after O
the O
MERS O
outbreak O
in O
that O
country O
. O

This O
information B-TERM
is O
available O
to O
the O
public O
via B-TERM
a O
number O
of O
apps O
and O
websites.Countries O
including O
Germany O
considered B-TERM
using O
both O
centralized O
and O
privacy O
- O
preserving O
systems O
. O

As O
of O
6 O
April O
2020 O
, O
the O
details B-TERM
had O
not O
yet O
been O
released O
. O

Privacy O
- O
preserving O
contact O
tracing O
is O
a O
well O
- O
established O
concept B-TERM
, O
with O
a O
substantial B-TERM
body O
of O
research O
literature O
dating O
back O
to O
at O
least O
2013.As O
of O
7 O
April O
2020 O
, O
over O
a O
dozen O
expert O
groups O
were O
working O
on O
privacy O
- O
friendly O
solutions O
, O
such O
as O
using O
Bluetooth O
Low O
Energy O
( O
BLE O
) O
to O
log O
a O
user O
's O
proximity O
to O
other O
cellphones O
. O

However O
, O
PEPP O
- O
PT O
is O
a O
co O
- O
ordination O
effort O
which O
contains O
both O
centralised O
and O
decentralised O
approaches O
, O
and O
is O
not O
a O
single O
protocol.Decentralised O
protocols O
include O
Decentralized O
Privacy O
- O
Preserving O
Proximity O
Tracing O
( O
DP O
- O
PPT O
/ O
DP O
- O
3T O
) O
, O
Temporary O
Contact O
Numbers O
( O
TCN O
, O
fka O
Contact O
Event O
Numbers O
, O
CEN O
) O
, O
Privacy O
Sensitive O
Protocols O
and O
Mechanisms O
for O
Mobile B-TERM
Contact O
Tracing O
( O
PACT O
) O
and O
others O
. O

In O
these O
protocols O
, O
identifiable O
personal B-TERM
data B-TERM
never O
leaves B-TERM
the O
device B-TERM
, O
and O
all O
matching O
happens O
on O
- O
device O
. O

The O
Privacy O
Group O
at O
MIT O
Media O
Lab O
has O
been O
developing O
SafePaths O
, O
a O
platform O
for O
using O
privacy O
- O
preserving O
techniques O
when O
collecting O
and O
using O
location B-TERM
or O
path O
intersection O
data B-TERM
to O
track O
the O
spread O
of O
COVID O
- O
19 O
. O

It O
is O
based O
on O
research O
from O
the O
whitepaper O
" O
Apps O
Gone O
Rogue O
: O
Maintaining O
Personal O
Privacy O
in O
an O
Epidemic O
" O
released O
in O
March O
2020.Another B-TERM
similar B-TERM
effort O
is O
the O
SafeTrace O
platform O
by O
Enigma O
MPC O
, O
a O
company B-TERM
developing O
privacy O
technologies O
that O
was O
also B-TERM
originally B-TERM
founded O
at O
the O
MIT O
Media O
Lab O
. O

SafeTrace O
utilizes O
secure O
hardware O
technologies O
to O
allow B-TERM
users O
to O
share O
sensitive O
location O
and O
health O
data B-TERM
with O
other O
users O
and O
officials O
, O
without O
compromising O
the O
privacy O
of O
that O
data B-TERM
. O

On O
5 O
April O
2020 O
, O
the O
global O
TCN O
Coalition O
was O
founded O
by O
groups O
that O
had O
coalesced O
around O
what O
was O
essentially O
the O
same O
approach O
and O
largely O
overlapping O
protocols O
, O
with O
the O
goal B-TERM
to O
reduce O
fragmentation O
, O
and O
enable O
global O
interoperability O
of O
tracing O
and O
alerting O
apps O
, O
a O
key O
aspect O
of O
achieving O
widespread O
adoption O
. O

On O
9 O
April O
2020 O
, O
the O
Singaporean O
government O
announced B-TERM
that O
it O
had O
open O
- O
sourced O
the O
BlueTrace O
protocol O
used B-TERM
by O
its O
official O
government O
app O
. O

On O
10 O
April O
2020 O
, O
Google O
and O
Apple O
, O
the O
companies B-TERM
that O
control O
the O
Android O
and O
iOS O
mobile B-TERM
platforms O
, O
announced B-TERM
an O
initiative O
for O
contact O
tracing O
, O
which O
they O
claimed B-TERM
would O
preserve O
privacy O
, O
based O
on O
a O
combination B-TERM
of O
Bluetooth O
Low O
Energy O
technology O
and O
privacy O
- O
preserving O
cryptography O
. O

They O
also B-TERM
published B-TERM
specifications O
of O
the O
core B-TERM
technologies O
used B-TERM
in O
the O
system O
. O

According O
to O
Apple O
and O
Google O
, O
the O
system O
is O
intended O
to O
be O
rolled O
out O
in O
three O
stages B-TERM
: O

rollout O
of O
tools O
to O
enable O
governments O
to O
create O
official O
privacy O
- O
preserving O
coronavirus O
tracing O
apps O

integration O
of O
this O
functionality O
directly B-TERM
into O
iOS O
and O
AndroidGoogle O
and O
Apple O
plan O
to O
address O
the O
take O
- O
up O
and O
persistent O
surveillance B-TERM
problems B-TERM
by O
first O
distributing O
the O
system O
through O
operating O
system O
updates O
, O
and O
later O
removing O
it O
in O
the O
same O
way O
once O
the O
threat B-TERM
has O
passed O
. O

Trade O
talks O
between O
the O
USA O
and O
China O
will O
restart O
on O
October O
10 O
in O
Washington O

The O
television O
channel O
CNBC O
has O
reported O
that O
a O
new O
round O
of O
trade O
talks O
between O
the O
United B-TERM
States O
and O
China O
will O
take O
place O
in O
Washington O
on O
October O
10 O
. O

According O
to O
their O
sources O
, O
the O
Chinese O
delegation O
is O
headed O
by O
Liu O
He O
, O
the O
Vice O
Premier O
of O
the O
State O
Council O
of O
China O
. O

The O
last O
round O
of O
trade O
talks O
between O
the O
USA O
and O
China O
took O
place O
in O
Shanghai O
in O
late O
July O
, O
but O
the O
parties O
failed O
to O
make O
any O
progress O
. O

The O
US O
and O
China O
's O
new O
reciprocal O
tariffs O
came O
into O
effect O
on O
September O
1 O
. O

United O
States O
President O
Donald O
Trump O
previously O
announced B-TERM
that O
Washington O
and O
Beijing O
could O
reach O
a O
trade O
agreement B-TERM
earlier O
than O
anticipated O
. O

Hand O
washing O
( O
or O
handwashing O
) O
, O
also B-TERM
known O
as O
hand O
hygiene O
, O
is O
the O
act O
of O
cleaning O
one O
's O
hands O
for O
the O
purpose B-TERM
of O
removing O
soil O
, O
grease O
, O
microorganisms O
, O
or O
other O
unwanted O
substances O
. O

Hand O
washing O
with O
soap O
consistently O
at O
certain O
" O
critical O
moments B-TERM
" O
during O
the O
day O
prevents O
the O
spread O
of O
many O
diseases B-TERM
, O
for O
example O
diarrhoea O
and O
cholera O
, O
which O
are O
transmitted O
through O
fecal O
- O
oral O
route O
. O

People O
can O
also B-TERM
become O
infected O
with O
respiratory O
diseases B-TERM
such O
as O
influenza O
or O
the O
common O
cold O
, O
for O
example O
, O
if O
they O
do O
not O
wash O
their O
hands O
before O
touching O
their O
eyes B-TERM
, O
nose O
, O
or O
mouth B-TERM
( O
i.e. O
, O
mucous O
membranes O
) O
. O

The O
five O
critical O
moments B-TERM
during O
the O
day O
where O
washing O
hands O
with O
soap O
is O
important O
include O
: O
before O
and O
after O
defecation O
, O
after O
cleaning O
a O
child O
's O
bottom O
or O
changing O
nappies O
, O
before O
feeding O
a O
child O
, O
before O
eating O
and O
before O
and O
after O
preparing O
food O
or O
handling O
raw O
meat O
, O
fish O
, O
or O
poultry O
. O

If O
water O
and O
soap O
are O
not O
available O
, O
hands O
can O
be O
cleaned O
with O
ash.The O
World O
Health O
Organization B-TERM
recommends O
washing O
hands O
: O

Before O
, O
during O
, O
and O
after O
preparing O
food O
. O

Before O
and O
after O
caring O
for O
a O
sick O
person O
. O

After O
changing O
the O
diapers O
or O
cleaning O
up O
a O
child O
who O
has O
used O
the O
toilet B-TERM
. O

After O
blowing O
your O
nose O
, O
coughing O
or O
sneezing O
. O

After O
touching O
animal O
, O
animal B-TERM
feed O
, O
or O
animal O
waste O
. O

Medical O
hand O
hygiene O
refers O
to O
hygiene O
practices O
related O
to O
medical O
procedures O
. O

Hand O
washing O
before O
administering O
medicine O
or O
medical O
care O
can O
prevent O
or O
minimize O
the O
spread O
of O
disease B-TERM
. O

The O
main B-TERM
medical O
purpose B-TERM
of O
washing O
hands O
is O
to O
cleanse O
the O
hands O
of O
pathogens O
( O
bacteria O
, O
viruses O
, O
or O
other O
microorganisms O
that O
can O
cause B-TERM
disease B-TERM
) O
and O
chemicals O
which O
can O
cause B-TERM
harm O
or O
diseases O
. O

This O
is O
especially O
important B-TERM
for O
people O
who O
handle O
food O
or O
work O
in O
the O
medical O
field O
, O
but O
also O
an O
important B-TERM
practice O
for O
the O
general O
public O
. O

Hand O
washing O
has O
many O
health O
benefits O
, O
including O
minimizing O
the O
spread O
of O
influenza O
, O
coronavirus O
, O
and O
other O
infectious O
diseases B-TERM
; O
preventing O
infectious O
causes O
of O
diarrhea O
; O
decreasing O
respiratory O
infections O
; O

and O
reducing B-TERM
infant O
mortality O
rate O
at O
home O
birth B-TERM
deliveries O
. O

A O
2013 O
study B-TERM
showed B-TERM
that O
improved O
hand O
washing O
practices O
may O
lead O
to O
small B-TERM
improvements O
in O
the O
length O
growth B-TERM
in O
children O
under O
five O
years O
of O
age O
. O

In O
developing O
countries O
, O
childhood O
mortality O
rates O
related O
to O
respiratory O
and O
diarrheal O
diseases B-TERM
can O
be O
reduced B-TERM
by O
introducing O
simple B-TERM
behavioral O
changes O
, O
such O
as O
hand O
washing O
with O
soap O
. O

This O
simple O
action O
can O
reduce B-TERM
the O
rate O
of O
mortality O
from O
these O
diseases B-TERM
by O
almost O
50 O
% O
. O

Interventions O
that O
promote O
hand O
washing O
can O
reduce B-TERM
diarrhoea O
episodes O
by O
about O
a O
third O
, O
and O
this O
is O
comparable O
to O
providing O
clean O
water O
in O
low O
income O
areas O
. O

48 O
% O
of O
reductions B-TERM
in O
diarrhoea O
episodes O
can O
be O
associated O
with O
hand O
washing O
with O
soap.Hand O
washing O
with O
soap O
is O
the O
single O
most O
effective B-TERM
and O
inexpensive O
way B-TERM
to O
prevent O
diarrhea O
and O
acute O
respiratory O
infections O
( O
ARI O
) O
, O
as O
automatic O
behavior O
performed O
in O
homes B-TERM
, O
schools O
, O
and O
communities O
worldwide O
. O

Pneumonia O
, O
a O
major O
ARI O
, O
is O
the O
number O
one O
cause O
of O
mortality O
among B-TERM
children O
under O
five O
years O
old O
, O
taking O
the O
lives O
of O
an O
estimated O
1.8 O
million O
children O
per O
year O
. O

Diarrhea O
and O
pneumonia O
together O
account O
for O
almost O
3.5 O
million O
child O
deaths O
annually O
. O

According O
to O
UNICEF O
, O
turning O
hand O
washing O
with O
soap O
before O
eating O
and O
after O
using O
the O
toilet B-TERM
into O
an O
ingrained O
habit O
can O
save O
more O
lives O
than O
any O
single O
vaccine B-TERM
or O
medical O
intervention O
, O
cutting O
deaths O
from O
diarrhea O
by O
almost O
half O
and O
deaths O
from O
acute O
respiratory O
infections O
by O
one O
- O
quarter O
. O

Hand O
washing O
is O
usually O
integrated O
together O
with O
other O
sanitation O
interventions O
as O
part O
of O
water O
, O
sanitation O
and O
hygiene O
( O
WASH O
) O
programmes O
. O

Hand O
washing O
also B-TERM
protects O
against O
impetigo O
which O
is O
transmitted O
through O
direct O
physical B-TERM
contact O
. O

A O
small B-TERM
detrimental O
effect O
of O
hand O
washing O
is O
that O
frequent O
hand O
washing O
can O
lead O
to O
skin O
damage O
due O
to O
drying O
of O
the O
skin O
. O

A O
2012 O
Danish O
study B-TERM
found O
that O
excessive O
hand O
washing O
can O
lead O
to O
an O
itchy O
, O
flaky O
skin O
condition O
known O
as O
hand O
eczema O
or O
hand O
dermatitis O
, O
which O
is O
especially B-TERM
common O
among B-TERM
health O
- O
care O
workers O
. O

Too O
frequent O
hand O
washing O
is O
also B-TERM
seen O
as O
one O
of O
the O
symptoms O
of O
obsessive O
- O
compulsive O
disorder O
( O
OCD O
) O
. O

There O
are O
five O
critical O
times O
during O
the O
day O
where O
washing O
hands O
with O
soap O
is O
important B-TERM
to O
reduce O
fecal O
- O
oral O
transmission O
of O
disease B-TERM
: O
after O
using O
the O
bathroom O
( O
urination O
, O
defecation O
) O
, O
after O
cleaning O
a O
child O
's O
bottom O
( O
changing O
nappies O
) O
, O
before O
feeding O
a O
child O
, O
before O
eating O
and O
before O
/ O
after O
preparing O
food O
or O
handling O
raw O
meat O
, O
fish O
, O
or O
poultry O
. O

Other O
occasions O
when O
correct O
handwashing O
technique O
should O
be O
practiced O
in O
order O
to O
prevent O
the O
transmission O
of O
disease B-TERM
include O
before O
and O
after O
treating O
a O
cut O
or O
wound O
; O
after O
sneezing O
, O
coughing O
, O
or O
blowing O
your O
nose O
; O
after O
touching O
animal B-TERM
waste O
or O
handling O
animals O
; O
and O
after O
touching O
garbage O
. O

In O
many O
countries O
, O
there O
is O
a O
low O
rate O
of O
hand O
washing O
with O
soap O
. O

A O
study B-TERM
of O
hand O
washing O
in O
54 O
countries O
in O
2015 O
found O
that O
on O
average O
, O
38.7 O
% O
of O
households O
practiced O
hand O
washing O
with O
soap.A O
2014 O
study B-TERM
showed B-TERM
that O
Saudi O
Arabia O
had O
the O
highest O
rate O
of O
97 O
percent O
; O
the O
United O
States O
near O
the O
middle O
with O
77 O
percent O
; O
and O
China O
with O
the O
lowest O
rate O
of O
23 O
percent.Several O
behaviour O
change B-TERM
methodologies O
now O
exist O
to O
increase O
uptake O
of O
the O
behaviour O
of O
hand O
washing O
with O
soap O
at O
the O
critical O
times.Group O
hand O
washing O
for O
school O
children O
at O
set O
times O
of O
the O
day O
is O
one O
option O
in O
developing O
countries O
to O
engrain O
hand O
washing O
in O
children O
's O
behaviors O
. O

The O
" O
Essential O
Health O
Care O
Program O
" O
implemented O
by O
the O
Department O
of O
Education O
in O
the O
Philippines O
is O
an O
example O
of O
at O
scale O
action O
to O
promote O
children O
's O
health O
and O
education O
. O

Deworming O
twice O
a O
year O
, O
supplemented O
with O
washing O
hands O
daily O
with O
soap O
, O
brushing O
teeth O
daily O
with O
fluoride O
, O
is O
at O
the O
core O
of O
this O
national O
program O
. O

It O
has O
also O
been O
successfully B-TERM
implemented O
in O
Indonesia O
. O

Removal B-TERM
of O
microorganisms O
from O
skin O
is O
enhanced O
by O
the O
addition O
of O
soaps O
or O
detergents O
to O
water O
. O

The O
main B-TERM
action O
of O
soaps O
and O
detergents O
is O
to O
reduce O
barriers O
to O
solution O
, O
and O
increase O
solubility O
. O

Water O
alone O
is O
an O
inefficient O
skin O
cleanser O
because O
fats O
and O
proteins O
, O
which O
are O
components B-TERM
of O
organic O
soil O
, O
are O
not O
readily O
dissolved O
in O
water O
. O

Cleansing O
is O
, O
however O
, O
aided O
by O
a O
reasonable O
flow O
of O
water O
.. O

Solid O
soap O
, O
because O
of O
its O
reusable O
nature O
, O
may O
hold O
bacteria O
acquired O
from O
previous B-TERM
uses O
. O

A O
small B-TERM
number B-TERM
of O
studies B-TERM
which O
have O
looked O
at O
the O
bacterial O
transfer O
from O
contaminated O
solid O
soap O
have O
concluded O
transfer O
is O
unlikely O
as O
the O
bacteria O
are O
rinsed O
off O
with O
the O
foam O
. O

The O
CDC O
still O
states O
" O
liquid O
soap O
with O
hands O
- O
free O
controls O
for O
dispensing O
is O
preferable O
. O
" O

Antibacterial O
soaps O
have O
been O
heavily O
promoted O
to O
a O
health O
- O
conscious O
public O
. O

To O
date O
, O
there O
is O
no O
evidence O
that O
using O
recommended O
antiseptics O
or O
disinfectants O
selects O
for O
antibiotic O
- O
resistant O
organisms O
in O
nature B-TERM
. O

However O
, O
antibacterial O
soaps O
contain O
common O
antibacterial O
agents O
such O
as O
triclosan O
, O
which O
has O
an O
extensive O
list O
of O
resistant O
strains O
of O
organisms O
. O

So O
, O
even O
if O
antibiotic O
resistant O
strains O
aren O
't O
selected O
for O
by O
antibacterial O
soaps O
, O
they O
might O
not O
be O
as O
effective O
as O
they O
are O
marketed O
to O
be O
. O

Besides B-TERM
the O
surfactant O
and O
skin O
- O
protecting O
agent O
, O
the O
sophisticated O
formulations O
may O
contain O
acids O
( O
acetic O
acid O
, O
ascorbic O
acid O
, O
lactic O
acid O
) O
as O
pH O
regulator O
, O
antimicrobially O
active B-TERM
benzoic O
acid O
and O
further O
skin O
conditioners O
( O
aloe O
vera O
, O
vitamins O
, O
menthol O
, O
plant O
extracts O
) O
.A O
comprehensive O
analysis B-TERM
from O
the O
University O
of O
Oregon O
School O
of O
Public O
Health O
indicated B-TERM
that O
plain B-TERM
soaps O
are O
as O
effective B-TERM
as O
consumer O
- O
grade O
anti O
- O
bacterial O
soaps O
containing O
triclosan O
in O
preventing O
illness B-TERM
and O
removing O
bacteria O
from O
the O
hands O
. O

Hot B-TERM
water O
that O
is O
comfortable B-TERM
for O
washing O
hands O
is O
not O
hot B-TERM
enough O
to O
kill O
bacteria O
. O

Bacteria O
grow O
much O
faster O
at O
body O
temperature O
( O
37 O
¬∞ O
C O
) O
. O

However O
, O
warm O
, O
soapy O
water O
is O
more O
effective B-TERM
than O
cold O
, O
soapy O
water O
at O
removing O
natural B-TERM
oils O
which O
hold O
soils O
and O
bacteria O
. O

Contrary O
to O
popular O
belief O
however O
, O
scientific O
studies B-TERM
have O
shown B-TERM
that O
using O
warm O
water O
has O
no O
effect O
on O
reducing O
the O
microbial O
load O
on O
hands O
. O

A O
hand O
sanitizer O
or O
hand O
antiseptic O
is O
a O
non O
- O
water O
- O
based O
hand O
hygiene O
agent O
. O

In O
the O
late O
1990s O
and O
early O
part O
of O
the O
21st O
century B-TERM
, O
alcohol O
rub O
non O
- O
water O
- O
based O
hand O
hygiene O
agents O
( O
also B-TERM
known O
as O
alcohol O
- O
based O
hand O
rubs O
, O
antiseptic O
hand O
rubs O
, O
or O
hand O
sanitizers O
) O
began O
to O
gain O
popularity O
. O

Most O
are O
based O
on O
isopropyl O
alcohol B-TERM
or O
ethanol O
formulated O
together O
with O
a O
thickening O
agent O
such O
as O
Carbomer O
( O
polymer O
of O
acrylic O
acid O
) O
into O
a O
gel O
, O
or O
a O
humectant O
such O
as O
glycerin O
into O
a O
liquid O
, O
or O
foam O
for O
ease O
of O
use O
and O
to O
decrease O
the O
drying O
effect O
of O
the O
alcohol O
. O

Adding O
diluted B-TERM
hydrogen O
- O
peroxide O
increases O
further O
the O
antimicrobial O
activity.Hand B-TERM
sanitizers O
containing O
a O
minimum O
of O
60 O
to O
95 O
% O
alcohol B-TERM
are O
efficient O
germ O
killers O
. O

Alcohol O
rub O
sanitizers O
kill O
bacteria O
, O
multi O
- O
drug O
resistant O
bacteria O
( O
MRSA O
and O
VRE O
) O
, O
tuberculosis O
, O
and O
some O
viruses O
( O
including O
HIV O
, O
herpes O
, O
RSV O
, O
rhinovirus O
, O
vaccinia O
, O
influenza O
, O
and O
hepatitis O
) O
and O
fungi O
. O

Alcohol O
rub O
sanitizers O
containing O
70 O
% O
alcohol B-TERM
kill O
99.97 O
% O
( O
3.5 O
log O
reduction B-TERM
, O
similar O
to O
35 O
decibel O
reduction B-TERM
) O
of O
the O
bacteria O
on O
hands O
30 O
seconds O
after O
application O
and O
99.99 O
% O
to O
99.999 O
% O
( O
4 O
to O
5 O
log O
reduction B-TERM
) O
of O
the O
bacteria O
on O
hands O
1 O
minute O
after O
application.Hand O
sanitizers O
are O
most O
effective B-TERM
against O
bacteria O
and O
less O
effective B-TERM
against O
some O
viruses O
. O

Alcohol O
- O
based O
hand O
sanitizers O
are O
almost O
entirely O
ineffective O
against O
norovirus O
( O
or O
Norwalk O
) O
type B-TERM
viruses O
, O
the O
most O
common O
cause O
of O
contagious O
gastroenteritis.Enough O
hand O
antiseptic O
or O
alcohol O
rub O
must O
be O
used B-TERM
to O
thoroughly O
wet O
or O
cover O
both O
hands O
. O

The O
front O
and O
back O
of O
both O
hands O
and O
between O
and O
the O
ends O
of O
all O
fingers O
are O
rubbed O
for O
approximately B-TERM
30 O
seconds O
until O
the O
liquid O
, O
foam O
or O
gel O
is O
dry O
. O

Finger O
tips O
must O
be O
washed O
well O
too O
, O
rubbing O
them O
in O
both O
palms.The O
US O
Center O
for O
Disease B-TERM
Control O
and O
Prevention O
recommends O
hand O
washing O
over O
hand O
sanitizer O
rubs O
, O
particularly B-TERM
when O
hands O
are O
visibly O
dirty O
. O

The O
increasing O
use O
of O
these O
agents O
is O
based O
on O
their O
ease O
of O
use O
and O
rapid B-TERM
killing O
activity O
against O
micro O
- O
organisms O
; O
however O
, O
they O
should O
not O
serve O
as O
a O
replacement O
for O
proper O
hand O
washing O
unless O
soap O
and O
water O
are O
unavailable O
. O

Frequent O
use O
of O
alcohol O
- O
based O
hand O
sanitizers O
can O
cause B-TERM
dry O
skin O
unless O
emollients O
and O
/ O
or O
skin O
moisturizers O
are O
added O
to O
the O
formula O
. O

The O
drying O
effect O
of O
alcohol B-TERM
can O
be O
reduced B-TERM
or O
eliminated B-TERM
by O
adding O
glycerin O
and O
/ O
or O
other O
emollients O
to O
the O
formula O
. O

In O
clinical O
trials O
, O
alcohol O
- O
based O
hand O
sanitizers O
containing O
emollients O
caused B-TERM
substantially B-TERM
less O
skin O
irritation O
and O
dryness O
than O
soaps O
or O
antimicrobial O
detergents O
. O

Allergic O
contact O
dermatitis O
, O
contact O
urticaria O
syndrome O
or O
hypersensitivity O
to O
alcohol O
or O
additives O
present O
in O
alcohol O
hand O
rubs O
rarely O
occur O
. O

The O
lower O
tendency O
to O
induce O
irritant O
contact O
dermatitis O
became O
an O
attraction O
as O
compared O
to O
soap O
and O
water O
hand O
washing O
. O

Despite O
their O
effectiveness B-TERM
, O
non O
- O
water O
agents O
do O
not O
cleanse O
the O
hands O
of O
organic O
material B-TERM
, O
but O
simply O
disinfect O
them O
. O

It O
is O
for O
this O
reason O
that O
hand O
sanitizers O
are O
not O
as O
effective B-TERM
as O
soap O
and O
water O
at O
preventing O
the O
spread O
of O
many O
pathogens O
, O
since O
the O
pathogens O
still O
remain O
on O
the O
hands O
. O

Alcohol O
- O
free O
hand O
sanitizer O
efficacy O
is O
heavily O
dependent O
on O
the O
ingredients O
and O
formulation O
, O
and O
historically O
has O
significantly B-TERM
under O
- O
performed O
alcohol B-TERM
and O
alcohol O
rubs O
. O

More O
recently O
, O
formulations O
that O
use O
benzalkonium O
chloride O
have O
been O
shown O
to O
have O
persistent O
and O
cumulative O
antimicrobial O
activity O
after O
application O
, O
unlike O
alcohol O
, O
which O
has O
been O
shown O
to O
decrease O
in O
efficacy O
after O
repeated O
use O
, O
probably O
due O
to O
progressive O
adverse O
skin O
reactions O
. O

Many O
people O
in O
low O
- O
income O
communities O
cannot O
afford O
soap O
and O
use O
ash O
or O
soil O
instead O
. O

Ash O
or O
soil O
may O
be O
more O
effective O
than O
water O
alone O
, O
but O
may O
be O
less O
effective B-TERM
than O
soap O
. O

One O
concern O
is O
that O
if O
the O
soil O
or O
ash O
is O
contaminated O
with O
microorganisms O
it O
may O
increase O
the O
spread O
of O
disease B-TERM
rather O
than O
decrease O
it O
. O

Like B-TERM
soap O
, O
ash O
is O
also O
a O
disinfecting O
agent O
because O
in O
contact O
with O
water O
, O
it O
forms O
an O
alkaline O
solution O
. O

WHO O
recommended O
ash O
or O
sand O
as O
alternative O
to O
soap O
when O
soap O
is O
not O
available O
. O

Correct O
handwashing O
technique O
recommended O
by O
the O
US O
Centers O
for O
Disease O
Control O
for O
prevention B-TERM
of O
transmission O
of O
disease O
includes O
the O
following O
steps B-TERM
: O

Wet O
hands O
with O
warm O
or O
cold O
running O
water O
. O

Running O
water O
is O
recommended O
because O
standing O
basins O
may O
be O
contaminated O
, O
while O
the O
temperature O
of O
the O
water O
does O
not O
seem O
to O
make O
a O
difference O
. O

Lather O
hands O
by O
rubbing O
them O
with O
a O
generous O
amount B-TERM
of O
soap O
, O
including O
the O
backs O
of O
hands O
, O
between O
fingers O
, O
and O
under O
nails O
. O

Soap O
lifts O
germs O
from O
the O
skin O
, O
and O
studies B-TERM
show B-TERM
that O
people O
tend O
to O
wash O
their O
hands O
more O
thoroughly O
when O
soap O
is O
used O
rather O
than O
water O
alone B-TERM
. O

Scrub O
for O
at O
least O
20 O
seconds O
. O

Scrubbing O
creates O
friction O
, O
which O
helps B-TERM
remove O
germs O
from O
skin O
, O
and O
scrubbing O
for O
longer O
periods O
removes O
more O
germs O
. O

Rinse O
well O
under O
running O
water O
. O

Rinsing O
in O
a O
basin O
can O
recontaminate O
hands O
. O

Dry O
with O
a O
clean O
towel O
or O
allow O
to O
air O
dry O
. O

Wet O
and O
moist O
hands O
are O
more O
easily O
recontaminated.The O
most O
commonly O
missed O
areas O
are O
the O
thumb O
, O
the O
wrist O
, O
the O
areas O
between O
the O
fingers O
, O
and O
under O
fingernails O
. O

Artificial O
nails O
and O
chipped O
nail O
polish O
may O
harbor O
microorganisms O
. O

Moisturizing O
lotion O
is O
often B-TERM
recommended O
to O
keep O
the O
hands O
from O
drying O
out O
; O
dry O
skin O
can O
lead O
to O
skin O
damage O
which O
can O
increase O
the O
risk O
for O
the O
transmission O
of O
infection O
. O

Various O
low O
- O
cost O
options O
can O
be O
made O
to O
facilitate O
hand O
washing O
where O
tap O
- O
water O
and O
/ O
or O
soap O
is O
not O
available O
e.g. O
pouring O
water O
from O
a O
hanging O
jerrycan O
or O
gourd O
with O
suitable O
holes B-TERM
and O
/ O
or O
using O
ash O
if O
needed B-TERM
in O
developing O
countries.In O
situations O
with O
limited O
water O
supply O
( O
such O
as O
schools O
or O
rural B-TERM
areas B-TERM
in O
developing O
countries O
) O
, O
there O
are O
water O
- O
conserving O
solutions O
, O
such O
as O
" O
tippy O
- O
taps O
" O
and O
other O
low O
- O
cost O
options O
. O

A O
tippy O
- O
tap O
is O
a O
simple B-TERM
technology O
using B-TERM
a O
jug O
suspended O
by O
a O
rope O
, O
and O
a O
foot O
- O
operated O
lever O
to O
pour O
a O
small O
amount O
of O
water O
over O
the O
hands O
and O
a O
bar O
of O
soap O
. O

Effective B-TERM
drying O
of O
the O
hands O
is O
an O
essential O
part O
of O
the O
hand O
hygiene O
process O
, O
but O
there O
is O
some O
debate O
over O
the O
most O
effective B-TERM
form O
of O
drying O
in O
public O
washrooms O
. O

A O
growing O
volume O
of O
research O
suggests O
paper O
towels O
are O
much O
more O
hygienic O
than O
the O
electric O
hand O
dryers O
found O
in O
many O
washrooms O
. O

In O
2008 O
, O
a O
study B-TERM
was O
conducted O
by O
the O
University O
of O
Westminster O
, O
London O
, O
and O
sponsored O
by O
the O
paper O
- O
towel O
industry O
the O
European O
Tissue O
Symposium O
, O
to O
compare O
the O
levels O
of O
hygiene O
offered O
by O
paper O
towels O
, O
warm O
- O
air B-TERM
hand O
dryers O
and O
the O
more O
modern B-TERM
jet O
- O
air O
hand O
dryers O
. O

After O
washing O
and O
drying O
hands O
with O
the O
warm O
- O
air B-TERM
dryer O
, O
the O
total O
number B-TERM
of O
bacteria O
was O
found O
to O
increase O
on O
average O
on O
the O
finger O
pads O
by O
194 O
% O
and O
on O
the O
palms O
by O
254 O
% O
. O

Drying O
with O
the O
jet O
- O
air O
dryer O
resulted O
in O
an O
increase O
on O
average O
of O
the O
total O
number B-TERM
of O
bacteria O
on O
the O
finger O
pads O
by O
42 O
% O
and O
on O
the O
palms O
by O
15 O
% O
. O

After O
washing O
and O
drying O
hands O
with O
a O
paper O
towel O
, O
the O
total O
number B-TERM
of O
bacteria O
was O
reduced O
on O
average O
on O
the O
finger O
pads O
by O
up O
to O
76 O
% O
and O
on O
the O
palms O
by O
up O
to O
77 O
% O
.The O
scientists O
also B-TERM
carried O
out O
tests O
to O
establish O
whether O
there O
was O
the O
potential O
for O
cross O
contamination O
of O
other O
washroom O
users O
and O
the O
washroom O
environment O
as O
a O
result O
of O
each O
type B-TERM
of O
drying O
method O
. O

The O
jet O
- O
air O
dryer O
, O
which O
blows O
air O
out O
of O
the O
unit O
at O
claimed B-TERM
speeds B-TERM
of O
180 O
m O
/ O
s O
( O
650 O
km O
/ O
h O
; O
400 O
mph O
) O
, O
was O
capable O
of O
blowing O
micro O
- O
organisms O
from O
the O
hands O
and O
the O
unit O
and O
potentially O
contaminating O
other O
washroom O
users O
and O
the O
washroom O
environment O
up O
to O
2 O
metres O
away O
. O

Use O
of O
a O
warm O
- O
air B-TERM
hand O
dryer O
spread O
micro O
- O
organisms O
up O
to O
0.25 O
metres O
from O
the O
dryer O
. O

Paper O
towels O
showed O
no O
significant B-TERM
spread O
of O
micro O
- O
organisms.In O
2005 O
, O
in O
a O
study B-TERM
conducted O
by O
T√úV O
Produkt O
und O
Umwelt O
, O
different O
hand O
drying O
methods B-TERM
were O
evaluated O
. O

The O
following O
changes B-TERM
in O
the O
bacterial O
count O
after O
drying O
the O
hands O
were O
observed O
: O

Many O
different O
hand O
dryer O
manufacturers O
exist O
, O
and O
hand O
driers O
have O
been O
compared O
against O
drying O
with O
paper O
towels O
. O

Hand O
washing O
using O
hand O
sanitizing O
wipes O
is O
an O
alternative O
during O
traveling B-TERM
in O
the O
absence O
of O
soap O
and O
water O
. O

Alcohol O
- O
based O
hand O
sanitizer O
should O
contain O
at O
least O
60 O
% O
alcohol B-TERM
. O

Medical O
hand O
- O
washing O
became O
mandatory O
long O
after O
Hungarian O
physician O
Ignaz O
Semmelweis O
discovered O
its O
effectiveness B-TERM
( O
in O
1846 O
) O
in O
preventing O
disease B-TERM
in O
a O
hospital O
environment O
. O

There O
are O
electronic O
devices B-TERM
that O
provide O
feedback O
to O
remind O
hospital O
staff B-TERM
to O
wash O
their O
hands O
when O
they O
forget O
. O

One O
study B-TERM
has O
found O
decreased O
infection O
rates O
with O
their O
use O
. O

Medical O
hand O
- O
washing O
is O
for O
a O
minimum O
of O
15 O
seconds O
, O
using O
generous O
amounts B-TERM
of O
soap O
and O
water O
or O
gel O
to O
lather O
and O
rub O
each O
part O
of O
the O
hands O
. O

Hands O
should O
be O
rubbed O
together O
with O
digits O
interlocking O
. O

If O
there O
is O
debris O
under O
fingernails O
, O
a O
bristle O
brush O
may O
be O
used B-TERM
to O
remove O
it O
. O

Since O
germs O
may O
remain O
in O
the O
water O
on O
the O
hands O
, O
it O
is O
important O
to O
rinse O
well O
and O
wipe O
dry O
with O
a O
clean O
towel O
. O

After O
drying O
, O
the O
paper O
towel O
should O
be O
used B-TERM
to O
turn O
off O
the O
water O
( O
and O
open O
any O
exit O
door O
if O
necessary O
) O
. O

This O
avoids O
re O
- O
contaminating O
the O
hands O
from O
those O
surfaces O
. O

The O
purpose B-TERM
of O
hand O
- O
washing O
in O
the O
health O
- O
care O
setting O
is O
to O
remove O
pathogenic O
microorganisms O
( O
" O
germs O
" O
) O
and O
avoid O
transmitting O
them O
. O

The O
New O
England O
Journal O
of O
Medicine O
reports O
that O
a O
lack O
of O
hand O
- O
washing O
remains O
at O
unacceptable O
levels O
in O
most O
medical O
environments O
, O
with O
large O
numbers B-TERM
of O
doctors B-TERM
and O
nurses O
routinely O
forgetting O
to O
wash O
their O
hands O
before O
touching O
patients B-TERM
, O
thus O
transmitting O
microorganisms O
. O

One O
study B-TERM
showed O
that O
proper O
hand O
- O
washing O
and O
other O
simple O
procedures O
can O
decrease O
the O
rate O
of O
catheter O
- O
related O
bloodstream O
infections O
by O
66 O
percent.The O
World O
Health O
Organization B-TERM
has O
published B-TERM
a O
sheet O
demonstrating O
standard O
hand O
- O
washing O
and O
hand O
- O
rubbing O
in O
health O
- O
care O
sectors O
. O

The O
draft B-TERM
guidance O
of O
hand O
hygiene O
by O
the O
organization O
can O
also B-TERM
be O
found O
at O
its O
website O
for O
public O
comment O
. O

A O
relevant O
review O
was O
conducted O
by O
Whitby O
et O
al O
. O

Commercial O
devices B-TERM
can O
measure O
and O
validate O
hand O
hygiene O
, O
if O
demonstration O
of O
regulatory O
compliance O
is O
required O
. O

The O
World O
Health O
Organization B-TERM
has O
" O
Five O
Moments B-TERM
" O
for O
washing O
hands O
: O

after O
exposure O
to O
blood B-TERM
/ O
body O
fluids O

before O
an O
aseptic O
task O
, O
and O

after O
patient B-TERM
care.The O
addition O
of O
antiseptic O
chemicals O
to O
soap O
( O
" O
medicated O
" O
or O
" O
antimicrobial O
" O
soaps O
) O
confers O
killing O
action O
to O
a O
hand O
- O
washing O
agent O
. O

Such O
killing O
action O
may O
be O
desired O
prior O
to O
performing O
surgery O
or O
in O
settings O
in O
which O
antibiotic O
- O
resistant O
organisms O
are O
highly O
prevalent.To O
' O
scrub O
' O
one O
's O
hands O
for O
a O
surgical O
operation O
, O
it O
is O
necessary B-TERM
to O
have O
a O
tap O
that O
can O
be O
turned O
on O
and O
off O
without O
touching O
it O
with O
the O
hands O
, O
some O
chlorhexidine O
or O
iodine O
wash O
, O
sterile O
towels O
for O
drying O
the O
hands O
after O
washing O
, O
and O
a O
sterile O
brush O
for O
scrubbing O
and O
another B-TERM
sterile O
instrument O
for O
cleaning O
under O
the O
fingernails O
. O

All O
jewelry O
should O
be O
removed O
. O

This O
procedure O
requires O
washing O
the O
hands O
and O
forearms O
up O
to O
the O
elbow O
, O
usually O
2 O
- O
6 O
minutes B-TERM
. O

Long O
scrub O
- O
times O
( O
10 O
minutes B-TERM
) O
are O
not O
necessary O
. O

When O
rinsing O
, O
water O
on O
the O
forearms O
must O
be O
prevented O
from O
running O
back O
to O
the O
hands O
. O

After O
hand O
- O
washing O
is O
completed O
, O
the O
hands O
are O
dried O
with O
a O
sterile O
cloth O
and O
a O
surgical O
gown O
is O
donned O
. O

To O
reduce B-TERM
the O
spread O
of O
germs O
, O
it O
is O
better O
to O
wash O
the O
hands O
or O
use B-TERM
a O
hand O
antiseptic O
before O
and O
after O
tending O
to O
a O
sick O
person O
. O

For O
control O
of O
staphylococcal O
infections O
in O
hospitals O
, O
it O
has O
been O
found O
that O
the O
greatest O
benefit O
from O
hand O
- O
cleansing O
came O
from O
the O
first O
20 O
% O
of O
washing O
, O
and O
that O
very O
little O
additional O
benefit O
was O
gained O
when O
hand O
cleansing O
frequency O
was O
increased O
beyond O
35 O
% O
. O

Washing O
with O
plain O
soap O
results O
in O
more O
than O
triple O
the O
rate O
of O
bacterial O
infectious O
disease B-TERM
transmitted O
to O
food O
as O
compared O
to O
washing O
with O
antibacterial O
soap.Comparing O
hand O
- O
rubbing O
with O
alcohol O
- O
based O
solution O
with O
hand O
washing O
with O
antibacterial O
soap O
for O
a O
median O
time O
of O
30 O
seconds O
each O
showed B-TERM
that O
the O
alcohol O
hand O
- O
rubbing O
reduced B-TERM
bacterial O
contamination O
26 O
% O
more O
than O
the O
antibacterial O
soap O
. O

But O
soap O
and O
water O
is O
more O
effective B-TERM
than O
alcohol O
- O
based O
hand O
rubs O
for O
reducing O
H1N1 O
influenza O
A O
virus O
and O
Clostridium O
difficile O
spores O
from O
hands.Interventions O
to O
improve O
hand O
hygiene O
in O
healthcare O
settings O
can O
involve O
education O
for O
staff O
on O
hand O
washing O
, O
increasing O
the O
availability O
of O
alcohol O
- O
based O
hand O
rub O
, O
and O
written O
and O
verbal O
reminders O
to O
staff O
. O

There O
is O
a O
need O
for O
more O
research O
into O
which O
of O
these O
interventions O
are O
most O
effective B-TERM
in O
different O
healthcare O
settings O
. O

In O
developing O
countries O
, O
hand O
washing O
with O
soap O
is O
recognized O
as O
a O
cost O
- O
effective B-TERM
, O
essential O
tool O
for O
achieving O
good O
health O
, O
and O
even O
good O
nutrition O
. O

However O
, O
a O
lack B-TERM
of O
reliable O
water O
supply O
, O
soap O
or O
hand O
washing O
facilities O
in O
people O
's O
homes B-TERM
, O
at O
schools O
and O
at O
the O
workplace O
make O
it O
a O
challenge O
to O
achieve O
universal O
hand O
washing O
behaviors O
. O

For O
example O
, O
in O
most O
of O
rural B-TERM
Africa O
hand O
washing O
taps O
close O
to O
every O
private O
or O
public O
toilet B-TERM
are O
scarce O
, O
even O
though B-TERM
cheap O
options O
exist O
to O
build O
hand O
washing O
stations O
. O

However O
, O
low O
hand O
washing O
rates O
rather O
can O
also B-TERM
be O
the O
result O
of O
engrained O
habits O
rather O
than O
due O
to O
a O
lack B-TERM
of O
soap O
or O
water O
. O

The O
promotion O
and O
advocacy O
of O
hand O
washing O
with O
soap O
can O
influence O
policy O
decisions B-TERM
, O
raise O
awareness O
about O
the O
benefits O
of O
hand O
washing O
and O
lead O
to O
long O
- O
term O
behavior O
change B-TERM
of O
the O
population O
. O

For O
this O
to O
work O
effectively O
, O
monitoring O
and O
evaluation O
are O
necessary O
. O

A O
systematic O
review O
of O
70 O
studies B-TERM
found O
that O
community O
- O
based O
approaches O
are O
effective B-TERM
at O
increasing O
hand O
washing O
in O
LMICs O
, O
while O
social O
marketing O
campaigns O
are O
less O
effective.One O
example O
for O
hand O
washing O
promotion O
in O
schools O
is O
the O
" O
Three O
Star O
Approach O
" O
by O
UNICEF O
that O
encourages O
schools O
to O
take O
simple B-TERM
, O
inexpensive O
steps O
to O
ensure O
that O
students O
wash O
their O
hands O
with O
soap O
, O
among O
other O
hygienic O
requirements B-TERM
. O

When O
minimum O
standards O
are O
achieved O
, O
schools O
can O
move O
from O
one O
to O
ultimately O
three O
stars O
. O

Building O
hand O
washing O
stations O
can O
be O
a O
part O
of O
hand O
washing O
promotion O
campaigns O
that O
are O
carried O
out O
in O
order O
to O
reduce O
diseases O
and O
child O
mortality O
. O

Global O
Hand O
washing O
Day O
is O
another B-TERM
example O
of O
an O
awareness O
- O
raising O
campaign O
that O
is O
trying O
to O
achieve O
behavior O
change.As B-TERM
a O
result B-TERM
of O
the O
2019 O
- O
20 O
coronavirus O
pandemic O
, O
UNICEF O
promoted O
the O
adoption O
of O
a O
handwashing O
emoji O
. O

Few O
studies B-TERM
have O
considered O
the O
overall O
cost O
effectiveness B-TERM
of O
hand O
washing O
in O
developing O
countries O
in O
relationship O
to O
DALYs O
averted O
. O

However O
, O
one O
review O
suggests O
that O
promoting O
hand O
washing O
with O
soap O
is O
significantly B-TERM
more O
cost O
- O
effective O
than O
other O
water O
and O
sanitation O
interventions O
. O

The O
importance B-TERM
of O
hand O
washing O
for O
human O
health O
- O
particularly B-TERM
for O
people O
in O
vulnerable O
circumstances O
like B-TERM
mothers B-TERM
who O
had O
just O
given O
birth O
or O
wounded O
soldiers B-TERM
in O
hospitals O
- O
was O
first O
recognized O
in O
the O
mid O
19th O
century B-TERM
by O
two B-TERM
pioneers O
of O
hand O
hygiene O
: O
the O
Hungarian O
physician O
Ignaz O
Semmelweis O
who O
worked O
in O
Vienna O
, O
Austria O
and O
Florence O
Nightingale O
, O
the O
English O
" O
founder O
of O
modern B-TERM
nursing O
. O
" O

At O
that O
time O
most O
people O
still O
believed O
that O
infections O
were O
caused O
by O
foul O
odors O
called B-TERM
miasmas O
. O

In O
the O
1980s O
, O
foodborne O
outbreaks O
and O
healthcare O
- O
associated O
infections O
led O
the O
United O
States O
Centers O
for O
Disease B-TERM
Control O
and O
Prevention B-TERM
to O
more O
actively O
promote O
hand O
hygiene O
as O
an O
important B-TERM
way O
to O
prevent O
the O
spread O
of O
infection O
. O

The O
outbreak O
of O
swine O
flu O
in O
2009 O
and O
the O
COVID O
- O
19 O
pandemic O
in O
2020 O
led O
to O
increased O
awareness O
in O
many O
countries O
of O
the O
importance O
of O
washing O
hands O
with O
soap O
to O
protect O
oneself O
from O
such O
infectious O
diseases B-TERM
. O

For O
example O
, O
posters O
with O
" O
correct B-TERM
hand O
washing O
techniques O
" O
were O
hung O
up O
next O
to O
hand O
washing O
sinks O
in O
public O
toilets O
and O
in O
the O
toilets O
of O
office O
buildings O
and O
airports O
in O
Germany O
. O

The O
phrase O
" O
washing O
one O
's O
hands O
of O
" O
something O
, O
means B-TERM
declaring O
one O
's O
unwillingness O
to O
take B-TERM
responsibility O
for O
the O
thing O
or O
share O
complicity O
in O
it O
. O

It O
originates O
from O
the O
bible O
passage O
in O
Matthew O
where O
Pontius O
Pilate O
washed O
his O
hands O
of O
the O
decision B-TERM
to O
crucify O
Jesus O
Christ O
, O
but O
has O
become O
a O
phrase O
with O
a O
much O
wider O
usage O
in O
some O
English O
communities O
. O

In O
Shakespeare O
's O
Macbeth O
, O
Lady B-TERM
Macbeth O
begins O
to O
compulsively O
wash O
her O
hands O
in O
an O
attempt O
to O
cleanse O
an O
imagined O
stain O
, O
representing O
her O
guilty O
conscience O
regarding O
crimes B-TERM
she O
had O
committed O
and O
induced O
her O
husband B-TERM
to O
commit O
. O

It O
has O
also B-TERM
been O
found O
that O
people O
, O
after O
having O
recalled O
or O
contemplated O
unethical O
acts O
, O
tend O
to O
wash O
hands O
more O
often B-TERM
than O
others O
, O
and O
tend O
to O
value O
hand O
washing O
equipment O
more O
. O

Furthermore O
, O
those O
who O
are O
allowed O
to O
wash O
their O
hands O
after O
such O
a O
contemplation O
are O
less O
likely B-TERM
to O
engage O
in O
other O
" O
cleansing O
" O
compensatory O
actions O
, O
such O
as O
volunteering O
. O

Religions O
prescribe O
hand O
washing O
for O
both O
hygienic O
and O
symbolic O
purposes.Symbolic O
hand O
washing O
, O
using O
water O
but O
no O
soap O
to O
wash O
hands O
, O
is O
a O
part O
of O
ritual O
hand O
washing O
featured O
in O
many O
religions O
, O
including O
Bah√° O
'√≠ O
Faith O
, O
Hinduism O
, O
tevilah O
and O
netilat O
yadayim O
in O
Judaism O
, O
Lavabo O
in O
Christianity O
, O
and O
Wudhu O
in O
Islam.Religions O
also B-TERM
prescribe O
hygienic O
hand O
washing O
, O
especially B-TERM
after O
certain O
actions O
. O

Hinduism O
, O
Judaism O
and O
Islam O
mandate O
washing O
of O
hands O
after O
using O
the O
toilet B-TERM
. O

And O
, O
Hinduism O
, O
Buddhism O
, O
Sikhism O
, O
Judaism O
and O
Islam O
mandate O
washing O
of O
hands O
before O
and O
after O
every O
meal O
. O

The O
outbreak O
of O
Coronavirus O
disease O
2019 O
( O
COVID O
- O
19 O
) O
, O
caused B-TERM
by O
severe O
acute O
respiratory O
syndrome O
( O
SARS O
) O
coronavirus O
2 O
( O
SARS O
- O
CoV O
- O
2 O
) O
, O
has O
thus O
far O
killed O
over O
3,000 O
people O
and O
infected O
over O
80,000 O
in O
China O
and O
elsewhere B-TERM
in O
the O
world O
, O
resulting O
in O
catastrophe O
for O
humans O
. O

Similar O
to O
its O
homologous O
virus O
, O
SARS O
- O
CoV O
, O
which O
caused O
SARS O
in O
thousands O
of O
people O
in O
2003 O
, O
SARS O
- O
CoV O
- O
2 O
might O
also B-TERM
be O
transmitted O
from O
the O
bats O
and O
causes B-TERM
similar B-TERM
symptoms O
through O
a O
similar B-TERM
mechanism O
. O

However O
, O
COVID O
- O
19 O
has O
lower O
severity O
and O
mortality O
than O
SARS O
but O
is O
much O
more O
transmissive O
and O
affects O
more O
elderly O
individuals O
than O
youth O
and O
more O
men O
than O
women O
. O

In O
response B-TERM
to O
the O
rapidly O
increasing B-TERM
number B-TERM
of O
publications O
on O
the O
emerging O
disease B-TERM
, O
this O
article O
attempts O
to O
provide O
a O
timely O
and O
comprehensive O
review O
of O
the O
swiftly O
developing O
research O
subject B-TERM
. O

We O
will O
cover O
the O
basics B-TERM
about O
the O
epidemiology O
, O
etiology O
, O
virology O
, O
diagnosis O
, O
treatment O
, O
prognosis O
, O
and O
prevention O
of O
the O
disease B-TERM
. O

Although B-TERM
many O
questions O
still O
require O
answers B-TERM
, O
we O
hope O
that O
this O
review O
helps B-TERM
in O
the O
understanding B-TERM
and O
eradication O
of O
the O
threatening O
disease B-TERM
. O

The O
Spring O
Festival O
on O
January O
25 O
, O
2020 O
has O
become O
an O
unprecedented B-TERM
and O
unforgettable O
memory O
to O
all O
Chinese O
who O
were O
urged O
to O
stay O
indoors O
for O
all O
the O
holiday O
and O
for O
many O
weeks O
after O
due O
to O
the O
outbreak O
of O
a O
novel O
viral O
disease O
. O

The O
virus O
is O
highly O
homologous O
to O
the O
coronavirus O
( O
CoV O
) O
that O
caused B-TERM
an O
outbreak O
of O
severe O
acute O
respiratory O
syndrome O
( O
SARS O
) O
in O
2003 O
; O
thus O
, O
it O
was O
named O
SARS O
- O
CoV O
- O
2 O
by O
the O
World O
Health O
Organization B-TERM
( O
WHO O
) O
on O
February O
11 O
, O
2020 O
, O
and O
the O
associated O
disease B-TERM
was O
named O
CoV O
Disease O
- O
19 O
( O
COVID O
- O
19 O
) O
. O

The O
epidemic O
started O
in O
Wuhan O
, O
China O
, O
and O
quickly O
spread O
throughout O
the O
entire B-TERM
country O
and O
to O
near O
50 O
others O
all O
over O
the O
world O
. O

As O
of O
March O
2 O
, O
2020 O
, O
the O
virus O
has O
resulted O
in O
over O
80,000 O
confirmed O
cases O
of O
COVID O
- O
19 O
, O
with O
more O
than O
40,000 O
patients B-TERM
discharged O
and O
over O
3,000 O
patients B-TERM
who O
died O
. O

WHO O
warns O
that O
COVID O
- O
19 O
is O
" O
public O
enemy O
number O
1 O
" O
and O
potentially O
more O
powerful O
than O
terrorism O
. O

According O
to O
PubMed O
( O
https O
: O
/ O
/ O
www.ncbi.nlm.nih.gov O
/ O
pubmed O
/ O
) O
, O
in O
less O
than O
two B-TERM
months O
, O
over O
200 O
papers O
have O
been O
published O
on O
COVID O
- O
19 O
including O
its O
virology O
, O
epidemiology O
, O
etiology O
, O
diagnosis O
, O
and O
treatment O
since O
the O
first O
report B-TERM
on O
January O
7 O
, O
2020 O
that O
determined O
the O
sequence B-TERM
of O
the O
virus O
isolated O
from O
multiple O
patients B-TERM
. O

This O
review O
attempts O
to O
summarize O
the O
research O
progress O
in O
the O
new O
and O
swiftly O
developing O
subject O
area B-TERM
. O

Whenever O
possible O
, O
we O
will O
try O
to O
compare O
COVID O
- O
19 O
with O
SARS O
and O
another B-TERM
CoV O
- O
caused B-TERM
disease B-TERM
, O
Middle O
East O
respiratory O
syndrome O
( O
MERS O
, O
an O
outbreak O
in O
2012 O
) O
. O

We O
will O
also B-TERM
discuss O
what O
we O
have O
learned O
so O
far O
regarding O
the O
prevention O
and O
prognosis O
of O
the O
disease B-TERM
as O
well O
as O
some O
remaining O
yet O
urgent O
questions O
. O

CoVs O
have O
been O
traditionally O
considered O
nonlethal O
pathogens O
to O
humans O
, O
mainly O
causing B-TERM
approximately B-TERM
15 O
% O
of O
common B-TERM
colds O
4 O
. O

However O
, O
in O
this O
century B-TERM
, O
we O
have O
encountered O
highly O
pathogenic O
human O
CoVs O
twice O
, O
i.e. O
, O
SARS O
- O
CoV O
and O
MERS O
- O
CoV O
, O
which O
caused B-TERM
an O
outbreak O
originally B-TERM
in O
China O
in O
2003 O
and O
Saudi O
Arabia O
in O
2012 O
, O
respectively O
, O
and O
soon B-TERM
spread O
to O
many O
other O
countries O
with O
horrible O
morbidity O
and O
mortality O
. O

Therefore O
, O
the O
current O
COVID O
- O
19 O
is O
the O
third O
CoV O
outbreak O
in O
the O
recorded O
history O
of O
humans O
. O

As O
shown B-TERM
in O
Fig O
. O
Fig.1,1 O
, O
clusters O
of O
pneumonia O
that O
had O
unknown B-TERM
origins O
were O
first O
reported O
from O
Wuhan O
on O
December O
31 O
, O
2019 O
to O
the O
China O
National O
Health O
Commission O
. O

Seven O
days O
later O
the O
sequence B-TERM
of O
the O
CoV O
was O
released O
. O

On O
January O
15 O
, O
2020 O
the O
first O
fatal B-TERM
case O
from O
Wuhan O
was O
reported O
. O

Meanwhile O
, O
the O
epidemic O
rapidly O
spread O
to O
the O
neighboring O
cities O
, O
provinces O
, O
and O
countries O
. O

On O
January O
20 O
, O
the O
infection O
of O
health O
- O
care O
providers O
was O
reported O
, O
suggesting O
that O
human O
- O
to O
- O
human O
transmission O
was O
possible O
. O

On O
January O
23 O
, O
the O
city O
of O
Wuhan O
was O
locked O
down O
with O
all O
its O
public O
transportation O
stopped O
. O

On O
January O
24 O
the O
first O
clinical O
study B-TERM
on O
the O
disease B-TERM
reported O
that O
, O
out O
of O
41 O
patients B-TERM
with O
confirmed O
cases O
, O
only O
21 O
had O
direct O
contact O
with O
the O
Wuhan O
seafood O
market O
that O
was O
considered O
the O
starting O
site O
of O
the O
infection O
from O
an O
unknown B-TERM
animal O
source O
. O

On O
January O
30 O
, O
WHO O
declared B-TERM
the O
outbreak O
a O
global O
health O
emergency O
. O

By O
the O
time O
of O
this O
report B-TERM
, O
the O
disease B-TERM
has O
already O
spread O
throughout O
China O
and O
near O
50 O
other O
countries O
all O
over O
the O
world O
( O
Fig O
. O
( O
Fig.2 O
) O
.2 O
) O
. O

As O
the O
situation B-TERM
is O
rapidly O
evolving O
, O
the O
final O
scope O
and O
severity O
of O
the O
outbreak O
remain O
to O
be O
determined O
. O

On O
February O
11 O
, O
2020 O
, O
a O
multi O
- O
center O
study B-TERM
on O
8,866 O
patients B-TERM
including O
4,021 O
confirmed O
COVID O
- O
19 O
patients O
presented O
a O
more O
updated O
illustration O
of O
the O
epidemic O
as O
follows O
( O
https O
: O
/ O
/ O
mp.weixin.qq.com O
/ O
s O
/ O
UlBi O
- O
HX O
_ O
rHPXa1qHA2bhdA O
) O
. O

SARS O
- O
CoV O
- O
2 O
infected O
people O
of O
all O
ages O
, O
but O
mainly B-TERM
at O
the O
age O
of O
30 O
- O
65 O
. O

Almost O
half O
( O
47.7 O
% O
) O
of O
the O
infected O
individuals O
were O
over O
50 O
years O
old O
, O
very O
few O
were O
under O
20 O
, O
and O
only O
14 O
infected O
individuals O
were O
under O
the O
age O
of O
10 O
. O

SARS O
- O
CoV O
- O
2 O
infected O
more O
men O
( O
0.31 O
/ O
100,000 O
) O
than O
women O
( O
0.27 O
/ O
100,000 O
) O
. O

COVID O
- O
19 O
expanded O
in O
clusters O
mainly O
in O
and O
around O
Hubei O
. O

COVID O
- O
19 O
took O
an O
average O
of O
5 O
( O
2 O
- O
9 O
) O
days O
from O
onset O
to O
diagnosis O
. O

The O
average O
incubation O
period O
was O
4.8 O
( O
3.0 O
- O
7.2 O
) O
days O
. O

The O
average O
time O
from O
onset O
to O
death O
was O
9.5 O
( O
4.8 O
- O
13 O
) O
days O
. O

The O
basic B-TERM
reproductive O
number O
( O
R0 O
) O
was O
3.77 O
( O
95 O
% O
CI O
: O
3.51 O
- O
4.05 O
) O
, O
and O
the O
adjusted O
R0 O
was O
2.23 O
- O
4.82 O
. O

The O
number B-TERM
of O
infected O
people O
increased B-TERM
exponentially O
before O
23 O
Jan. O
2020 O
, O
matching O
the O
time O
of O
massive O
transportation O
before O
the O
Spring O
Festival O
in O
China O
. O

The O
mortality O
of O
patients B-TERM
with O
confirmed O
cases O
was O
1.44 O
% O
( O
95 O
% O
CI O
: O
1.10 O
- O
1.86 O
% O
) O
, O
and O
the O
adjusted O
mortality O
of O
all O
the O
patients B-TERM
was O
3.06 O
% O
( O
95 O
% O
CI O
: O
2.02 O
- O
4.59 O
% O
) O
. O

Three O
major O
risk O
factors O
for O
COVID O
- O
19 O
were O
sex O
( O
male O
) O
, O
age O
( O
‚â• O
60 O
) O
, O
and O
severe O
pneumonia O
. O

CoVs O
are O
a O
subfamily O
of O
large O
and O
enveloped O
viruses O
containing O
a O
single O
strand O
of O
sense O
RNA O
. O

They O
can O
be O
divided B-TERM
into O
four O
genera O
, O
i.e. O
, O
alpha O
, O
beta O
, O
gamma O
, O
and O
delta O
, O
of O
which O
alpha- O
and O
beta O
- O
CoVs O
are O
known O
to O
infect O
humans O
. O

The O
envelope O
spike O
( O
S O
) O
glycoprotein O
binds O
to O
its O
cellular O
receptors O
angiotensin O
- O
converting O
enzyme O
2 O
( O
ACE2 O
) O
and O
dipeptidyl O
peptidase O
4 O
( O
DPP4 O
) O
for O
SARS O
- O
CoV O
and O
MERS O
- O
CoV O
, O
respectively O
, O
and O
then O
membrane O
fusion O
occurs O
. O

The O
viral O
RNA O
genome O
is O
released O
into O
the O
cytoplasm O
; O
after O
replication O
of O
the O
viral O
genome O
, O
genomic O
RNA O
accompanied O
by O
envelope O
glycoproteins O
and O
nucleocapsid O
proteins B-TERM
forms O
virion O
- O
containing O
vesicles O
, O
which O
then O
fuse O
with O
the O
plasma O
membrane O
to O
release O
the O
virus O
. O

The O
first O
genomic O
sequence B-TERM
of O
SARS O
- O
CoV O
- O
2 O
was O
reported O
on O
January O
10 O
, O
2020 O
. O

SARS O
- O
CoV O
- O
2 O
was O
found O
to O
be O
a O
new O
type B-TERM
of O
beta O
- O
CoV O
with O
more O
than O
99.98 O
% O
genetic O
identity O
among O
10 O
sequenced O
samples O
collected O
from O
the O
original O
site O
of O
the O
outbreak O
, O
the O
Huanan O
Seafood O
Market O
in O
Wuhan O
. O

SARS O
- O
CoV O
- O
2 O
is O
genetically O
more O
similar O
to O
SARS O
- O
CoV O
than O
to O
MERS O
- O
CoV O
. O

Through O
transmission O
electron O
microscopy O
, O
SARS O
- O
CoV O
- O
2 O
particles O
were O
found O
in O
ultrathin O
sections O
of O
human O
airway O
epithelium O
. O

Human O
ACE2 O
was O
found O
to O
be O
a O
receptor O
for O
SARS O
- O
CoV O
- O
2 O
as O
well O
as O
SARS O
- O
CoV O
. O

However O
, O
the O
S O
protein B-TERM
of O
SARS O
- O
CoV O
- O
2 O
binds O
to O
human O
ACE2 O
more O
weakly O
than O
that O
of O
SARS O
- O
CoV O
, O
which O
is O
coincident O
with O
the O
fact O
that O
SARS O
- O
CoV O
- O
2 O
causes B-TERM
less O
severe O
infection O
in O
patients B-TERM
than O
SARS O
- O
CoV O
. O

SARS O
- O
CoV O
- O
2 O
can O
also B-TERM
form O
a O
novel O
short O
protein B-TERM
encoded O
by O
orf3b O
and O
a O
secreted O
protein B-TERM
encoded O
by O
orf8 O
. O

The O
orf3b O
of O
SARS O
- O
CoV O
- O
2 O
may O
play O
a O
role B-TERM
in O
the O
viral O
pathogenicity O
and O
inhibit O
the O
expression O
of O
IFNŒ≤ O
; O
however O
, O
orf8 O
does O
not O
contain O
any O
known O
functional O
domain O
or O
motif O
. O

On O
February O
18 O
, O
2020 O
, O
Zhou O
, O
et O
al O
. O
, O
reported O
the O
cryo O
- O
EM O
structure O
of O
the O
full O
- O
length O
human O
ACE2 O
at O
2.9 O
√Ö O
resolution O
in O
complex O
with O
the O
amino O
acid O
transporter O
B0AT1 O
. O

They O
found O
that O
the O
complex O
, O
which O
had O
open B-TERM
and O
closed O
conformations O
, O
was O
assembled O
as O
a O
dimer O
and O
the O
ACE2 O
- O
B0AT1 O
complex O
can O
bind O
two B-TERM
S O
proteins B-TERM
, O
which O
provides O
evidence O
for O
CoV O
recognition O
and O
infection O
. O

B0AT1 O
may O
become O
a O
therapeutic O
target O
for O
drug O
screening O
to O
suppress O
SARS O
- O
CoV O
- O
2 O
infection O
. O

The O
origin O
and O
intermediate O
host O

It O
has O
been O
known O
that O
both O
SARS O
- O
CoV O
and O
MERS O
- O
CoV O
originated O
from O
bats O
and O
were O
transmitted O
to O
humans O
via B-TERM
civet O
cats O
and O
camels O
, O
respectively O
. O

Through O
a O
phylogenetic O
comparison O
of O
SARS O
- O
CoV O
- O
2 O
with O
other O
CoVs O
, O
bats O
were O
considered O
the O
native O
host O
of O
SARS O
- O
CoV O
- O
2 O
as O
the O
new O
virus O
is O
96 O
% O
identical B-TERM
to O
two B-TERM
SARS O
- O
like O
CoVs O
from O
bats O
called O
bat O
- O
SL O
- O
CoVZX45 O
and O
bat O
- O
SL O
- O
CoVZX21 O
. O

However O
, O
what O
intermediate O
host O
helped O
the O
virus O
cross O
the O
species O
barrier O
to O
infect O
humans O
remains O
unknown B-TERM
, O
and O
the O
transmission O
route O
is O
yet O
to O
be O
elucidated O
. O

Ji O
, O
et O
al O
. O
, O
proposed O
snakes O
as O
a O
carrier O
of O
the O
virus O
from O
bats O
to O
humans O
which O
involved O
homologous O
recombination O
within O
the O
S O
protein B-TERM
. O

According O
to O
a O
study B-TERM
, O
researchers O
in O
Guangzhou O
, O
China O
, O
suggested O
that O
pangolins O
- O
long O
- O
snouted O
, O
ant O
- O
eating B-TERM
mammals O
often B-TERM
used B-TERM
in O
traditional O
Chinese O
medicine O
- O
are O
the O
potential O
intermediate O
host O
of O
SARS O
- O
CoV O
- O
2 O
based O
on O
99 O
% O
genetic O
homology O
in O
a O
CoV O
discovered O
in O
pangolins O
and O
SARS O
- O
CoV O
- O
2 O
. O

However O
, O
1 O
% O
difference B-TERM
spread O
all O
over O
two O
genomes O
is O
still O
a O
big B-TERM
difference O
; O
thus O
, O
conclusive O
results B-TERM
for O
concrete O
evidence O
are O
awaited O
( O
Fig O
. O
( O
Fig.33 O
) O
. O

The O
physicochemical O
properties O
of O
SARS O
- O
CoV O
- O
2 O
are O
largely O
not O
yet O
known O
. O

SARS O
- O
CoV O
and O
MERS O
- O
CoV O
can O
survive O
in O
vitro O
for O
48 O
hours O
in O
a O
dry O
environment O
and O
up O
to O
5 O
days O
under O
20 O
¬∞ O
C O
and O
40 O
% O
-50 O
% O
humidity O
. O

SARS O
- O
CoV O
- O
2 O
may O
possess B-TERM
similar B-TERM
properties O
. O

It O
has O
been O
reported O
that O
SARS O
- O
CoV O
- O
2 O
is O
sensitive O
to O
ultraviolet O
rays O
and O
heat O
at O
56 O
¬∞ O
C O
for O
30 O
minutes B-TERM
; O
ether O
, O
75 O
% O
ethanol O
, O
chlorine O
- O
containing O
disinfectant O
, O
peracetic O
acid O
, O
chloroform O
, O
and O
other O
fatty O
solvents O
, O
but O
not O
chlorhexidine O
, O
can O
effectively O
inactivate O
the O
virus O
. O

The O
entire O
human O
population O
generally O
lacks O
immunity O
to O
SARS O
- O
CoV O
- O
2 O
and O
hence O
is O
susceptible O
to O
the O
novel O
virus O
. O

Currently O
, O
no O
detailed O
study B-TERM
has O
been O
reported O
regarding O
the O
immunological O
response B-TERM
to O
SARS O
- O
CoV O
- O
2 O
. O

Thus O
, O
we O
can O
only O
refer O
to O
previous O
studies B-TERM
on O
other O
CoVs O
, O
especially O
SARS O
- O
CoV O
and O
MERS O
- O
CoV O
( O
Fig O
. O
( O
Fig.4 O
) O
.4 O
) O
. O

In O
general O
, O
after O
a O
virus O
invades O
the O
host O
, O
it O
is O
first O
recognized O
by O
the O
host O
innate O
immune O
system O
through O
pattern O
recognition O
receptors O
( O
PRRs O
) O
including O
C O
- O
type O
lectin O
- O
like O
receptors O
, O
Toll O
- O
like O
receptor O
( O
TLR O
) O
, O
NOD O
- O
like O
receptor O
( O
NLR O
) O
, O
and O
RIG O
- O
I O
- O
like O
receptor O
( O
RLR O
) O
. O

Through O
different O
pathways O
, O
the O
virus O
induces O
the O
expression O
of O
inflammatory O
factors O
, O
maturation O
of O
dendritic O
cells O
, O
and O
synthesis O
of O
type B-TERM
I O
interferons O
( O
IFNs O
) O
which O
limit O
the O
spreading O
of O
the O
virus O
and O
accelerate O
macrophage O
phagocytosis O
of O
viral O
antigens O
. O

However O
, O
the O
N O
protein B-TERM
of O
SARS O
- O
CoV O
can O
help O
the O
virus O
escape B-TERM
from O
the O
immune O
responses B-TERM
. O

Soon B-TERM
, O
the O
adaptive O
immune O
response B-TERM
joins O
the O
fight O
against O
the O
virus O
. O

T O
lymphocytes O
including O
CD4 O
+ O
and O
CD8 O
+ O
T O
cells O
play O
an O
important B-TERM
role B-TERM
in O
the O
defense B-TERM
. O

CD4 O
+ O
T O
cells O
stimulate O
B O
cells O
to O
produce O
virus O
- O
specific O
antibodies O
, O
and O
CD8 O
+ O
T O
cells O
directly B-TERM
kill O
virus O
- O
infected O
cells O
. O

T O
helper O
cells O
produce B-TERM
proinflammatory O
cytokines O
to O
help B-TERM
the O
defending O
cells O
. O

However O
, O
CoV O
can O
inhibit O
T O
cell O
functions B-TERM
by O
inducing O
apoptosis O
of O
T O
cells O
. O

The O
humoral O
immunity O
including O
complements O
such O
as O
C3a O
and O
C5a O
and O
antibodies O
is O
also B-TERM
essential O
in O
combating O
the O
viral O
infection O
. O

For O
example O
, O
antibodies O
isolated O
from O
a O
recovered O
patient B-TERM
neutralized O
MERS O
- O
CoV O
. O

On O
the O
other O
hand O
, O
an O
overreaction O
of O
the O
immune O
system O
generates O
a O
large O
number B-TERM
of O
free B-TERM
radicals O
locally B-TERM
that O
can O
cause O
severe O
damages O
to O
the O
lungs O
and O
other O
organs O
, O
and O
, O
in O
the O
worst O
scenario O
, O
multi O
- O
organ O
failure O
and O
even O
death O
. O

The O
SARS O
- O
CoV O
- O
2 O
infection O
, O
featured O
by O
clustering O
onset O
, O
is O
more O
likely O
to O
affect O
elderly O
people O
with O
comorbidities O
and O
pregnant O
women O
. O

It O
is O
common O
that O
for O
people O
who O
are O
exposed O
to O
a O
large O
number B-TERM
of O
viruses O
or O
whose O
immune O
functions O
are O
compromised O
, O
they O
have O
higher O
chance O
to O
be O
infected O
than O
others O
. O

The O
estimated O
mean O
incubation O
period O
of O
SARS O
- O
CoV O
- O
2 O
is O
1 O
- O
14 O
days O
, O
mostly B-TERM
3 O
- O
7 O
days O
based O
on O
a O
study O
of O
the O
first O
425 O
cases O
in O
Wuhan O
. O

However O
, O
a O
study O
on O
1,099 O
cases O
demonstrates B-TERM
that O
the O
incubation O
period O
was O
3 O
days O
on O
average O
and O
ranged O
from O
0 O
to O
24 O
days O
. O

A O
more O
recent O
study B-TERM
, O
as O
described O
above O
, O
demonstrates B-TERM
that O
the O
incubation O
period O
was O
4.8 O
( O
3.0 O
- O
7.2 O
) O
days O
based O
on O
the O
demography O
of O
8,866 O
cases O
. O

It O
is O
very O
important B-TERM
for O
health O
authorities O
to O
adjust O
the O
effective O
quarantine O
time O
based O
on O
the O
most O
accurate O
incubation O
period O
, O
thus O
preventing O
infected O
but O
symptomless O
people O
from O
transmitting O
the O
virus O
to O
others O
. O

As O
a O
common B-TERM
practice O
, O
individuals O
exposed O
to O
, O
or O
infected O
by O
, O
the O
virus O
are O
usually O
required O
to O
be O
quarantined O
for O
14 O
days O
. O

Should O
the O
quarantine O
time O
be O
extended O
to O
24 O
days O
? O

Fever O
is O
often B-TERM
the O
major O
and O
initial O
symptom O
of O
COVID O
- O
19 O
, O
which O
can O
be O
accompanied O
by O
no O
symptom O
or O
other O
symptoms O
such O
as O
dry O
cough O
, O
shortness O
of O
breath O
, O
muscle B-TERM
ache O
, O
dizziness O
, O
headache O
, O
sore O
throat O
, O
rhinorrhea O
, O
chest O
pain B-TERM
, O
diarrhea O
, O
nausea O
, O
and O
vomiting O
. O

Some O
patients B-TERM
experienced O
dyspnea O
and O
/ O
or O
hypoxemia O
one O
week O
after O
the O
onset O
of O
the O
disease B-TERM
. O

In O
severe O
cases O
, O
patients B-TERM
quickly O
progressed O
to O
develop O
acute O
respiratory O
syndrome O
, O
septic O
shock O
, O
metabolic O
acidosis O
, O
and O
coagulopathy O
. O

Patients B-TERM
with O
fever O
and O
/ O
or O
respiratory O
symptoms O
and O
acute O
fever O
, O
even O
without O
pulmonary O
imaging O
abnormalities O
, O
should O
be O
screened O
for O
the O
virus O
for O
early O
diagnosis O
. O

A O
demographic O
study B-TERM
in O
late O
December O
of O
2019 O
showed O
that O
the O
percentages O
of O
the O
symptoms O
were O
98 O
% O
for O
fever O
, O
76 O
% O
for O
dry O
cough O
, O
55 O
% O
for O
dyspnea O
, O
and O
3 O
% O
for O
diarrhea O
; O
8 O
% O
of O
the O
patients B-TERM
required O
ventilation O
support O
. O

Similar B-TERM
findings B-TERM
were O
reported O
in O
two B-TERM
recent B-TERM
studies B-TERM
of O
a O
family B-TERM
cluster O
and O
a O
cluster O
caused O
by O
transmission O
from O
an O
asymptomatic O
individual O
. O

Comparably O
, O
a O
demographic O
study B-TERM
in O
2012 O
showed O
that O
MERS O
- O
CoV O
patients B-TERM
also B-TERM
had O
fever O
( O
98 O
% O
) O
, O
dry O
cough O
( O
47 O
% O
) O
, O
and O
dyspnea O
( O
55 O
% O
) O
as O
their O
main B-TERM
symptoms O
. O

However O
, O
80 O
% O
of O
them O
required O
ventilation O
support O
, O
much O
more O
than O
COVID O
- O
19 O
patients B-TERM
and O
consistent O
with O
the O
higher O
lethality O
of O
MERS O
than O
of O
COVID O
- O
19 O
. O

Diarrhea O
( O
26 O
% O
) O
and O
sore O
throat O
( O
21 O
% O
) O
were O
also B-TERM
observed O
with O
MERS O
patients B-TERM
. O

In O
SARS O
patients B-TERM
, O
it O
has O
been O
demonstrated O
that O
fever O
( O
99 O
% O
-100 O
% O
) O
, O
dry O
cough O
( O
29 O
% O
-75 O
% O
) O
, O
dyspnea O
( O
40 O
% O
-42 O
% O
) O
, O
diarrhea O
( O
20 O
- O
25 O
% O
) O
, O
and O
sore O
throat O
( O
13 O
- O
25 O
% O
) O
were O
the O
major O
symptoms O
and O
ventilation O
support O
was O
required O
for O
approximately O
14 O
% O
-20 O
% O
of O
the O
patients B-TERM
. O

By O
February O
14 O
, O
the O
mortality O
of O
COVID O
- O
19 O
was O
2 O
% O
when O
the O
confirmed O
cases O
reached O
66,576 O
globally O
. O

Comparably O
, O
the O
mortality O
of O
SARS O
by O
November O
2002 O
was O
10 O
% O
of O
8,096 O
confirmed O
cases O
. O

For O
MERS O
, O
based O
on O
a O
demographic O
study B-TERM
in O
June O
2012 O
, O
the O
mortality O
was O
37 O
% O
of O
2,494 O
confirmed O
cases O
. O

An O
earlier O
study B-TERM
reported O
that O
the O
R0 O
of O
SARS O
- O
CoV O
- O
2 O
was O
as O
high O
as O
6.47 O
with O
a O
95 O
% O
confidence O
interval O
( O
CI O
) O
of O
5.71 O
- O
7.23 O
, O
whereas O
the O
R0 O
of O
SARS O
- O
CoV O
only O
ranged O
from O
2 O
to O
4 O
. O

A O
comparison O
of O
SARS O
- O
CoV O
- O
2 O
with O
MERS O
- O
CoV O
and O
SARA O
- O
CoV O
regarding O
their O
symptoms O
, O
mortality O
, O
and O
R0 O
is O
presented O
in O
Table O
Table1.1. O

The O
above O
figures O
suggest O
that O
SARS O
- O
CoV O
- O
2 O
has O
a O
higher O
ability O
to O
spread O
than O
MERS O
- O
CoV O
and O
SARS O
- O
CoV O
, O
but O
it O
is O
less O
lethal O
than O
the O
latter O
two B-TERM
. O

Thus O
, O
it O
is O
much O
more O
challenging O
to O
control O
the O
epidemic O
of O
SARS O
- O
CoV O
- O
2 O
than O
those O
of O
MERS O
- O
CoV O
and O
SARS O
- O
CoV O
. O

Clustered O
onset O
often B-TERM
happens O
in O
the O
same O
family B-TERM
or O
from O
the O
same O
gathering O
or O
vehicle O
such O
as O
a O
cruise O
ship O
. O

Patients B-TERM
often B-TERM
have O
a O
history O
of O
travel O
or O
residence O
in O
Wuhan O
or O
other O
affected O
areas O
or O
contact O
with O
infected O
individuals O
or O
patients O
in O
the O
recent B-TERM
two B-TERM
weeks O
before O
the O
onset O
. O

However O
, O
it O
has O
been O
reported O
that O
people O
can O
carry O
the O
virus O
without O
symptoms O
longer O
than O
two B-TERM
weeks O
and O
cured O
patients B-TERM
discharged O
from O
hospitals O
can O
carry O
the O
virus O
again O
, O
which O
sends O
out O
an O
alarm O
to O
increase O
the O
time O
for O
quarantine O
. O

Patients B-TERM
have O
normal B-TERM
or O
reduced O
number B-TERM
of O
peripheral O
white O
blood B-TERM
cells O
( O
especially B-TERM
lymphocytes O
) O
at O
the O
early O
stage B-TERM
. O

For O
example O
, O
lymphopenia O
with O
white O
blood O
cell O
count O
< O
4 O
√ó O
109 O
/ O
L O
including O
lymphocyte O
count O
< O
1 O
√ó O
109 O
/ O
L O
, O
and O
elevated O
aspartate O
aminotransferase O
levels O
and O
viremia O
were O
found O
in O
1,099 O
COVID O
- O
19 O
patients B-TERM
. O

The O
levels O
of O
liver O
and O
muscle O
enzymes O
and O
myoglobin O
were O
increased O
in O
the O
blood B-TERM
of O
some O
patients B-TERM
, O
and O
C O
- O
reactive O
protein O
and O
erythrocyte O
sedimentation O
were O
increased O
in O
the O
blood B-TERM
of O
most O
patients O
. O

In O
patients B-TERM
with O
severe O
cases O
, O
the O
level O
of O
D O
- O
dimer O
, O
a O
fibrin O
degradation O
product B-TERM
present O
in O
the O
blood B-TERM
, O
was O
elevated O
, O
and O
lymphocyte O
count O
was O
progressively O
reduced O
. O

Abnormalities O
in O
chest O
radiography O
are O
found O
in O
most O
COVID O
- O
19 O
patients B-TERM
and O
featured O
by O
bilateral O
patchy O
shadows O
or O
ground O
glass O
opacity O
in O
the O
lungs O
. O

Patients B-TERM
often B-TERM
develop O
an O
atypical O
pneumonia O
, O
acute O
lung O
injury O
, O
and O
acute O
respiratory O
distress O
syndrome O
( O
ARDS O
) O
. O

When O
ARDS O
happens O
, O
uncontrolled O
inflammation O
, O
fluid O
accumulation O
, O
and O
progressive O
fibrosis O
severely O
compromise O
the O
gas O
exchange O
. O

Dysfunction O
of O
type B-TERM
- O
I O
and O
type O
- O
II O
pneumocytes O
decreases O
the O
surfactant O
level O
and O
increases O
surface O
tension O
, O
thus O
reducing B-TERM
the O
ability O
of O
the O
lungs O
to O
expand O
and O
heightening O
the O
risk O
of O
lung O
collapse O
. O

Therefore O
, O
the O
worst O
chest O
radiographic O
findings B-TERM
often B-TERM
parallel O
the O
most O
severe O
extent O
of O
the O
disease B-TERM
. O

On O
February O
18 O
, O
2020 O
, O
the O
first O
pathological O
analysis O
of O
COVID O
- O
19 O
demonstrated O
the O
desquamation O
of O
pneumocytes O
, O
hyaline O
membrane O
formation O
, O
and O
interstitial O
lymphocyte O
infiltration O
, O
and O
multinucleated O
syncytial O
cells O
in O
the O
lungs O
of O
a O
patient O
who O
died O
of O
the O
disease O
, O
consistent O
with O
the O
pathology O
of O
viral O
infection O
and O
ARDS O
and O
similar O
to O
that O
of O
SARS O
and O
MERS O
patients B-TERM
. O

The O
detection O
of O
SARS O
- O
CoV O
- O
2 O
RNA O
via B-TERM
reverse O
- O
transcriptase O
polymerase O
chain O
reaction O
( O
RT O
- O
PCR O
) O
was O
used O
as O
the O
major O
criteria O
for O
the O
diagnosis O
of O
COVID O
- O
19 O
. O

However O
, O
due O
to O
the O
high O
false O
- O
negative O
rate O
, O
which O
may O
accelerate O
the O
epidemic O
, O
clinical O
manifestations O
started O
to O
be O
used O
for O
diagnosis O
( O
which O
no O
longer O
solely O
relied O
on O
RT O
- O
PCR O
) O
in O
China O
on O
February O
13 O
, O
2020 O
. O

A O
similar B-TERM
situation B-TERM
also O
occurred O
with O
the O
diagnosis O
of O
SARS O
. O

Therefore O
, O
a O
combination O
of O
disease B-TERM
history O
, O
clinical O
manifestations O
, O
laboratory O
tests O
, O
and O
radiological O
findings B-TERM
is O
essential O
and O
imperative O
for O
making O
an O
effective B-TERM
diagnosis O
. O

On O
February O
14 O
, O
2020 O
, O
the O
Feng O
Zhang O
group O
described O
a O
protocol O
of O
using O
the O
CRISPR O
- O
based O
SHERLOCK O
technique O
to O
detect O
SARS O
- O
CoV O
- O
2 O
, O
which O
detects O
synthetic O
SARS O
- O
CoV O
- O
2 O
RNA O
fragments O
at O
20 O
√ó O
10 O
- O
18 O
mol O
/ O
L O
to O
200 O
√ó O
10 O
- O
18 O
mol O
/ O
L O
( O
10 O
- O
100 O
copies O
per O
microliter O
of O
input O
) O
using O
a O
dipstick O
in O
less O
than O
an O
hour O
without O
requiring O
elaborate O
instrumentation O
. O

Hopefully O
, O
the O
new O
technique O
can O
dramatically O
enhance B-TERM
the O
sensitivity O
and O
convenience O
if O
verified O
in O
clinical O
samples O
. O

Due O
to O
the O
lack B-TERM
of O
experience O
with O
the O
novel O
CoV O
, O
physicians O
can O
mainly O
provide O
supportive O
care O
to O
COVID O
- O
19 O
patients B-TERM
, O
while O
attempting B-TERM
a O
variety O
of O
therapies O
that O
have O
been O
used B-TERM
or O
proposed O
before O
for O
the O
treatment O
of O
other O
CoVs O
such O
as O
SARS O
- O
CoV O
and O
MERS O
- O
CoV O
and O
other O
viral O
diseases B-TERM
( O
Table O
( O
Table2 O
) O
.2 O
) O
. O

These O
therapies O
include O
current B-TERM
and O
potential O
treatments O
with O
antiviral O
drugs O
, O
immunosuppressants O
, O
steroids O
, O
plasma O
from O
recovered O
patients B-TERM
, O
Chinese O
medicine O
, O
and O
psychological O
support O
. O

Even O
plasma O
from O
recovered O
patients B-TERM
was O
proposed O
to O
be O
used B-TERM
for O
treatment O
. O

Pharmaceutical O
companies B-TERM
are O
racing O
to O
develop O
antibodies O
and O
vaccines B-TERM
against O
the O
virus O
. O

SARS O
- O
CoV O
- O
2 O
mainly B-TERM
attacks O
the O
lungs O
in O
the O
beginning O
and O
probably O
also B-TERM
attacks O
, O
to O
a O
lesser O
degree O
, O
other O
organs O
that O
express O
ACE2 O
, O
such O
as O
the O
gastrointestinal O
system O
and O
the O
kidneys O
. O

Nevertheless O
, O
respiratory O
dysfunction O
and O
failure O
are O
the O
major O
threat B-TERM
to O
the O
patients B-TERM
and O
the O
major O
cause O
of O
death O
. O

Thus O
, O
respiratory O
support O
is O
critical O
to O
relieve O
the O
symptoms O
and O
save O
lives O
and O
includes O
general O
oxygen O
therapy O
, O
high O
- O
flow B-TERM
oxygen O
, O
noninvasive O
ventilation O
, O
and O
invasive O
mechanical O
ventilation O
depending O
on O
the O
severity O
of O
the O
disease B-TERM
. O

Patients B-TERM
with O
severe O
respiratory O
symptoms O
have O
to O
be O
supported O
by O
extracorporeal O
membrane O
oxygenation O
( O
ECMO O
) O
, O
a O
modified O
cardiopulmonary O
bypass O
technique O
used B-TERM
for O
the O
treatment O
of O
life O
- O
threatening O
cardiac O
or O
respiratory O
failure O
. O

In O
addition B-TERM
, O
the O
maintenance O
of O
electrolyte O
balance O
, O
the O
prevention B-TERM
and O
treatment O
of O
secondary O
infection O
and O
septic O
shock O
, O
and O
the O
protection O
of O
the O
functions B-TERM
of O
the O
vital B-TERM
organs O
are O
also B-TERM
essential O
for O
SARS O
- O
CoV O
- O
2 O
patients B-TERM
. O

It O
has O
been O
known O
that O
a O
cytokine O
storm B-TERM
results B-TERM
from O
an O
overreaction O
of O
the O
immune O
system O
in O
SARS O
and O
MERS O
patients B-TERM
. O

Cytokine O
storm B-TERM
is O
a O
form O
of O
systemic O
inflammatory O
response B-TERM
featured O
by O
the O
release O
of O
a O
series O
of O
cytokines O
including O
TNFŒ± O
, O
IL O
- O
1Œ≤ O
, O
IL O
- O
2 O
, O
IL O
- O
6 O
, O
IFNŒ± O
, O
IFNŒ≤ O
, O
IFNŒ≥ O
, O
and O
MCP O
- O
1 O
. O

These O
cytokines O
induce O
immune O
cells O
to O
release O
a O
vast B-TERM
number B-TERM
of O
free B-TERM
radicals O
which O
are O
the O
major O
cause O
of O
ARDS O
and O
multiple O
organ O
failure O
. O

Immunosuppression O
is O
essential O
in O
the O
treatment O
of O
cytokine O
storms B-TERM
, O
especially O
in O
severe O
patients B-TERM
. O

Corticosteroids O
and O
tocilizumab O
, O
an O
anti O
- O
IL6 O
monoclonal O
antibody O
, O
have O
been O
used O
to O
treat O
cytokine O
storm B-TERM
. O

Other O
immunosuppression O
treatments O
for O
cytokine O
storm B-TERM
include O
the O
modulation O
of O
T O
cell O
- O
directed O
immune O
response B-TERM
; O
the O
blockade O
of O
IFN O
- O
Œ≥ O
, O
IL O
- O
1 O
, O
and O
TNF O
; O
JAK O
inhibition O
; O
blinatumomab O
; O
suppressor O
of O
cytokine O
signaling O
4 O
; O
and O
HDAC O
inhibitors O
. O

Steroids O
, O
as O
immunosuppressants O
, O
were O
widely O
used O
in O
the O
treatment O
of O
SARS O
to O
reduce O
the O
severity O
of O
inflammatory O
damage O
. O

However O
, O
steroids O
at O
high O
dosages O
were O
not O
beneficial O
to O
severe O
lung O
injury O
in O
SARS O
and O
COVID O
- O
19 O
patients B-TERM
. O

Instead O
, O
they O
may O
cause B-TERM
severe O
side O
effects O
, O
especially B-TERM
avascular O
osteonecrosis O
, O
dramatically O
affecting O
the O
prognosis O
. O

Nevertheless O
, O
short O
courses O
of O
corticosteroids O
at O
low O
- O
to O
- O
moderate O
doses O
have O
been O
recommended O
to O
be O
used O
prudently O
for O
critically O
ill O
COVID O
- O
19 O
patients B-TERM
. O

At O
the O
time O
of O
writing O
, O
no O
effective B-TERM
antiviral O
therapy O
has O
been O
confirmed O
. O

However O
, O
intravenous O
administration O
with O
remdesivir O
, O
a O
nucleotide O
analog O
, O
has O
been O
found O
to O
be O
efficacious O
in O
an O
American O
patient B-TERM
with O
COVID O
- O
19 O
. O

Remdesivir O
is O
a O
novel O
antiviral O
drug O
developed O
by O
Gilead O
initially B-TERM
for O
the O
treatment O
of O
diseases B-TERM
caused B-TERM
by O
Ebola O
and O
Marlburg O
viruses O
. O

Later O
, O
remdesivir O
also B-TERM
demonstrated O
possible O
inhibition O
of O
other O
single O
stranded O
RNA O
viruses O
including O
MERS O
and O
SARS O
viruses O
. O

Based O
on O
these O
, O
Gilead O
has O
provided O
the O
compound O
to O
China O
to O
conduct O
a O
pair O
of O
trials O
on O
SARS O
- O
CoV O
- O
2 O
- O
infected O
individuals O
, O
and O
the O
results B-TERM
are O
highly O
anticipated O
. O

In O
addition B-TERM
, O
baricitinb O
, O
interferon O
- O
Œ± O
, O
lopinavir O
/ O
ritonavir O
, O
and O
ribavirin O
have O
been O
suggested O
as O
potential O
therapies O
for O
patients B-TERM
with O
acute O
respiratory O
symptoms O
. O

Diarrhea O
, O
nausea O
, O
vomiting O
, O
liver O
damage O
, O
and O
other O
adverse O
reactions O
can O
occur O
following O
combined O
therapy O
with O
lopinavir O
/ O
ritonavir O
. O

The O
interaction O
of O
these O
treatments O
with O
other O
drugs O
used O
in O
the O
patients B-TERM
should O
be O
monitored O
carefully O
. O

Plasma O
from O
recovered O
patients B-TERM
and O
antibody O
generation O

The O
collection O
of O
the O
blood B-TERM
from O
patients B-TERM
who O
recovered O
from O
a O
contagious O
disease B-TERM
to O
treat O
other O
patients B-TERM
suffering O
from O
the O
same O
disease B-TERM
or O
to O
protect O
healthy O
individuals O
from O
catching O
the O
disease O
has O
a O
long O
history O
. O

Indeed O
, O
recovered O
patients B-TERM
often B-TERM
have O
a O
relatively O
high O
level O
of O
antibodies O
against O
the O
pathogen O
in O
their O
blood B-TERM
. O

Antibodies O
are O
an O
immunoglobulin O
( O
Ig O
) O
produced O
by O
B O
lymphocytes O
to O
fight O
pathogens O
and O
other O
foreign O
objects B-TERM
and O
they O
recognize O
unique O
molecules O
in O
the O
pathogens O
and O
neutralize O
them O
directly O
. O

Based O
on O
this O
, O
plasma O
was O
collected O
from O
the O
blood O
of O
a O
group O
of O
patients B-TERM
who O
recovered O
from O
COVID O
- O
19 O
and O
was O
injected O
into O
10 O
seriously O
ill O
patients B-TERM
. O

Their O
symptoms O
improved O
within O
24 O
hours O
, O
accompanied O
by O
reduced O
inflammation O
and O
viral O
loads O
and O
improved O
oxygen O
saturation O
in O
the O
blood B-TERM
. O

However O
, O
verification O
and O
clarification O
are O
necessary O
to O
propose O
the O
method B-TERM
for O
large O
- O
scale O
use B-TERM
before O
specific O
therapies O
are O
not O
yet O
developed O
. O

In O
addition B-TERM
, O
given O
the O
therapeutic O
effects O
, O
some O
disadvantages O
associated O
with O
the O
plasma O
should O
be O
considered O
carefully O
. O

For O
example O
, O
antibodies O
can O
overstimulate O
the O
immune O
response O
and O
cause B-TERM
cytokine O
release O
syndrome O
, O
which O
is O
potentially O
a O
life O
- O
threatening O
toxicity O
. O

The O
concentration O
of O
antibodies O
in O
the O
blood B-TERM
is O
usually O
low O
, O
and O
the O
demand O
for O
the O
plasma O
is O
large O
to O
treat O
critically O
ill O
patients B-TERM
. O

It O
is O
difficult O
to O
develop O
and O
produce B-TERM
specific O
antibodies O
rapidly O
enough B-TERM
to O
fight O
against O
a O
global O
epidemic O
. O

Thus O
, O
it O
is O
more O
critical O
and O
practical O
to O
isolate O
B O
cells O
from O
recovered O
patients B-TERM
and O
identify O
the O
genetic O
codes O
encoding O
effective O
antibodies O
or O
screen O
for O
effective O
antibodies O
against O
essential O
proteins B-TERM
of O
the O
virus O
. O

This O
way O
, O
we O
can O
readily O
scale O
up O
the O
production O
of O
the O
antibodies O
. O

TCM O
has O
been O
used B-TERM
to O
treat O
a O
variety O
of O
diseases B-TERM
in O
China O
for O
thousands O
of O
years O
. O

However O
, O
its O
effects O
largely O
rely O
on O
a O
combination B-TERM
of O
multiple O
components B-TERM
in O
a O
formula B-TERM
that O
varies O
depending O
on O
the O
diagnosis O
of O
a O
disease B-TERM
based O
on O
the O
theories O
of O
TCM O
. O

Most O
of O
the O
effective B-TERM
components B-TERM
remain O
unknown B-TERM
or O
are O
vague O
as O
it O
is O
difficult O
to O
extract O
and O
verify O
such O
components O
or O
their O
optimal O
combinations B-TERM
. O

Currently O
, O
due O
to O
the O
lack B-TERM
of O
effective B-TERM
and O
specific O
therapy O
for O
COVID O
- O
19 O
, O
TCM O
has O
become O
one O
of O
the O
major O
alternative O
treatments O
for O
patients B-TERM
with O
light O
to O
moderate O
symptoms O
or O
for O
those O
who O
have O
recovered O
from O
severe O
stages B-TERM
. O

For O
example O
, O
Shu O
Feng O
Jie O
Du O
capsules O
and O
Lian O
Hua O
Qing O
Wen O
capsules O
were O
found O
to O
be O
effective B-TERM
for O
COVID O
- O
19 O
treatment O
. O

Top O
cure O
rates O
in O
the O
treatment O
of O
COVID O
- O
19 O
patients B-TERM
were O
observed O
in O
several O
provinces O
in O
China O
that O
used O
TCM O
in O
87 O
% O
of O
their O
patients B-TERM
, O
including O
Gansu O
( O
63.7 O
% O
) O
, O
Ningxia O
( O
50 O
% O
) O
, O
and O
Hunan O
( O
50 O
% O
) O
, O
whereas O
Hubei O
province O
, O
which O
used O
TCM O
in O
only O
approximately O
30 O
% O
of O
its O
COVID O
- O
19 O
patients B-TERM
, O
had O
the O
lowest O
cure O
rate O
( O
13 O
% O
) O
. O

However O
, O
this O
is O
quite B-TERM
a O
rough O
comparison O
as O
many O
other O
impact B-TERM
factors O
such O
as O
the O
number B-TERM
and O
severity O
of O
the O
patients B-TERM
should O
be O
included O
in O
the O
evaluation O
. O

On O
February O
18 O
, O
2020 O
, O
Boli O
Zhang O
and O
coworkers O
published B-TERM
a O
study B-TERM
to O
compare O
western O
medicine O
( O
WM O
) O
treatment O
alone O
with O
combined O
treatment O
of O
WM O
and O
TCM O
. O

They O
found O
that O
the O
times O
needed O
for O
body O
temperature O
recovery O
, O
symptom O
disappearance O
, O
and O
hospitalization O
were O
remarkably O
shorter O
in O
the O
WM O
+ O
TCM O
group O
than O
in O
the O
WM O
only O
group O
. O

Most O
impressively O
, O
the O
rate O
for O
symptomatic O
worsening O
( O
from O
light O
to O
severe O
) O
was O
remarkably O
lower O
for O
the O
WM O
+ O
TCM O
group O
than O
for O
the O
WM O
only O
group O
( O
7.4 O
% O
versus O
46.2 O
% O
) O
and O
the O
mortality O
was O
lower O
in O
the O
WM O
+ O
TCM O
group O
than O
WM O
only O
group O
( O
8.8 O
% O
versus O
39 O
% O
) O
. O

Nevertheless O
, O
the O
efficacy O
and O
safety O
of O
TCM O
still O
await O
more O
well O
- O
controlled O
trials O
at O
larger O
scales O
and O
in O
more O
centers O
. O

It O
would O
also B-TERM
be O
intriguing O
to O
characterize O
the O
mechanism O
of O
actions O
and O
clarify O
the O
effective O
components B-TERM
of O
TCM O
treatments O
or O
their O
combinations B-TERM
if O
possible O
. O

Patients B-TERM
with O
suspected O
or O
confirmed O
COVID O
- O
19 O
mostly B-TERM
experience O
great O
fear B-TERM
of O
the O
highly O
contagious O
and O
even O
fatal B-TERM
disease B-TERM
, O
and O
quarantined O
people O
also B-TERM
experience O
boredom O
, O
loneliness O
, O
and O
anger O
. O

Furthermore O
, O
symptoms O
of O
the O
infection O
such O
as O
fever O
, O
hypoxia O
, O
and O
cough O
as O
well O
as O
adverse O
effects O
of O
the O
treatments O
such O
as O
insomnia O
caused B-TERM
by O
corticosteroids O
can O
lead O
to O
more O
anxiety O
and O
mental O
distress O
. O

In O
the O
early O
phase O
of O
the O
SARS O
outbreak O
, O
a O
range O
of O
psychiatric O
morbidities O
including O
persistent O
depression O
, O
anxiety O
, O
panic O
attacks O
, O
psychomotor O
excitement O
, O
psychotic O
symptoms O
, O
delirium O
, O
and O
even O
suicidality O
were O
reported O
. O

Mandatory O
contact O
tracing O
and O
quarantine O
, O
as O
a O
part O
of O
the O
public O
health O
responses O
to O
the O
COVID O
- O
19 O
outbreak O
, O
can O
make O
people O
more O
anxious O
and O
guilty O
about O
the O
effects O
of O
the O
contagion O
, O
quarantine O
, O
and O
stigma O
on O
their O
families B-TERM
and O
friends B-TERM
. O

Thus O
, O
mental O
health O
care O
should O
be O
provided O
to O
COVID O
- O
19 O
patients B-TERM
, O
suspected O
individuals O
, O
and O
people O
in O
contact O
with O
them O
as O
well O
as O
the O
general O
public O
who O
are O
in O
need O
. O

The O
psychological O
support O
should O
include O
the O
establishment O
of O
multidisciplinary O
mental O
health O
teams O
, O
clear O
communications O
with O
regular O
and O
accurate O
updates O
about O
the O
SARS O
- O
CoV O
- O
2 O
outbreak O
and O
treatment O
plans B-TERM
and O
the O
use B-TERM
of O
professional B-TERM
electronic O
devices B-TERM
and O
applications B-TERM
to O
avoid O
close O
contact O
with O
each O
other O
. O

Effective B-TERM
vaccines B-TERM
are O
essential O
for O
interrupting O
the O
chain O
of O
transmission O
from O
animal B-TERM
reservoirs O
and O
infected O
humans O
to O
susceptible O
hosts O
and O
are O
often B-TERM
complementary O
to O
antiviral O
treatment O
in O
the O
control O
of O
epidemics O
caused B-TERM
by O
emerging O
viruses O
. O

Efforts O
have O
been O
made O
to O
develop O
S O
protein B-TERM
- O
based O
vaccines B-TERM
to O
generate O
long O
- O
term O
and O
potent O
neutralizing O
antibodies O
and O
/ O
or O
protective O
immunity O
against O
SARS O
- O
CoV O
. O

Live O
- O
attenuated O
vaccines B-TERM
have O
been O
evaluated O
in O
animal B-TERM
models O
for O
SARS O
. O

However O
, O
the O
in O
vivo O
efficacy O
of O
these O
vaccine B-TERM
candidates O
in O
elderly O
individuals O
and O
lethal B-TERM
- O
challenge O
models O
and O
their O
protection O
against O
zoonotic O
virus O
infection O
have O
yet O
to O
be O
determined O
before O
a O
clinical O
study B-TERM
is O
initiated O
. O

This O
is O
probably B-TERM
because O
SARS O
died O
down O
17 O
years O
ago O
and O
no O
new O
case O
has O
been O
reported O
since O
. O

In O
contrast O
, O
sporadic O
cases O
and O
clusters O
of O
MERS O
continue O
to O
occur O
in O
the O
Middle O
East O
and O
spread O
to O
other O
regions B-TERM
owing B-TERM
to O
the O
persistence O
of O
zoonotic O
sources O
in O
endemic O
areas O
. O

Vaccination B-TERM
strategies O
have O
been O
developed O
for O
MERS O
by O
using O
inactivated O
virus O
, O
DNA O
plasmids O
, O
viral O
vectors O
, O
nanoparticles O
, O
virus O
- O
like O
particles O
and O
recombinant O
protein B-TERM
subunits O
and O
some O
have O
been O
evaluated O
in O
animal B-TERM
models O
. O

The O
development O
of O
a O
safe O
and O
effective B-TERM
vaccine B-TERM
against O
SARS O
- O
CoV O
- O
2 O
for O
non O
- O
immune O
individuals O
is O
an O
urgent O
and O
critical O
task O
for O
controlling O
the O
ongoing O
epidemic O
. O

However O
, O
it O
is O
challenging O
to O
overcome O
the O
difficulty O
because O
of O
the O
long O
period O
of O
time O
( O
averaged O
18 O
months O
) O
needed B-TERM
for O
vaccine B-TERM
development O
and O
the O
dynamic O
variations O
of O
CoVs O
. O

As O
a O
novel O
disease B-TERM
, O
COVID O
- O
19 O
has O
just O
started O
to O
manifest O
its O
full O
clinical O
course O
throughout O
thousands O
of O
patients B-TERM
. O

In O
most O
cases O
, O
patients B-TERM
can O
recover O
gradually O
without O
sequelae O
. O

However O
, O
similar O
to O
SARS O
and O
MERS O
, O
COVID O
- O
19 O
is O
also B-TERM
associated O
with O
high O
morbidity O
and O
mortality O
in O
patients B-TERM
with O
severe O
cases O
. O

Therefore O
, O
building O
a O
prognosis O
model O
for O
the O
disease B-TERM
is O
essential O
for O
health O
- O
care O
agencies O
to O
prioritize O
their O
services O
, O
especially B-TERM
in O
resource O
- O
constrained O
areas B-TERM
. O

Based O
on O
clinical O
studies B-TERM
reported O
thus O
far O
, O
the O
following O
factors O
may O
affect O
or O
be O
associated O
with O
the O
prognosis O
of O
COVID O
- O
19 O
patients B-TERM
( O
Table O
( O
Table33 O
) O
: O

Age O
: O
Age O
was O
the O
most O
important B-TERM
factor O
for O
the O
prognosis O
of O
SARS O
, O
which O
is O
also B-TERM
true O
for O
COVID O
- O
19 O
. O

COVID O
- O
19 O
mainly O
happened O
at O
the O
age O
of O
30 O
- O
65 O
with O
47.7 O
% O
of O
those O
patients B-TERM
being O
over O
50 O
in O
a O
study B-TERM
of O
8,866 O
cases O
as O
described O
above O
. O

Patients B-TERM
who O
required O
intensive O
care O
were O
more O
likely O
to O
have O
underlying O
comorbidities O
and O
complications O
and O
were O
significantly O
older B-TERM
than O
those O
who O
did O
not O
( O
at O
the O
median O
age O
of O
66 O
versus O
51 O
) O
, O
suggesting O
age O
as O
a O
prognostic O
factor O
for O
the O
outcome O
of O
COVID O
- O
19 O
patients B-TERM
. O

Sex O
: O
SARS O
- O
CoV O
- O
2 O
has O
infected O
more O
men O
than O
women O
( O
0.31 O
/ O
100,000 O
versus O
0.27 O
/ O
100,000 O
) O
, O
as O
described O
above O
. O

Comorbidities O
and O
complications B-TERM
: O
Patients B-TERM
with O
COVID O
- O
19 O
who O
require O
intensive O
care O
are O
more O
likely O
to O
suffer O
from O
acute O
cardiac O
injury O
and O
arrhythmia O
. O

Cardiac O
events O
were O
also B-TERM
the O
main B-TERM
reason O
for O
death O
in O
SARS O
patients B-TERM
. O

It O
has O
been O
reported O
that O
SARS O
- O
CoV O
- O
2 O
can O
also B-TERM
bind O
to O
ACE2 O
- O
positive O
cholangiocytes O
, O
which O
might O
lead O
to O
liver O
dysfunctions O
in O
COVID O
- O
19 O
patients B-TERM
. O

It O
is O
worth O
noting O
that O
age O
and O
underlying O
disease B-TERM
are O
strongly O
correlated O
and O
might O
interfere O
with O
each O
other O
. O

Abnormal O
laboratory O
findings O
: O
The O
C O
- O
reactive O
protein B-TERM
( O
CRP O
) O
level O
in O
blood B-TERM
reflects O
the O
severity O
of O
inflammation O
or O
tissue O
injury O
and O
has O
been O
proposed O
to O
be O
a O
potential O
prognostic O
factor O
for O
disease B-TERM
, O
response B-TERM
to O
therapy O
, O
and O
ultimate O
recovery O
. O

The O
correlation O
of O
CRP O
level O
to O
the O
severity O
and O
prognosis O
of O
COVID O
- O
19 O
has O
also B-TERM
been O
proposed O
. O

In O
addition B-TERM
, O
elevated O
lactate O
dehydrogenase O
( O
LDH O
) O
, O
aspartate O
aminotransferase O
( O
AST O
) O
, O
alanine O
aminotransferase O
( O
ALT O
) O
, O
and O
creatine O
kinase O
( O
CK O
) O
may O
also B-TERM
help O
predict B-TERM
the O
outcome B-TERM
. O

These O
enzymes O
are O
expressed O
extensively O
in O
multiple O
organs O
, O
especially B-TERM
in O
the O
heart B-TERM
and O
liver O
, O
and O
are O
released O
during O
tissue O
damage O
. O

Thus O
, O
they O
are O
traditional O
markers O
for O
heart O
or O
liver O
dysfunctions O
. O

Major O
clinical O
symptoms O
: O
Chest O
radiography O
and O
temporal O
progression B-TERM
of O
clinical O
symptoms O
should O
be O
considered O
together O
with O
the O
other O
issues O
for O
the O
prediction O
of O
outcomes B-TERM
and O
complications B-TERM
of O
COVID O
- O
19 O
. O

Use O
of O
steroids O
: O
As O
described O
above O
, O
steroids O
are O
immunosuppressant O
commonly O
used O
as O
an O
adjunctive O
therapy O
for O
infectious O
diseases O
to O
reduce O
the O
severity O
of O
inflammatory O
damage O
. O

Since O
a O
high O
dosage O
of O
corticosteroids O
was O
widely O
used O
in O
severe O
SARS O
patients B-TERM
, O
many O
survivors O
suffered O
from O
avascular O
osteonecrosis O
with O
life O
- O
long O
disability O
and O
poor O
life O
quality B-TERM
. O

Thus O
, O
if O
needed O
, O
steroids O
should O
be O
used O
at O
low O
dosage O
and O
for O
a O
short O
time O
in O
COVID O
- O
19 O
patients B-TERM
. O

Mental O
stress O
: O
As O
described O
above O
, O
during O
the O
COVID O
- O
19 O
outbreak O
many O
patients B-TERM
have O
suffered O
from O
extraordinary O
stress O
as O
they O
often B-TERM
endured O
long O
periods O
of O
quarantine O
and O
extreme O
uncertainty O
and O
witnessed O
the O
death O
of O
close O
family O
members O
and O
fellow O
patients B-TERM
. O

It O
is O
imperative O
to O
provide O
psychological O
counseling O
and O
long O
- O
term O
support O
to O
help B-TERM
these O
patients B-TERM
recover O
from O
the O
stress O
and O
return O
to O
normal B-TERM
life O
. O

According O
to O
demographic O
studies B-TERM
so O
far O
, O
COVID O
- O
19 O
seems O
to O
have O
different O
epidemiological O
features O
from O
SARS O
. O

In O
addition B-TERM
to O
replicating O
in O
the O
lower O
respiratory O
tract O
, O
SARS O
- O
CoV O
- O
2 O
can O
efficiently O
replicate O
in O
the O
upper O
respiratory O
tract O
and O
causes O
mild O
or O
no O
symptoms O
in O
the O
early O
phase O
of O
infection O
, O
similar O
to O
other O
CoVs O
that O
cause B-TERM
common O
colds O
. O

Therefore O
, O
infected O
patients B-TERM
at O
the O
early O
phase O
or O
incubation O
period O
can O
produce O
a O
large O
amount O
of O
virus O
during O
daily O
activities O
, O
causing O
great O
difficulty O
for O
the O
control O
of O
the O
epidemic O
. O

However O
, O
the O
transmission O
of O
SARS O
- O
CoV O
was O
considered O
to O
occur O
when O
the O
patients B-TERM
are O
severely O
ill O
, O
while O
most O
transmission O
did O
not O
happen O
at O
the O
early O
phase O
. O

Thus O
, O
the O
current O
outbreak O
of O
COVID O
- O
19 O
is O
much O
more O
severe O
and O
difficult B-TERM
to O
control O
than O
the O
outbreak O
of O
SARS O
. O

Great O
efforts O
are O
currently O
underway O
in O
China O
including O
the O
lockdown O
of O
Wuhan O
and O
surrounding O
cities O
and O
continuous O
quarantine O
of O
almost O
the O
entire B-TERM
population O
in O
hopes O
of O
interrupting O
the O
transmission O
of O
SARS O
- O
CoV O
- O
2 O
. O

Although B-TERM
these O
actions O
have O
been O
dramatically O
damaging O
the O
economy O
and O
other O
sectors O
of O
the O
country O
, O
the O
number B-TERM
of O
new O
patients B-TERM
is O
declining O
, O
indicating O
the O
slowdown O
of O
the O
epidemic O
. O

The O
most O
optimistic O
estimate O
is O
that O
the O
outbreak O
will O
end O
by O
March O
and O
the O
downswing O
phase O
will O
last O
for O
3 O
- O
4 O
months O
. O

However O
, O
some O
other O
experts B-TERM
are O
not O
that O
optimistic O
. O

Paul O
Hunter O
, O
et O
al O
. O
, O
estimated O
that O
COVID O
- O
19 O
, O
which O
seems B-TERM
substantially O
more O
infectious O
than O
SARS O
, O
will O
not O
end O
in O
2020 O
. O

Ira O
Longini O
, O
et O
al O
. O
, O
established O
a O
model O
to O
predict O
the O
outcome O
of O
the O
epidemic O
and O
suggested O
that O
SARS O
- O
CoV O
- O
2 O
could O
infect O
two B-TERM
- O
thirds O
of O
the O
global O
population O
. O

A O
Canadian O
group O
reported O
that O
SARS O
- O
CoV O
- O
2 O
was O
detected O
in O
both O
mid O
- O
turbinate O
and O
throat O
swabs O
of O
patients B-TERM
who O
recovered O
and O
left O
the O
hospital O
2 O
weeks O
earlier O
, O
which O
indicates B-TERM
that O
the O
newly O
identified O
virus O
could O
become O
a O
cyclical B-TERM
episode O
similar O
to O
influenza O
. O

However O
, O
promising O
signs O
have O
occurred O
in O
China O
based O
on O
the O
declining B-TERM
number B-TERM
of O
new O
cases O
, O
indicating B-TERM
the O
current O
strategies O
might O
have O
been O
working O
. O

Ebola O
was O
originally O
predicted O
to O
cause O
up O
to O
a O
million O
cases O
with O
half O
a O
million O
deaths O
. O

However O
, O
via O
strict O
quarantine O
and O
isolation O
, O
the O
disease B-TERM
has O
eventually B-TERM
been O
put O
under O
control O
. O

It O
is O
possible O
, O
similar O
to O
SARS O
- O
CoV O
, O
that O
SARS O
- O
CoV O
- O
2 O
might O
become O
weaker O
in O
infectivity O
and O
eventually O
die O
down O
or O
become O
a O
less O
pathogenic O
virus O
co O
- O
existent O
with O
humans O
. O

A O
comparison O
of O
the O
epidemic O
of O
COVID O
- O
19 O
with O
that O
of O
SARS O
and O
MERS O
is O
provided O
below O
( O
Fig O
. O
( O
Fig.55 O
) O
. O

SARS O
- O
CoV O
- O
2 O
is O
highly O
transmittable O
through O
coughing O
or O
sneezing O
, O
and O
possibly B-TERM
also B-TERM
through O
direct O
contact O
with O
materials B-TERM
contaminated O
by O
the O
virus O
. O

The O
virus O
was O
also B-TERM
found O
in O
feces O
, O
which O
raises O
a O
new O
possibility O
of O
feces O
- O
to O
- O
mouth O
transmission O
. O

A O
recent B-TERM
study B-TERM
on O
138 O
cases O
reported O
that O
41 O
% O
of O
the O
cases O
were O
possibly B-TERM
caused O
by O
nosocomial O
infections O
, O
including O
17 O
patients B-TERM
with O
other O
prior O
diseases B-TERM
and O
40 O
health O
- O
care O
providers O
. O

Thus O
, O
great O
precaution O
should O
be O
used O
to O
protect O
humans O
, O
especially B-TERM
health O
- O
care O
providers O
, O
social O
workers O
, O
family O
members O
, O
colleagues O
, O
and O
even O
bystanders O
in O
contact O
with O
patients B-TERM
or O
infected O
people O
. O

The O
first O
line O
of O
defense O
that O
could O
be O
used O
to O
lower O
the O
risk O
of O
infection O
is O
through O
wearing O
face O
masks O
; O
both O
the O
use O
of O
surgical O
masks O
and O
N95 O
respirator O
masks O
( O
series O
# O
1860s O
) O
helps O
control O
the O
spread O
of O
viruses O
. O

Surgical O
face O
masks O
prevent O
liquid O
droplets O
from O
a O
potentially O
infected O
individual O
from O
traveling O
through O
the O
air B-TERM
or O
sticking O
onto O
surfaces O
of O
materials O
, O
where O
they O
could O
be O
passed O
on O
to O
others O
. O

However O
, O
only O
N95 O
( O
series O
# O
1860s O
) O
masks O
can O
protect B-TERM
against O
the O
inhalation O
of O
virions O
as O
small O
as O
10 O
to O
80 O
nm O
, O
with O
only O
5 O
% O
of O
the O
virions O
being O
able O
to O
penetrate O
completely O
; O
SARS O
- O
CoV O
- O
2 O
is O
similar O
to O
SARS O
- O
CoV O
in O
size B-TERM
and O
both O
are O
approximately B-TERM
85 O
nm O
. O

Since O
particles O
can O
penetrate O
even O
five O
surgical O
masks O
stacked O
together B-TERM
, O
health O
- O
care O
providers O
in O
direct O
contact O
with O
patients B-TERM
must O
wear O
N95 O
( O
series O
# O
1860s O
) O
masks O
but O
not O
surgical O
masks O
. O

In O
addition B-TERM
to O
masks O
, O
health O
- O
care O
providers O
should O
wear O
fitted O
isolation O
gowns O
in O
order O
to O
further O
reduce B-TERM
contact O
with O
viruses O
. O

Viruses O
can O
also B-TERM
infect O
an O
individual O
through O
the O
eyes B-TERM
. O

On O
January O
22 O
, O
2020 O
, O
a O
doctor B-TERM
was O
infected O
with O
SARS O
- O
CoV O
- O
2 O
although O
he O
wore O
an O
N95 O
mask O
; O
the O
virus O
might O
have O
entered O
his O
body O
through O
his O
inflammatory O
eyes B-TERM
. O

Thus O
, O
health O
- O
care O
providers O
should O
also B-TERM
wear O
transparent O
face O
shields O
or O
goggles O
while O
working O
with O
patients O
. O

For O
the O
general O
public O
in O
affected O
or O
potentially O
affected O
areas O
, O
it O
is O
highly O
suggested O
that O
everybody O
wash O
their O
hands O
with O
disinfectant O
soaps O
more O
often B-TERM
than O
usual B-TERM
, O
try B-TERM
to O
stay O
indoors O
for O
self O
- O
quarantine O
and O
limit O
contact O
with O
potentially O
infected O
individuals O
. O

Three O
feet O
is O
considered O
an O
appropriate O
distance B-TERM
for O
people O
to O
stay O
away O
from O
a O
patient B-TERM
. O

These O
actions O
are O
effective O
methods O
to O
lower O
the O
risk O
of O
infection O
as O
well O
as O
prevent O
the O
spread O
of O
the O
virus O
. O

Although O
SARS O
- O
CoV O
- O
2 O
came O
as O
a O
new O
virus O
to O
the O
human O
world O
, O
its O
high O
homology O
to O
SARS O
- O
CoV O
as O
reported O
on O
7 O
January O
2020 O
should O
have O
caused O
high O
alert O
to O
China O
based O
on O
her O
deep O
memory O
of O
the O
SARS O
outbreak O
in O
2003 O
. O

However O
, O
not O
until O
19 O
January O
2020 O
did O
the O
director O
of O
the O
Center O
of O
Disease B-TERM
Control O
of O
Wuhan O
comfort O
the O
citizens O
by O
saying O
that O
the O
novel O
virus O
has O
low O
contagiousness O
and O
limited O
reproductivity O
from O
human O
to O
human O
and O
that O
it O
is O
not O
a O
problem O
to O
prevent O
and O
contain O
the O
disease B-TERM
. O

This O
message O
remarkably O
relaxed O
the O
alarm O
of O
the O
public O
, O
especially B-TERM
when O
the O
entire B-TERM
country O
was O
preparing O
for O
the O
Spring O
Festival O
, O
and O
the O
critical O
time O
was O
missed O
to O
contain O
the O
disease B-TERM
at O
its O
minimal O
scale O
in O
Wuhan O
. O

The O
disease O
control O
agencies O
in O
China O
may O
take O
this O
hard O
lesson O
and O
make O
critical O
improvements B-TERM
in O
the O
future O
. O

For O
example O
, O
these O
agencies O
should O
be O
( O
1 O
) O
more O
careful O
when O
making O
public O
announcements O
as O
every O
word O
counts O
to O
citizens O
and O
can O
change O
their O
attitude O
and O
decisions B-TERM
; O
( O
2 O
) O
more O
sensitive O
and O
reactive O
to O
unusual B-TERM
information B-TERM
from O
clinics O
rather O
than O
waiting B-TERM
for O
formal O
reports O
from O
doctors B-TERM
or O
officials O
; O
( O
3 O
) O
more O
restrictive O
to O
contain O
a O
potential O
epidemic O
at O
its O
early O
stage B-TERM
rather O
than O
attempting O
to O
comfort O
the O
public O
; O
and O
( O
4 O
) O
more O
often B-TERM
to O
issue O
targeted O
and O
effective B-TERM
drills O
to O
increase O
the O
public O
's O
awareness O
about O
epidemic O
diseases B-TERM
and O
to O
test O
and O
improve O
the O
response O
system O
of O
the O
society O
periodically O
. O

The O
outbreak O
of O
COVID O
- O
19 O
caused B-TERM
by O
the O
novel O
virus O
SARS O
- O
CoV O
- O
2 O
started O
in O
the O
end B-TERM
of O
December O
2019 O
. O

In O
less O
than O
two B-TERM
months O
, O
it O
has O
spread O
all O
over O
China O
and O
near O
50 O
other O
countries O
globally O
at O
the O
time O
of O
this O
writing O
. O

Since O
the O
virus O
is O
very O
similar B-TERM
to O
SARS O
- O
CoV O
and O
the O
symptoms O
are O
also O
similar O
between O
COVID O
- O
19 O
and O
SARS O
, O
the O
outbreak O
of O
COVID O
- O
19 O
has O
created O
a O
sense B-TERM
of O
SARS O
recurring O
. O

However O
, O
there O
are O
some O
remarkable O
differences B-TERM
between O
COVID O
- O
19 O
and O
SARS O
, O
which O
are O
essential O
for O
containing O
the O
epidemic O
and O
treating O
the O
patients B-TERM
. O

COVID O
- O
19 O
affects O
more O
elderly O
individuals O
than O
youth O
and O
more O
men O
than O
women O
, O
and O
the O
severity O
and O
death O
rate O
are O
also B-TERM
higher O
in O
elderly O
individual O
than O
in O
youth O
. O

SARS O
has O
higher O
mortality O
than O
COVID O
- O
19 O
( O
10.91 O
% O
versus O
1.44 O
% O
) O
. O

COVID O
- O
19 O
patients O
transmit O
the O
virus O
even O
when O
they O
are O
symptomless O
whereas O
SARS O
patients B-TERM
do O
so O
usually O
when O
they O
are O
severely O
ill O
, O
which O
causes O
much O
greater O
difficulty O
to O
contain O
the O
spread O
of O
COVID O
- O
19 O
than O
SARS O
. O

This O
partially O
explains O
why O
SARS O
- O
CoV O
- O
2 O
spread O
much O
faster O
and O
broader O
than O
SARS O
- O
CoV O
. O

The O
regular O
RNA O
assay O
for O
SARS O
- O
CoV O
- O
2 O
can O
be O
negative O
in O
some O
COVID O
- O
19 O
patients B-TERM
. O

On O
the O
other O
hand O
, O
cured O
patients B-TERM
can O
be O
positive O
for O
the O
virus O
again O
. O

These O
findings O
dramatically O
increase O
the O
risk O
of O
virus O
spreading O
. O

Given O
such O
rapid B-TERM
progress O
in O
research O
on O
COVID O
- O
19 O
, O
several O
critical O
issues O
remain O
to O
be O
solved O
, O
as O
follows O
: O

Where O
did O
SARS O
- O
CoV O
- O
2 O
come O
from O
? O

Although O
96 O
% O
genetic O
homolog O
was O
found O
between O
SARS O
- O
CoV O
- O
2 O
and O
two B-TERM
bat O
SARS O
- O
like O
CoVs O
, O
we O
still O
cannot O
conclude O
that O
SARS O
- O
CoV O
- O
2 O
is O
from O
bats O
. O

What O
animal B-TERM
was O
the O
intermediate O
species O
to O
transmit O
the O
virus O
from O
the O
original O
host O
, O
say O
bats O
, O
to O
humans O
? O

Without O
knowing O
answers B-TERM
to O
# O
1 O
and O
2 O
, O
we O
cannot O
efficiently O
cut O
the O
transmission O
, O
and O
the O
outbreak O
can O
relapse O
at O
any O
time O
. O

Although O
molecular O
modeling O
and O
biochemical O
assays O
have O
demonstrated O
that O
SARS O
- O
CoV O
- O
2 O
binds O
to O
ACE2 O
, O
how O
exactly B-TERM
does O
the O
virus O
enter O
the O
airway O
cells O
and O
cause O
subsequent O
pathological O
changes B-TERM
? O

Does O
the O
virus O
also B-TERM
bind O
ACE2 O
- O
expressing O
cells O
in O
other O
organs O
? O

Without O
clear O
answers B-TERM
to O
these O
questions O
, O
we O
cannot O
achieve O
fast O
and O
accurate O
diagnosis O
and O
effective B-TERM
treatment O
. O

How O
long O
will O
the O
epidemic O
last O
? O

How O
is O
the O
virus O
genetically O
evolving B-TERM
during O
transmission O
among O
humans O
? O

Will O
it O
become O
a O
pandemic O
worldwide O
, O
die O
down O
like B-TERM
SARS O
or O
relapse O
periodically O
like B-TERM
the O
flu O
? O

It O
is O
essential O
but O
may O
take O
some O
time O
to O
search O
for O
answers B-TERM
to O
the O
above O
and O
many O
other O
questions O
. O

However O
, O
with O
whatever O
expense O
it O
may O
demand O
, O
we O
have O
no O
other O
choice B-TERM
but O
to O
stop O
the O
epidemic O
as O
soon B-TERM
as O
possible O
and O
bring O
our O
life O
back O
to O
normal B-TERM
. O

State O
Duma O
to O
check O
Voice B-TERM
of O
America O
, O
Meduza O
and O
BBC O
for O
violations O
of O
the O
law O

The O
State O
Duma O
committee O
for O
investigating O
foreign B-TERM
interference O
in O
Russia O
's O
internal O
affairs O
will O
check O
some O
mass O
media O
for O
infringements O
of O
Russian O
legislation O
. O

Interfax O
reports O
this O
citing O
committee O
head B-TERM
Vasily O
Piskarev O
. O

Meduza O
, O
MBKh O
Media O
, O
Voice B-TERM
of O
America O
, O
Current O
Time O
, O
Radio O
Liberty O
and O
BBC O
News O
Russian O
fell O
into O
the O
committee O
's O
field O
of O
view O
. O

Planned O
checks O
of O
the O
Google O
and O
Facebook O
services O
were O
previously O
reported O
. O

Piskarev O
also B-TERM
said O
that O
he O
will O
ask O
the O
Foreign O
Ministry O
to O
make O
a O
decision B-TERM
about O
the O
continued O
accreditation O
of O
Germany B-TERM
's O
Deutsche O
Welle O
, O
in O
the O
publications O
of O
which O
the O
committee O
found B-TERM
signs O
of O
justification O
of O
extremism O
. O

In O
September O
Roskomnadzor O
found O
political O
advertising O
in O
the O
Google O
, O
Facebook O
and O
YouTube O
services O
. O

According O
to O
the O
department O
's O
data B-TERM
, O
it O
occurred O
during O
the O
Russian O
elections O
of O
8 O
December O
. O

The O
State O
Duma O
committee O
was O
told O
of O
the O
violations O
. O

Later O
Google O
said O
the O
company B-TERM
supports O
responsible O
political O
advertising O
. O

In O
the O
opinion O
of O
staff B-TERM
, O
it O
is O
obliged O
to O
comply O
with O
the O
laws O
of O
the O
country O
. O

The O
company B-TERM
Facebook O
noted O
that O
compliance O
with O
electoral B-TERM
legislation O
is O
the O
responsibility O
of O
the O
advertiser O
, O
and O
not O
the O
platform O
. O

The O
head B-TERM
of O
Roskomnadzor O
Alexander O
Zharov O
accused O
the O
companies B-TERM
of O
applying O
double O
standards O
in O
the O
placement O
of O
political O
advertising O
. O

b O
'A O
COVID O
- O
19 O
vaccine O
is O
a O
hypothetical O
vaccine B-TERM
against O
coronavirus O
disease O
2019 O
( O
COVID O
- O
19 O
) O
. O

Although O
no O
vaccine B-TERM
has O
completed O
clinical O
trials O
, O
there O
are O
multiple O
attempts O
in O
progress O
to O
develop O
such O
a O
vaccine B-TERM
. O

In O
late O
February O
2020 O
, O
the O
World O
Health O
Organization B-TERM
( O
WHO O
) O
said O
it O
did O
not O
expect B-TERM
a O
vaccine B-TERM
against O
SARS O
- O
CoV O
- O
2 O
, O
the O
causative O
virus O
, O
to O
become O
available O
in O
less O
than O
18 O
months O
. O

Five O
vaccine B-TERM
candidates O
were O
in O
Phase O
I O
safety O
studies B-TERM
in O
April O
. O

COVID O
- O
19 O
was O
identified O
in O
December O
2019 O
. O

A O
major O
outbreak O
spread O
around O
the O
world O
in O
2020 O
, O
leading O
to O
considerable B-TERM
investment O
and O
research O
activity B-TERM
to O
develop O
a O
vaccine B-TERM
. O

Many O
organizations B-TERM
are O
using B-TERM
published B-TERM
genomes O
to O
develop O
possible B-TERM
vaccines B-TERM
against O
SARS O
- O
CoV O
- O
2 O
. O

Stated O
in O
April O
, O
imperatives O
of O
the O
CEPI O
initiative O
for O
vaccine B-TERM
development O
are O
speed B-TERM
, O
manufacturing O
capacity O
, O
deployment O
at O
scale O
, O
and O
global O
access O
. O

In O
April O
, O
CEPI O
scientists O
reported O
that O
10 O
different O
technology O
platforms O
were O
under O
research O
and O
development O
during O
early O
2020 O
to O
create O
an O
effective B-TERM
vaccine B-TERM
against O
COVID O
- O
19 O
. O

Major O
platform O
targets B-TERM
advanced O
into O
Phase O
I O
safety O
studies B-TERM
include O
: O

nucleic O
acid O
( O
DNA O
and O
RNA O
) O
( O
Phase O
I O
developer O
and O
vaccine B-TERM
candidate O
: O
Moderna O
, O
mRNA O
- O
1273 O
) O

viral O
vector O
( O
Phase O
I O
developer O
and O
vaccine B-TERM
candidate O
: O
CanSino O
Biologics O
, O
adenovirus O
type B-TERM
5 O
vector O
) O

As O
reported O
by O
CEPI O
scientists O
in O
April O
, O
115 O
total O
vaccine B-TERM
candidates O
are O
in O
early O
stages B-TERM
of O
development O
, O
with O
78 O
confirmed O
as O
active B-TERM
projects B-TERM
( O
79 O
, O
according O
to O
the O
Milken O
Institute O
) O
, O
and O
37 O
others O
announced B-TERM
, O
but O
with O
little O
public O
information B-TERM
available O
( O
presumed O
to O
be O
in O
planning O
or O
being O
designed O
) O
. O

A O
Phase O
I O
- O
II O
trial O
conducts O
preliminary O
safety O
and O
immunogenicity O
testing O
, O
is O
typically O
randomized O
, O
placebo O
- O
controlled O
, O
and O
at O
multiple O
sites O
, O
while O
determining O
more O
precise O
, O
effective B-TERM
doses O
. O

Phase O
III O
trials O
typically O
involve O
more O
participants O
, O
including O
a O
control O
group O
, O
and O
test O
effectiveness B-TERM
of O
the O
vaccine O
to O
prevent O
the O
disease B-TERM
, O
while O
monitoring O
for O
adverse O
effects O
at O
the O
optimal O
dose O
. O

Of O
79 O
vaccine B-TERM
candidates O
in O
active B-TERM
development O
( O
confirmed O
as O
of O
early O
April O
2020 O
) O
, O
74 O
were O
not O
yet O
in O
human O
evaluation O
( O
still O
in O
" O
preclinical O
" O
research O
) O
. O

Around O
24 O
January O
2020 O
in O
Australia O
, O
the O
University O
of O
Queensland O
announced B-TERM
that O
it O
is O
investigating O
the O
potential O
of O
a O
molecular O
clamp O
vaccine B-TERM
that O
would O
genetically O
modify O
viral O
proteins B-TERM
in O
order O
to O
stimulate O
an O
immune O
reaction O
. O

Around O
24 O
January O
2020 O
in O
Canada O
, O
the O
International O
Vaccine O
Centre O
( O
VIDO O
- O
InterVac O
) O
at O
the O
University O
of O
Saskatchewan O
announced B-TERM
the O
commencement O
of O
work O
on O
a O
vaccine B-TERM
, O
aiming B-TERM
to O
start O
human O
testing O
in O
2021 O
. O

Vaccine B-TERM
development O
projects B-TERM
were O
announced B-TERM
at O
the O
Chinese O
Center O
for O
Disease B-TERM
Control O
and O
Prevention O
on O
26 O
January O
2020 O
, O
and O
the O
University O
of O
Hong O
Kong O
on O
28 O
January O
. O

Around O
29 O
January O
2020 O
, O
Janssen O
Pharmaceutical O
Companies B-TERM
, O
led O
by O
Hanneke O
Schuitemaker O
, O
announced B-TERM
that O
it O
had O
begun O
work O
on O
developing O
a O
vaccine B-TERM
. O

Janssen O
is O
co O
- O
developing O
an O
oral O
vaccine B-TERM
with O
its O
biotechnology O
partner O
, O
Vaxart O
. O

On O
18 O
March O
2020 O
, O
Emergent O
BioSolutions O
announced B-TERM
a O
manufacturing O
partnership O
with O
Vaxart O
to O
develop O
the O
vaccine B-TERM
. O

On O
8 O
February O
2020 O
, O
the O
laboratory O
OncoGen O
in O
Romania O
published B-TERM
a O
paper O
on O
the O
design O
of O
a O
vaccine B-TERM
with O
similar B-TERM
technology O
to O
the O
one O
used O
for O
cancer O
neoantigen O
vaccination B-TERM
therapy O
. O

On O
25 O
March O
the O
head B-TERM
of O
the O
research O
institute O
announced B-TERM
that O
they O
had O
finalized O
the O
synthesis O
of O
the O
vaccine B-TERM
and O
were O
beginning O
the O
tests O
. O

On O
27 O
February O
2020 O
, O
a O
Generex O
subsidiary O
company B-TERM
, O
NuGenerex O
Immuno O
- O
Oncology O
, O
announced B-TERM
they O
were O
beginning O
a O
vaccine B-TERM
project B-TERM
to O
create O
an O
Ii O
- O
Key O
peptide O
vaccine O
against O
COVID O
- O
19 O
. O

They O
wanted O
to O
produce O
a O
vaccine B-TERM
candidate O
that O
could O
be O
tested O
in O
humans O
" O
within O
90 O
days O
. O
" O

On O
5 O
March O
2020 O
, O
Washington O
University O
in O
St. O
Louis O
announced B-TERM
its O
projects B-TERM
to O
develop O
a O
vaccine B-TERM
. O

On O
5 O
March O
2020 O
, O
the O
United O
States O
Army O
Medical O
Research O
and O
Materiel O
Command O
at O
Fort O
Detrick O
and O
the O
Walter O
Reed O
Army O
Institute O
of O
Research O
in O
Silver O
Spring O
, O
both O
in O
western O
Maryland O
, O
announced B-TERM
they O
were O
working O
on O
a O
vaccine B-TERM
. O

Around O
10 O
March O
2020 O
, O
Emergent O
Biosolutions O
announced B-TERM
that O
it O
had O
teamed O
with O
Novavax O
Inc O
. O

in O
the O
development O
and O
manufacture O
of O
a O
vaccine B-TERM
. O

The O
partners O
further O
announced B-TERM
plans B-TERM
for O
preclinical O
testing O
and O
a O
Phase O
I O
clinical O
trial O
by O
July O
2020 O
. O

On O
12 O
March O
2020 O
, O
India O
's O
Health O
Ministry O
announced B-TERM
they O
are O
working O
with O
11 O
isolates O
, O
and O
that O
even O
on O
a O
fast O
track O
it O
would O
take O
at O
least O
around O
one O
- O
and O
- O
a O
- O
half O
to O
two B-TERM
years O
to O
develop O
a O
vaccine B-TERM
. O

On O
12 O
March O
2020 O
, O
Medicago O
, O
a O
biotechnology O
company B-TERM
in O
Quebec O
City O
, O
Quebec O
, O
reported O
development O
of O
a O
coronavirus O
- O
like O
particle O
under O
partial O
funding O
from O
the O
Canadian O
Institutes O
for O
Health O
Research O
. O

The O
vaccine B-TERM
candidate O
is O
in O
laboratory O
research O
, O
with O
human O
testing O
planned O
for O
July O
or O
August O
2020 O
. O

Earlier O
that O
week O
, O
The O
Guardian O
reported O
that O
the O
US O
President O
Donald O
Trump O
had O
offered O
CureVac O
" O
' O
large O
sums O
of O
money O
' O
for O
exclusive O
access O
to O
a O
Covid O
- O
19 O
vaccine B-TERM
, O
" O
against O
which O
the O
German O
government O
protested O
. O

On O
17 O
March O
2020 O
, O
American O
pharmaceutical O
company B-TERM
Pfizer O
announced B-TERM
a O
partnership O
with O
German B-TERM
company B-TERM
BioNTech O
to O
jointly O
develop O
a O
mRNA O
- O
based O
vaccine O
. O

mRNA O
- O
based O
vaccine B-TERM
candidate O
BNT162 O
, O
currently O
in O
pre O
- O
clinical O
testing O
with O
clinical O
trials O
expected O
to O
begin O
in O
April O
2020 O
. O

In O
Italy O
on O
17 O
March O
2020 O
, O
Takis O
Biotech O
, O
an O
Italian O
biotech O
company B-TERM
announced B-TERM
they O
will O
have O
pre O
- O
clinical O
testing O
results B-TERM
in O
April O
2020 O
and O
their O
final O
vaccine B-TERM
candidate O
could O
begin O
human O
testing O
by O
fall O
. O

In O
France O
on O
19 O
March O
2020 O
, O
the O
Coalition O
for O
Epidemic O
Preparedness O
Innovations O
( O
CEPI O
) O
announced B-TERM
a O
US O
$ O
4.9 O
million O
investment O
in O
a O
COVID O
- O
19 O
vaccine B-TERM
research O
consortium O
involving O
the O
Institut O
Pasteur O
, O
Themis O
Bioscience O
( O
Vienna O
, O
Austria O
) O
, O
and O
the O
University O
of O
Pittsburgh O
, O
bringing O
CEPI O
's O
total O
investment O
in O
COVID O
- O
19 O
vaccine B-TERM
development O
to O
US O
$ O
29 O
million O
. O

CEPI O
's O
other O
investment O
partners O
for O
COVID O
- O
19 O
vaccine B-TERM
development O
are O
Moderna O
, O
Curevac O
, O
Inovio O
, O
Novavax O
, O
the O
University O
of O
Hong O
Kong O
, O
the O
University O
of O
Oxford O
, O
and O
the O
University O
of O
Queensland O
. O

On O
20 O
March O
2020 O
, O
Russian O
health O
officials O
announced B-TERM
that O
scientists O
have O
begun O
animal B-TERM
testing O
of O
six O
different O
vaccine B-TERM
candidates O
. O

Imperial O
College O
London O
researchers O
announced B-TERM
on O
20 O
March O
2020 O
that O
they O
are O
developing O
a O
self O
- O
amplifying O
RNA O
vaccine B-TERM
for O
COVID O
- O
19 O
. O

The O
vaccine B-TERM
candidate O
was O
developed O
within O
14 O
days O
of O
receiving O
the O
sequence B-TERM
from O
China O
. O

In O
late O
March O
, O
the O
Canadian O
government O
announced B-TERM
C O
$ O
275 O
million O
in O
funding O
for O
96 O
research O
projects B-TERM
on O
medical O
countermeasures O
against O
COVID O
- O
19 O
, O
including O
numerous O
vaccine B-TERM
candidates O
at O
Canadian O
companies B-TERM
and O
universities O
, O
such O
as O
the O
Medicago O
and O
University O
of O
Saskatchewan O
initiatives O
. O

Around B-TERM
the O
same O
time O
, O
the O
Canadian O
government O
announced B-TERM
C O
$ O
192 O
million O
specifically O
for O
developing O
a O
COVID O
- O
19 O
vaccine B-TERM
, O
with O
plans B-TERM
to O
establish O
a O
national O
" O
vaccine O
bank O
" O
of O
several O
new O
vaccines B-TERM
that O
could O
be O
used B-TERM
if O
another O
coronavirus O
outbreak O
occurs O
. O

On O
2 O
April O
2020 O
, O
researchers O
at O
the O
University O
of O
Pittsburgh O
School O
of O
Medicine O
reported O
on O
testing O
of O
PittCoVacc O
, O
a O
possible B-TERM
COVID O
- O
19 O
vaccine B-TERM
in O
mice O
, O
stating O
that O
" O
MNA O
delivered O
SARS O
- O
CoV O
- O
2 O
S1 O
subunit O
vaccines B-TERM
elicited O
potent O
antigen O
- O
specific O
antibody O
responses B-TERM
[ O
in O
the O
mice O
] O
that O
were O
evident O
beginning O
2 O
weeks O
after O
immunization O
. O
" O

In O
Canada O
on O
16 O
April O
2020 O
, O
the O
University O
of O
Waterloo O
School O
of O
Pharmacy O
announced B-TERM
design O
of O
a O
DNA O
- O
based O
vaccine B-TERM
candidate O
as O
a O
possible O
nasal O
spray O
. O

Using O
bacteriophages O
, O
the O
DNA O
will O
be O
designed O
to O
replicate O
inside O
human O
bacteria O
to O
produce O
harmless O
virus O
- O
like O
particles O
, O
which O
may O
stimulate O
the O
immune O
system O
to O
produce O
antibodies O
against O
the O
SARS O
- O
CoV O
- O
2 O
virus O
. O

In O
March O
2020 O
, O
the O
US O
government O
, O
industry B-TERM
, O
and O
three O
universities O
pooled O
resources O
to O
access O
supercomputers O
from O
IBM O
, O
combined B-TERM
with O
cloud O
computing O
resources O
from O
Hewlett O
Packard O
Enterprise O
, O
Amazon O
, O
Microsoft O
, O
and O
Google O
. O

Some O
vaccines B-TERM
have O
heterologous O
effects O
, O
also B-TERM
called B-TERM
non O
- O
specific O
effects O
. O

That O
means B-TERM
they O
can O
have O
benefits O
beyond B-TERM
the O
disease B-TERM
they O
prevent O
. O

A O
further O
randomized O
trial O
in O
Australia O
is O
seeking O
to O
enrol O
4,170 O
healthcare O
workers O
. O

It O
is O
possible O
vaccines B-TERM
in O
development O
will O
not O
be O
safe O
or O
effective O
. O

Early O
research O
to O
assess O
vaccine O
efficacy O
using O
COVID O
- O
19 O
- O
specific O
animal B-TERM
models O
, O
such O
as O
ACE2 O
- O
transgenic O
mice O
, O
other O
laboratory O
animals B-TERM
, O
and O
non O
- O
human O
primates O
, O
indicate O
a O
need O
for O
biosafety O
- O
level O
3 O
containment O
measures B-TERM
for O
handling O
live O
viruses O
, O
and O
international O
coordination O
to O
ensure O
standardized O
safety O
procedures O
. O

Vaccines B-TERM
against O
SARS O
and O
MERS O
have O
been O
tested O
in O
non O
- O
human O
animal B-TERM
models O
. O

As O
of O
2020 O
, O
there O
is O
no O
cure O
or O
protective O
vaccine B-TERM
for O
SARS O
that O
has O
been O
shown O
to O
be O
both O
safe O
and O
effective B-TERM
in O
humans O
. O

According O
to O
research O
papers O
published B-TERM
in O
2005 O
and O
2006 O
, O
the O
identification O
and O
development O
of O
novel O
vaccines B-TERM
and O
medicines O
to O
treat O
SARS O
was O
a O
priority O
for O
governments O
and O
public O
health O
agencies O
around O
the O
world.There O
is O
also B-TERM
no O
proven O
vaccine B-TERM
against O
MERS O
. O

When O
MERS O
became O
prevalent O
, O
it O
was O
believed O
that O
existing O
SARS O
research O
may O
provide O
a O
useful O
template O
for O
developing O
vaccines B-TERM
and O
therapeutics O
against O
a O
MERS O
- O
CoV O
infection O
. O

As O
of O
March O
2020 O
, O
there O
was O
one O
( O
DNA O
based O
) O
MERS O
vaccine B-TERM
which O
completed O
phase O
I O
clinical O
trials O
in O
humans O
, O
and O
three O
others O
in O
progress O
, O
all O
of O
which O
are O
viral O
- O
vectored O
vaccines B-TERM
, O
two B-TERM
adenoviral O
- O
vectored O
( O
ChAdOx1 O
- O
MERS O
, O
BVRS O
- O
GamVac O
) O
, O
and O
one O
MVA O
- O
vectored O
( O
MVA O
- O
MERS O
- O
S O
) O
. O

Social O
media O
posts O
have O
promoted O
a O
conspiracy O
theory O
claiming O
the O
virus O
behind O
COVID O
- O
19 O
was O
known O
and O
that O
a O
vaccine B-TERM
was O
already O
available O
. O

The O
patents O
cited O
by O
various O
social O
media O
posts O
reference O
existing O
patents O
for O
genetic O
sequences B-TERM
and O
vaccines B-TERM
for O
other O
strains O
of O
coronavirus O
such O
as O
the O
SARS O
coronavirus O
. O

Stoltenberg O
discussed O
Ukraine O
's O
accession O
to O
NATO O
with O
Zelensky O

Secretary O
- O
General O
of O
NATO O
Jens O
Stoltenberg O
and O
Ukrainian O
President O
Volodymyr O
Zelensky O
discussed O
Ukraine O
's O
membership O
of O
the O
alliance B-TERM
at O
the O
74th O
session O
of O
the O
UN O
General O
Assembly O
. O

The O
secretary O
- O
general O
spoke O
of O
the O
discussions O
during O
his O
appearance O
at O
Columbia O
University O
in O
New O
York O
. O

Answering B-TERM
a O
question O
regarding O
whether O
the O
issue O
was O
raised O
during O
their O
meeting O
, O
Stoltenberg O
said O
that O
they O
did O
actually O
discuss O
the O
question O
and O
also B-TERM
stressed O
that O
he O
did O
not O
set O
a O
time O
frame O
for O
Ukraine O
's O
entry B-TERM
. O

According O
to O
him O
, O
any O
country O
that O
wanted B-TERM
to O
join O
the O
North O
Atlantic O
alliance B-TERM
had O
to O
meet O
certain O
requirements B-TERM
dictating O
concrete O
standards O
, O
RT O
reported O
. O

Alternative O
to O
the O
NATO O
path O
suggested O
to O
Zelensky O
in O
Crimea O

Instead O
of O
pursuing O
NATO O
accession O
the O
president O
of O
Ukraine O
Volodymyr O
Zelensky O
should O
work O
on O
establishing O
good O
neighborly O
relations O
with O
Russia O
. O

The O
co O
- O
chair O
of O
the O
Assembly O
of O
Slavic O
Peoples O
of O
the O
Republic O
of O
Crimea O
Roman O
Chegrinets O
spoke O
about O
this O
on O
Friday O
, O
27 O
September O
. O

" O
Sir O
president O
of O
Ukraine O
should O
not O
repeat O
the O
mistakes O
of O
his O
predecessor O
, O
but O
heed O
the O
advice B-TERM
of O
[ O
US O
president O
] O
Donald O
Trump O
, O
which O
he O
listened O
to O
with O
a O
sour O
face B-TERM
, O
and O
improve O
relations O
with O
the O
president O
of O
Russia O
, O
" O
Chegrinets O
told O
RIA O
Novosti O
journalists O
. O

Chegrinets O
noted O
that O
he O
finds O
Zelensky O
to O
be O
a O
good O
actor O
, O
but O
a O
bad B-TERM
politician O
. O

In O
his O
words O
, O
the O
Ukrainian O
president O
will O
be O
able O
to O
remain O
in O
power B-TERM
only O
if O
relations O
improve O
with O
Russia O
. O

Earlier O
on O
27 O
September O
the O
NATO O
Secretary O
General O
Jens O
Stoltenberg O
said O
that O
he O
had O
a O
conversation B-TERM
with O
Zelensky O
on O
the O
subject O
of O
the O
country O
's O
accession O
to O
the O
alliance B-TERM
. O

In O
his O
words O
, O
for O
this O
Ukraine O
must O
fulfill B-TERM
certain O
conditions B-TERM
. O

On O
5 O
June O
Rada O
deputy O
Yevgeny O
Balitsky O
said O
that O
the O
possible B-TERM
accession O
of O
Ukraine O
to O
the O
alliance B-TERM
does O
not O
guarantee O
improved O
life O
in O
the O
country O
. O

Money O
is O
more O
important B-TERM
than O
football O
. O

Barcelona O
is O
coercing O
Neymar O

Spanish O
club O
Barcelona O
and O
its O
former B-TERM
Brazilian O
football O
player O
Neymar O
are O
attempting B-TERM
to O
resolve O
a O
financial O
dispute B-TERM
, O
which O
arose O
after O
the O
striker O
's O
move O
to O
French O
club O
Paris O
Saint O
- O
Germain O
. O

The O
matter O
almost O
reached O
the O
courts O
, O
but O
the O
Catalonians O
offered O
the O
player O
a O
resolution O
without O
the O
need O
for O
the O
courts O
' O
involvement O
. O

Otherwise O
, O
they O
refused O
to O
allow O
his O
return O
. O

Neymar O
and O
his O
astute O
father B-TERM
, O
who O
is O
also B-TERM
the O
Brazilian O
's O
agent O
, O
contrived O
an O
interesting O
maneuverer O
: O
according O
to O
the O
agreement B-TERM
with O
Barcelona O
, O
which O
the O
player O
signed O
in O
2016 O
, O
he O
was O
due O
to O
receive B-TERM
40 O
million O
euros O
. O

However O
, O
after O
literally O
one O
year O
, O
the O
forward O
moved O
to O
Paris O
Saint O
- O
Germain O
for O
a O
record O
222 O
million O
euros O
. O

Nonetheless O
, O
he O
received B-TERM
22 O
million O
from O
the O
Catalonians O
and O
now O
wants B-TERM
to O
claim O
the O
remaining O
18 O
million O
. O

Moreover O
, O
the O
Brazilian O
's O
lawyers O
insist O
that O
the O
club O
owes O
him O
interest O
for O
late O
payments O
. O

When O
Neymar O
's O
demands O
became O
known O
in O
the O
capital O
of O
Catalonia O
, O
Barcelona O
filed O
a O
counterclaim O
. O

The O
club O
insists O
that O
the O
bonus B-TERM
is O
dependent O
on O
the O
entire B-TERM
contract B-TERM
being O
fulfilled O
- O
from O
2016 O
to O
2022 O
. O

As O
such O
, O
the O
club O
considers B-TERM
that O
the O
player O
is O
entitled O
to O
only O
one O
- O
quarter O
of O
the O
40 O
million O
euros O
and O
demands O
the O
return O
of O
a O
portion B-TERM
of O
the O
first O
payment O
. O

But O
most O
interestingly O
, O
Neymar O
and O
Barcelona O
almost O
agreed O
that O
the O
" O
prodigal O
" O
player O
would O
return O
to O
Catalonia O
's O
fold O
in O
summer O
. O

But O
the O
agreement O
collapsed O
, O
however O
, O
hope O
remains O
that O
the O
forward O
will O
return O
. O

Citing O
insiders O
, O
Sports.ru O
reports O
that O
the O
club O
's O
lawyers O
informed B-TERM
the O
player O
's O
representatives O
that O
if O
the O
financial O
demands O
are O
not O
settled O
out O
of O
court O
, O
then O
the O
Brazilian O
's O
return O
can O
be O
ruled O
out O
. O

Neymar O
himself O
wants B-TERM
so O
strongly O
to O
return O
that O
he O
has O
asked O
for O
guarantees O
that O
the O
Catalonians O
will O
buy O
him O
back O
. O

Mart O
Laar O
: O
EKRE O
members O
will O
not O
join O
the O
Bank O
of O
Estonia O
council O

Members O
of O
EKRE O
have O
not O
been O
, O
nor O
will O
they O
be O
, O
invited O
to O
join O
the O
council O
. O

Conclusions B-TERM
are O
drawn O
on O
the O
credibility O
of O
the O
Estonian O
state B-TERM
based O
on O
the O
composition O
of O
the O
Bank O
of O
Estonia O
's O
council O
. O

As O
long O
as O
members O
of O
the O
EKRE O
continue O
to O
speak B-TERM
before O
they O
think B-TERM
, O
none O
of O
them O
will O
be O
invited O
to O
join O
the O
council O
. O

" O
The O
Chairman O
of O
the O
Supervisory O
Board O
of O
Eesti O
Pank O
cannot O
go O
and O
apologize O
for O
the O
statements O
made O
by O
members O
of O
the O
Supervisory O
Board O
, O
" O
Laar O
said O
in O
an O
interview O
with O
Delfi O
, O
reported O
by O
the O
ERR O
information O
portal O
. O

Laar O
noted O
, O
however O
, O
that O
EKRE O
is O
represented O
at O
Eesti O
Pank O
council O
meetings O
. O

Beside O
Laar O
, O
the O
current O
, O
seventh O
composition O
of O
the O
council O
includes O
Liina O
Tonisson O
, O
Kaie O
Kerem O
, O
Urmas O
Varblane O
, O
Kalev O
Kallo O
, O
Jaanus O
Tamkivi O
( O
Estonian O
Reform B-TERM
Party O
) O
, O
Enn O
Listra O
and O
Rein O
Minka O
. O

Laar O
is O
proposing O
to O
replace B-TERM
two B-TERM
member O
of O
the O
council O
- O
Tonisson O
and O
Kallo O
- O
in O
their O
place B-TERM
would O
be O
invited O
Enn O
Eesmaa O
( O
Estonian O
Centre O
Party O
) O
and O
Ivari O
Padar O
( O
Social O
Democratic O
Party O
) O
. O

Meanwhile O
, O
the O
Estonian O
Reform B-TERM
Party O
would O
like O
to O
see O
Jaanus O
Tamkivi O
replaced O
on O
the O
council O
by O
Andres O
Sutt O
. O

In O
response O
to O
this O
, O
Laar O
said O
that O
the O
Estonian O
Reform B-TERM
Party O
's O
goal B-TERM
was O
to O
receive B-TERM
two B-TERM
seats O
on O
the O
Bank O
of O
Estonia O
's O
council O
- O
so O
that O
Andres O
Sutt O
joined O
the O
board O
in O
addition B-TERM
to O
Jaanus O
Tamkivi O
. O

On O
Tuesday O
, O
September O
24 O
, O
Riigikogu O
declined O
Laar O
's O
proposal O
to O
invite O
new O
members O
to O
the O
Bank O
of O
Estonia O
's O
council O
. O

Russian O
MFA O
commented O
on O
scandal O
in O
Kyrgyzstan O
with O
Malakhov O
's O
show O

The O
Russian O
MFA O
commented O
on O
the O
situation B-TERM
with O
the O
outrage B-TERM
caused B-TERM
by O
an O
episode O
of O
Andrei O
Malakhov O
's O
progam O
" O
Live O
, O
" O
reports O
RIA O
Novosti O
. O

Earlier O
, O
the O
Russian O
diplomat O
was O
called O
to O
the O
Kyrgyz O
MFA O
after O
the O
show O
aired O
. O

The O
republic O
's O
MFA O
believes B-TERM
the O
host O
made O
some O
inappropriate O
statements O
regarding B-TERM
the O
situation B-TERM
with O
the O
Kyrgyzstani O
citizen O
Islambek O
Akbarov O
, O
who O
was O
involved O
in O
an O
accident O
in O
which O
the O
Russian O
Alexander O
Marugov O
died O
. O

Malakhov O
said O
that O
the O
Kyrgyzstani O
citizen O
could O
have O
faked O
the O
accident B-TERM
. O

The O
accident O
occurred O
on O
July O
8 O
in O
Moscow O
. O

Marugov O
crashed O
on O
a O
motorcyle O
into O
the O
taxi O
Akbarov O
was O
driving O
. O

According O
to O
preliminary O
information B-TERM
, O
the O
taxi O
driver O
is O
at O
fault O
for O
the O
accident B-TERM
. O

Malakhov O
, O
who O
Kyrgyzstani O
citizens O
demanded O
an O
apology O
from O
, O
said O
his O
words O
were O
simply O
his O
personal B-TERM
opinion O
. O

As O
the O
Russian O
Diplomatic O
Department O
explained O
, O
the O
Kyrgyz O
MFA O
did O
not O
summon O
the O
Russian O
diplomats O
- O
there O
was O
a O
planned O
working O
visit O
during O
which O
they O
discussed O
the O
host O
's O
statements O
, O
among O
other O
issues O
. O

" O
Andrei O
Malakhov O
's O
point O
of O
view O
is O
the O
opinion O
of O
a O
journalist O
, O
his O
personal B-TERM
view O
of O
the O
situation B-TERM
, O
" O
the O
MFA O
said O
, O
noting O
that O
the O
incident B-TERM
does O
not O
affect O
Russian O
- O
Kyrgyzstani O
interstate O
relations O
. O

b O
'Angiotensin O
- O
converting O
enzyme O
2 O
( O
ACE2 O
) O
is O
an O
enzyme O
attached O
to O
the O
outer O
surface O
( O
cell O
membranes O
) O
of O
cells O
in O
the O
lungs O
, O
arteries O
, O
heart B-TERM
, O
kidney O
, O
and O
intestines O
. O

ACE2 O
counters O
the O
activity B-TERM
of O
the O
related O
angiotensin O
- O
converting O
enzyme O
( O
ACE O
) O
by O
reducing B-TERM
the O
amount O
of O
angiotensin O
- O
II O
and O
increasing O
Ang O
( O
1 O
- O
7 O
) O
making O
it O
a O
promising O
drug O
target O
for O
treating O
cardiovascular O
diseases.ACE2 O
also B-TERM
serves O
as O
the O
entry O
point O
into O
cells O
for O
some O
coronaviruses O
. O

The O
human O
version O
of O
the O
enzyme O
is O
often B-TERM
referred O
to O
as O
hACE2 O
. O

Angiotensin O
- O
converting O
enzyme O
2 O
is O
a O
zinc O
containing O
metalloenzyme O
located O
on O
the O
surface O
of O
endothelial O
and O
other O
cells O
. O

ACE2 O
protein B-TERM
contains O
an O
N O
- O
terminal O
peptidase O
M2 O
domain O
and O
a O
C O
- O
terminal O
collectrin O
renal O
amino O
acid O
transporter O
domain O
. O

ACE2 O
is O
a O
single O
- O
pass O
type B-TERM
I O
membrane O
protein B-TERM
, O
with O
its O
enzymatically O
active B-TERM
domain O
exposed O
on O
the O
surface O
of O
cells O
in O
lungs O
and O
other O
tissues O
. O

The O
extracellular O
domain O
of O
ACE2 O
is O
cleaved O
from O
the O
transmembrane O
domain O
by O
another B-TERM
enzyme O
known O
as O
sheddase O
, O
and O
the O
resulting B-TERM
soluble O
protein B-TERM
is O
released O
into O
the O
blood O
stream O
and O
ultimately O
excreted O
into O
urine O
. O

ACE2 O
is O
present O
in O
most O
organs O
: O
ACE2 O
is O
attached O
to O
the O
cell O
membrane O
of O
mainly O
lung O
type B-TERM
II O
alveolar O
cells O
, O
enterocytes O
of O
the O
small O
intestine O
, O
arterial O
and O
venous O
endothelial O
cells O
and O
arterial O
smooth B-TERM
muscle B-TERM
cells O
in O
most O
organs O
. O

ACE2 O
mRNA O
expression O
is O
also B-TERM
found O
in O
the O
cerebral O
cortex O
, O
striatum O
, O
hypothalamus O
, O
and O
brainstem O
. O

The O
primary O
function B-TERM
of O
ACE2 O
is O
to O
act O
as O
a O
counter O
balance O
to O
ACE O
. O

ACE O
cleaves O
angiotensin O
I O
hormone O
into O
the O
vasoconstricting O
angiotensin O
II O
. O

ACE2 O
in O
turn O
cleaves O
the O
carboxyl O
- O
terminal O
amino O
acid O
phenylalanine O
from O
angiotensin O
II O
( O
Asp O
- O
Arg O
- O
Val O
- O
Tyr O
- O
Ile O
- O
His O
- O
Pro O
- O
Phe O
) O
and O
hydrolyses O
it O
into O
the O
vasodilator O
angiotensin O
( O
1 O
- O
7 O
) O
, O
( O
H O
- O
Asp O
- O
Arg O
- O
Val O
- O
Tyr O
- O
Ile O
- O
His O
- O
Pro O
- O
OH O
) O
. O

ACE2 O
can O
also B-TERM
cleave O
a O
number O
of O
other O
peptides O
including O
[ O
des O
- O
Arg9 O
] O
-bradykinin O
, O
apelin O
, O
neurotensin O
, O
dynorphin O
A O
, O
and O
ghrelin O
. O

ACE2 O
also B-TERM
regulates O
the O
membrane O
trafficking O
of O
the O
neutral O
amino O
acid O
transporter O
SLC6A19 O
and O
has O
been O
implicated O
in O
Hartnup O
's O
disease B-TERM
. O

As O
a O
transmembrane O
protein O
, O
ACE2 O
serves O
as O
the O
main B-TERM
entry O
point O
into O
cells O
for O
some O
coronaviruses O
, O
including O
HCoV O
- O
NL63 O
; O
SARS O
- O
CoV O
( O
the O
virus O
that O
causes B-TERM
SARS O
) O
; O
and O
SARS O
- O
CoV O
- O
2 O
( O
the O
virus O
that O
causes B-TERM
COVID O
- O
19 O
) O
. O

More O
specifically O
, O
the O
binding O
of O
the O
spike O
S1 O
protein O
of O
SARS O
- O
CoV O
and O
SARS O
- O
CoV2 O
to O
the O
enzymatic O
domain O
of O
ACE2 O
on O
the O
surface O
of O
cells O
results O
in O
endocytosis O
and O
translocation O
of O
both O
the O
virus O
and O
the O
enzyme O
into O
endosomes O
located O
within O
cells O
. O

This O
entry O
process O
also B-TERM
requires O
priming O
of O
the O
S O
protein B-TERM
by O
the O
host O
serine O
protease O
TMPRSS2 O
, O
the O
inhibition O
of O
which O
is O
under O
current O
investigation O
as O
a O
potential O
therapeutic.This O
has O
led O
some O
to O
hypothesize O
that O
decreasing B-TERM
the O
levels O
of O
ACE2 O
, O
in O
cells O
, O
might O
help B-TERM
in O
fighting O
the O
infection O
. O

However O
, O
multiple O
professional B-TERM
societies O
and O
regulatory O
bodies O
have O
recommended O
continuing O
standard O
ACE O
inhibitor O
and O
ARB O
therapy O
. O

A O
systematic O
review O
and O
meta O
- O
analysis O
published B-TERM
on O
July O
11 O
, O
2012 O
, O
found O
that O
" O
use O
of O
ACE O
inhibitors O
was O
associated O
with O
a O
significant B-TERM
34 O
% O
reduction B-TERM
in O
risk O
of O
pneumonia O
compared O
with O
controls O
. O
" O

Moreover O
, O
" O
the O
risk O
of O
pneumonia O
was O
also B-TERM
reduced B-TERM
in O
patients B-TERM
treated O
with O
ACE O
inhibitors O
who O
were O
at O
higher O
risk O
of O
pneumonia O
, O
in O
particular O
those O
with O
stroke O
and O
heart O
failure O
. O

Use O
of O
ACE O
inhibitors O
was O
also B-TERM
associated O
with O
a O
reduction B-TERM
in O
pneumonia O
related O
mortality O
, O
although B-TERM
the O
results B-TERM
were O
less O
robust O
than O
for O
overall O
risk O
of O
pneumonia O
. O
" O

Recombinant O
human O
ACE2 O
( O
rhACE2 O
) O
is O
surmised O
to O
be O
a O
novel O
therapy O
for O
acute O
lung O
injury O
, O
and O
appeared O
to O
improve O
pulmonary O
hemodynamics O
and O
oxygen O
saturation O
in O
piglets O
with O
a O
lipopolysaccharide O
- O
induced O
acute O
respiratory O
distress O
syndrome O
. O

The O
half O
- O
life O
of O
rhACE2 O
in O
human O
beings O
is O
about O
10 O
hours O
and O
the O
onset O
of O
action O
is O
30 O
minutes B-TERM
in O
addition B-TERM
to O
the O
course O
of O
effect O
( O
duration O
) O
of O
24 O
hours O
. O

Several O
findings O
suggest O
that O
rhACE2 O
may O
be O
a O
promising O
drug O
for O
those O
with O
intolerance O
to O
classic O
renin O
- O
angiotensin O
system O
inhibitors O
( O
RAS O
inhibitors O
) O
or O
in O
diseases B-TERM
where O
circulating O
angiotensin O
II O
is O
elevated.Infused O
rhACE2 O
has O
been O
evaluated O
in O
clinical O
trials O
for O
the O
treatment O
of O
acute O
respiratory O
distress O
syndrome O
. O

Figure O
Skaters O
Artemeva O
and O
Nazarychev O
Win O
Junior O
Grand O
Prix O
Round O
in O
Zagreb O

TASS O
has O
reported O
that O
Russian O
figure O
skaters O
Iullia O
Artemeva O
and O
Mikhail O
Nazarychev O
have O
taken O
gold O
in O
the O
Junior O
Grand O
Prix O
pairs O
competition B-TERM
in O
Zagreb O
. O

For O
their O
short O
and O
free O
programs O
, O
Artemeva O
and O
Nazarychev O
received B-TERM
179.83 O
points O
. O

Another O
Russian O
pair O
, O
Diana O
Mukhametzyanova O
and O
Ilya O
Mironov O
, O
were O
in O
second O
place B-TERM
with O
177.58 O
points O
and O
bronze O
was O
won O
by O
Germans O
Annika O
Hocke O
and O
Rober O
Kunkel O
( O
156.31 O
points O
) O
. O

Russian O
pair O
Anna O
Sheglova O
and O
Ilya O
Kalashnikov O
took O
fourth O
place B-TERM
( O
149.67 O
points O
) O
. O

The O
winners O
of O
this O
round O
in O
Zagreb O
have O
advanced O
to O
the O
Junior O
Grand O
Prix O
Final O
. O

It O
will O
take O
place O
from O
December O
5 O
to O
8 O
in O
Torino O
. O

Later O
on O
September O
27 O
, O
the O
juniors O
will O
perform O
their O
free O
skating O
programs O
in O
singles O
. O

The O
competition O
in O
the O
Croatian O
capital O
will O
end O
on O
Saturday O
, O
September O
28 O
. O

On O
September O
21 O
, O
Russian O
ice O
skater O
Aleksandra O
Trusova O
set O
new O
world O
records O
during O
her O
program O
and O
for O
the O
number O
of O
points O
earned O
in O
a O
competition O
in O
Slovakia O
. O

The O
judges O
gave O
her O
163.78 O
points O
for O
her O
free O
skating O
and O
74.91 O
points O
for O
her O
short O
program O
. O

For O
the O
15 O
- O
year O
- O
old O
athletes O
, O
this O
was O
their O
first O
competition B-TERM
at O
the O
senior O
level O
. O

Alexander O
Lukashenko O
intends B-TERM
to O
use B-TERM
only O
cosmetics O
produced O
in O
Belarus O

Belarusian O
president O
Alexander O
Lukashenko O
intends B-TERM
to O
use B-TERM
only O
cosmetics O
produced O
in O
Belarus O
. O

Lukashenko O
visited O
a O
local B-TERM
cosmetics O
production O
company B-TERM
in O
Minsk O
today O
. O

He O
stated O
that O
imported O
cosmetics O
are O
not O
better O
than O
those O
from O
Belarus O
and O
that O
the O
advantage B-TERM
of O
domestic O
products O
is O
that O
they O
are O
made O
from O
local B-TERM
raw O
materials O
. O

" O
We O
should O
use B-TERM
our O
own O
, O
" O
the O
Belarusian O
leader B-TERM
said O
. O

Alexander O
Lukashenko O
spoke B-TERM
about O
the O
need O
to O
promote O
the O
sale O
of O
Belarusian O
cosmetics O
abroad O
. O

In O
August O
, O
the O
Belarusian O
leader B-TERM
advised O
local B-TERM
sugar O
processors O
to O
find B-TERM
new O
markets O
for O
their O
products O
. O

Lukashenko O
encouraged O
companies B-TERM
not O
to O
focus O
on O
exporting O
to O
Russia O
and O
" O
not O
to O
suffer O
. O
" O

The O
situation B-TERM
with O
the O
export O
of O
sugar O
has O
gotten O
worse O
due O
to O
the O
excess B-TERM
of O
product B-TERM
in O
the O
market O
, O
recalls O
RBK O
. O

This O
relates O
to O
Russia O
as O
well O
, O
where O
the O
price O
of O
sugar O
now O
costs O
50 O
kopecks O
less O
per O
kilogram O
than O
in O
Belarus O
due O
to O
the O
excess B-TERM
. O

Truck O
fatally O
strikes O
seven O
- O
year O
- O
old O
girl B-TERM
at O
crosswalk O
in O
Domodedovo O

A O
driver O
struck O
a O
mother B-TERM
and O
daughter O
at O
a O
crosswalk O
in O
Domodedovo O
, O
the O
head B-TERM
of O
the O
press O
service O
for O
the O
Russian O
Ministry O
of O
Internal O
Affairs O
in O
the O
Moscow O
Oblast O
Tatiana O
Petrova O
reported O
to O
Interfax O
. O

According O
to O
Petrova O
, O
the O
incident B-TERM
occurred O
on O
Friday O
at O
08 O
: O
25 O
on O
Gagarin O
Street O
. O

The O
mother B-TERM
and O
daughter B-TERM
were O
hit O
by O
a O
Domodedovo O
resident O
, O
born O
in O
1994 O
, O
driving O
a O
Gaz O
truck O
. O

As O
a O
result B-TERM
of O
the O
accident B-TERM
, O
the O
seven O
- O
year O
- O
old O
child O
died O
on O
the O
spot O
, O
and O
the O
woman O
was O
hopsitalized O
. O

" O
A O
criminal O
case O
was O
opened O
agaisnt O
the O
driver O
under O
part O
3 O
, O
article O
264 O
of O
the O
Russian O
criminal O
code O
( O
violation O
of O
traffic O
laws O
and O
operation O
of O
vehicles O
causing O
a O
death O
by O
negligence O
) O
, O
" O
a O
representative O
of O
the O
regional O
police B-TERM
headquarters O
reported O
. O

The O
given O
article O
provides O
for O
a O
maximum O
penalty O
of O
up O
to O
5 O
years O
' O
imprisonment O
. O

The O
perpetrator O
is O
currently O
detained O
, O
concluded O
Petrova O
. O

The O
2019 O
- O
20 O
coronavirus O
pandemic O
is O
an O
ongoing O
pandemic O
of O
coronavirus O
disease B-TERM
2019 O
( O
COVID O
- O
19 O
) O
, O
caused B-TERM
by O
severe O
acute O
respiratory O
syndrome O
coronavirus O
2 O
( O
SARS O
- O
CoV O
- O
2 O
) O
. O

The O
outbreak O
was O
identified O
in O
Wuhan O
, O
China O
, O
in O
December O
2019 O
, O
declared B-TERM
to O
be O
a O
Public O
Health O
Emergency O
of O
International O
Concern O
on O
30 O
January O
2020 O
, O
and O
recognized O
as O
a O
pandemic O
on O
11 O
March O
2020 O
. O

As O
of O
10 O
April O
2020 O
, O
approximately B-TERM
1.61 O
million O
cases O
of O
COVID O
- O
19 O
have O
been O
reported O
in O
210 O
countries O
and O
territories O
, O
resulting B-TERM
in O
approximately B-TERM
97,000 O
deaths O
. O

About O
364,000 O
people O
have O
recovered O
. O

The O
case O
fatality O
rate O
has O
been O
estimated O
to O
be O
4 O
% O
in O
China O
, O
while O
globally O
ranging O
from O
13.04 O
% O
in O
Algeria O
to O
.08 O
% O
in O
New O
Zealand O
. O

Common O
symptoms O
include O
fever O
, O
cough O
and O
shortness O
of O
breath O
. O

Complications B-TERM
may O
include O
pneumonia O
and O
acute O
respiratory O
distress O
syndrome O
. O

The O
time O
from O
exposure O
to O
onset O
of O
symptoms O
is O
typically O
around B-TERM
five O
days O
, O
but O
may O
range O
from O
two B-TERM
to O
fourteen O
days O
. O

There O
is O
no O
known O
vaccine B-TERM
or O
specific O
antiviral O
treatment O
. O

Primary O
treatment O
is O
symptomatic O
and O
supportive O
therapy.Recommended O
preventive O
measures B-TERM
include O
hand O
washing O
, O
covering O
one O
's O
mouth B-TERM
when O
coughing O
, O
maintaining O
distance B-TERM
from O
other O
people O
, O
and O
monitoring O
and O
self O
- O
isolation O
for O
people O
who O
suspect O
they O
are O
infected O
. O

Authorities O
worldwide O
have O
responded O
by O
implementing O
travel B-TERM
restrictions O
, O
quarantines O
, O
curfews O
, O
workplace O
hazard O
controls O
, O
and O
facility O
closures O
. O

The O
pandemic O
has O
led O
to O
severe O
global O
socioeconomic O
disruption O
, O
the O
postponement O
or O
cancellation B-TERM
of O
sporting O
, O
religious O
, O
political O
and O
cultural O
events O
, O
and O
widespread O
shortages B-TERM
of O
supplies O
exacerbated O
by O
panic O
buying O
. O

Schools O
and O
universities O
have O
closed O
either B-TERM
on O
a O
nationwide O
or O
local O
basis O
in O
193 O
countries O
, O
affecting O
approximately B-TERM
99.4 O
percent O
of O
the O
world O
's O
student O
population O
. O

Misinformation O
about O
the O
virus O
has O
spread O
online O
, O
and O
there O
have O
been O
incidents O
of O
xenophobia O
and O
discrimination O
against O
Chinese O
people O
, O
other O
people O
of O
East O
and O
Southeast O
Asian O
descent O
and O
appearance O
, O
and O
others O
from O
areas B-TERM
with O
significant B-TERM
virus O
cases O
. O

Due O
to O
reduced O
travel B-TERM
and O
closures O
of O
heavy O
industry B-TERM
, O
there O
has O
been O
a O
decrease B-TERM
in O
air B-TERM
pollution O
and O
carbon O
emissions O
. O

Health O
authorities O
in O
Wuhan O
, O
China O
( O
the O
capital O
of O
Hubei O
province O
) O
reported O
a O
cluster O
of O
pneumonia O
cases O
of O
unknown B-TERM
cause O
on O
31 O
December O
2019 O
, O
and O
an O
investigation O
was O
launched O
in O
early O
January O
2020 O
. O

The O
cases O
mostly B-TERM
had O
links O
to O
the O
Huanan O
Seafood O
Wholesale O
Market O
and O
so O
the O
virus O
is O
thought B-TERM
to O
have O
a O
zoonotic O
origin O
. O

The O
virus O
that O
caused B-TERM
the O
outbreak O
is O
known O
as O
SARS O
- O
CoV O
- O
2 O
, O
a O
newly O
discovered O
virus O
closely O
related O
to O
bat O
coronaviruses O
, O
pangolin O
coronaviruses O
, O
and O
SARS O
- O
CoV.The O
earliest O
known O
person O
with O
symptoms O
was O
later O
discovered O
to O
have O
fallen O
ill O
on O
1 O
December O
2019 O
, O
and O
that O
person O
did O
not O
have O
visible O
connections O
with O
the O
later O
wet O
market O
cluster O
. O

Of O
the O
early O
cluster O
of O
cases O
reported O
in O
December O
2019 O
, O
two B-TERM
- O
thirds O
were O
found O
to O
have O
a O
link O
with O
the O
market O
. O

On O
13 O
March O
2020 O
, O
an O
unverified O
report O
from O
the O
South O
China O
Morning O
Post O
suggested O
that O
a O
case O
traced O
back O
to O
17 O
November O
2019 O
, O
in O
a O
55 O
- O
year O
- O
old O
from O
Hubei O
province O
, O
may O
have O
been O
the O
first.On O
26 O
February O
2020 O
, O
the O
WHO O
reported O
that O
, O
as O
new O
cases O
reportedly O
declined O
in O
China O
but O
suddenly O
increased O
in O
Italy O
, O
Iran O
, O
and O
South O
Korea O
, O
the O
number B-TERM
of O
new O
cases O
outside O
China O
had O
exceeded O
the O
number B-TERM
of O
new O
cases O
within O
China O
for O
the O
first O
time O
. O

There O
may O
be O
substantial O
underreporting O
of O
cases O
, O
particularly O
among O
those O
with O
milder O
symptoms O
. O

By O
26 O
February O
, O
relatively O
few O
cases O
had O
been O
reported O
among B-TERM
youths O
, O
with O
those O
19 O
and O
under O
making O
up O
2.4 O
% O
of O
cases O
worldwide.The O
United O
Kingdom O
's O
chief B-TERM
scientific O
adviser O
, O
Patrick O
Vallance O
, O
estimated O
that O
60 O
% O
of O
the O
British O
population O
would O
need O
to O
become O
infected O
before O
effective B-TERM
herd O
immunity O
could O
be O
achieved O
. O

Cases O
refers O
to O
the O
number O
of O
people O
who O
have O
been O
tested O
for O
COVID O
- O
19 O
, O
and O
whose O
test O
has O
been O
confirmed O
positive O
according O
to O
official O
protocols O
. O

As O
of O
23 O
March O
, O
no O
country O
had O
tested O
more O
than O
3 O
% O
of O
its O
population O
, O
and O
many O
countries O
have O
had O
official O
policies O
not O
to O
test O
those O
with O
only O
mild O
symptoms O
, O
such O
as O
Italy O
, O
the O
Netherlands O
, O
Spain O
, O
and O
Switzerland O
. O

A O
study B-TERM
published B-TERM
on O
16 O
March O
found O
that O
in O
China O
, O
up O
to O
23 O
January O
, O
an O
estimated O
86 O
% O
of O
COVID O
- O
19 O
infections O
had O
not O
been O
detected O
, O
and O
that O
these O
undocumented O
infections O
were O
the O
infection O
source O
for O
79 O
% O
of O
documented O
cases O
. O

A O
statistical O
analysis B-TERM
published B-TERM
30 O
March O
estimated O
that O
numbers B-TERM
of O
infections O
in O
Italy O
were O
considerably O
greater O
than O
the O
reported O
cases O
. O

The O
initial O
estimates O
of O
the O
basic B-TERM
reproduction O
number B-TERM
( O
R0 O
) O
for O
COVID O
- O
19 O
were O
1.4 O
to O
2.4 O
. O

A O
study B-TERM
published B-TERM
by O
the O
US O
Center O
for O
Disease B-TERM
Control O
and O
Prevention O
has O
concluded O
that O
it O
may O
be O
5.7 O
. O

Most O
people O
with O
COVID O
- O
19 O
recover O
. O

For O
those O
who O
do O
not O
, O
the O
time O
from O
development O
of O
symptoms O
to O
death O
has O
been O
between O
6 O
and O
41 O
days O
, O
with O
the O
most O
common O
being O
14 O
days O
. O

As O
of O
10 O
April O
2020 O
, O
approximately B-TERM
97,000 O
deaths O
had O
been O
attributed O
to O
COVID O
- O
19 O
. O

In O
China O
, O
as O
of O
5 O
February O
about O
80 O
% O
of O
deaths O
were O
in O
those O
over O
60 O
, O
and O
75 O
% O
had O
pre O
- O
existing O
health O
conditions O
including O
cardiovascular O
diseases B-TERM
and O
diabetes.Official O
tallies O
of O
deaths O
from O
the O
COVID O
- O
19 O
pandemic O
generally O
refer O
to O
dead O
people O
who O
tested O
positive O
for O
COVID O
according O
to O
official O
protocols O
. O

The O
number B-TERM
of O
true O
fatalities O
from O
COVID O
- O
19 O
may O
be O
much O
higher O
, O
as O
it O
may O
not O
include O
people O
who O
die O
without O
testing O
- O
e.g. O
at O
home O
, O
in O
nursing O
homes B-TERM
, O
etc O
. O

Partial O
data B-TERM
from O
Italy O
found O
that O
the O
number B-TERM
of O
excess O
deaths O
during O
the O
pandemic O
exceeded O
the O
official O
COVID O
death O
tally O
by O
a O
factor O
of O
4 O
- O
5x O
. O

A O
spokeswoman O
for O
the O
U.S. O
Centers O
for O
Disease B-TERM
Control O
and O
Prevention O
( O
CDC O
) O
acknowledged O
" O
We O
know O
that O
[ O
the O
stated O
death O
toll O
] O
is O
an O
underestimation O
, O
" O
a O
statement O
corroborated O
by O
anecdotal O
reports O
of O
undercounting O
in O
the O
U.S. O
Such O
underestimation O
often B-TERM
occurs O
in O
pandemics O
, O
such O
as O
the O
2009 O
H1N1 O
swine O
flu O
epidemic.The O
first O
confirmed O
death O
was O
in O
Wuhan O
on O
9 O
January O
2020 O
. O

The O
first O
death O
outside O
mainland O
China O
occurred O
on O
1 O
February O
in O
the O
Philippines O
, O
and O
the O
first O
death O
outside O
Asia O
was O
in O
France O
on O
14 O
February O
. O

By O
28 O
February O
, O
outside O
mainland O
China O
, O
more O
than O
a O
dozen O
deaths O
each O
were O
recorded O
in O
Iran O
, O
South O
Korea O
, O
and O
Italy O
. O

By O
13 O
March O
, O
more O
than O
forty O
countries O
and O
territories O
had O
reported O
deaths O
, O
on O
every O
continent B-TERM
except O
Antarctica.Several O
measures O
are O
commonly O
used O
to O
quantify O
mortality O
. O

These O
numbers B-TERM
vary O
by O
region O
and O
over O
time O
, O
and O
are O
influenced O
by O
the O
volume O
of O
testing O
, O
healthcare O
system O
quality O
, O
treatment O
options O
, O
time O
since O
initial O
outbreak O
, O
and O
population O
characteristics O
such O
as O
age O
, O
sex O
, O
and O
overall O
health.The O
death O
- O
to O
- O
case O
ratio O
reflects O
the O
number B-TERM
of O
deaths O
divided B-TERM
by O
the O
number B-TERM
of O
diagnosed O
cases O
within O
a O
given O
time O
interval O
. O

Based O
on O
Johns O
Hopkins O
University O
statistics O
, O
the O
global O
death O
- O
to O
- O
case O
ratio O
is O
6.0 O
% O
( O
97,039 O
/ O
1,617,204 O
) O
as O
of O
10 O
April O
2020 O
. O

The O
number O
varies O
by O
region B-TERM
. O

In O
China O
, O
estimates O
for O
the O
death O
- O
to O
- O
case O
ratio O
decreased O
from O
17.3 O
% O
( O
for O
those O
with O
symptom O
onset O
1 O
- O
10 O
January O
2020 O
) O
to O
0.7 O
% O
( O
for O
those O
with O
symptom O
onset O
after O
1 O
February O
2020 O
) O
.Other O
measures O
include O
the O
case O
fatality O
rate O
( O
CFR O
) O
, O
which O
reflects O
the O
percent O
of O
diagnosed O
people O
who O
die O
from O
a O
disease B-TERM
, O
and O
the O
infection O
fatality O
rate O
( O
IFR O
) O
, O
which O
reflects O
the O
percent O
of O
infected O
( O
diagnosed O
and O
undiagnosed O
) O
who O
die O
from O
a O
disease B-TERM
. O

These O
statistics O
are O
not O
timebound O
and O
follow O
a O
specific O
population O
from O
infection O
through O
case O
resolution O
. O

A O
number O
of O
academics O
have O
attempted B-TERM
to O
calculate O
these O
numbers O
for O
specific O
populations O
. O

The O
University O
of O
Oxford O
's O
Centre O
for O
Evidence O
- O
Based O
Medicine O
estimates O
that O
the O
infection O
fatality O
rate O
for O
the O
pandemic O
as O
a O
whole O
is O
between O
0.1 O
% O
and O
0.39 O
% O
. O

The O
upper O
estimate O
of O
this O
range O
is O
consistent O
with O
the O
results B-TERM
from O
the O
first O
random O
testing O
for O
COVID O
- O
19 O
in O
Germany O
, O
and O
a O
statistical O
study B-TERM
analysing O
the O
impact B-TERM
of O
testing O
on O
CFR O
estimates O
. O

The O
WHO O
asserts O
that O
the O
pandemic O
can O
be O
controlled O
. O

The O
peak O
and O
ultimate O
duration O
of O
the O
outbreak O
are O
uncertain O
and O
may O
differ O
by O
location B-TERM
. O

Maciej O
Boni O
of O
Penn O
State O
University O
stated O
, O
" O
Left O
unchecked O
, O
infectious O
outbreaks O
typically O
plateau O
and O
then O
start O
to O
decline O
when O
the O
disease O
runs O
out O
of O
available O
hosts O
. O

But O
it O
's O
almost O
impossible B-TERM
to O
make O
any O
sensible O
projection O
right O
now O
about O
when O
that O
will O
be O
. O
" O

The O
Chinese O
government O
's O
senior O
medical O
adviser O
Zhong O
Nanshan O
argued O
that O
" O
it O
could O
be O
over O
by O
June O
" O
if O
all O
countries O
can O
be O
mobilized O
to O
follow O
the O
WHO O
's O
advice B-TERM
on O
measures B-TERM
to O
stop O
the O
spread O
of O
the O
virus O
. O

On O
17 O
March O
, O
Adam O
Kucharski O
of O
the O
London O
School O
of O
Hygiene O
& O
Tropical O
Medicine O
stated O
that O
SARS O
- O
CoV O
- O
2 O
" O
is O
going O
to O
be O
circulating O
, O
potentially O
for O
a O
year O
or O
two B-TERM
. O
" O

According O
to O
the O
Imperial O
College O
study B-TERM
led O
by O
Neil O
Ferguson O
, O
physical B-TERM
distancing O
and O
other O
measures B-TERM
will O
be O
required O
" O
until O
a O
vaccine B-TERM
becomes O
available O
( O
potentially O
18 O
months O
or O
more O
) O
. O
" O

William O
Schaffner O
of O
Vanderbilt O
University O
stated O
, O
" O
I O
think B-TERM
it O
's O
unlikely O
that O
this O
coronavirus O
- O
because O
it O
's O
so O
readily O
transmissible O
- O
will O
disappear B-TERM
completely O
" O
and O
it O
" O
might O
turn O
into O
a O
seasonal O
disease B-TERM
, O
making O
a O
comeback O
every O
year O
. O
" O

The O
virulence O
of O
the O
comeback O
would O
depend O
on O
herd O
immunity O
and O
the O
extent O
of O
mutation O
. O

Symptoms O
of O
COVID O
- O
19 O
can O
be O
relatively O
non O
- O
specific O
and O
infected O
people O
may O
be O
asymptomatic O
. O

The O
two B-TERM
most O
common O
symptoms O
are O
fever O
( O
88 O
% O
) O
and O
dry O
cough O
( O
68 O
% O
) O
. O

Less O
common O
symptoms O
include O
fatigue O
, O
respiratory O
sputum O
production O
( O
phlegm O
) O
, O
loss B-TERM
of O
the O
sense O
of O
smell O
, O
shortness O
of O
breath O
, O
muscle B-TERM
and O
joint O
pain B-TERM
, O
sore O
throat O
, O
headache O
, O
chills O
, O
vomiting O
, O
hemoptysis O
, O
diarrhea O
, O
or O
cyanosis.The O
WHO O
states O
that O
approximately B-TERM
one O
person O
in O
six O
becomes O
seriously O
ill O
and O
has O
difficulty O
breathing O
. O

The O
U.S. O
Centers O
for O
Disease O
Control O
and O
Prevention O
( O
CDC O
) O
lists O
emergency O
symptoms O
as O
difficulty O
breathing O
, O
persistent O
chest O
pain O
or O
pressure O
, O
sudden O
confusion O
, O
difficulty O
waking O
, O
and O
bluish O
face O
or O
lips O
; O
immediate O
medical O
attention O
is O
advised O
if O
these O
symptoms O
are O
present.Further O
development O
of O
the O
disease B-TERM
can O
lead O
to O
severe O
pneumonia O
, O
acute O
respiratory O
distress O
syndrome O
, O
sepsis O
, O
septic O
shock O
and O
death O
. O

Some O
of O
those O
infected O
may O
be O
asymptomatic O
, O
with O
no O
clinical O
symptoms O
but O
with O
test O
results B-TERM
that O
confirm O
infection O
, O
so O
researchers O
have O
issued O
advice O
that O
those O
with O
close O
contact O
to O
confirmed O
infected O
people O
should O
be O
closely O
monitored O
and O
examined O
to O
rule O
out O
infection O
. O

Chinese O
estimates O
of O
the O
asymptomatic O
ratio O
range O
from O
few O
to O
44 O
% O
. O

The O
usual B-TERM
incubation O
period O
( O
the O
time O
between O
infection O
and O
symptom O
onset O
) O
ranges O
from O
one O
to O
14 O
days O
; O
it O
is O
most O
commonly O
five O
days.As O
an O
example O
of O
uncertainty O
, O
the O
estimate O
of O
the O
fraction O
of O
people O
with O
COVID O
- O
19 O
who O
lost O
their O
sense O
of O
smell O
was O
initially B-TERM
30 O
% O
and O
later O
fell O
to O
15 O
% O
. O

Some O
details B-TERM
about O
how O
the O
disease B-TERM
is O
spread O
are O
still O
being O
determined O
. O

The O
disease B-TERM
is O
believed O
to O
be O
primarily B-TERM
spread O
during O
close O
contact O
and O
by O
small B-TERM
droplets O
produced O
during O
coughing O
, O
sneezing O
, O
or O
talking O
; O
with O
close O
contact O
being O
within O
1 O
to O
2 O
metres O
( O
3 O
to O
6 O
feet O
) O
. O

Studies B-TERM
have O
found O
that O
an O
uncovered O
coughing O
can O
lead O
to O
droplets O
travelling O
up O
to O
4.5 O
metres O
( O
15 O
feet O
) O
to O
8.2 O
metres O
( O
27 O
feet O
) O
. O

Some O
have O
proposed O
that O
the O
virus O
may O
also B-TERM
be O
transmitted O
by O
small O
droplets O
that O
stay O
for O
more O
prolonged O
periods O
in O
the O
air O
, O
that O
may O
be O
generated O
during O
speech.Respiratory O
droplets O
may O
also B-TERM
be O
produced O
during O
breathing O
out O
, O
including O
when O
talking O
, O
though O
the O
virus O
is O
not O
generally O
airborne O
. O

The O
droplets O
can O
land O
in O
the O
mouths B-TERM
or O
noses O
of O
people O
who O
are O
nearby O
or O
possibly O
be O
inhaled O
into O
the O
lungs O
. O

Some O
medical O
procedures O
such O
as O
intubation O
and O
cardiopulmonary O
resuscitation O
( O
CPR O
) O
may O
cause O
respiratory O
secretions O
to O
be O
aerosolized O
and O
thus O
result O
in O
airborne O
spread O
. O

It O
may O
also B-TERM
spread O
when O
one O
touches O
a O
contaminated O
surface O
, O
including O
skin O
, O
and O
then O
touches O
their O
eyes B-TERM
, O
nose O
, O
or O
mouth B-TERM
. O

While O
there O
are O
concerns O
it O
may O
spread O
by O
faeces O
, O
this O
risk O
is O
believed O
to O
be O
low O
. O

The O
Government O
of O
China O
denied O
the O
possibility B-TERM
of O
faecal O
- O
oral O
transmission O
of O
SARS O
- O
CoV O
- O
2.The O
virus O
is O
most O
contagious O
during O
the O
first O
three O
days O
after O
onset O
of O
symptoms O
, O
although B-TERM
spread O
may O
be O
possible O
before O
symptoms O
appear O
and O
in O
later O
stages B-TERM
of O
the O
disease B-TERM
. O

People O
have O
tested O
positive O
for O
the O
disease O
up O
to O
three O
days O
before O
onset O
of O
symptoms O
suggesting O
transmission O
is O
possible O
before O
developing O
significant O
symptoms O
. O

Only O
few O
reports O
of O
laboratory O
- O
confirmed O
asymptomatic O
cases O
exist O
, O
but O
asymptomatic O
transmission O
has O
been O
identified O
by O
some O
countries O
during O
contact O
tracing O
investigations O
. O

The O
European O
Centre O
for O
Disease O
Prevention O
and O
Control O
( O
ECDC O
) O
states O
that O
while O
it O
is O
not O
entirely O
clear B-TERM
how O
easily O
the O
disease O
spreads O
, O
one O
person O
generally O
infects O
two O
to O
three O
others.The O
virus O
survives O
for O
hours O
to O
days O
on O
surfaces O
. O

Specifically O
, O
the O
virus O
was O
found O
to O
be O
detectable O
for O
up O
to O
three O
days O
on O
plastic O
( O
polypropylene O
) O
and O
304 O
stainless O
steel O
, O
for O
one O
day O
on O
cardboard O
, O
and O
for O
up O
to O
four O
hours O
on O
copper O
. O

This O
, O
however O
, O
varies O
based O
on O
the O
humidity O
and O
temperature.Pets O
and O
other O
animals B-TERM
have O
tested O
positive O
for O
COVID O
- O
19 O
. O

There O
is O
no O
evidence O
animals B-TERM
can O
pass O
the O
virus O
on O
to O
humans O
, O
though B-TERM
British O
authorities O
advise O
washing O
one O
's O
hands O
after O
contact O
with O
animals B-TERM
, O
like B-TERM
after O
contact O
with O
other O
surfaces O
infected O
people O
could O
have O
touched O
. O

Severe O
acute O
respiratory O
syndrome O
coronavirus O
2 O
( O
SARS O
- O
CoV O
- O
2 O
) O
is O
a O
novel O
virus O
, O
first O
isolated O
from O
three O
people O
with O
pneumonia O
connected O
to O
the O
cluster O
of O
acute O
respiratory O
illness B-TERM
cases O
in O
Wuhan O
. O

All O
features O
of O
the O
novel O
SARS O
- O
CoV O
- O
2 O
virus O
occur O
in O
related O
coronaviruses O
in O
nature.Outside B-TERM
the O
human O
body O
, O
the O
virus O
is O
killed O
by O
household O
soap O
, O
which O
dissolves O
its O
protective O
envelope.SARS O
- O
CoV O
- O
2 O
is O
closely O
related O
to O
the O
original O
SARS O
- O
CoV O
. O

It O
is O
thought O
to O
have O
a O
zoonotic O
origin O
. O

Genetic O
analysis B-TERM
has O
revealed B-TERM
that O
the O
coronavirus O
genetically O
clusters O
with O
the O
genus O
Betacoronavirus O
, O
in O
subgenus O
Sarbecovirus O
( O
lineage O
B O
) O
together B-TERM
with O
two B-TERM
bat O
- O
derived O
strains O
. O

It O
is O
96 O
% O
identical B-TERM
at O
the O
whole O
genome O
level O
to O
other O
bat O
coronavirus O
samples O
( O
BatCov O
RaTG13 O
) O
. O

In O
February O
2020 O
, O
Chinese O
researchers O
found O
that O
there O
is O
only O
one O
amino O
acid O
difference B-TERM
in O
certain O
parts O
of O
the O
genome O
sequences B-TERM
between O
the O
viruses O
from O
pangolins O
and O
those O
from O
humans O
. O

Whole O
- O
genome O
comparison O
to O
date O
has O
found O
at O
most O
92 O
% O
of O
genetic O
material O
shared O
between O
pangolin O
coronavirus O
and O
SARS O
- O
CoV O
- O
2 O
, O
which O
is O
insufficient O
to O
prove O
pangolins O
to O
be O
the O
intermediate O
host O
. O

Infection O
by O
the O
virus O
can O
be O
provisionally O
diagnosed O
on O
the O
basis B-TERM
of O
symptoms O
, O
though B-TERM
confirmation O
is O
ultimately O
by O
reverse O
transcription O
polymerase O
chain O
reaction O
( O
rRT O
- O
PCR O
) O
of O
infected O
secretions O
or O
CT O
imaging O
. O

A O
study B-TERM
comparing O
PCR O
to O
CT O
in O
Wuhan O
has O
suggested O
that O
CT O
is O
significantly B-TERM
more O
sensitive O
than O
PCR O
, O
though B-TERM
less O
specific O
, O
with O
many O
of O
its O
imaging O
features O
overlapping O
with O
other O
pneumonias O
and O
disease B-TERM
processes O
. O

As O
of O
March O
2020 O
, O
the O
American O
College O
of O
Radiology O
recommends O
that O
" O
CT O
should O
not O
be O
used B-TERM
to O
screen O
for O
or O
as O
a O
first O
- O
line B-TERM
test O
to O
diagnose O
COVID O
- O
19 O
. O
" O

The O
WHO O
has O
published B-TERM
several O
RNA O
testing O
protocols O
for O
SARS O
- O
CoV O
- O
2 O
, O
with O
the O
first O
issued O
on O
17 O
January O
. O

The O
test O
uses O
real O
- O
time O
reverse O
transcription O
polymerase O
chain O
reaction O
( O
rRT O
- O
PCR O
) O
. O

The O
test O
can O
be O
done O
on O
respiratory O
or O
blood B-TERM
samples O
. O

Results B-TERM
are O
generally O
available O
within O
a O
few O
hours O
to O
days O
. O

Generally O
this O
test O
is O
carried O
out O
on O
a O
nasopharyngeal O
swab O
though B-TERM
a O
throat O
swab O
may O
also B-TERM
be O
used.A O
number O
of O
laboratories O
and O
companies B-TERM
are O
developing O
serological O
tests O
, O
which O
detect O
antibodies O
. O

As O
of O
6 O
April O
2020 O
, O
none O
of O
these O
has O
been O
proved O
sufficiently O
accurate O
to O
be O
approved O
for O
widespread O
use O
. O

In O
the O
US O
a O
serological O
test O
developed O
by O
Cellex O
has O
been O
approved O
for O
emergency O
use O
by O
certified O
laboratories O
only O
. O

Characteristic O
imaging O
features B-TERM
on O
radiographs O
and O
computed O
tomography O
( O
CT O
) O
of O
people O
who O
are O
symptomatic O
include O
asymmetric O
peripheral O
ground O
glass O
opacities O
and O
absent O
pleural O
effusions O
. O

The O
Italian O
Radiological O
Society O
is O
compiling O
an O
international O
online O
database O
of O
imaging O
findings O
for O
confirmed O
cases O
. O

Due O
to O
overlap O
with O
other O
infections O
such O
as O
adenovirus O
, O
imaging O
without O
confirmation O
by O
PCR O
is O
of O
limited O
specificity O
in O
identifying O
COVID O
- O
19 O
. O

A O
large O
study B-TERM
in O
China O
compared O
chest O
CT O
results B-TERM
to O
PCR O
and O
demonstrated O
that O
though B-TERM
imaging O
is O
less O
specific O
for O
the O
infection O
, O
it O
is O
faster O
and O
more O
sensitive O
, O
suggesting O
its O
consideration O
as O
a O
screening O
tool O
in O
epidemic O
areas B-TERM
. O

Artificial O
intelligence O
- O
based O
convolutional O
neural O
networks O
have O
been O
developed O
to O
detect O
imaging O
features O
of O
the O
virus O
with O
both O
radiographs O
and O
CT O
. O

Strategies O
for O
preventing O
transmission O
of O
the O
disease B-TERM
include O
maintaining O
overall O
good O
personal B-TERM
hygiene O
, O
washing O
hands O
, O
avoiding O
touching O
the O
eyes B-TERM
, O
nose O
, O
or O
mouth B-TERM
with O
unwashed O
hands O
, O
and O
coughing O
or O
sneezing O
into O
a O
tissue O
and O
putting O
the O
tissue O
directly O
into O
a O
waste O
container O
. O

Those O
who O
may O
already O
have O
the O
infection O
have O
been O
advised O
to O
wear O
a O
surgical O
mask O
in O
public O
. O

Physical O
distancing O
measures O
are O
also B-TERM
recommended O
to O
prevent O
transmission.Many O
governments O
have O
restricted O
or O
advised O
against O
all O
non O
- O
essential O
travel B-TERM
to O
and O
from O
countries O
and O
areas B-TERM
affected O
by O
the O
outbreak O
. O

However O
, O
the O
virus O
has O
reached O
the O
stage O
of O
community O
spread O
in O
large O
parts O
of O
the O
world O
. O

This O
means B-TERM
that O
the O
virus O
is O
spreading O
within O
communities O
, O
and O
some O
community O
members O
don O
't O
know O
where O
or O
how O
they O
were O
infected.Health O
care O
providers O
taking O
care O
of O
someone O
who O
may O
be O
infected O
are O
recommended O
to O
use B-TERM
standard O
precautions O
, O
contact O
precautions O
, O
and O
eye B-TERM
protection.Contact O
tracing O
is O
an O
important B-TERM
method B-TERM
for O
health O
authorities O
to O
determine O
the O
source O
of O
an O
infection O
and O
to O
prevent O
further O
transmission O
. O

The O
use O
of O
location O
data B-TERM
from O
mobile B-TERM
phones O
by O
governments O
for O
this O
purpose B-TERM
has O
prompted O
privacy O
concerns O
, O
with O
Amnesty O
International O
and O
over O
100 O
other O
organizations B-TERM
issuing O
a O
statement O
calling O
for O
limits O
on O
this O
kind B-TERM
of O
surveillance B-TERM
. O

Various O
mobile O
apps O
have O
been O
implemented O
or O
proposed O
for O
voluntary O
use O
, O
and O
as O
of O
April O
7 O
, O
2020 O
, O
over O
a O
dozen O
expert O
groups O
were O
working O
on O
privacy O
- O
friendly O
solutions O
, O
such O
as O
using O
Bluetooth O
to O
log O
a O
user O
's O
proximity O
to O
other O
cellphones O
. O

Users O
then O
receive B-TERM
a O
message O
if O
they O
've O
been O
in O
close O
contact O
with O
someone O
who O
has O
tested O
positive O
for O
COVID O
- O
19.Misconceptions O
are O
circulating O
about O
how O
to O
prevent O
infection O
; O
for O
example O
, O
rinsing O
the O
nose O
and O
gargling O
with O
mouthwash O
are O
not O
effective O
. O

There O
is O
no O
COVID O
- O
19 O
vaccine B-TERM
, O
though B-TERM
many O
organizations B-TERM
are O
working O
to O
develop O
one O
. O

Hand O
washing O
is O
recommended O
to O
prevent O
the O
spread O
of O
the O
disease B-TERM
. O

The O
CDC O
recommends O
that O
people O
wash O
hands O
often B-TERM
with O
soap O
and O
water O
for O
at O
least O
twenty O
seconds O
, O
especially B-TERM
after O
going O
to O
the O
toilet B-TERM
or O
when O
hands O
are O
visibly O
dirty O
; O
before O
eating O
; O
and O
after O
blowing O
one O
's O
nose O
, O
coughing O
, O
or O
sneezing O
. O

This O
is O
because O
outside O
the O
human O
body O
, O
the O
virus O
is O
killed O
by O
household O
soap O
, O
which O
bursts O
its O
protective O
bubble O
. O

CDC O
further O
recommended O
using B-TERM
an O
alcohol O
- O
based O
hand O
sanitizer O
with O
at O
least O
60 O
% O
alcohol B-TERM
by O
volume O
when O
soap O
and O
water O
are O
not O
readily O
available O
. O

The O
WHO O
advises O
people O
to O
avoid O
touching O
the O
eyes B-TERM
, O
nose O
, O
or O
mouth B-TERM
with O
unwashed O
hands O
. O

Surfaces O
may O
be O
decontaminated O
with O
a O
number O
of O
solutions O
( O
within O
one O
minute B-TERM
of O
exposure O
to O
the O
disinfectant O
for O
a O
stainless O
steel O
surface O
) O
, O
including O
62 O
- O
71 O
% O
ethanol O
, O
50 O
- O
100 O
% O
isopropanol O
, O
0.1 O
% O
sodium O
hypochlorite O
, O
0.5 O
% O
hydrogen O
peroxide O
, O
and O
0.2 O
- O
7.5 O
% O
povidone O
- O
iodine O
. O

Other O
solutions O
, O
such O
as O
benzalkonium O
chloride O
and O
chrohexidine O
gluconate O
, O
are O
less O
effective B-TERM
. O

The O
CDC O
recommends O
that O
if O
a O
COVID O
case O
is O
suspected O
or O
confirmed O
at O
a O
facility O
such O
as O
an O
office B-TERM
or O
day O
care O
, O
all O
areas O
such O
as O
offices O
, O
bathrooms O
, O
common B-TERM
areas O
, O
shared O
electronic O
equipment B-TERM
like B-TERM
tablets O
, O
touch O
screens O
, O
keyboards O
, O
remote O
controls O
, O
and O
ATM O
machines O
used B-TERM
by O
the O
ill O
persons O
, O
should O
be O
disinfected O
. O

Health O
organizations B-TERM
recommended O
that O
people O
cover O
their O
mouth B-TERM
and O
nose O
with O
a O
bent O
elbow O
or O
a O
tissue O
when O
coughing O
or O
sneezing O
, O
and O
disposing O
of O
any O
tissue O
immediately B-TERM
. O

Surgical O
masks O
are O
recommended O
for O
those O
who O
may O
be O
infected O
, O
as O
wearing O
a O
mask O
can O
limit O
the O
volume O
and O
travel O
distance O
of O
expiratory O
droplets O
dispersed O
when O
talking O
, O
sneezing O
, O
and O
coughing O
. O

The O
WHO O
has O
issued O
instructions O
on O
when O
and O
how O
to O
use B-TERM
masks O
. O

According O
to O
Stephen O
Griffin O
, O
a O
virologist O
at O
the O
University O
of O
Leeds O
, O
" O
Wearing O
a O
mask O
can O
reduce B-TERM
the O
propensity O
[ O
of O
] O
people O
to O
touch O
their O
faces B-TERM
, O
which O
is O
a O
major O
source O
of O
infection O
without O
proper O
hand O
hygiene O
. O
" O
Masks O
have O
also B-TERM
been O
recommended O
for O
use O
by O
those O
taking O
care O
of O
someone O
who O
may O
have O
the O
disease O
. O

The O
WHO O
has O
recommended O
the O
wearing O
of O
masks O
by O
healthy O
people O
only O
if O
they O
are O
at O
high O
risk O
, O
such O
as O
those O
who O
are O
caring O
for O
a O
person O
with O
COVID O
- O
19 O
, O
although B-TERM
they O
also B-TERM
acknowledge O
that O
wearing O
masks O
may O
help O
people O
avoid O
touching O
their O
face B-TERM
. O

Several O
countries O
have O
started O
to O
encourage O
the O
use O
of O
face O
masks O
by O
members O
of O
the O
public O
. O

In O
the O
U.S. O
, O
the O
CDC O
recommends O
wearing O
non O
- O
medical O
face O
mask O
made O
out O
of O
cloth.China O
has O
specifically O
recommended O
the O
use O
of O
disposable O
medical O
masks O
by O
healthy O
members O
of O
the O
public O
, O
particularly B-TERM
when O
coming O
into O
close O
contact O
( O
1 O
metre O
( O
3 O
ft O
) O
or O
less O
) O
with O
other O
people O
. O

Hong O
Kong O
recommends O
wearing O
a O
surgical O
mask O
when O
taking O
public O
transport O
or O
staying O
in O
crowded O
places B-TERM
. O

Thailand O
's O
health O
officials O
are O
encouraging O
people O
to O
make O
cloth O
facemasks O
at O
home O
and O
wash O
them O
daily O
. O

The O
Czech O
Republic O
and O
Slovakia O
banned O
going O
out O
in O
public O
without O
wearing O
a O
mask O
or O
covering O
one O
's O
nose O
and O
mouth B-TERM
. O

On O
16 O
March O
, O
Vietnam O
requested O
everyone O
to O
wear O
a O
face O
mask O
when O
going O
to O
public O
areas O
in O
order O
to O
protect O
themselves O
and O
others O
. O

The O
Austrian O
government O
mandated O
that O
everyone O
entering O
a O
grocery O
store B-TERM
must O
wear O
a O
face O
mask O
. O

Israel O
has O
asked O
all O
residents O
to O
wear O
face O
masks O
when O
in O
public O
. O

Taiwan O
, O
which O
has O
been O
producing O
ten O
million O
masks O
per O
day O
since O
mid O
- O
March O
, O
required O
passengers O
on O
trains O
and O
intercity O
buses O
to O
wear O
face O
masks O
on O
1 O
April O
. O

Panama O
has O
made O
it O
obligatory O
to O
wear O
a O
face O
mask O
whenever O
going O
outside O
, O
while O
also O
recommending O
the O
manufacture O
of O
a O
homemade O
face O
mask O
for O
those O
who O
cannot O
purchase O
face O
masks O
. O

Face O
masks O
have O
also B-TERM
been O
widely O
used O
in O
Japan O
, O
South O
Korea O
, O
Malaysia O
, O
and O
Singapore O
. O

Social O
distancing O
( O
also B-TERM
known O
as O
physical B-TERM
distancing O
) O
includes O
infection O
control O
actions O
intended O
to O
slow O
the O
spread O
of O
disease B-TERM
by O
minimizing O
close O
contact O
between O
individuals O
. O

Methods O
include O
quarantines O
; O
travel B-TERM
restrictions O
; O
and O
the O
closing O
of O
schools O
, O
workplaces O
, O
stadiums O
, O
theatres O
, O
or O
shopping O
centres O
. O

Individuals O
may O
apply B-TERM
social O
distancing O
methods O
by O
staying O
at O
home B-TERM
, O
limiting O
travel B-TERM
, O
avoiding O
crowded O
areas O
, O
using B-TERM
no O
- O
contact O
greetings O
, O
and O
physically O
distancing O
themselves O
from O
others O
. O

Many O
governments O
are O
now O
mandating O
or O
recommending O
social O
distancing O
in O
regions B-TERM
affected O
by O
the O
outbreak O
. O

The O
maximum O
gathering O
size O
recommended O
by O
US O
government O
bodies O
and O
health O
organizations B-TERM
was O
swiftly O
reduced B-TERM
from O
250 O
people O
( O
if O
there O
was O
no O
known O
COVID O
- O
19 O
spread O
in O
a O
region B-TERM
) O
to O
50 O
people O
, O
and O
later O
to O
10 O
people O
. O

On O
22 O
March O
2020 O
, O
Germany O
banned O
public O
gatherings O
of O
more O
than O
two B-TERM
people.Older O
adults O
and O
those O
with O
underlying O
medical O
conditions O
such O
as O
diabetes O
, O
heart B-TERM
disease B-TERM
, O
respiratory O
disease B-TERM
, O
hypertension O
, O
and O
compromised O
immune O
systems O
face B-TERM
increased O
risk O
of O
serious O
illness O
and O
complications O
and O
have O
been O
advised O
by O
the O
CDC O
to O
stay O
home O
as O
much O
as O
possible O
in O
areas O
of O
community O
outbreak.In O
late O
March O
2020 O
, O
the O
WHO O
and O
other O
health O
bodies O
began O
to O
replace B-TERM
the O
use O
of O
the O
term O
" O
social O
distancing O
" O
with O
" O
physical B-TERM
distancing O
, O
" O
to O
clarify O
that O
the O
aim B-TERM
is O
to O
reduce B-TERM
physical O
contact O
while O
maintaining O
social O
connections O
, O
either O
virtually O
or O
at O
a O
distance B-TERM
. O

The O
use O
of O
the O
term O
" O
social O
distancing O
" O
had O
led O
to O
implications O
that O
people O
should O
engage O
in O
complete O
social O
isolation O
, O
rather O
than O
encouraging O
them O
to O
stay O
in O
contact O
with O
others O
through O
alternative O
means.Some O
authorities O
have O
issued O
sexual O
health O
guidelines O
for O
use B-TERM
during O
the O
pandemic O
. O

These O
include O
recommendations O
to O
only O
have O
sex O
with O
someone O
you O
live O
with O
, O
who O
does O
not O
have O
the O
virus O
or O
symptoms O
of O
the O
virus O
. O

Self O
- O
isolation O
at O
home O
has O
been O
recommended O
for O
those O
diagnosed O
with O
COVID O
- O
19 O
and O
those O
who O
suspect O
they O
have O
been O
infected O
. O

Health O
agencies O
have O
issued O
detailed O
instructions O
for O
proper O
self O
- O
isolation.Many O
governments O
have O
mandated O
or O
recommended O
self O
- O
quarantine O
for O
entire B-TERM
populations O
living O
in O
affected O
areas B-TERM
. O

The O
strongest O
self O
- O
quarantine O
instructions O
have O
been O
issued O
to O
those O
in O
high O
risk O
groups O
. O

Those O
who O
may O
have O
been O
exposed O
to O
someone O
with O
COVID O
- O
19 O
and O
those O
who O
have O
recently O
travelled O
to O
a O
country O
or O
region B-TERM
with O
widespread O
transmission O
have O
been O
advised O
to O
self O
- O
quarantine O
for O
14 O
days O
from O
the O
time O
of O
last O
possible B-TERM
exposure O
. O

Strategies O
in O
the O
control O
of O
an O
outbreak O
are O
containment O
or O
suppression O
, O
and O
mitigation O
. O

Containment O
is O
undertaken O
in O
the O
early O
stages B-TERM
of O
the O
outbreak O
and O
aims B-TERM
to O
trace O
and O
isolate O
those O
infected O
as O
well O
as O
introduce O
other O
measures B-TERM
of O
infection O
control O
and O
vaccinations B-TERM
to O
stop O
the O
disease B-TERM
from O
spreading O
to O
the O
rest B-TERM
of O
the O
population O
. O

When O
it O
is O
no O
longer O
possible O
to O
contain O
the O
spread O
of O
the O
disease B-TERM
, O
efforts O
then O
move O
to O
the O
mitigation O
stage B-TERM
: O
measures B-TERM
are O
taken O
to O
slow O
the O
spread O
and O
mitigate O
its O
effects O
on O
the O
healthcare O
system O
and O
society O
. O

A O
combination O
of O
both O
containment O
and O
mitigation O
measures B-TERM
may O
be O
undertaken O
at O
the O
same O
time O
. O

Suppression O
requires O
more O
extreme O
measures B-TERM
so O
as O
to O
reverse O
the O
pandemic O
by O
reducing B-TERM
the O
basic B-TERM
reproduction O
number B-TERM
to O
less O
than O
1.Part O
of O
managing O
an O
infectious O
disease B-TERM
outbreak O
is O
trying O
to O
decrease B-TERM
the O
epidemic O
peak O
, O
known O
as O
flattening O
the O
epidemic O
curve O
. O

This O
decreases O
the O
risk O
of O
health O
services O
being O
overwhelmed O
and O
provides O
more O
time O
for O
vaccines B-TERM
and O
treatments O
to O
be O
developed O
. O

Non O
- O
pharmaceutical O
interventions O
that O
may O
manage O
the O
outbreak O
include O
personal O
preventive O
measures B-TERM
, O
such O
as O
hand O
hygiene O
, O
wearing O
face O
- O
masks O
, O
and O
self O
- O
quarantine O
; O
community O
measures B-TERM
aimed O
at O
physical O
distancing O
such O
as O
closing O
schools O
and O
cancelling O
mass O
gathering O
events O
; O
community O
engagement O
to O
encourage O
acceptance O
and O
participation O
in O
such O
interventions O
; O
as O
well O
as O
environmental O
measures B-TERM
such O
surface O
cleaning.More O
drastic O
actions O
aimed O
at O
containing O
the O
outbreak O
were O
taken O
in O
China O
once O
the O
severity O
of O
the O
outbreak O
became O
apparent O
, O
such O
as O
quarantining O
entire O
cities O
and O
imposing O
strict O
travel O
bans O
. O

Other O
countries O
also B-TERM
adopted O
a O
variety O
of O
measures B-TERM
aimed O
at O
limiting O
the O
spread O
of O
the O
virus O
. O

South O
Korea O
introduced O
mass O
screening O
and O
localized O
quarantines O
, O
and O
issued O
alerts O
on O
the O
movements B-TERM
of O
infected O
individuals O
. O

Singapore O
provided O
financial O
support O
for O
those O
infected O
who O
quarantined O
themselves O
and O
imposed O
large O
fines O
for O
those O
who O
failed O
to O
do O
so O
. O

Taiwan O
increased B-TERM
face O
mask O
production O
and O
penalized O
hoarding O
of O
medical O
supplies.Simulations O
for O
Great O
Britain O
and O
the O
United O
States O
show B-TERM
that O
mitigation O
( O
slowing O
but O
not O
stopping O
epidemic O
spread O
) O
and O
suppression O
( O
reversing O
epidemic O
growth B-TERM
) O
have O
major O
challenges B-TERM
. O

Optimal O
mitigation O
policies O
might O
reduce B-TERM
peak O
healthcare O
demand O
by O
2 O
/ O
3 O
and O
deaths O
by O
half O
, O
but O
still O
result B-TERM
in O
hundreds O
of O
thousands O
of O
deaths O
and O
health O
systems O
being O
overwhelmed O
. O

Suppression O
can O
be O
preferred O
but O
needs O
to O
be O
maintained O
for O
as O
long O
as O
the O
virus O
is O
circulating O
in O
the O
human O
population O
( O
or O
until O
a O
vaccine B-TERM
becomes O
available O
, O
if O
that O
comes O
first O
) O
, O
as O
transmission O
otherwise O
quickly O
rebounds O
when O
measures B-TERM
are O
relaxed O
. O

Long O
- O
term O
intervention O
to O
suppress O
the O
pandemic O
causes O
social O
and O
economic O
costs O
. O

There O
are O
no O
specific O
antiviral O
medications O
approved O
for O
COVID O
- O
19 O
, O
but O
development O
efforts O
are O
underway O
, O
including O
testing O
of O
existing O
medications O
. O

Taking O
over O
- O
the O
- O
counter O
cold O
medications O
, O
drinking O
fluids O
, O
and O
resting O
may O
help B-TERM
alleviate O
symptoms O
. O

Depending O
on O
the O
severity O
, O
oxygen O
therapy O
, O
intravenous O
fluids O
, O
and O
breathing O
support O
may O
be O
required O
. O

The O
use O
of O
steroids O
may O
worsen O
outcomes O
. O

Several O
compounds O
that O
were O
previously O
approved O
for O
treatment O
of O
other O
viral O
diseases B-TERM
are O
being O
investigated O
for O
use O
in O
treating O
COVID O
- O
19 O
. O

The O
WHO O
also B-TERM
stated O
that O
some O
" O
traditional O
and O
home O
remedies O
" O
can O
provide O
relief O
of O
the O
symptoms O
caused B-TERM
by O
SARS O
- O
CoV O
- O
19 O
. O

Increasing O
capacity O
and O
adapting O
healthcare O
for O
the O
needs O
of O
COVID O
- O
19 O
patients B-TERM
is O
described O
by O
the O
WHO O
as O
a O
fundamental O
outbreak O
response O
measure B-TERM
. O

The O
ECDC O
and O
the O
European O
regional B-TERM
office B-TERM
of O
the O
WHO O
have O
issued O
guidelines O
for O
hospitals O
and O
primary O
healthcare O
services O
for O
shifting O
of O
resources O
at O
multiple O
levels O
, O
including O
focusing O
laboratory O
services O
towards O
COVID O
- O
19 O
testing O
, O
cancelling O
elective O
procedures O
whenever B-TERM
possible B-TERM
, O
separating O
and O
isolating O
COVID O
- O
19 O
positive O
patients B-TERM
, O
and O
increasing O
intensive O
care O
capabilities O
by O
training O
personnel O
and O
increasing O
the O
number B-TERM
of O
available O
ventilators O
and O
beds O
. O

There O
are O
various O
theories O
about O
where O
the O
very O
first O
case O
( O
the O
so O
- O
called B-TERM
patient B-TERM
zero O
) O
may O
have O
originated O
. O

The O
first O
known O
case O
of O
the O
novel O
coronavirus O
may O
trace O
back O
to O
1 O
December O
2019 O
in O
Wuhan O
, O
Hubei O
, O
China O
. O

Within O
a O
month O
, O
the O
number B-TERM
of O
coronavirus O
cases O
in O
Hubei O
gradually O
increased O
. O

These O
were O
mostly O
linked O
to O
the O
Huanan O
Seafood O
Wholesale O
Market O
, O
which O
also B-TERM
sold O
live O
animals B-TERM
, O
and O
one O
theory O
is O
that O
the O
virus O
came O
from O
one O
of O
these O
kinds O
of O
animals B-TERM
; O
or O
, O
in O
other O
words O
, O
has O
a O
zoonotic O
origin.A O
pneumonia O
cluster O
of O
unknown O
cause O
was O
observed O
on O
26 O
December O
and O
treated O
by O
the O
doctor B-TERM
Zhang O
Jixian O
in O
Hubei O
Provincial O
Hospital O
, O
who O
informed O
the O
Wuhan O
Jianghan O
CDC O
on O
27 O
December O
. O

On O
30 O
December O
, O
a O
group O
of O
doctors B-TERM
at O
Wuhan O
Central O
Hospital O
alerted O
their O
colleagues O
of O
a O
" O
SARS O
- O
like O
coronavirus O
. O
" O

Eight O
of O
these O
doctors B-TERM
, O
including O
Li O
Wenliang O
, O
were O
admonished O
by O
the O
police B-TERM
for O
spreading O
false B-TERM
rumours O
, O
and O
another O
, O
Ai O
Fen O
, O
was O
reprimanded O
by O
her O
superiors O
for O
raising O
the O
alarm O
. O

The O
Wuhan O
Municipal O
Health O
Commission O
later O
released O
a O
public O
notice O
on O
31 O
December O
and O
informed B-TERM
the O
WHO O
. O

Enough B-TERM
cases O
of O
unknown B-TERM
pneumonia O
had O
been O
reported O
to O
health O
authorities O
in O
Wuhan O
to O
trigger O
an O
investigation O
in O
early O
January.During O
the O
early O
stages B-TERM
of O
the O
outbreak O
, O
the O
number B-TERM
of O
cases O
doubled O
approximately B-TERM
every O
seven O
and O
a O
half O
days O
. O

In O
early O
and O
mid O
- O
January O
2020 O
, O
the O
virus O
spread O
to O
other O
Chinese O
provinces O
, O
helped B-TERM
by O
the O
Chinese O
New O
Year O
migration O
and O
Wuhan O
being O
a O
transport O
hub O
and O
major O
rail O
interchange O
. O

On O
20 O
January O
, O
China O
reported O
nearly O
140 O
new O
cases O
in O
one O
day O
, O
including O
two B-TERM
people O
in O
Beijing O
and O
one O
in O
Shenzhen O
. O

Later O
official O
data B-TERM
shows O
that O
6,174 O
people O
had O
already O
developed O
symptoms O
by O
20 O
January O
2020.As O
of O
26 O
March O
, O
the O
United B-TERM
States O
has O
overtaken O
China O
and O
Italy O
with O
the O
highest O
number B-TERM
of O
confirmed O
cases O
in O
the O
world.As O
of O
9 O
April O
2020 O
, O
more O
than O
1.61 O
million O
cases O
have O
been O
reported O
worldwide O
; O
more O
than O
97,000 O
people O
have O
died O
and O
more O
than O
364,000 O
have O
recovered O
. O

Around B-TERM
200 O
countries O
and O
territories O
have O
had O
at O
least O
one O
case O
. O

Due O
to O
the O
pandemic O
in O
Europe O
, O
many O
countries O
in O
the O
Schengen O
Area O
have O
restricted O
free B-TERM
movement B-TERM
and O
set O
up O
border O
controls O
. O

National O
reactions O
have O
included O
containment O
measures B-TERM
such O
as O
quarantines O
( O
known O
as O
stay O
- O
at O
- O
home O
orders O
, O
shelter O
- O
in O
- O
place O
orders O
, O
or O
lockdown O
) O
and O
curfews.As O
of O
2 O
April O
, O
nearly O
300 O
million O
people O
, O
or O
about O
90 O
% O
of O
the O
population O
, O
are O
under O
some O
form O
of O
lockdown O
in O
the O
United O
States O
, O
more O
than O
50 O
million O
people O
are O
in O
lockdown O
in O
the O
Philippines O
, O
about O
59 O
million O
people O
are O
in O
lockdown O
in O
South O
Africa O
, O
and O
1.3 O
billion O
people O
are O
in O
lockdown O
in O
India O
. O

On O
26 O
March O
, O
1.7 O
billion O
people O
worldwide O
were O
under O
some O
form O
of O
lockdown O
, O
which O
increased O
to O
2.6 O
billion O
people O
two B-TERM
days O
later O
- O
around B-TERM
a O
third O
of O
the O
world O
's O
population O
. O

The O
first O
confirmed O
case O
of O
COVID O
- O
19 O
has O
been O
traced O
back O
to O
1 O
December O
2019 O
in O
Wuhan O
; O
one O
unconfirmed O
report O
suggests O
the O
earliest O
case O
was O
on O
17 O
November O
. O

Doctor B-TERM
Zhang O
Jixian O
observed O
a O
cluster O
of O
pneumonia O
cases O
of O
unknown B-TERM
cause O
on O
26 O
December O
, O
upon O
which O
her O
hospital O
informed O
Wuhan O
Jianghan O
CDC O
on O
27 O
December O
. O

Initial O
genetic O
testing O
of O
patient B-TERM
samples O
on O
27 O
December O
2019 O
indicated B-TERM
the O
presence B-TERM
of O
a O
SARS O
- O
like O
coronavirus O
. O

A O
public O
notice O
was O
released O
by O
Wuhan O
Municipal O
Health O
Commission O
on O
31 O
December O
. O

The O
WHO O
was O
informed O
on O
the O
same O
day O
. O

As O
these O
notifications O
occurred O
, O
doctors B-TERM
in O
Wuhan O
were O
warned O
by O
police B-TERM
for O
" O
spreading O
rumours O
" O
about O
the O
outbreak O
. O

The O
Chinese O
National O
Health O
Commission O
initially B-TERM
claimed O
that O
there O
was O
no O
" O
clear B-TERM
evidence O
" O
of O
human O
- O
to O
- O
human O
transmission O
. O

In O
late O
January O
, O
the O
Chinese O
government O
launched O
a O
radical O
campaign O
later O
described O
by O
the O
Chinese O
Communist O
Party O
general O
secretary O
Xi O
Jinping O
as O
a O
" O
people O
's O
war B-TERM
" O
to O
contain O
the O
spread O
of O
the O
virus O
. O

In O
what O
has O
been O
described O
as O
" O
the O
largest O
quarantine O
in O
human O
history O
, O
" O
a O
cordon O
sanitaire O
was O
announced B-TERM
on O
23 O
January O
stopping O
travel O
in O
and O
out O
of O
Wuhan O
, O
which O
was O
extended O
to O
a O
total O
of O
15 O
cities O
in O
Hubei O
, O
affecting O
a O
total O
of O
about O
57 O
million O
people O
. O

Private O
vehicle O
use O
was O
banned O
in O
the O
city O
. O

Chinese O
New O
Year O
( O
25 O
January O
) O
celebrations O
were O
cancelled O
in O
many O
places B-TERM
. O

The O
authorities O
also B-TERM
announced B-TERM
the O
construction B-TERM
of O
a O
temporary O
hospital O
, O
Huoshenshan O
Hospital O
, O
which O
was O
completed O
in O
10 O
days O
. O

Another B-TERM
hospital O
was O
built O
afterwards B-TERM
, O
Leishenshan O
Hospital O
, O
to O
handle O
additional O
patients B-TERM
. O

In O
addition O
to O
newly O
constructed O
hospitals O
, O
China O
also B-TERM
converted O
14 O
other O
facilities O
in O
Wuhan O
, O
such O
as O
convention O
centers O
and O
stadiums O
, O
into O
temporary O
hospitals.On O
26 O
January O
, O
the O
government O
instituted O
further O
measures B-TERM
to O
contain O
the O
COVID O
- O
19 O
outbreak O
, O
including O
issuing O
health O
declarations O
for O
travellers O
and O
extending O
the O
Spring O
Festival O
holiday O
. O

Universities O
and O
schools O
around O
the O
country O
were O
also O
closed O
. O

The O
regions B-TERM
of O
Hong O
Kong O
and O
Macau O
instituted O
several O
measures B-TERM
, O
particularly O
in O
regard O
to O
schools O
and O
universities O
. O

Remote O
working O
measures O
were O
instituted O
in O
several O
Chinese O
regions B-TERM
. O

Travel B-TERM
restrictions O
were O
enacted O
in O
and O
outside O
of O
Hubei O
. O

Public O
transport O
was O
modified O
, O
and O
museums O
throughout O
China O
were O
temporarily O
closed O
. O

Control O
of O
public O
movement B-TERM
was O
applied O
in O
many O
cities O
, O
and O
it O
has O
been O
estimated O
that O
about O
760 O
million O
people O
( O
more O
than O
half O
the O
population O
) O
faced O
some O
form O
of O
outdoor O
restriction.After O
the O
outbreak O
entered O
its O
global O
phase O
in O
March O
, O
Chinese O
authorities O
took B-TERM
strict O
measures B-TERM
to O
prevent O
the O
virus O
from O
" O
importing O
" O
from O
other O
countries O
. O

For O
example O
, O
Beijing O
has O
imposed O
a O
14 O
- O
day O
mandatory O
quarantine O
for O
all O
international O
travellers O
entering O
the O
city.On O
23 O
March O
, O
mainland O
China O
only O
one O
case O
had O
transmitted O
domestically O
in O
the O
five O
days O
prior O
, O
in O
this O
instance O
via O
a O
traveller O
returning O
to O
Guangzhou O
from O
Istanbul O
. O

On O
24 O
March O
2020 O
, O
Chinese O
Premier O
Li O
Keqiang O
reported O
that O
the O
spread O
of O
domestically O
transmitted O
cases O
has O
been O
basically O
blocked O
and O
the O
outbreak O
has O
been O
controlled O
in O
China O
. O

The O
same O
day O
travel B-TERM
restrictions O
were O
eased O
in O
Hubei O
, O
apart B-TERM
from O
Wuhan O
, O
two B-TERM
months O
after O
the O
lockdown O
was O
imposed.The O
Chinese O
Ministry O
of O
Foreign B-TERM
Affairs O
announced B-TERM
on O
26 O
March O
2020 O
that O
entry O
for O
visa O
or O
residence O
permit O
holders O
would O
be O
suspended O
from O
28 O
March O
onwards O
, O
with O
no O
specific O
details O
on O
when O
this O
policy O
will O
end O
. O

Those O
who O
wish B-TERM
to O
enter O
China O
will O
have O
to O
apply O
for O
visas O
in O
Chinese O
embassies O
or O
consulates O
. O

The O
Chinese O
government O
encouraged O
businesses O
and O
factories B-TERM
to O
re O
- O
open O
on O
30 O
March O
, O
and O
provided O
monetary O
stimulus O
packages O
for O
firms.The O
State O
Council O
declared B-TERM
a O
day O
of O
mourning O
to O
begin O
with O
a O
national O
three O
- O
minute B-TERM
moment B-TERM
of O
silence B-TERM
on O
10 O
: O
00 O
4 O
April O
, O
coinciding O
with O
Qingming O
Festival O
, O
although O
the O
central O
government O
asked O
families O
to O
pay O
their O
respects O
online O
in O
observance O
of O
physical B-TERM
distancing O
as O
to O
avoid O
a O
renewed O
COVID O
- O
19 O
outbreak O
. O

COVID O
- O
19 O
was O
confirmed O
to O
have O
spread O
to O
South O
Korea O
on O
20 O
January O
2020 O
from O
China O
. O

The O
nation O
's O
health O
agency O
reported O
a O
significant B-TERM
increase B-TERM
in O
confirmed O
cases O
on O
20 O
February O
, O
largely O
attributed O
to O
a O
gathering O
in O
Daegu O
of O
a O
new O
religious O
movement B-TERM
known O
as O
the O
Shincheonji O
Church O
of O
Jesus O
. O

Shincheonji O
devotees O
visiting O
Daegu O
from O
Wuhan O
were O
suspected O
to O
be O
the O
origin O
of O
the O
outbreak O
. O

As O
of O
22 O
February O
, O
among O
9,336 O
followers B-TERM
of O
the O
church O
, O
1,261 O
or O
about O
13 O
% O
reported O
symptoms.South O
Korea O
declared B-TERM
the O
highest O
level O
of O
alert O
on O
23 O
February O
2020 O
. O

On O
28 O
February O
, O
more O
than O
2,000 O
confirmed O
cases O
were O
reported O
in O
Korea O
, O
rising O
to O
3,150 O
on O
29 O
February O
. O

All O
South O
Korean O
military B-TERM
bases B-TERM
were O
quarantined O
after O
tests O
confirmed O
that O
three O
soldiers B-TERM
were O
positive O
for O
the O
virus O
. O

Airline O
schedules O
were O
also O
affected O
and O
therefore O
they O
were O
changed.South O
Korea O
introduced O
what O
was O
considered O
the O
largest O
and O
best O
- O
organized O
programme O
in O
the O
world O
to O
screen O
the O
population O
for O
the O
virus O
, O
and O
isolate O
any O
infected O
people O
as O
well O
as O
tracing O
and O
quarantining O
those O
who O
contacted O
them O
. O

Screening O
methods B-TERM
included O
mandatory O
self O
- O
reporting O
of O
symptoms O
by O
new O
international O
arrivals O
through O
mobile B-TERM
application B-TERM
, O
drive O
- O
thru O
testing O
for O
the O
virus O
with O
the O
results B-TERM
available O
the O
next B-TERM
day O
, O
and O
increasing O
testing O
capability O
to O
allow B-TERM
up O
to O
20,000 O
people O
to O
be O
tested O
every O
day O
. O

South O
Korea O
's O
programme O
is O
considered O
to O
be O
a O
success O
in O
controlling O
the O
outbreak O
despite O
not O
quarantining O
entire B-TERM
cities.The O
South O
Korean O
society O
was O
initially B-TERM
polarized O
on O
President O
Moon O
Jae O
- O
in O
's O
response B-TERM
to O
the O
crisis O
. O

Many O
Koreans O
signed O
petitions O
either B-TERM
calling O
for O
the O
impeachment O
of O
Moon O
over O
what O
they O
claimed O
to O
be O
government O
mishandling O
of O
the O
outbreak O
, O
or O
praising O
his O
response O
. O

On O
23 O
March O
, O
it O
was O
reported O
that O
South O
Korea O
had O
the O
lowest O
one O
- O
day O
case O
total O
in O
four O
weeks O
. O

On O
29 O
March O
it O
was O
reported O
that O
beginning O
1 O
April O
all O
new O
overseas O
arrivals O
will O
be O
quarantined O
for O
two O
weeks O
. O

Per O
media O
reports O
on O
1 O
April O
, O
South O
Korea O
has O
received O
requests O
for O
virus O
testing O
assistance O
from O
121 O
different O
countries O
. O

Iran O
reported O
its O
first O
confirmed O
cases O
of O
SARS O
- O
CoV O
- O
2 O
infections O
on O
19 O
February O
in O
Qom O
, O
where O
, O
according O
to O
the O
Ministry O
of O
Health O
and O
Medical O
Education O
, O
two B-TERM
people O
died O
later O
that O
day O
. O

Early O
measures B-TERM
announced O
by O
the O
government O
included O
the O
cancellation B-TERM
of O
concerts O
and O
other O
cultural O
events O
, O
sporting O
events O
, O
and O
Friday O
prayers O
, O
and O
closures O
of O
universities O
, O
higher O
education O
institutions O
, O
and O
schools O
. O

Iran O
allocated O
five O
trillion O
rials O
to O
combat O
the O
virus O
. O

President O
Hassan O
Rouhani O
said O
on O
26 O
February O
2020 O
that O
there O
were O
no O
plans O
to O
quarantine O
areas B-TERM
affected O
by O
the O
outbreak O
, O
and O
only O
individuals O
would O
be O
quarantined O
. O

Plans B-TERM
to O
limit O
travel B-TERM
between O
cities O
were O
announced B-TERM
in O
March O
, O
although O
heavy O
traffic O
between O
cities O
ahead O
of O
the O
Persian O
New O
Year O
Nowruz O
continued O
. O

Shia O
shrines O
in O
Qom O
remained O
open B-TERM
to O
pilgrims O
until O
16 O
March O
2020.Iran O
became O
a O
centre O
of O
the O
spread O
of O
the O
virus O
after O
China O
during O
February O
. O

Amidst O
claims O
of O
a O
cover O
- O
up O
of O
the O
extent O
of O
the O
outbreak O
in O
Iran O
, O
more O
than O
ten O
countries O
had O
traced O
their O
cases O
back O
to O
Iran O
by O
28 O
February O
, O
indicating B-TERM
that O
the O
extent O
of O
the O
outbreak O
may O
be O
more O
severe O
than O
the O
388 O
cases O
reported O
by O
the O
Iranian O
government O
by O
that O
date O
. O

The O
Iranian O
Parliament O
was O
shut O
down O
, O
with O
23 O
of O
its O
290 O
members O
reported O
to O
have O
had O
tested O
positive O
for O
the O
virus O
on O
3 O
March O
. O

On O
12 O
March O
, O
the O
Human O
Rights O
Watch O
urged O
the O
Iranian O
prison O
authorities O
to O
unconditionally O
release O
the O
human O
rights O
defenders O
detained O
for O
peaceful B-TERM
dissent O
, O
and O
to O
also B-TERM
temporarily O
release O
all O
the O
eligible O
prisoners O
. O

It O
stated O
that O
there O
is O
a O
greater O
risk O
of O
the O
virus O
to O
spread O
in O
closed O
institutions O
like B-TERM
detention O
centres O
, O
which O
also O
lack B-TERM
adequate O
medical O
care O
. O

On O
15 O
March O
, O
the O
Iranian O
government O
reported O
100 O
deaths O
in O
a O
single O
day O
, O
the O
most O
recorded O
in O
the O
country O
since O
the O
outbreak O
began O
. O

At O
least O
12 O
sitting O
or O
former B-TERM
Iranian O
politicians O
and O
government O
officials O
had O
died O
from O
the O
disease B-TERM
by O
17 O
March O
. O

By O
23 O
March O
, O
Iran O
was O
experiencing O
50 O
new O
cases O
every O
hour O
and O
one O
new O
death O
every O
ten O
minutes B-TERM
due O
to O
coronavirus O
. O

According O
to O
a O
WHO O
official O
, O
there O
may O
be O
five O
times O
more O
cases O
in O
Iran O
than O
what O
is O
being O
reported O
. O

It O
is O
also B-TERM
suggested O
that O
U.S. O
sanctions O
on O
Iran O
may O
be O
affecting O
the O
country O
's O
financial O
ability O
to O
respond O
to O
the O
viral O
outbreak O
. O

The O
UN O
High O
Commissioner O
for O
Human O
Rights O
has O
demanded O
economic O
sanctions O
to O
be O
eased O
for O
nations O
most O
affected O
by O
the O
pandemic O
, O
including O
Iran O
. O

The O
outbreak O
was O
confirmed O
to O
have O
spread O
to O
Italy O
on O
31 O
January O
, O
when O
two B-TERM
Chinese O
tourists O
tested O
positive O
for O
SARS O
- O
CoV O
- O
2 O
in O
Rome O
. O

Cases O
began O
to O
rise O
sharply O
, O
which O
prompted O
the O
Italian O
government O
to O
suspend O
all O
flights O
to O
and O
from O
China O
and O
declare B-TERM
a O
state O
of O
emergency O
. O

An O
unassociated O
cluster O
of O
COVID O
- O
19 O
cases O
was O
later O
detected O
, O
starting O
with O
16 O
confirmed O
cases O
in O
Lombardy O
on O
21 O
February.On O
22 O
February O
, O
the O
Council O
of O
Ministers O
announced O
a O
new O
decree O
- O
law O
to O
contain O
the O
outbreak O
, O
including O
quarantining O
more O
than O
50,000 O
people O
from O
11 O
different O
municipalities O
in O
northern O
Italy O
. O

Prime O
Minister O
Giuseppe O
Conte O
said O
, O
" O
In O
the O
outbreak O
areas O
, O
entry O
and O
exit O
will O
not O
be O
provided O
. O

Suspension O
of O
work O
activities O
and O
sports O
events O
has O
already O
been O
ordered O
in O
those O
areas B-TERM
. O
" O
On O
4 O
March O
, O
the O
Italian O
government O
ordered O
the O
full O
closure O
of O
all O
schools O
and O
universities O
nationwide O
as O
Italy O
reached O
100 O
deaths O
. O

All O
major O
sporting O
events O
, O
including O
Serie O
A O
football O
matches O
, O
were O
to O
be O
held O
behind O
closed O
doors O
until O
April O
, O
but O
on O
9 O
March O
, O
all O
sport O
was O
suspended O
completely O
for O
at O
least O
one O
month O
. O

On O
11 O
March O
, O
Prime O
Minister O
Conte O
ordered O
stoppage O
of O
nearly O
all O
commercial O
activity B-TERM
except O
supermarkets O
and O
pharmacies.On O
6 O
March O
, O
the O
Italian O
College O
of O
Anaesthesia O
, O
Analgesia O
, O
Resuscitation O
and O
Intensive O
Care O
( O
SIAARTI O
) O
published B-TERM
medical O
ethics B-TERM
recommendations O
regarding O
triage O
protocols O
that O
might O
be O
employed O
. O

On O
19 O
March O
, O
Italy O
overtook O
China O
as O
the O
country O
with O
the O
most O
coronavirus O
- O
related O
deaths O
in O
the O
world O
after O
reporting O
3,405 O
fatalities O
from O
the O
pandemic O
. O

On O
22 O
March O
, O
it O
was O
reported O
that O
Russia O
had O
sent O
nine O
military B-TERM
planes O
with O
medical O
equipment B-TERM
to O
Italy O
. O

As O
of O
5 O
April O
, O
there O
were O
128,948 O
confirmed O
cases O
, O
15,887 O
deaths O
, O
and O
21,815 O
recoveries O
in O
Italy O
, O
with O
the O
majority O
of O
those O
cases O
occurring O
in O
the O
Lombardy O
region B-TERM
. O

A O
CNN O
report O
indicated O
that O
the O
combination B-TERM
of O
Italy O
's O
large O
elderly O
population O
and O
inability O
to O
test O
all O
who O
have O
the O
virus O
to O
date O
may O
be O
contributing B-TERM
to O
the O
high O
fatality O
rate O
. O

The O
United O
Kingdom O
's O
response O
to O
the O
virus O
first O
emerged O
as O
one O
of O
the O
most O
relaxed O
of O
the O
affected O
countries O
, O
and O
until O
18 O
March O
2020 O
, O
the O
British O
government O
did O
not O
impose O
any O
form O
of O
social O
distancing O
or O
mass O
quarantine O
measures B-TERM
on O
its O
citizens O
. O

As O
a O
result B-TERM
, O
the O
government O
received O
criticism O
for O
the O
perceived O
lack O
of O
pace O
and O
intensity O
in O
its O
response B-TERM
to O
concerns O
faced O
by O
the O
public.On O
16 O
March O
, O
Prime O
Minister O
Boris O
Johnson O
made O
an O
announcement O
advising O
against O
all O
non O
- O
essential O
travel B-TERM
and O
social O
contact O
, O
suggesting O
people O
work O
from O
home B-TERM
where O
possible O
and O
avoid O
venues O
such O
as O
pubs O
, O
restaurants O
, O
and O
theatres O
. O

On O
20 O
March O
, O
the O
government O
announced B-TERM
that O
all O
leisure O
establishments O
such O
as O
pubs O
and O
gyms O
were O
to O
close O
as O
soon O
as O
possible O
, O
and O
promised O
to O
pay O
up O
to O
80 O
% O
of O
workers O
' O
wages O
to O
a O
limit O
of O
¬£ O
2,500 O
per O
month O
to O
prevent O
unemployment O
in O
the O
crisis.On O
23 O
March O
, O
the O
Prime O
Minister O
announced B-TERM
tougher O
social O
distancing O
measures B-TERM
, O
banning O
gatherings O
of O
more O
than O
two B-TERM
people O
and O
restricting O
travel O
and O
outdoor O
activity O
to O
that O
deemed O
strictly O
necessary O
. O

Unlike O
previous B-TERM
measures B-TERM
, O
these O
restrictions O
were O
enforceable O
by O
police B-TERM
through O
the O
issuing O
of O
fines O
and O
the O
dispersal O
of O
gatherings O
. O

Most O
businesses O
were O
ordered O
to O
close O
, O
with O
exceptions O
for O
businesses O
deemed O
" O
essential O
, O
" O
including O
supermarkets O
, O
pharmacies O
, O
banks O
, O
hardware O
shops B-TERM
, O
petrol O
stations O
, O
and O
garages O
. O

On O
20 O
January O
, O
the O
first O
known O
case O
of O
COVID O
- O
19 O
was O
confirmed O
in O
the O
Pacific O
Northwest O
state O
of O
Washington O
in O
a O
man O
who O
had O
returned O
from O
Wuhan O
on O
15 O
January O
. O

The O
White O
House B-TERM
Coronavirus O
Task O
Force O
was O
established O
on O
29 O
January O
. O

On O
31 O
January O
, O
the O
Trump O
administration O
declared B-TERM
a O
public O
health O
emergency O
, O
and O
placed B-TERM
restrictions O
on O
entry O
for O
travellers O
from O
China O
. O

On O
28 O
January O
2020 O
, O
the O
Center O
for O
Disease B-TERM
Control O
- O
the O
leading B-TERM
public O
health O
institute O
of O
the O
U.S. O
government O
- O
announced B-TERM
they O
had O
developed O
their O
own O
testing O
kit O
. O

Despite O
doing O
so O
, O
the O
United O
States O
had O
a O
slow O
start O
in O
testing O
, O
which O
obscured O
the O
true B-TERM
extent O
of O
the O
outbreak O
at O
the O
time O
. O

Testing O
was O
marred O
by O
defective O
test O
kits O
produced O
by O
the O
federal O
government O
in O
February O
, O
a O
lack B-TERM
of O
federal O
government O
approval O
for O
non O
- O
government O
test O
kits O
( O
by O
academia O
, O
companies B-TERM
and O
hospitals O
) O
until O
the O
end B-TERM
of O
February O
, O
and O
restrictive O
criteria O
for O
people O
to O
qualify O
for O
a O
test O
until O
early O
March O
( O
a O
doctor B-TERM
's O
order O
was O
required O
thereafter O
) O
. O

By O
27 O
February O
, O
The O
Washington O
Post O
reported O
fewer O
than O
4,000 O
tests O
had O
been O
conducted O
in O
the O
United O
States O
. O

By O
13 O
March O
, O
The O
Atlantic O
reported O
that O
less O
than O
14,000 O
tests O
had O
been O
conducted O
. O

On O
22 O
March O
, O
the O
Associated O
Press O
reported O
: O
" O
Many O
people O
who O
have O
symptoms O
and O
a O
doctor O
's O
order O
have O
waited O
hours O
or O
days O
for O
a O
test O
. O
" O
After O
the O
first O
death O
in O
the O
United O
States O
was O
reported O
in O
Washington O
state O
on O
29 O
February O
, O
Governor O
Jay O
Inslee O
declared O
a O
state O
of O
emergency O
, O
an O
action O
that O
was O
soon O
followed O
by O
other O
states O
. O

Schools O
in O
the O
Seattle O
area O
cancelled O
classes O
on O
3 O
March O
, O
and O
by O
mid O
- O
March O
, O
schools O
across O
the O
country O
were O
shutting O
down.On O
6 O
March O
2020 O
, O
the O
United B-TERM
States O
was O
advised O
of O
projections O
for O
the O
impact B-TERM
of O
the O
new O
coronavirus O
on O
the O
country O
by O
a O
group O
of O
epidemiologists O
at O
Imperial O
College O
London O
. O

On O
the O
same O
day O
President O
Trump O
signed O
the O
Coronavirus O
Preparedness O
and O
Response O
Supplemental O
Appropriations O
Act O
, O
which O
provided O
$ O
8.3 O
billion O
in O
emergency O
funding O
for O
federal O
agencies O
to O
respond O
to O
the O
outbreak O
. O

Corporations O
imposed O
employee O
travel O
restrictions O
, O
cancelled O
conferences O
, O
and O
encouraged O
employees B-TERM
to O
work O
from O
home B-TERM
. O

Sports O
events O
and O
seasons O
were O
cancelled.On O
11 O
March O
, O
Trump O
announced B-TERM
travel B-TERM
restrictions O
for O
most O
of O
Europe O
, O
excluding O
the O
United O
Kingdom O
, O
for O
30 O
days O
, O
effective O
13 O
March O
. O

The O
following O
day O
, O
he O
expanded O
the O
restrictions O
to O
include O
the O
United O
Kingdom O
and O
Ireland O
. O

On O
13 O
March O
, O
he O
declared B-TERM
a O
national O
emergency O
, O
which O
made O
federal O
funds O
available O
to O
respond O
to O
the O
crisis O
. O

Beginning O
on O
15 O
March O
, O
many O
businesses O
closed O
or O
reduced B-TERM
hours O
throughout O
the O
U.S. O
to O
try O
to O
reduce O
the O
spread O
of O
the O
virus O
. O

By O
17 O
March O
, O
the O
epidemic O
had O
been O
confirmed O
in O
all O
50 O
states O
and O
in O
the O
District O
of O
Columbia.On O
23 O
March O
, O
it O
was O
reported O
that O
New O
York O
City O
had O
10,700 O
cases O
of O
the O
coronavirus O
, O
more O
than O
the O
total O
number B-TERM
of O
cases O
in O
South O
Korea O
. O

On O
25 O
March O
, O
the O
governor O
said O
that O
social O
distancing O
seemed O
to O
be O
working O
, O
as O
estimates O
of O
case O
doubling O
slowed O
from O
2.0 O
days O
to O
4.7 O
days O
. O

As O
of O
28 O
March O
, O
there O
were O
32,308 O
confirmed O
cases O
in O
New O
York O
City O
, O
and O
672 O
people O
had O
died O
from O
the O
virus.On O
26 O
March O
, O
the O
United O
States O
was O
reported O
to O
have O
more O
confirmed O
coronavirus O
infection O
cases O
than O
any O
other O
country O
in O
the O
world O
, O
including O
China O
and O
Italy.As O
of O
8 O
April O
, O
400,335 O
cases O
have O
been O
confirmed O
in O
the O
United O
States O
, O
and O
12,841 O
people O
have O
died O
. O

Per O
media O
reports O
on O
30 O
March O
, O
U.S. O
President O
Trump O
has O
decided O
to O
extend O
social O
distancing O
guidelines O
until O
30 O
April O
. O

On O
the O
same O
day O
, O
the O
USNS O
Comfort O
, O
a O
hospital O
ship B-TERM
with O
about O
1000 O
beds O
, O
made O
anchor O
in O
New O
York O
. O

On O
3 O
April O
, O
the O
U.S. O
had O
a O
record O
884 O
deaths O
due O
to O
the O
coronavirus O
in O
a O
24 O
- O
hour O
period O
. O

In O
the O
state O
of O
New O
York O
the O
cases O
have O
exceeded O
100,000 O
people O
on O
3 O
April.The O
White O
House B-TERM
has O
been O
criticized O
for O
downplaying O
the O
threat B-TERM
and O
controlling O
the O
messaging B-TERM
by O
directing O
health O
officials O
and O
scientists O
to O
coordinate O
public O
statements O
and O
publications O
related O
to O
the O
virus O
with O
the O
office B-TERM
of O
Vice O
- O
President O
Mike O
Pence O
. O

Overall O
approval O
of O
Trump O
's O
management O
of O
the O
crisis O
has O
been O
polarized O
along O
partisan O
lines O
. O

Some O
U.S. O
officials O
and O
commentators O
criticized O
the O
U.S. O
reliance O
on O
importation O
of O
critical O
materials B-TERM
, O
including O
essential O
medical O
supplies O
, O
from O
China O
. O

An O
analysis B-TERM
of O
air O
travel O
patterns O
was O
used O
to O
map O
and O
predict O
patterns O
of O
spread O
and O
was O
published B-TERM
in O
The O
Journal O
of O
Travel O
Medicine O
in O
mid O
- O
January O
2020 O
. O

Based O
on O
2018 O
information B-TERM
from O
the O
International O
Air O
Transport O
Association O
, O
Bangkok O
, O
Hong O
Kong O
, O
Tokyo O
, O
and O
Taipei O
had O
the O
largest O
volume O
of O
travellers O
from O
Wuhan O
. O

Dubai O
, O
Sydney O
, O
and O
Melbourne O
were O
also B-TERM
reported O
as O
popular O
destinations O
for O
people O
travelling O
from O
Wuhan O
. O

Bali O
was O
reported O
as O
least O
able O
among O
the O
20 O
most O
popular O
destination O
cities O
in O
terms O
of O
preparedness O
, O
while O
cities O
in O
Australia O
were O
considered O
most O
able.Australia O
released O
its O
Emergency O
Response O
Plan B-TERM
for O
Novel O
Coronavirus O
( O
COVID O
- O
19 O
) O
on O
7 O
February O
. O

It O
stated O
that O
much O
was O
yet O
to O
be O
discovered O
about O
COVID O
- O
19 O
, O
and O
that O
Australia O
would O
emphasize O
border O
control O
and O
communication O
in O
its O
response O
to O
the O
pandemic O
. O

On O
21 O
March O
, O
a O
human O
biosecurity O
emergency O
was O
declared B-TERM
in O
Australia O
. O

Owing B-TERM
to O
the O
effective B-TERM
quarantine O
of O
public O
transport O
in O
Wuhan O
and O
Hubei O
, O
several O
countries O
have O
planned O
to O
evacuate O
their O
citizens O
and O
diplomatic O
staff O
from O
the O
area B-TERM
, O
primarily B-TERM
through O
chartered O
flights O
of O
the O
home O
nation O
, O
with O
Chinese O
authorities O
providing O
clearance O
. O

Canada O
, O
the O
United B-TERM
States O
, O
Japan O
, O
India O
, O
Sri O
Lanka O
, O
Australia O
, O
France O
, O
Argentina O
, O
Germany O
, O
and O
Thailand O
were O
among O
the O
first O
to O
plan O
the O
evacuation O
of O
their O
citizens O
. O

Pakistan O
has O
said O
that O
it O
will O
not O
be O
evacuating O
any O
citizens O
from O
China O
. O

On O
7 O
February O
, O
Brazil O
evacuated O
34 O
Brazilians O
or O
family O
members O
in O
addition O
to O
four O
Poles O
, O
a O
Chinese O
person O
, O
and O
an O
Indian O
citizen O
. O

The O
citizens O
of O
Poland O
, O
China O
, O
and O
India O
deplaned O
in O
Poland O
, O
where O
the O
Brazilian O
plane O
made O
a O
stopover O
before O
following O
its O
route O
to O
Brazil O
. O

Brazilian O
citizens O
who O
went O
to O
Wuhan O
were O
quarantined O
at O
a O
military B-TERM
base O
near O
Bras√≠lia O
. O

On O
the O
same O
day O
, O
215 O
Canadians O
( O
176 O
from O
the O
first O
plane O
, O
and O
39 O
from O
a O
second O
plane O
chartered O
by O
the O
U.S. O
government O
) O
were O
evacuated O
from O
Wuhan O
to O
CFB O
Trenton O
to O
be O
quarantined O
for O
two B-TERM
weeks O
. O

On O
11 O
February O
, O
another B-TERM
plane O
of O
185 O
Canadians O
from O
Wuhan O
landed O
at O
CFB O
Trenton O
. O

Australian O
authorities O
evacuated O
277 O
citizens O
on O
3 O
and O
4 O
February O
to O
the O
Christmas O
Island O
Detention O
Centre O
, O
which O
had O
been O
repurposed O
as O
a O
quarantine O
facility O
, O
where O
they O
remained O
for O
14 O
days O
. O

A O
New O
Zealand O
evacuation O
flight O
arrived O
in O
Auckland O
on O
5 O
February O
; O
its O
passengers O
( O
including O
some O
from O
Australia O
and O
the O
Pacific O
) O
were O
quarantined O
at O
a O
naval O
base O
in O
Whangaparoa O
, O
north O
of O
Auckland O
. O

On O
15 O
February O
, O
the O
United B-TERM
States O
announced B-TERM
that O
it O
would O
evacuate O
Americans O
aboard O
the O
cruise O
ship O
Diamond O
Princess O
. O

On O
21 O
February O
, O
a O
plane O
carrying O
129 O
Canadian O
passengers O
who O
had O
been O
evacuated O
from O
Diamond O
Princess O
landed O
in O
Trenton O
, O
Ontario O
. O

In O
early O
March O
, O
the O
Indian O
government O
began O
evacuating O
its O
citizens O
from O
Iran.On O
14 O
March O
a O
South O
African O
Airways O
aircraft O
chartered O
by O
the O
South O
African O
Government O
repatriated O
112 O
South O
African O
citizens O
. O

Medical O
screening O
was O
performed O
prior O
to O
departure O
, O
and O
four O
South O
Africans O
who O
were O
showing O
signs O
of O
coronavirus O
were O
left B-TERM
behind O
to O
mitigate O
risk O
. O

Only O
South O
Africans O
who O
tested O
negative O
were O
repatriated O
. O

Test O
results O
cleared O
all O
the O
South O
Africans O
, O
including O
the O
flight O
crew B-TERM
, O
pilots O
, O
hotel B-TERM
staff O
, O
police B-TERM
and O
soldiers B-TERM
involved O
in O
the O
humanitarian O
mission O
who O
, O
as O
a O
precautionary O
measure B-TERM
, O
all O
remained O
under O
observation O
and O
in O
quarantine O
for O
a O
14 O
- O
day O
period O
at O
The O
Ranch O
Resort O
. O

On O
20 O
March O
, O
the O
United O
States O
began O
to O
partially O
withdrawal O
its O
troops O
from O
Iraq O
due O
to O
the O
pandemic O
. O

On O
5 O
February O
, O
the O
Chinese O
foreign B-TERM
ministry O
stated O
that O
21 O
countries O
( O
including O
Belarus O
, O
Pakistan O
, O
Trinidad O
and O
Tobago O
, O
Egypt O
, O
and O
Iran O
) O
had O
sent O
aid O
to O
China O
. O

Some O
Chinese O
students O
at O
American O
universities O
joined O
together B-TERM
to O
help O
send O
aid O
to O
virus O
- O
stricken O
parts O
of O
China O
, O
with O
a O
joint O
group O
in O
the O
greater O
Chicago O
area O
reportedly O
managing O
to O
send O
50,000 O
N95 O
masks O
to O
hospitals O
in O
the O
Hubei O
province O
on O
30 O
January.The O
humanitarian O
aid O
organization B-TERM
Direct O
Relief O
, O
in O
coordination O
with O
FedEx O
, O
sent O
200,000 O
face O
masks O
along O
with O
other O
personal O
protective O
equipment O
, O
including O
gloves O
and O
gowns O
, O
by O
emergency O
airlift O
to O
the O
Wuhan O
Union O
Hospital O
by O
30 O
January O
. O

On O
5 O
February O
, O
Bill O
and O
Melinda O
Gates O
announced B-TERM
a O
$ O
100 O
million O
donation O
to O
the O
WHO O
to O
fund O
vaccine B-TERM
research O
and O
treatment O
efforts O
along O
with O
protecting O
" O
at O
- O
risk O
populations O
in O
Africa O
and O
South O
Asia O
. O
" O

Interaksyon O
reported O
that O
the O
Chinese O
government O
donated O
200,000 O
masks O
to O
the O
Philippines O
on O
6 O
February O
, O
after O
Senator O
Richard O
Gordon O
shipped O
3.16 O
million O
masks O
to O
Wuhan O
. O

On O
19 O
February O
, O
the O
Singapore O
Red O
Cross O
announced B-TERM
that O
it O
would O
send O
$ O
2.26 O
million O
worth O
of O
aid O
to O
China O
. O

Japan O
donated O
one O
million O
face O
masks O
to O
Wuhan O
, O
Turkey O
dispatched O
medical O
equipment B-TERM
, O
Russia O
sent O
more O
than O
13 O
tonnes O
of O
medical O
supplies O
to O
Wuhan O
, O
Malaysia O
announced B-TERM
a O
donation O
of O
18 O
million O
medical O
gloves O
to O
China O
, O
Germany O
delivered O
various O
medical O
supplies O
including O
10,000 O
Hazmat O
suits O
, O
and O
the O
United B-TERM
States O
donated O
17.8 O
tons O
of O
medical O
supplies O
to O
China O
and O
promised O
an O
additional O
$ O
100 O
million O
in O
financial O
support O
to O
affected O
countries.After O
cases O
in O
China O
seemed O
to O
stabilize O
, O
the O
country O
has O
been O
sending O
aid O
to O
various O
nations O
hit O
by O
the O
pandemic O
. O

In O
March O
, O
China O
, O
Cuba O
and O
Russia O
sent O
medical O
supplies O
and O
experts B-TERM
to O
help B-TERM
Italy O
deal O
with O
its O
coronavirus O
outbreak O
. O

Businessman O
Jack O
Ma O
sent O
1.1 O
million O
testing O
kits O
, O
6 O
million O
face O
masks O
, O
and O
60,000 O
protective O
suits O
to O
Addis O
Ababa O
, O
Ethiopia O
for O
distribution O
by O
the O
African O
Union B-TERM
. O

He O
later O
sent O
5,000 O
testing O
kits O
, O
100,000 O
face O
masks O
and O
5 O
ventilators O
to O
Panama O
. O

Ma O
also B-TERM
donated O
medical O
supplies O
to O
Canada.The O
Netherlands O
, O
Spain O
, O
Turkey O
, O
Georgia O
, O
and O
the O
Czech O
Republic O
expressed O
their O
concerns O
over O
Chinese O
- O
made O
masks O
and O
test O
kits O
. O

For O
instance O
, O
Spain O
withdrew O
58,000 O
Chinese O
- O
made O
coronavirus O
testing O
kits O
with O
an O
accuracy O
rate O
of O
just O
30 O
% O
, O
meanwhile O
, O
the O
Netherlands O
recalled O
600,000 O
Chinese O
face O
masks O
which O
were O
defective O
. O

Belgium O
recalled O
100,000 O
unusable O
masks O
, O
thought O
to O
be O
from O
China O
, O
but O
were O
in O
fact O
from O
Colombia O
. O

On O
the O
other O
hand O
, O
Chinese O
aid O
has O
been O
well O
- O
received B-TERM
in O
parts O
of O
Latin O
America O
and O
Africa.On O
2 O
April O
, O
the O
World O
Bank O
launched O
emergency O
support O
operations O
for O
developing O
countries O
. O

The O
WHO O
has O
commended O
the O
efforts O
of O
Chinese O
authorities O
in O
managing O
and O
containing O
the O
epidemic O
. O

The O
WHO O
noted O
the O
contrast O
between O
the O
2002 O
- O
2004 O
SARS O
outbreak O
, O
where O
Chinese O
authorities O
were O
accused O
of O
secrecy O
that O
impeded B-TERM
prevention O
and O
containment O
efforts O
, O
and O
the O
current O
crisis O
where O
the O
central O
government O
" O
has O
provided O
regular O
updates O
to O
avoid O
panic O
ahead O
of O
Lunar O
New O
Year O
holidays O
. O
" O

On O
23 O
January O
, O
in O
reaction O
to O
the O
central O
authorities O
' O
decision B-TERM
to O
implement O
a O
transportation O
ban O
in O
Wuhan O
, O
WHO O
representative O
Gauden O
Galea O
remarked O
that O
while O
it O
was O
" O
certainly O
not O
a O
recommendation O
the O
WHO O
has O
made O
, O
" O
it O
was O
also B-TERM
" O
a O
very O
important B-TERM
indication O
of O
the O
commitment O
to O
contain O
the O
epidemic O
in O
the O
place B-TERM
where O
it O
is O
most O
concentrated O
" O
and O
called B-TERM
it O
" O
unprecedented B-TERM
in O
public O
health O
history O
. O
" O
On O
30 O
January O
, O
following B-TERM
confirmation O
of O
human O
- O
to O
- O
human O
transmission O
outside O
China O
and O
the O
increase B-TERM
in O
the O
number O
of O
cases O
in O
other O
countries O
, O
the O
WHO O
declared B-TERM
the O
outbreak O
a O
Public O
Health O
Emergency O
of O
International O
Concern O
( O
PHEIC O
) O
, O
the O
sixth O
PHEIC O
since B-TERM
the O
measure B-TERM
was O
first O
invoked O
during O
the O
2009 O
swine O
flu O
pandemic O
. O

WHO O
Director O
- O
General O
Tedros O
Adhanom O
said O
that O
the O
PHEIC O
was O
due O
to O
" O
the O
risk O
of O
global O
spread O
, O
especially B-TERM
to O
low- O
and O
middle O
- O
income O
countries O
without O
robust O
health O
systems O
. O

In O
response O
to O
the O
implementations O
of O
travel B-TERM
restrictions O
, O
Tedros O
stated O
that O
" O
there O
is O
no O
reason O
for O
measures B-TERM
that O
unnecessarily O
interfere O
with O
international O
travel O
and O
trade O
" O
and O
that O
the O
" O
WHO O
doesn O
't O
recommend O
limiting O
trade O
and O
movement B-TERM
. O
" O

On O
5 O
February O
, O
the O
WHO O
appealed O
to O
the O
global O
community O
for O
a O
$ O
675 O
million O
contribution O
to O
fund O
strategic O
preparedness O
in O
low O
- O
income O
countries O
, O
citing O
the O
urgency O
to O
support O
those O
countries O
which O
" O
do O
not O
have O
the O
systems O
in O
place O
to O
detect O
people O
who O
have O
contracted O
the O
virus O
, O
even O
if O
it O
were O
to O
emerge O
. O
" O

Tedros O
further O
made O
statements O
declaring B-TERM
that O
" O
we O
are O
only O
as O
strong O
as O
our O
weakest B-TERM
link O
" O
and O
urged O
the O
international O
community O
to O
" O
invest O
today O
or O
pay O
more O
later O
. O
" O
On O
11 O
February O
, O
the O
WHO O
in O
a O
press O
conference B-TERM
established O
COVID O
- O
19 O
as O
the O
name B-TERM
of O
the O
disease B-TERM
. O

On O
the O
same O
day O
, O
Tedros O
stated O
that O
UN O
Secretary O
- O
General O
Ant√≥nio O
Guterres O
had O
agreed O
to O
provide O
the O
" O
power O
of O
the O
entire B-TERM
UN O
system O
in O
the O
response B-TERM
. O
" O

A O
UN O
Crisis O
Management B-TERM
Team O
was O
activated O
as O
a O
result B-TERM
, O
allowing O
coordination O
of O
the O
entire B-TERM
United B-TERM
Nations O
response O
, O
which O
the O
WHO O
states O
will O
allow O
them O
to O
" O
focus O
on O
the O
health O
response O
while O
the O
other O
agencies O
can O
bring O
their O
expertise O
to O
bear O
on O
the O
wider O
social O
, O
economic O
and O
developmental O
implications B-TERM
of O
the O
outbreak O
. O
" O

On O
14 O
February O
, O
a O
WHO O
- O
led B-TERM
Joint B-TERM
Mission O
Team O
with O
China O
was O
activated O
to O
provide O
international O
and O
WHO O
experts B-TERM
on O
the O
ground O
in O
China O
to O
assist O
in O
the O
domestic O
management O
and O
evaluate O
" O
the O
severity O
and O
the O
transmissibility O
of O
the O
disease B-TERM
" O
by O
hosting O
workshops O
and O
meetings O
with O
key O
national O
- O
level O
institutions O
and O
to O
conduct O
field O
visits O
to O
assess O
the O
" O
impact O
of O
response O
activities O
at O
provincial O
and O
county O
levels O
, O
including O
urban O
and O
rural B-TERM
settings O
. O
" O
On O
25 O
February O
, O
the O
WHO O
declared B-TERM
that O
" O
the O
world O
should O
do O
more O
to O
prepare O
for O
a O
possible B-TERM
coronavirus O
pandemic O
, O
" O
stating O
that O
while O
it O
was O
still O
too O
early O
to O
call B-TERM
it O
a O
pandemic O
, O
countries O
should O
nonetheless O
be O
" O
in O
a O
phase O
of O
preparedness O
. O
" O

In O
response O
to O
a O
developing O
outbreak O
in O
Iran O
, O
the O
WHO O
sent O
a O
Joint O
Mission O
Team O
there O
to O
assess O
the O
situation.On B-TERM
28 O
February O
, O
WHO O
officials O
said O
that O
the O
coronavirus O
threat O
assessment O
at O
the O
global O
level O
would O
be O
raised O
from O
" O
high O
" O
to O
" O
very O
high O
, O
" O
its O
highest O
level O
of O
alert O
and O
risk O
assessment O
. O

Mike O
Ryan O
, O
executive O
director O
of O
the O
WHO O
's O
health O
emergencies O
program O
, O
warned O
in O
a O
statement O
that O
" O
This O
is O
a O
reality O
check O
for O
every O
government O
on O
the O
planet O
: O
Wake O
up O
. O

This O
virus O
may O
be O
on O
its O
way O
and O
you O
need O
to O
be O
ready O
, O
" O
urging O
that O
the O
right O
response O
measures B-TERM
could O
help B-TERM
the O
world O
avoid O
" O
the O
worst O
of O
it O
. O
" O

Ryan O
further O
stated O
that O
the O
current B-TERM
data B-TERM
did O
not O
warrant O
public O
health O
officials O
to O
declare B-TERM
a O
global O
pandemic O
, O
saying O
that O
such O
a O
declaration B-TERM
would O
mean B-TERM
" O
we O
're O
essentially O
accepting O
that O
every O
human O
on O
the O
planet O
will O
be O
exposed O
to O
that O
virus O
. O
" O

On O
11 O
March O
, O
the O
WHO O
declared B-TERM
the O
coronavirus O
outbreak O
a O
pandemic O
. O

The O
Director O
- O
General O
said O
that O
the O
WHO O
was O
" O
deeply O
concerned O
both O
by O
the O
alarming O
levels O
of O
spread O
and O
severity O
, O
and O
by O
the O
alarming O
levels O
of O
inaction O
. O
" O
The O
WHO O
has O
faced O
significant O
criticism O
for O
what O
is O
seen O
as O
inadequate O
handling O
of O
the O
pandemic O
, O
including O
the O
late O
declaration B-TERM
of O
a O
public O
health O
emergency O
and O
the O
classification O
of O
the O
virus O
as O
a O
pandemic O
. O

The O
backlash O
included O
a O
petition O
for O
the O
WHO O
Director O
- O
General O
Tedros O
Adhanom O
to O
tender O
his O
resignation O
, O
signed O
by O
733,000 O
people O
as O
of O
6 O
April O
. O

On O
26 O
March O
2020 O
, O
dozens O
of O
UN O
human O
rights O
experts B-TERM
emphasized O
respecting O
the O
rights O
of O
every O
individual O
during O
the O
COVID O
- O
19 O
pandemic O
. O

The O
expert O
group O
stated O
that O
everyone O
is O
entitled O
to O
life O
- O
saving O
interventions O
and O
the O
government O
holds O
this O
responsibility O
. O

The O
group O
stressed O
that O
the O
lack B-TERM
of O
resources O
or O
health O
insurance O
should O
never O
serve O
as O
a O
justification O
for O
discrimination O
against O
a O
specific O
group O
. O

The O
experts B-TERM
underscored O
that O
every O
individual O
has O
the O
right O
to O
health O
, O
including O
people O
with O
disabilities O
, O
belonging O
to O
minority O
groups O
, O
older B-TERM
people O
, O
internally O
displaced O
people O
, O
the O
homeless O
, O
those O
living O
in O
extremely B-TERM
poor O
conditions B-TERM
, O
people O
in O
detention O
, O
as O
well O
as O
refugees O
and O
other O
unspecified O
groups O
in O
need O
of O
government O
support O
. O

International O
governmental O
organizations B-TERM
are O
addressing O
the O
economic O
and O
social O
impacts O
of O
the O
COVID O
- O
19 O
crisis O
. O

The O
Organisation B-TERM
for O
Economic O
Co O
- O
operation O
and O
Development O
has O
launched O
a O
platform O
to O
provide O
timely O
and O
comprehensive O
information B-TERM
on O
policy O
responses O
in O
countries O
around O
the O
world O
, O
as O
well O
as O
viewpoints O
and O
advice B-TERM
. O

From O
policies O
to O
strengthen O
health O
systems O
and O
the O
world O
economy O
to O
addressing O
the O
effects O
of O
lockdown O
and O
restrictions O
on O
travel B-TERM
, O
the O
digital O
hub O
includes O
a O
Country O
Policy O
Tracker O
, O
and O
aims B-TERM
to O
help B-TERM
countries O
learn O
from O
each O
other O
and O
to O
facilitate B-TERM
a O
co O
- O
ordinated O
global O
response O
to O
the O
coronavirus O
challenge O
. O

The O
Chinese O
government O
has O
been O
criticized O
by O
the O
United O
States O
, O
UK O
Minister O
for O
the O
Cabinet B-TERM
Office O
Michael O
Gove O
, O
and O
Brazil O
President O
Jair O
Bolsonaro O
's O
son O
Eduardo O
Bolsonaro O
for O
its O
handling O
of O
the O
pandemic O
, O
which O
began O
in O
the O
Chinese O
province O
of O
Hubei O
. O

A O
number O
of O
provincial O
- O
level O
administrators O
of O
the O
Communist O
Party O
of O
China O
( O
CPC O
) O
were O
dismissed O
over O
their O
handling O
of O
the O
quarantine O
efforts O
in O
Central O
China O
, O
a O
sign O
of O
discontent O
with O
the O
political O
establishment O
's O
response O
to O
the O
outbreak O
in O
those O
regions B-TERM
. O

Some O
commentators O
believe B-TERM
that O
this O
move O
was O
intended O
to O
protect B-TERM
Chinese O
Communist O
Party O
general O
secretary O
Xi O
Jinping O
from O
the O
public O
's O
anger B-TERM
over O
the O
coronavirus O
outbreak O
. O

Some O
Chinese O
officials O
, O
e.g. O
Zhao O
Lijian O
rejected O
an O
earlier O
acknowledgement O
of O
the O
coronavirus O
outbreak O
starting O
in O
Wuhan O
, O
in O
favour O
of O
conspiracy O
theories O
about O
the O
COVID O
- O
19 O
originating O
from O
the O
U.S. O
or O
Italy O
. O

The O
U.S. O
administration O
of O
Donald O
Trump O
has O
referred O
to O
the O
coronavirus O
as O
" O
Chinese O
virus O
" O
or O
" O
Wuhan O
virus O
" O
saying O
that O
China O
's O
" O
censorship O
supercharged O
a O
virus O
that O
has O
now O
turned O
into O
a O
global O
pandemic O
, O
" O
which O
has O
in O
turn O
been O
criticized O
by O
some O
critics O
as O
racism O
and O
" O
distract O
[ O
ing O
] O
from O
his O
administration O
's O
failure O
to O
contain O
the O
disease B-TERM
. O
" O

The O
Daily O
Beast O
obtained O
a O
U.S. O
government O
cable O
outlining O
a O
communications O
stratagem O
with O
apparent O
origins O
in O
the O
National O
Security O
Council O
, O
with O
the O
strategy O
being O
quoted O
as O
" O
Everything O
is O
about O
China O
. O

We O
're O
being O
told O
to O
try O
and O
get O
this O
messaging B-TERM
out O
in O
any O
way B-TERM
possible B-TERM
, O
including O
press O
conferences B-TERM
and O
television O
appearances O
. O
" O
Outlets O
such O
as O
Politico O
, O
Foreign O
Policy O
, O
and O
Bloomberg O
have O
claimed B-TERM
that O
China O
's O
efforts O
to O
send O
aid O
to O
virus O
- O
stricken O
countries O
is O
part O
of O
a O
propaganda O
push O
for O
global O
influence B-TERM
. O

EU O
foreign O
policy O
chief O
Josep O
Borrell O
warned O
that O
there O
is O
" O
a O
geo O
- O
political O
component B-TERM
including O
a O
struggle O
for O
influence B-TERM
through O
spinning O
and O
the O
' O
politics O
of O
generosity O
' O
. O
" O

Borrell O
also B-TERM
said O
that O
" O
China O
is O
aggressively O
pushing O
the O
message O
that O
, O
unlike O
the O
US O
, O
it O
is O
a O
responsible O
and O
reliable O
partner O
. O
" O

China O
has O
also B-TERM
called O
for O
the O
US O
to O
lift O
its O
sanctions O
off O
of O
Syria O
, O
Venezuela O
and O
Iran O
, O
while O
reportedly O
sending O
aid O
to O
the O
latter O
two B-TERM
countries O
. O

Jack O
Ma O
's O
donation O
of O
100,000 O
masks O
to O
Cuba O
was O
blocked O
by O
US O
sanctions O
on O
3 O
April O
. O

US O
authorities O
have O
also B-TERM
been O
accused O
of O
diverting O
aid O
meant O
for O
other O
nations O
to O
their O
own O
country O
. O

And O
there O
have O
been O
mask O
- O
related O
disputes B-TERM
reported O
between O
other O
countries O
, O
such O
as O
Germany O
, O
Austria O
and O
Switzerland O
; O
and O
the O
Czech O
Republic O
and O
Italy O
. O

In O
addition B-TERM
, O
Turkey O
seized O
hundreds O
of O
ventilators O
destined O
for O
Spain O
. O

In O
early O
March O
, O
the O
Italian O
government O
criticized O
the O
European O
Union B-TERM
's O
lack B-TERM
of O
solidarity O
with O
coronavirus O
- O
affected O
Italy O
. O

Maurizio O
Massari O
, O
Italy O
's O
ambassador O
to O
the O
EU O
, O
said O
that O
" O
Only O
China O
responded O
bilaterally O
. O

Certainly O
, O
this O
is O
not O
a O
good O
sign O
of O
European O
solidarity O
. O
" O

On O
22 O
March O
, O
after O
a O
phone O
call O
with O
Italian O
Prime O
Minister O
Giuseppe O
Conte O
, O
Russian O
president O
Vladimir O
Putin O
arranged O
the O
Russian O
army O
to O
send O
military B-TERM
medics O
, O
special O
disinfection O
vehicles O
, O
and O
other O
medical O
equipment B-TERM
to O
Italy O
. O

Italy O
's O
La O
Stampa O
newspaper O
cited O
an O
anonymous O
" O
high O
- O
level O
political O
source O
" O
that O
80 O
percent O
of O
Russia O
's O
aid O
was O
" O
useless B-TERM
or O
of O
little O
use O
to O
Italy O
. O
" O

The O
source O
accused O
Russia O
of O
embarking O
on O
a O
" O
geopolitical O
and O
diplomatic O
" O
charm O
offensive O
. O

The O
President O
of O
Lombardy O
, O
Attilio O
Fontana O
, O
and O
Italian O
Foreign B-TERM
Minister O
Luigi O
Di O
Maio O
dismissed O
the O
media O
reports O
and O
expressed O
their O
gratitude O
. O

Russia O
also B-TERM
sent O
a O
cargo O
plane O
with O
medical O
aid O
to O
the O
United O
States O
. O

Kremlin O
spokesman O
Dmitry O
Peskov O
said O
that O
" O
when O
offering O
assistance O
to O
US O
colleagues O
, O
[ O
Putin O
] O
assumes B-TERM
that O
when O
US O
manufacturers O
of O
medical O
equipment B-TERM
and O
materials B-TERM
gain O
momentum O
, O
they O
will O
also B-TERM
be O
able B-TERM
to O
reciprocate O
if O
necessary O
. O
" O

The O
planned O
NATO O
" O
Defender O
2020 O
" O
military O
exercise O
in O
Germany O
, O
Poland O
, O
and O
the O
Baltic O
states O
, O
the O
largest O
NATO O
war O
exercise O
since B-TERM
the O
end B-TERM
of O
the O
Cold O
War B-TERM
, O
will O
be O
held O
on O
a O
reduced O
scale O
. O

The O
Campaign O
for O
Nuclear O
Disarmament O
's O
general O
secretary O
Kate O
Hudson O
criticized O
the O
Defender O
2020 O
exercise O
: O
" O
In O
the O
current O
public O
- O
health O
crisis O
, O
it O
jeopardizes O
the O
lives O
not O
only O
of O
the O
troops O
from O
the O
US O
and O
the O
many O
European O
countries O
participating O
but O
the O
inhabitants B-TERM
of O
the O
countries O
in O
which O
they O
are O
operating O
. O
" O
The O
Iranian O
government O
has O
been O
heavily B-TERM
affected O
by O
the O
virus O
, O
with O
around B-TERM
two B-TERM
dozen O
parliament O
members O
infected O
as O
well O
as O
fifteen O
other O
current O
or O
former B-TERM
political O
figures O
. O

Iran O
's O
President O
Hassan O
Rouhani O
wrote O
a O
public O
letter O
to O
world O
leaders B-TERM
asking O
for O
help O
on O
14 O
March O
2020 O
, O
saying O
that O
his O
country O
is O
struggling O
to O
fight O
the O
outbreak O
due O
to O
lack O
of O
access O
to O
international O
markets O
as O
a O
result O
of O
the O
United O
States O
sanctions O
against O
Iran.The O
outbreak O
has O
prompted O
calls O
for O
the O
United O
States O
to O
adopt O
social O
policies O
common O
in O
other O
wealthy O
countries O
, O
including O
universal O
health O
care O
, O
universal O
child O
care O
, O
paid O
family O
leave O
, O
and O
higher O
levels O
of O
funding O
for O
public O
health O
. O

Political O
analysts O
anticipated O
it O
may O
negatively O
affect O
Donald O
Trump O
's O
chances O
of O
re O
- O
election O
in O
the O
2020 O
presidential O
election.Diplomatic O
relations O
between O
Japan O
and O
South O
Korea O
worsened O
due O
to O
the O
pandemic O
. O

South O
Korea O
criticized O
Japan O
's O
" O
ambiguous O
and O
passive O
quarantine O
efforts O
" O
after O
Japan O
announced B-TERM
anybody O
coming O
from O
South O
Korea O
will O
be O
placed B-TERM
in O
two O
weeks O
' O
quarantine O
at O
government O
- O
designated O
sites O
. O

The O
South O
Korean O
society O
was O
initially B-TERM
polarized O
on O
President O
Moon O
Jae O
- O
in O
's O
response B-TERM
to O
the O
crisis O
. O

Many O
Koreans O
signed O
petitions O
either O
calling O
for O
the O
impeachment O
of O
Moon O
over O
what O
they O
claimed O
to O
be O
government O
mishandling O
of O
the O
outbreak O
, O
or O
praising O
his O
response.The O
pandemic O
has O
allowed O
countries O
to O
pass O
emergency O
legislation O
in O
response O
. O

Some O
commentators O
have O
expressed O
concerns O
that O
it O
could O
allow B-TERM
governments O
to O
strengthen B-TERM
their O
grip O
on O
power O
. O

In O
Hungary O
, O
its O
parliament O
voted O
to O
allow O
the O
prime O
minister O
, O
Viktor O
Orb√°n O
, O
to O
rule O
by O
decree B-TERM
indefinitely O
, O
suspend O
parliament O
as O
well O
as O
elections O
and O
punish O
those O
deemed O
to O
have O
spread O
false O
information B-TERM
about O
the O
virus O
and O
the O
government O
's O
handling O
of O
the O
crisis O
. O

The O
coronavirus O
outbreak O
has O
been O
blamed O
for O
several O
instances O
of O
supply O
shortages O
, O
stemming O
from O
globally O
increased B-TERM
usage O
of O
equipment B-TERM
to O
fight O
the O
outbreaks O
, O
panic O
buying O
, O
and O
disruption O
to O
factory O
and O
logistic O
operations O
. O

The O
United O
States O
Food O
and O
Drug O
Administration B-TERM
has O
issued O
warnings B-TERM
about O
shortages B-TERM
of O
drugs O
and O
medical O
equipment B-TERM
due O
to O
increased O
consumer O
demand O
and O
supplier O
disruption O
. O

Several O
localities O
also B-TERM
witnessed O
panic O
buying O
that O
led O
to O
shelves O
being O
cleared O
of O
grocery O
essentials O
such O
as O
food O
, O
toilet O
paper O
, O
and O
bottled O
water O
, O
inducing O
supply O
shortages O
. O

The O
technology O
industry B-TERM
in O
particular O
has O
been O
warning O
about O
delays B-TERM
to O
shipments O
of O
electronic O
goods O
. O

According O
to O
WHO O
director O
- O
general O
Tedros O
Adhanom O
, O
the O
demand O
for O
personal O
protection O
equipment O
has O
risen O
100 O
- O
fold O
. O

This O
demand O
has O
led O
to O
the O
increase B-TERM
in O
prices O
of O
up O
to O
twenty O
times O
the O
normal B-TERM
price O
and O
also B-TERM
induced O
delays B-TERM
on O
the O
supply O
of O
medical O
items O
for O
four O
to O
six O
months O
. O

It O
has O
also B-TERM
caused B-TERM
a O
shortage B-TERM
of O
personal O
protective O
equipment O
worldwide O
, O
with O
the O
WHO O
warning O
that O
this O
will O
endanger O
health O
workers O
. O

In O
Australia O
, O
the O
pandemic O
provided O
a O
new O
opportunity O
for O
daigou O
shoppers O
to O
sell O
Australian O
products O
into O
China O
. O

The O
activity B-TERM
has O
created O
a O
shortage O
of O
baby O
formula O
in O
some O
supermarkets O
and O
was O
subsequently B-TERM
banned O
by O
the O
Australian O
government.Despite O
the O
high O
prevalence O
of O
COVID O
- O
19 O
cases O
in O
Northern O
Italy O
and O
the O
Wuhan O
region B-TERM
, O
and O
the O
ensuing O
high O
demand O
for O
food O
products B-TERM
, O
both O
areas B-TERM
have O
been O
spared O
from O
acute O
food O
shortages B-TERM
. O

Measures B-TERM
by O
China O
and O
Italy O
against O
the O
hoarding O
and O
illicit B-TERM
trade O
of O
critical O
products B-TERM
have O
been O
successful O
, O
avoiding O
acute O
food O
shortages B-TERM
that O
were O
anticipated O
in O
Europe O
as O
well O
as O
in O
North O
America O
. O

Northern O
Italy O
with O
its O
significant B-TERM
agricultural B-TERM
production O
has O
not O
seen O
a O
large O
reduction O
, O
but O
prices O
may O
increase O
according O
to O
industry O
representatives O
. O

Empty O
food O
shelves O
were O
only O
encountered O
temporarily O
, O
even O
in O
Wuhan O
city O
, O
while O
Chinese O
government O
officials O
released O
pork O
reserves O
to O
assure O
sufficient O
nourishment O
of O
the O
population O
. O

Similar B-TERM
laws O
exist O
in O
Italy O
requiring O
food O
producers O
to O
keep O
reserves O
for O
such O
emergencies O
. O

Damage B-TERM
to O
the O
global O
economy O
has O
been O
felt O
in O
China O
: O
according O
to O
a O
media O
report O
on O
16 O
March O
, O
the O
economy O
in O
China O
was O
very O
hard O
hit O
in O
the O
first O
two B-TERM
months O
of O
2020 O
due O
to O
the O
measures B-TERM
taken B-TERM
by O
the O
government O
to O
curtail O
virus O
spread O
, O
and O
retail O
sales O
plunged O
20.5 O
% O
. O

As O
mainland O
China O
is O
a O
major O
economy O
and O
manufacturing O
hub O
, O
the O
viral O
outbreak O
has O
been O
seen O
to O
pose O
a O
major O
destabilizing O
threat B-TERM
to O
the O
global O
economy O
. O

Agathe O
Demarais O
of O
the O
Economist O
Intelligence O
Unit O
has O
forecast B-TERM
that O
markets O
will O
remain O
volatile O
until O
a O
clearer O
image O
emerges O
on O
potential O
outcomes B-TERM
. O

In O
January O
2020 O
, O
some O
analysts O
estimated O
that O
the O
economic O
fallout O
of O
the O
epidemic O
on O
global O
growth B-TERM
could O
surpass O
that O
of O
the O
2002 O
- O
2004 O
SARS O
outbreak O
. O

One O
estimate O
from O
an O
expert B-TERM
at O
Washington O
University O
in O
St. O
Louis O
gave O
a O
$ O
300 O
+ O
billion O
impact B-TERM
on O
the O
world O
's O
supply O
chain O
that O
could O
last O
up O
to O
two B-TERM
years O
. O

The O
Organization B-TERM
of O
the O
Petroleum O
Exporting O
Countries O
( O
OPEC O
) O
reportedly O
" O
scrambled O
" O
after O
a O
steep O
decline B-TERM
in O
oil O
prices O
due O
to O
lower O
demand O
from O
China O
. O

Global O
stock O
markets O
fell O
on O
24 O
February O
due O
to O
a O
significant B-TERM
rise O
in O
the O
number O
of O
COVID O
- O
19 O
cases O
outside O
mainland O
China O
. O

On O
27 O
February O
, O
due O
to O
mounting O
worries O
about O
the O
coronavirus O
outbreak O
, O
various O
U.S. O
stock O
indexes O
including O
the O
NASDAQ O
- O
100 O
, O
the O
S O
& O
P O
500 O
Index O
, O
and O
the O
Dow O
Jones O
Industrial O
Average O
posted O
their O
sharpest O
falls O
since O
2008 O
, O
with O
the O
Dow O
falling O
1,191 O
points O
, O
the O
largest O
one O
- O
day O
drop O
since O
the O
financial O
crisis O
of O
2007 O
- O
08 O
. O

All O
three O
indexes B-TERM
ended B-TERM
the O
week O
down O
more O
than O
10 O
% O
. O

On O
28 O
February O
, O
Scope O
Ratings O
GmbH O
affirmed O
China O
's O
sovereign O
credit O
rating O
, O
but O
maintained O
a O
Negative O
Outlook O
. O

Stocks O
plunged O
again O
based O
on O
coronavirus O
fears O
, O
the O
largest O
fall O
being O
on O
16 O
March O
. O

Many O
consider B-TERM
an O
economic O
recession O
to O
be O
likely O
. O

Economist O
Mohamed O
El O
- O
Erian O
praised O
central O
banks O
' O
and O
states B-TERM
' O
timely O
emergency O
measures B-TERM
. O

Central O
banks O
are O
reacting O
more O
quickly O
than O
they O
did O
to O
the O
2008 O
financial O
crash O
. O

Tourism O
is O
one O
of O
the O
worst O
affected O
sectors O
due O
to O
travel O
bans O
, O
closing O
of O
public O
places B-TERM
including O
travel O
attractions O
, O
and O
advice B-TERM
of O
governments O
against O
any O
travel B-TERM
all O
over O
the O
world O
. O

As O
a O
consequence B-TERM
, O
numerous O
airlines O
have O
cancelled O
flights O
due O
to O
lower O
demand O
, O
including O
British O
Airways O
, O
China O
Eastern O
Airlines O
, O
and O
Qantas O
, O
while O
British O
regional B-TERM
airline O
Flybe O
collapsed O
. O

The O
impact B-TERM
on O
the O
cruise O
line B-TERM
industry B-TERM
was O
at O
a O
level O
never O
seen O
before O
. O

Several O
train O
stations O
and O
ferry O
ports O
have O
also B-TERM
been O
closed O
. O

The O
epidemic O
coincided O
with O
the O
Chunyun O
, O
a O
major O
travel O
season O
associated O
with O
the O
Chinese O
New O
Year O
holiday O
. O

A O
number B-TERM
of O
events O
involving O
large O
crowds O
were O
cancelled O
by O
national O
and O
regional B-TERM
governments O
, O
including O
annual O
New O
Year O
festivals O
, O
with O
private O
companies B-TERM
also B-TERM
independently O
closing O
their O
shops B-TERM
and O
tourist O
attractions O
such O
as O
Hong O
Kong O
Disneyland O
and O
Shanghai O
Disneyland O
. O

Many O
Lunar O
New O
Year O
events O
and O
tourist O
attractions O
have O
been O
closed O
to O
prevent O
mass O
gatherings O
, O
including O
the O
Forbidden O
City O
in O
Beijing O
and O
traditional O
temple O
fairs O
. O

In O
24 O
of O
China O
's O
31 O
provinces O
, O
municipalities O
and O
regions O
, O
authorities O
extended O
the O
New O
Year O
's O
holiday O
to O
10 O
February O
, O
instructing O
most O
workplaces O
not O
to O
re O
- O
open O
until O
that O
date O
. O

These O
regions B-TERM
represented O
80 O
% O
of O
the O
country O
's O
GDP O
and O
90 O
% O
of O
exports O
. O

Hong O
Kong O
raised O
its O
infectious O
disease B-TERM
response O
level O
to O
the O
highest O
and O
declared B-TERM
an O
emergency O
, O
closing O
schools O
until O
March O
and O
cancelling O
its O
New O
Year O
celebrations.The O
retail O
sector O
has O
been O
impacted O
globally O
, O
with O
reductions O
in O
store B-TERM
hours O
or O
temporary O
closures O
. O

Visits O
to O
retailers O
in O
Europe O
and O
Latin O
America O
declined O
by O
40 O
% O
. O

North O
America O
and O
Middle O
East O
retailers O
saw O
a O
50 O
- O
60 O
% O
drop O
. O

This O
also O
resulted B-TERM
in O
a O
33 O
- O
43 O
% O
drop O
in O
foot O
traffic O
to O
shopping O
centres O
in O
March O
compared O
to O
February O
. O

Shopping O
mall O
operators O
around O
the O
world O
imposed O
additional O
measures B-TERM
, O
such O
increased O
sanitation O
, O
installation O
of O
thermal O
scanners O
to O
check O
the O
temperature O
of O
shoppers O
, O
and O
cancellation B-TERM
of O
events.According O
to O
a O
United B-TERM
Nations O
Economic O
Commission O
for O
Latin O
America O
estimate O
, O
the O
pandemic O
- O
induced O
recession O
could O
leave B-TERM
between O
14 O
and O
22 O
million O
more O
people O
in O
extreme O
poverty O
in O
Latin O
America O
than O
would O
have O
been O
in O
that O
situation B-TERM
without O
the O
pandemic O
. O

In O
January O
and O
February O
2020 O
, O
during O
the O
height O
of O
the O
epidemic O
in O
Wuhan O
, O
about O
5 O
million O
people O
in O
China O
lost O
their O
jobs O
. O

Many O
of O
China O
's O
nearly O
300 O
million O
rural B-TERM
migrant O
workers O
have O
been O
stranded O
at O
home B-TERM
in O
inland O
provinces O
or O
trapped O
in O
Hubei O
province.In O
March O
2020 O
, O
more O
than O
10 O
million O
Americans O
lost O
their O
jobs O
and O
applied O
for O
government O
aid O
. O

The O
coronavirus O
outbreak O
could O
cost O
47 O
million O
jobs O
in O
the O
United O
States O
and O
unemployment O
rate O
may O
hit O
32 O
% O
, O
according O
to O
estimates O
by O
the O
Federal O
Reserve O
Bank O
of O
St. O
Louis.The O
lockdown O
in O
India O
has O
left B-TERM
tens O
of O
millions O
of O
Indian O
migrant O
workers O
( O
who O
are O
paid O
through O
daily B-TERM
wages O
) O
unemployed.The O
survey O
from O
the O
Angus O
Reid O
Institute O
found O
that O
44 O
% O
of O
Canadian O
households O
have O
experienced O
some O
type O
of O
unemployment.Nearly O
900,000 O
workers O
lost O
their O
jobs O
in O
Spain O
since O
it O
went O
into O
lockdown O
in O
mid O
- O
March O
2020 O
. O

During O
the O
second O
half O
of O
March O
, O
4 O
million O
French O
workers O
applied O
for O
temporary O
unemployment O
benefits O
and O
1 O
million O
British O
workers O
applied O
for O
a O
universal O
credit O
scheme.Almost O
half O
a O
million O
companies B-TERM
in O
Germany O
have O
sent O
their O
workers O
on O
a O
government O
- O
subsidized O
short O
- O
time O
working O
schemes O
known O
as O
Kurzarbeit O
. O

The O
German B-TERM
short O
- O
time O
work O
compensation O
scheme O
has O
been O
adopted O
by O
France O
and O
Britain O
. O

The O
performing O
arts O
and O
cultural O
heritage O
sectors O
have O
been O
profoundly O
affected O
by O
the O
pandemic O
, O
impacting O
organizations B-TERM
' O
operations O
as O
well O
as O
individuals O
- O
both O
employed O
and O
independent O
- O
globally O
. O

Arts O
and O
culture O
sector O
organizations B-TERM
attempted B-TERM
to O
uphold O
their O
( O
often B-TERM
publicly O
funded O
) O
mission O
to O
provide O
access O
to O
cultural O
heritage O
to O
the O
community O
, O
maintain O
the O
safety O
of O
their O
employees B-TERM
and O
the O
public O
, O
and O
support O
artists O
where O
possible O
. O

By O
March O
2020 O
, O
across O
the O
world O
and O
to O
varying O
degrees O
, O
museums O
, O
libraries O
, O
performance O
venues O
, O
and O
other O
cultural O
institutions O
had O
been O
indefinitely O
closed O
with O
their O
exhibitions O
, O
events O
and O
performances O
cancelled O
or O
postponed O
. O

In O
response O
there O
were O
intensive O
efforts O
to O
provide O
alternative O
services O
through O
digital O
platforms.Another B-TERM
recent B-TERM
and O
rapidly O
accelerating O
fallout O
of O
the O
disease O
is O
the O
cancellation B-TERM
of O
religious O
services O
, O
major O
events O
in O
sports O
, O
and O
other O
social O
events O
, O
such O
as O
music O
festivals O
and O
concerts O
, O
technology O
conferences B-TERM
, O
and O
fashion O
shows O
. O

The O
film O
industry O
has O
also B-TERM
experienced O
disruption.The O
Vatican O
announced B-TERM
that O
Holy O
Week O
observances O
in O
Rome O
, O
which O
occur O
during O
the O
last O
week O
of O
the O
Christian O
penitential O
season O
of O
Lent O
, O
have O
been O
cancelled O
. O

Many O
dioceses O
have O
recommended O
older O
Christians O
to O
stay O
at O
home O
rather O
than O
attending O
Mass O
on O
Sundays O
; O
some O
churches O
have O
made O
church O
services O
available O
via O
radio O
, O
online O
live O
streaming O
or O
television O
while O
others O
are O
offering O
drive O
- O
in O
worship O
. O

With O
the O
Roman O
Catholic O
Diocese O
of O
Rome O
closing O
its O
churches O
and O
chapels O
and O
St. O
Peter O
's O
Square O
emptied O
of O
Christian O
pilgrims O
, O
other O
religious O
bodies O
also B-TERM
cancelled O
services O
and O
limited O
public O
gatherings O
in O
churches O
, O
mosques O
, O
synagogues O
, O
temples O
and O
gurdwaras O
. O

Iran O
's O
Health O
Ministry O
announced B-TERM
the O
cancellation B-TERM
of O
Friday O
prayers O
in O
areas B-TERM
affected O
by O
the O
outbreak O
and O
shrines O
were O
later O
closed O
, O
while O
Saudi O
Arabia O
banned O
the O
entry O
of O
foreign B-TERM
pilgrims O
as O
well O
as O
its O
residents O
to O
holy O
sites O
in O
Mecca O
and O
Medina O
. O

The O
pandemic O
has O
caused O
the O
most O
significant B-TERM
disruption O
to O
the O
worldwide O
sporting O
calendar O
since O
the O
Second O
World O
War B-TERM
. O

Most O
major O
sporting O
events O
have O
been O
either B-TERM
cancelled O
or O
postponed O
, O
including O
the O
2019 O
- O
20 O
UEFA O
Champions O
League O
, O
2019 O
- O
20 O
Premier O
League O
, O
UEFA O
Euro O
2020 O
, O
2019 O
- O
20 O
NBA O
season O
, O
and O
2019 O
- O
20 O
NHL O
season O
. O

The O
outbreak O
disrupted O
plans B-TERM
for O
the O
2020 O
Summer O
Olympics O
, O
which O
were O
originally O
scheduled O
to O
start O
at O
the O
end B-TERM
of O
July O
; O
the O
International O
Olympic O
Committee O
announced B-TERM
on O
24 O
March O
that O
the O
event O
will O
be O
" O
rescheduled O
to O
a O
date O
beyond O
2020 O
but O
not O
later O
than O
summer O
2021 O
. O
" O
Casinos O
and O
other O
gaming O
venues O
worldwide O
have O
closed O
and O
live O
poker O
tournaments O
have O
been O
either B-TERM
postponed O
or O
cancelled O
. O

This O
has O
led O
many O
gamblers O
to O
move O
online O
, O
with O
many O
online O
gambling O
sites O
reporting O
significant B-TERM
increases B-TERM
in O
their O
rates O
of O
new O
sign O
- O
ups.The O
entertainment O
industry B-TERM
has O
also B-TERM
been O
affected O
, O
with O
various O
music O
groups O
suspending O
or O
cancelling O
concert O
tours O
. O

Many O
large O
theatres O
such O
as O
those O
on O
Broadway O
also B-TERM
suspended O
all O
performances O
. O

Some O
artists O
have O
explored O
ways O
to O
continue O
to O
produce O
and O
share O
work O
over O
the O
internet O
as O
an O
alternative O
to O
traditional O
live O
performance O
, O
such O
as O
live O
streaming O
concerts O
or O
creating O
web O
- O
based O
" O
festivals O
" O
for O
artists O
to O
perform B-TERM
, O
distribute O
, O
and O
publicize O
their O
work O
. O

Online O
, O
numerous O
coronavirus O
- O
themed O
Internet O
memes O
have O
spread O
as O
many O
turn O
to O
humour O
and O
distraction O
amid O
uncertainty O
. O

Since O
the O
outbreak O
of O
COVID O
- O
19 O
, O
heightened O
prejudice O
, O
xenophobia O
, O
and O
racism O
have O
been O
noted O
toward O
people O
of O
Chinese O
and O
East O
Asian O
descent O
, O
and O
against O
people O
from O
hotspots O
in O
Europe O
, O
the O
United O
States O
and O
other O
countries O
. O

Incidents O
of O
fear B-TERM
, O
suspicion O
, O
and O
hostility B-TERM
have O
been O
observed O
in O
many O
countries O
, O
particularly B-TERM
in O
Europe O
, O
East O
Asia O
, O
North O
America O
, O
and O
the O
Asia O
- O
Pacific O
region B-TERM
. O

Reports O
from O
February O
( O
when O
the O
majority O
of O
the O
cases O
had O
still O
been O
confined O
to O
China O
) O
have O
documented O
racist O
sentiments O
expressed O
in O
various O
groups O
worldwide O
of O
Chinese O
people O
deserving O
the O
virus O
or O
receiving B-TERM
what O
has O
been O
claimed O
as O
justified O
retribution O
. O

Some O
countries O
in O
Africa O
have O
also B-TERM
seen O
a O
rise O
in O
anti O
- O
Chinese O
sentiment O
. O

Many O
residents O
of O
Wuhan O
and O
Hubei O
have O
reported O
discrimination O
based O
on O
their O
regional B-TERM
origin O
. O

There O
has O
been O
support O
for O
the O
Chinese O
, O
both O
on O
and O
offline O
, O
and O
towards O
those O
in O
virus O
- O
stricken O
areas B-TERM
. O

Following O
the O
progression O
of O
the O
outbreak O
to O
new O
hotspot O
countries O
, O
people O
from O
Italy O
, O
the O
first O
country O
in O
Europe O
to O
experience O
a O
serious O
outbreak O
of O
COVID O
- O
19 O
, O
could O
also B-TERM
be O
subjected O
to O
suspicion O
and O
xenophobia.Citizens O
in O
countries O
including O
Malaysia O
, O
New O
Zealand O
, O
Singapore O
, O
and O
South O
Korea O
initially O
signed O
petitions O
lobbying O
to O
ban O
Chinese O
people O
from O
entering O
their O
countries O
in O
an O
effort O
to O
stop O
the O
disease O
. O

In O
Japan O
, O
the O
hashtag O
# O
ChineseDontComeToJapan O
trended O
on O
Twitter O
. O

Chinese O
people O
as O
well O
as O
other O
Asians O
in O
the O
United B-TERM
Kingdom O
and O
the O
United O
States O
have O
reported O
increasing O
levels O
of O
racist O
abuse O
, O
as O
well O
as O
assaults O
. O

U.S. O
president O
Donald O
Trump O
has O
faced O
criticism O
for O
referring B-TERM
to O
the O
coronavirus O
as O
the O
" O
Chinese O
Virus O
, O
" O
a O
term O
considered B-TERM
by O
critics O
to O
be O
racist O
and O
anti O
- O
Chinese O
. O

Protesters O
in O
Ukraine O
attacked O
buses O
carrying O
Ukrainian O
and O
foreign B-TERM
evacuees O
from O
Wuhan O
to O
Novi O
Sanzhary O
. O

Students O
who O
come O
from O
Northeast O
India O
, O
which O
shares O
a O
border O
with O
China O
, O
and O
study O
in O
major O
Indian O
cities O
have O
reportedly B-TERM
experienced O
harassment O
related O
to O
the O
coronavirus O
outbreak O
. O

The O
Bharatiya O
Janata O
Party O
's O
State O
unit O
president O
in O
West O
Bengal O
Dilip O
Ghosh O
stated O
that O
the O
Chinese O
had O
destroyed O
nature O
and O
" O
that O
's O
why O
the O
God O
took O
revenge O
against O
them O
. O
" O

The O
remarks O
were O
later O
condemned O
by O
the O
Chinese O
consulate O
in O
Kolkata O
, O
calling B-TERM
it O
" O
erroneous O
. O
" O
In O
China O
, O
xenophobia O
and O
racism O
agains O
non O
- O
Chinese O
residents O
has O
been O
inflamed O
by O
the O
pandemic O
, O
with O
foreigners O
described O
as O
" O
foreign B-TERM
garbage O
" O
and O
targeted O
for O
" O
disposal O
. O
" O

Many O
newspapers O
with O
paywalls O
have O
removed B-TERM
them O
for O
some O
or O
all O
of O
their O
coronavirus O
coverage O
. O

Many O
scientific O
publishers O
made O
scientific O
papers O
related O
to O
the O
outbreak O
available O
with O
open B-TERM
access O
. O

Some O
scientists O
chose O
to O
share O
their O
results B-TERM
quickly O
on O
preprint O
servers O
such O
as O
bioRxiv O
. O

Emerging O
infectious O
disease B-TERM
- O
Infectious O
disease B-TERM
of O
emerging O
pathogen O
, O
often B-TERM
novel O
in O
its O
outbreak O
range O
or O
transmission O
mode O

Globalization O
and O
disease B-TERM
- O
Overview O
of O
globalization O
and O
disease O
transmission O

List B-TERM
of O
epidemics O
and O
pandemics O
- O
A O
list O
of O
death O
tolls O
due O
to O
infectious O
disease B-TERM

Wildlife O
smuggling O
and O
zoonoses O
- O
Health O
risks O
associated O
with O
the O
trade O
in O
exotic O
wildlife O

b O
'Drug O
repositioning O
( O
also B-TERM
known O
as O
drug O
repurposing O
, O
re O
- O
profiling O
, O
re O
- O
tasking O
or O
therapeutic O
switching O
) O
is O
the O
repurposing O
of O
an O
approved O
drug O
for O
the O
treatment O
of O
a O
different O
disease B-TERM
or O
medical O
condition O
than O
that O
for O
which O
it O
was O
originally B-TERM
developed O
. O

This O
is O
one O
line O
of O
scientific O
research O
which O
is O
currently O
being O
pursued O
to O
develop O
safe O
and O
effective B-TERM
COVID O
- O
19 O
treatments O
. O

Other O
research O
directions B-TERM
include O
the O
development O
of O
a O
COVID O
- O
19 O
vaccine B-TERM
and O
convalescent O
plasma O
transfusion.SARS O
- O
CoV O
- O
2 O
has O
about O
66 O
druggable O
proteins B-TERM
, O
each O
of O
which O
has O
multiple O
ligand O
binding O
sites O
. O

Analyzing O
those O
binding O
sites O
provide O
the O
reasonable O
project O
of O
developing O
effective B-TERM
antiviral O
drug O
against O
COVID O
- O
19 O
proteins B-TERM
. O

Of O
the O
most O
important B-TERM
SARS O
- O
CoV O
- O
2 O
target O
proteins B-TERM
are O
papain O
- O
like O
protease O
, O
RNA O
dependent O
RNA O
polymerase O
, O
helicase O
, O
S O
protein B-TERM
, O
and O
ADP O
ribophosphatase O
. O

Hussein O
A O
A O
, O
et O
al O
studied O
several O
candidate O
compounds O
which O
then O
optimized O
and O
analyzed O
for O
their O
skeleton O
similarity O
with O
the O
highest O
similar O
approved O
drugs O
in O
order O
to O
accelerate O
a O
potent O
anti O
- O
SARS O
- O
CoV O
- O
2 O
drug O
development O
in O
his O
preclinical O
study O
to O
be O
recommended O
in O
a O
clinical O
study B-TERM
design O
. O

Chloroquine O
is O
an O
anti O
- O
malarial O
medication O
that O
is O
also B-TERM
used O
against O
some O
auto O
- O
immune O
diseases B-TERM
. O

On O
18 O
March O
, O
the O
WHO O
announced B-TERM
that O
chloroquine O
and O
the O
related O
hydroxychloroquine O
would O
be O
among O
the O
four O
drugs O
studied O
as O
part O
of O
the O
Solidarity O
clinical O
trial O
. O

New O
York O
governor O
Andrew O
Cuomo O
announced O
that O
New O
York O
State O
trials O
of O
chloroquine O
and O
hydroxychloroquine O
would O
begin O
on O
24 O
March.On O
28 O
March O
, O
the O
FDA O
authorized O
the O
use O
of O
hydroxychloroquine O
sulfate O
and O
chloroquine O
phosphate O
under O
an O
Emergency O
Use O
Authorization O
( O
EUA O
) O
. O

The O
treatment O
has O
not O
been O
approved O
by O
the O
FDA O
's O
clinical O
trials O
process O
and O
is O
authorized O
under O
the O
EUA O
only O
as O
an O
experimental O
treatment O
for O
emergency O
use O
in O
patients B-TERM
who O
are O
hospitalized O
but O
are O
not O
able O
to O
receive B-TERM
treatment O
in O
a O
clinical O
trial O
. O

The O
CDC O
has O
said O
that O
" O
the O
use O
, O
dosing O
, O
or O
duration O
of O
hydroxychloroquine O
for O
prophylaxis O
or O
treatment O
of O
SARS O
- O
CoV O
- O
2 O
infection O
" O
are O
not O
yet O
established O
. O

Doctors B-TERM
have O
said O
they O
are O
using B-TERM
the O
drug O
when O
" O
there O
's O
no O
other O
option O
. O
" O

A O
Turkish O
research O
team O
in O
Istanbul O
is O
conducting O
a O
small B-TERM
study B-TERM
on O
the O
use O
of O
chloroquine O
in O
combination B-TERM
with O
zinc O
, O
vitamin O
A O
, O
vitamin O
C O
and O
vitamin O
D. O

Large O
studies B-TERM
are O
underway O
at O
Duke O
University O
and O
the O
University O
of O
Oxford O
. O

NYU O
Langone O
Medical O
School O
is O
conducting O
a O
trial O
on O
the O
safety O
and O
efficacy O
of O
preventative O
use O
of O
hydroxychloroquine O
. O

Chinese O
clinical O
trials O
in O
Wuhan O
and O
Shenzhen O
claimed O
to O
show B-TERM
favipiravir O
was O
" O
clearly O
effective B-TERM
. O
" O

35 O
patients B-TERM
in O
Shenzhen O
tested O
negative O
in O
a O
median O
of O
4 O
days O
, O
while O
the O
length O
of O
illness B-TERM
was O
11 O
days O
in O
the O
45 O
patients B-TERM
who O
did O
not O
receive O
it O
. O

In O
a O
study B-TERM
conducted O
in O
Wuhan O
on O
240 O
patients B-TERM
with O
pneumonia O
, O
half O
were O
given O
favipiravir O
and O
half O
received B-TERM
umifenovir O
. O

The O
Italian O
Pharmaceutical O
Agency O
reminded O
the O
public O
that O
the O
existing O
evidence O
in O
support O
of O
the O
drug O
is O
scant O
and O
preliminary O
. O

On O
2 O
April O
, O
Germany O
announced O
that O
it O
would O
purchase O
the O
drug O
from O
Japan O
for O
its O
stockpile O
, O
and O
use O
the O
military O
to O
deliver O
the O
drug O
to O
university O
hospitals O
, O
where O
the O
drug O
will O
be O
used O
to O
treat O
COVID O
- O
19 O
patients O
. O

According O
to O
the O
South O
China O
Morning O
Post O
, O
Shinzo O
Abe O
has O
made O
overtures O
to O
the O
Trump O
administration O
about O
purchasing O
the O
drug.The O
drug O
may O
be O
less O
effective B-TERM
in O
severe O
cases O
of O
illness B-TERM
where O
the O
virus O
has O
already O
multiplied O
. O

It O
may O
not O
be O
safe O
for O
use O
by O
pregnant O
women O
or O
those O
trying B-TERM
to O
conceive O
. O

One O
study B-TERM
of O
lopinavir O
/ O
ritonavir O
( O
Kaletra O
) O
, O
a O
combination B-TERM
of O
the O
antivirals O
lopinavir O
and O
ritonavir O
, O
concluded B-TERM
that O
" O
no O
benefit O
was O
observed O
. O
" O

The O
drugs O
were O
designed O
to O
inhibit O
HIV O
from O
replicating O
by O
binding O
to O
the O
protease O
. O

A O
team O
of O
researchers O
at O
the O
University O
of O
Colorado O
are O
trying B-TERM
to O
modify O
the O
drugs O
to O
find B-TERM
a O
compound O
that O
will O
bind O
with O
the O
protease O
of O
SARS O
- O
CoV O
- O
2.There O
are O
criticisms O
within O
the O
scientific O
community O
about O
directing O
resources O
to O
repurposing O
drugs O
specifically O
developed O
for O
HIV O
/ O
AIDS O
. O

The O
WHO O
included O
lopinavir O
/ O
ritonavir O
in O
the O
international O
Solidarity O
trial O
. O

Remdesivir O
was O
created O
and O
developed O
by O
Gilead O
Sciences O
as O
a O
treatment O
for O
Ebola O
virus O
disease O
and O
Marburg O
virus O
infections O
. O
Gilead O
Sciences O
subsequently B-TERM
discovered O
that O
Remdesivir O
had O
antiviral O
activity B-TERM
in O
vitro O
against O
multiple O
filo- O
, O
pneumo- O
, O
paramyxo- O
, O
and O
corona- O
viruses O
. O

One O
issue O
with O
antiviral O
treatment O
is O
the O
development O
of O
resistance O
through O
mutations O
that O
can O
lead O
to O
more O
severe O
disease B-TERM
and O
transmission O
. O

Some O
early O
pretrial O
studies B-TERM
suggest O
remdesivir O
may O
have O
a O
high O
genetic O
barrier O
to O
resistance.There O
are O
several O
clinical O
trials O
underway O
, O
including O
two B-TERM
conducted O
by O
Cleveland O
University O
Hospitals O
; O
one O
for O
people O
with O
moderate O
illness O
and O
another B-TERM
for O
those O
with O
more O
severe O
illness O
. O

There O
are O
three O
ongoing O
clinical O
trials O
of O
intravenous O
vitamin O
C O
for O
people O
who O
are O
hospitalized O
and O
severely O
ill O
with O
COVID O
- O
19 O
; O
two B-TERM
placebo O
controlled O
( O
China O
, O
Canada O
) O
and O
one O
with O
no O
control O
( O
Italy O
) O
. O

New O
York O
State O
began O
trials O
for O
the O
antibiotic O
azithromycin O
on O
24 O
March O
2020 O
. O

Japan O
's O
National O
Center O
for O
Global O
Health O
and O
Medicine O
( O
NCGM O
) O
is O
planning O
a O
clinical O
trial O
for O
Teijin O
's O
Alvesco O
( O
ciclesonide O
) O
, O
an O
inhaled O
corticosteroid O
for O
asthma O
, O
for O
the O
treatment O
of O
pre O
- O
symptomatic O
patients B-TERM
infected O
with O
the O
novel O
coronavirus O
. O

A O
form O
of O
angiotensin O
- O
converting O
enzyme O
2 O
, O
a O
Phase O
II O
trial O
is O
underway O
with O
200 O
patients B-TERM
to O
be O
recruited O
from O
severe O
, O
hospitalized O
cases O
in O
Denmark O
, O
Germany O
, O
and O
Austria O
to O
determine O
the O
effectiveness B-TERM
of O
the O
treatment O
. O

Researchers O
from O
the O
Montreal O
Heart O
Institute O
in O
Canada O
are O
currently O
studying O
the O
role B-TERM
of O
colchicine O
in O
reducing O
inflammation O
and O
pulmonary O
complications B-TERM
in O
patients B-TERM
suffering O
from O
mild O
symptoms O
of O
COVID O
- O
19 O
. O

The O
study B-TERM
, O
named B-TERM
COLCORONA O
, O
is O
recruiting O
6000 O
adults O
aged O
40 O
and O
over O
who O
were O
diagnosed O
with O
COVID O
- O
19 O
and O
experience O
mild O
symptoms O
not O
requiring O
hospitalization O
. O

Women O
who O
are O
pregnant O
or O
breastfeeding O
or O
who O
do O
not O
have O
an O
effective B-TERM
contraceptive O
method O
are O
not O
eligible O
. O

Several O
anticoagulants O
are O
being O
tested O
in O
Italy O
. O

Low O
- O
molecular O
- O
weight O
heparin O
is O
being O
widely O
used O
to O
treat O
patients B-TERM
, O
prompting O
the O
Italian O
Medicines O
Agency O
to O
publish B-TERM
guidelines O
on O
its O
use O
. O

A O
multicenter O
study B-TERM
on O
300 O
patients B-TERM
researching O
the O
use O
of O
enoxaparin O
sodium O
at O
prophylaxis O
and O
therapeutic O
dosages O
was O
announced B-TERM
in O
Italy O
on O
April O
14 O
. O

Since O
SARS O
- O
CoV O
- O
2 O
is O
a O
virus O
, O
considerable B-TERM
scientific O
attention O
has O
been O
focused O
on O
repurposing O
approved O
anti O
- O
viral O
drugs O
that O
were O
developed O
for O
prior O
outbreaks O
such O
as O
MERS O
, O
SARS O
, O
and O
West O
Nile O
virus O
. O

Ribavirin O
: O
ribavirin O
was O
recommended O
for O
COVID O
- O
19 O
treatment O
according O
to O
Chinese O
7th O
edition O
guidelines O

Umifenovir O
: O
umifenovir O
was O
recommended O
for O
COVID O
- O
19 O
treatment O
according O
to O
Chinese O
7th O
edition O
guidelines O

Some O
antibiotics O
that O
have O
been O
identified O
as O
potentially O
repurposable O
as O
COVID O
- O
19 O
treatments O
: O

Tocilizumab O
( O
Anti O
- O
IL O
- O
6 O
receptor O
) O
: O
Approved O
by O
China O
. O

Also B-TERM
trials O
in O
Italy O
and O
China. O
and O
see O
Tocilizumab O
# O
COVID O
- O
19 O
. O

Former B-TERM
head B-TERM
of O
DPR O
told O
of O
his O
work O
in O
Russia O

The O
former B-TERM
acting O
head B-TERM
of O
the O
self O
- O
proclaimed O
Donetsk O
People O
's O
Republic O
( O
DPR O
) O
Dmitry O
Trapeznikov O
, O
heading O
the O
administration O
of O
Elista O
, O
evaluated O
the O
city O
's O
condition O
. O

The O
bureaucrat O
spoke O
about O
this O
in O
comments O
to O
the O
Telegram O
channel O
Podyom O
. O

According O
to O
him O
, O
the O
city O
is O
in O
a O
depressed O
economic O
state O
. O

" O
The O
economy O
needs O
to O
be O
equalized O
, O
it O
needs O
some O
housekeeping O
: O
here O
, O
of O
course O
, O
the O
roads O
need B-TERM
fixing O
, O
and O
the O
external O
lighting O
, O
" O
he O
said O
, O
adding O
that O
one O
of O
his O
tasks O
is O
to O
create O
a O
comfortable O
, O
well O
- O
appointed O
city O
. O

Trapeznikov O
was O
nominated O
to O
the O
post O
of O
Elista O
mayor O
by O
Kalmykia O
head B-TERM
Batu O
Khasikov O
. O

The O
former B-TERM
acting O
DPR O
head B-TERM
admitted O
that O
he O
has O
long O
been O
acquainted O
with O
the O
region B-TERM
's O
leader B-TERM
. O

In O
particular O
, O
he O
more O
than O
once O
visited O
the O
republic O
, O
where O
he O
worked O
with O
youth O
and O
ran O
sports O
events O
. O

" O
And O
so O
he O
contacted O
me O
, O
invited O
me O
to O
visit O
Kalmykia O
and O
give O
an O
expert O
evaluation O
of O
the O
city O
's O
condition O
, O
and O
then O
proposed O
taking O
charge O
of O
the O
city O
, O
" O
the O
bureaucrat O
added B-TERM
. O

Separately O
Trapeznikov O
commented O
on O
information B-TERM
from O
a O
source O
of O
RBK O
which O
belongs O
to O
Grigory O
Berezkin O
, O
which O
said O
that O
his O
nomination O
was O
suggested O
to O
the O
Kalmykia O
leader B-TERM
by O
presidential O
aide O
Vladislav O
Surkov O
, O
who O
, O
according O
to O
the O
publication O
's O
information O
, O
" O
has O
long O
been O
friends O
" O
with O
Khasikov O
. O

" O
People O
can O
write O
anything O
. O

Even O
to O
the O
extent O
of O
various O
made O
- O
up O
stories O
. O

I O
think B-TERM
it O
's O
not O
worth O
paying O
any O
attention O
, O
" O
he O
added B-TERM
. O

The O
Elista O
mayor O
also B-TERM
added B-TERM
that O
he O
has O
Russian O
citizenship O
, O
as O
well O
as O
a O
DPR O
passport O
. O

On O
26 O
September O
he O
took O
leadership O
of O
the O
Elista O
administration O
. O

Workplace O
hazard O
controls O
for O
COVID O
- O
19 O

Workplace O
hazard O
controls O
for O
COVID O
- O
19 O
are O
the O
application B-TERM
of O
occupational O
safety O
and O
health O
methodologies O
for O
hazard O
controls O
to O
the O
prevention O
of O
coronavirus O
disease O
2019 O
( O
COVID O
- O
19 O
) O
. O

The O
proper O
hazard O
controls O
in O
the O
workplace O
depend O
on O
the O
worksite O
and O
job O
task O
, O
based O
on O
a O
risk O
assessment O
of O
sources O
of O
exposure O
, O
disease O
severity O
in O
the O
community O
, O
and O
risk O
factors O
of O
individual O
workers O
who O
may O
be O
vulnerable O
to O
contracting O
COVID O
- O
19 O
. O

According O
to O
the O
U.S. O
Occupational O
Safety O
and O
Health O
Administration B-TERM
( O
OSHA O
) O
, O
lower O
exposure O
risk O
jobs O
have O
minimal O
occupational O
contact O
with O
the O
public O
and O
other O
coworkers O
, O
for O
which O
basic B-TERM
infection O
prevention O
measures B-TERM
are O
recommended O
, O
including O
hand O
washing O
, O
encouraging O
workers O
to O
stay O
home O
if O
they O
are O
sick O
, O
respiratory O
etiquette O
, O
and O
maintaining O
routine O
cleaning O
and O
disinfecting O
of O
the O
work O
environment O
. O

Medium O
exposure O
risk O
jobs O
include O
those O
that O
require O
frequent O
or O
close O
contact O
with O
people O
who O
are O
not O
known O
or O
suspected O
with O
COVID O
- O
19 O
, O
but O
may O
be O
infected O
due O
to O
ongoing O
community O
transmission O
or O
international O
travel B-TERM
. O

This O
includes O
workers O
who O
have O
contact O
with O
the O
general O
public O
such O
as O
in O
schools O
, O
high O
- O
population O
- O
density O
work O
environments O
, O
and O
some O
high O
- O
volume O
retail O
settings O
. O

Hazard O
controls O
for O
this O
group O
, O
in O
addition B-TERM
to O
basic B-TERM
infection O
prevention O
measures B-TERM
, O
include O
ventilation O
using O
high O
- O
efficiency O
air O
filters O
, O
sneeze O
guards O
, O
and O
having O
personal B-TERM
protective O
equipment O
available O
in O
case O
a O
person O
with O
COVID O
- O
19 O
is O
encountered O
. O

OSHA O
considers B-TERM
healthcare O
and O
mortuary O
workers O
exposed O
to O
known O
or O
suspected O
person O
with O
COVID O
- O
19 O
to O
be O
at O
high O
exposure O
risk O
, O
which O
increases O
to O
very O
high O
exposure O
risk O
if O
workers O
perform O
aerosol O
- O
generating O
procedures O
on O
, O
or O
collect O
or O
handle O
specimens O
from O
, O
known O
or O
suspected O
person O
with O
COVID O
- O
19 O
. O

Hazard O
controls O
appropriate O
for O
these O
workers O
include O
engineering O
controls O
such O
as O
negative O
pressure B-TERM
ventilation O
rooms O
, O
and O
personal B-TERM
protective O
equipment O
appropriate O
to O
the O
job O
task O
. O

COVID O
- O
19 O
outbreaks O
can O
have O
several O
effects O
within O
the O
workplace O
. O

Workers O
may O
be O
absent O
from O
work O
due O
to O
becoming O
sick O
, O
needing O
to O
care O
for O
others O
, O
or O
from O
fear B-TERM
of O
possible B-TERM
exposure O
. O

Patterns O
of O
commerce O
may O
change O
, O
both O
in O
terms O
of O
what O
goods O
are O
demanded O
, O
and O
the O
means O
of O
acquiring O
these O
goods O
( O
such O
as O
shopping O
at O
off O
- O
peak O
hours O
or O
through O
delivery O
or O
drive O
- O
through O
services O
) O
. O

Lastly O
, O
shipments O
of O
items O
from O
geographic O
areas O
severely O
affected O
by O
COVID O
- O
19 O
may O
be O
interrupted.An O
infectious O
disease O
preparedness O
and O
response O
plan B-TERM
can O
be O
used B-TERM
to O
guide O
protective O
actions O
. O

Plans B-TERM
address O
the O
levels O
of O
risk O
associated O
with O
various O
worksites O
and O
job O
tasks O
, O
including O
sources O
of O
exposure O
, O
risk O
factors O
arising O
from O
home B-TERM
and O
community O
settings O
, O
and O
risk O
factors O
of O
individual O
workers O
such O
as O
old B-TERM
age O
or O
chronic O
medical O
conditions O
. O

They O
also B-TERM
outline O
controls O
necessary B-TERM
to O
address B-TERM
those O
risks O
, O
and O
contingency O
plans B-TERM
for O
situations B-TERM
that O
may O
arise O
as O
a O
result B-TERM
of O
outbreaks O
. O

Infectious O
disease O
preparedness O
and O
response O
plans B-TERM
may O
be O
subject O
to O
national O
or O
subnational O
recommendations O
. O

Objectives B-TERM
for O
response O
to O
an O
outbreak O
include O
reducing O
transmission O
among B-TERM
staff O
, O
protecting O
people O
who O
are O
at O
higher O
risk O
for O
adverse O
health O
complications B-TERM
, O
maintaining O
business O
operations O
, O
and O
minimizing O
adverse O
effects O
on O
other O
entities O
in O
their O
supply O
chains O
. O

The O
disease B-TERM
severity O
in O
the O
community O
where O
the O
business O
is O
located O
affects O
the O
responses O
taken O
. O

The O
hierarchy O
of O
hazard O
controls O
is O
a O
framework O
widely O
used B-TERM
in O
occupational O
safety O
and O
health O
to O
group O
hazard O
controls O
by O
effectiveness B-TERM
. O

Where O
COVID O
- O
19 O
hazards O
cannot O
be O
eliminated O
, O
the O
most O
effective B-TERM
controls O
are O
engineering O
controls O
, O
followed B-TERM
by O
administrative O
controls O
, O
and O
lastly O
personal B-TERM
protective O
equipment O
. O

Engineering O
controls O
involve O
isolating O
employees B-TERM
from O
work O
- O
related O
hazards O
without O
relying O
on O
worker O
behavior O
, O
and O
can O
be O
the O
most O
cost O
- O
effective O
solution O
to O
implement O
. O

Administrative O
controls O
are O
changes B-TERM
in O
work O
policy O
or O
procedures O
that O
require O
action O
by O
the O
worker O
or O
employer O
. O

Personal B-TERM
protective O
equipment O
( O
PPE O
) O
is O
considered O
less O
effective B-TERM
than O
engineering O
and O
administrative O
controls O
, O
but O
can O
help B-TERM
prevent O
some O
exposures O
. O

All O
types B-TERM
of O
PPE O
must O
be O
selected O
based O
upon O
the O
hazard O
to O
the O
worker O
, O
properly O
fitted O
as O
applicable O
( O
e.g. O
, O
respirators O
) O
, O
consistently B-TERM
and O
properly O
worn O
, O
regularly B-TERM
inspected O
, O
maintained O
, O
and O
replaced O
, O
as O
necessary O
, O
and O
properly O
removed O
, O
cleaned O
, O
and O
stored O
or O
disposed O
of O
to O
avoid O
contamination O
. O

According O
to O
the O
U.S. O
Occupational O
Safety O
and O
Health O
Administration B-TERM
( O
OSHA O
) O
, O
lower O
exposure O
risk O
jobs O
have O
minimal O
occupational O
contact O
with O
the O
public O
and O
other O
coworkers O
. O

Basic B-TERM
infection O
prevention O
measures B-TERM
recommended O
for O
all O
workplaces O
include O
frequent O
and O
thorough O
hand O
washing O
, O
encouraging O
workers O
to O
stay O
home O
if O
they O
are O
sick O
, O
respiratory O
etiquette O
including O
covering O
coughs O
and O
sneezes O
, O
providing O
tissues O
and O
trash O
receptacles O
, O
preparing O
for O
telecommuting O
or O
staggered O
shifts O
if O
needed O
, O
discouraging O
workers O
from O
using O
others O
' O
tools O
and O
equipment B-TERM
, O
and O
maintaining O
routine O
cleaning O
and O
disinfecting O
of O
the O
work O
environment O
. O

Prompt O
identification O
and O
isolation O
of O
potentially O
infectious O
individuals O
is O
a O
critical O
step B-TERM
in O
protecting O
workers O
, O
customers B-TERM
, O
visitors O
, O
and O
others O
at O
a O
worksite O
. O

The O
U.S. O
Centers O
for O
Disease B-TERM
Control O
and O
Prevention O
( O
CDC O
) O
recommends O
that O
employees B-TERM
who O
have O
symptoms O
of O
acute O
respiratory O
illness O
are O
to O
stay O
home B-TERM
until O
they O
are O
free O
of O
fever O
, O
signs O
of O
a O
fever O
, O
and O
any O
other O
symptoms O
for O
at O
least O
24 O
hours O
without O
the O
use O
of O
fever O
- O
reducing O
or O
other O
symptom O
- O
altering O
medicines O
, O
and O
that O
sick O
leave O
policies O
are O
flexible O
, O
permit O
employees B-TERM
to O
stay O
home B-TERM
to O
care O
for O
a O
sick O
family B-TERM
member O
, O
and O
that O
employees B-TERM
are O
aware O
of O
these O
policies O
. O

According O
to O
OSHA O
, O
medium O
exposure O
risk O
jobs O
include O
those O
that O
require O
frequent O
or O
close O
contact O
within O
six O
feet O
( O
1.8 O
m O
) O
of O
people O
who O
are O
not O
known O
or O
suspected O
COVID O
- O
19 O
patients O
, O
but O
may O
be O
infected O
with O
SARS O
- O
CoV O
- O
2 O
due O
to O
ongoing O
community O
transmission O
around O
the O
business O
location O
, O
or O
because O
the O
individual O
has O
recent B-TERM
international O
travel B-TERM
to O
a O
location O
with O
widespread O
COVID O
- O
19 O
transmission O
. O

These O
include O
workers O
who O
have O
contact O
with O
the O
general O
public O
such O
as O
in O
schools O
, O
high O
- O
population O
- O
density O
work O
environments O
, O
and O
some O
high O
- O
volume O
retail O
settings.Engineering O
controls O
for O
this O
and O
higher O
risk O
groups O
include O
installing O
high O
- O
efficiency O
air O
filters O
, O
increasing O
ventilation O
rates O
, O
installing O
physical O
barriers O
such O
as O
clear O
plastic O
sneeze O
guards O
, O
and O
installing O
a O
drive O
- O
through O
window O
for O
customer O
service.Administrative O
controls O
for O
this O
and O
higher O
risk O
groups O
include O
encouraging O
sick O
workers O
to O
stay O
at O
home O
, O
replacing O
face O
- O
to O
- O
face O
meetings O
with O
virtual O
communications O
, O
establishing O
staggered O
shifts O
, O
discontinuing O
nonessential O
travel O
to O
locations O
with O
ongoing O
COVID O
- O
19 O
outbreaks O
, O
developing O
emergency O
communications O
plans O
including O
a O
forum O
for O
answering O
workers O
" O
concerns O
, O
providing O
workers O
with O
up O
- O
to O
- O
date O
education O
and O
training O
on O
COVID O
- O
19 O
risk O
factors O
and O
protective O
behaviors O
, O
training O
workers O
who O
need O
to O
use B-TERM
protecting O
clothing O
and O
equipment B-TERM
how O
to O
use O
it O
, O
providing O
resources O
and O
a O
work O
environment O
that O
promotes O
personal B-TERM
hygiene O
, O
requiring O
regular O
hand O
washing O
, O
limiting O
customers B-TERM
' O
and O
the O
public O
's O
access O
to O
the O
worksite O
, O
and O
posting O
signage O
about O
hand O
washing O
and O
other O
COVID O
- O
19 O
protective O
measures.Depending O
on O
the O
work O
task O
, O
workers O
with O
at O
least O
medium O
exposure O
risk O
may O
need O
to O
wear O
personal O
protective O
equipment O
including O
some O
combination B-TERM
of O
gloves O
, O
a O
gown O
, O
a O
face O
shield O
or O
face B-TERM
mask O
, O
or O
goggles O
. O

Workers O
in O
this O
risk O
group O
rarely O
require O
use O
of O
respirators O
. O

If O
a O
person O
becomes O
sick O
on O
an O
airplane O
, O
proper O
controls O
to O
protect O
workers O
and O
other O
passengers O
include O
separating O
the O
sick O
person O
from O
others O
by O
a O
distance B-TERM
of O
6 O
feet O
, O
designating O
one O
crew B-TERM
member O
to O
serve O
the O
sick O
person O
, O
and O
offering O
a O
face O
mask O
to O
the O
sick O
person O
or O
asking O
the O
sick O
person O
to O
cover O
their O
mouth B-TERM
and O
nose O
with O
tissues O
when O
coughing O
or O
sneezing O
. O

Cabin O
crew B-TERM
should O
wear O
disposable O
medical O
gloves O
when O
tending O
to O
a O
sick O
traveler B-TERM
or O
touching O
body O
fluids O
or O
potentially O
contaminated O
surfaces O
, O
and O
possibly B-TERM
additional O
personal B-TERM
protective O
equipment O
if O
the O
sick O
traveler O
has O
fever O
, O
persistent O
cough O
, O
or O
difficulty O
breathing O
. O

Gloves O
and O
other O
disposable O
items O
should O
be O
disposed O
of O
in O
a O
biohazard O
bag O
, O
and O
contaminated O
surfaces O
should O
be O
cleaned O
and O
disinfected O
afterwards.For B-TERM
commercial O
shipping O
, O
including O
cruise O
ships O
and O
other O
passenger O
vessels B-TERM
, O
hazard O
controls O
include O
postponing O
travel B-TERM
when O
sick O
, O
and O
self O
- O
isolating O
and O
informing O
the O
onboard O
medical O
center O
immediately O
if O
one O
develops O
a O
fever O
or O
other O
symptoms O
while O
on O
board O
. O

Ideally O
, O
medical O
follow O
- O
up O
should O
occur O
in O
the O
isolated O
person O
's O
cabin.For O
schools O
and O
childcare O
facilities O
, O
CDC O
recommends O
short O
- O
term O
closure O
to O
clean O
or O
disinfect O
if O
an O
infected O
person O
has O
been O
in O
a O
school O
building O
regardless O
of O
community O
spread O
. O

When O
there O
is O
minimal O
to O
moderate O
community O
transmission O
, O
social O
distancing B-TERM
strategies O
can O
be O
implemented O
such O
as O
canceling O
field O
trips O
, O
assemblies B-TERM
, O
and O
other O
large O
gatherings O
such O
as O
physical O
education O
or O
choir O
classes O
or O
meals O
in O
a O
cafeteria O
, O
increasing B-TERM
the O
space O
between O
desks O
, O
staggering O
arrival O
and O
dismissal O
times O
, O
limiting O
nonessential O
visitors O
, O
and O
using O
a O
separate O
health O
office B-TERM
location O
for O
children O
with O
flu O
- O
like B-TERM
symptoms O
. O

When O
there O
is O
substantial B-TERM
transmission O
in O
the O
local B-TERM
community O
, O
in O
addition B-TERM
to O
social O
distancing O
strategies O
, O
extended O
school O
dismissals O
may O
be O
considered.For O
law O
enforcement O
personnel O
performing B-TERM
daily B-TERM
routine O
activities O
, O
the O
immediate O
health O
risk O
is O
considered O
low O
by O
CDC O
. O

Law O
enforcement O
officials O
who O
must O
make O
contact O
with O
individuals O
confirmed O
or O
suspected O
to O
have O
COVID O
- O
19 O
are O
recommended O
to O
follow O
the O
same O
guidelines O
as O
emergency O
medical O
technicians O
, O
including O
proper O
personal B-TERM
protective O
equipment O
. O

If O
close O
contact O
occurs O
during O
apprehension O
, O
workers O
should O
clean O
and O
disinfect O
their O
duty O
belt B-TERM
and O
gear O
prior O
to O
reuse O
using O
a O
household O
cleaning O
spray O
or O
wipe O
, O
and O
follow O
standard O
operating O
procedures O
for O
the O
containment O
and O
disposal O
of O
used O
PPE O
and O
for O
containing O
and O
laundering O
clothes O
. O

OSHA O
considers B-TERM
certain O
healthcare O
and O
mortuary O
workers O
to O
be O
at O
high O
or O
very O
high O
categories O
of O
exposure O
risk O
. O

High O
exposure O
risk O
jobs O
include O
healthcare O
delivery O
, O
support O
, O
laboratory O
, O
and O
medical O
transport O
workers O
who O
are O
exposed O
to O
known O
or O
suspected O
COVID O
- O
19 O
patients B-TERM
. O

These O
become O
very O
high O
exposure O
risk O
if O
workers O
perform O
aerosol O
- O
generating O
procedures O
on O
, O
or O
collect O
or O
handle O
specimens O
from O
, O
known O
or O
suspected O
COVID O
- O
19 O
patients O
. O

Aerosol O
- O
generating O
procedures O
include O
intubation O
, O
cough O
induction O
procedures O
, O
bronchoscopies O
, O
some O
dental O
procedures O
and O
exams O
, O
or O
invasive O
specimen O
collection O
. O

High O
exposure O
risk O
mortuary O
jobs O
include O
workers O
involved O
in O
preparing O
the O
bodies O
of O
people O
who O
had O
known O
or O
suspected O
cases O
of O
COVID O
- O
19 O
at O
the O
time O
of O
their O
death O
; O
these O
become O
very O
high O
exposure O
risk O
if O
they O
perform O
an O
autopsy.Additional O
engineering O
controls O
for O
these O
risk O
groups O
include O
isolation O
rooms O
for O
patients B-TERM
with O
known O
or O
suspected O
COVID O
- O
19 O
, O
including O
when O
aerosol O
- O
generating O
procedures O
are O
performed O
. O

Specialized O
negative O
pressure B-TERM
ventilation O
may O
be O
appropriate O
in O
some O
healthcare O
and O
mortuary O
settings O
. O

Specimens O
should O
be O
handled O
with O
Biosafety O
Level O
3 O
precautions O
. O

The O
World O
Health O
Organization O
( O
WHO O
) O
recommends O
that O
incoming O
patients B-TERM
be O
separated O
into O
distinct O
waiting O
areas O
depending O
on O
whether O
they O
are O
a O
suspected O
COVID O
- O
19 O
case.In O
addition B-TERM
to O
other O
PPE O
, O
OSHA O
recommends O
respirators O
for O
those O
who O
work O
within O
6 O
feet O
of O
patients B-TERM
known O
to O
be O
, O
or O
suspected O
of O
being O
, O
infected O
with O
SARS O
- O
CoV O
- O
2 O
, O
and O
those O
performing O
aerosol O
- O
generating O
procedures O
. O

In O
the O
United O
States O
, O
NIOSH O
- O
approved O
N95 O
filtering O
facepiece O
respirators O
or O
better O
must O
be O
used B-TERM
in O
the O
context O
of O
a O
comprehensive O
, O
written O
respiratory O
protection O
program O
that O
includes O
fit O
- O
testing O
, O
training O
, O
and O
medical O
exams O
. O

Other O
types B-TERM
of O
respirators O
can O
provide O
greater O
protection O
and O
improve O
worker O
comfort.The O
WHO O
does O
not O
recommend O
coveralls O
, O
as O
COVID O
- O
19 O
is O
a O
respiratory O
disease B-TERM
rather O
than O
being O
transmitted O
through O
bodily O
fluids O
. O

WHO O
recommends O
only O
a O
surgical O
mask O
for O
point O
- O
of O
- O
entry O
screening O
personnel O
. O

For O
those O
who O
are O
collecting O
respiratory O
specimens O
from O
, O
caring O
for O
, O
or O
transporting O
COVID O
- O
19 O
patients B-TERM
without O
any O
aerosol O
- O
generating O
procedures O
, O
WHO O
recommends O
a O
surgical O
mask O
, O
goggles O
, O
or O
face B-TERM
shield O
, O
gown O
, O
and O
gloves O
. O

If O
an O
aerosol O
- O
generating O
procedure O
is O
performed O
, O
the O
surgical O
mask O
is O
replaced O
with O
an O
N95 O
or O
FFP2 O
respirator O
. O

Given O
that O
the O
global O
supply O
of O
PPE O
is O
insufficient O
, O
WHO O
recommends O
minimizing O
the O
need B-TERM
for O
PPE O
through O
telemedicine O
, O
physical O
barriers O
such O
as O
clear O
windows O
, O
allowing O
only O
those O
involved O
in O
direct O
care O
to O
enter O
a O
room O
with O
a O
COVID O
- O
19 O
patient O
, O
using O
only O
the O
PPE O
necessary O
for O
the O
specific O
task O
, O
continuing O
use O
of O
the O
same O
respirator O
without O
removing O
it O
while O
caring O
for O
multiple O
patients B-TERM
with O
the O
same O
diagnosis O
, O
monitoring O
and O
coordinating O
the O
PPE O
supply O
chain O
, O
and O
discouraging O
the O
use B-TERM
of O
masks O
for O
asymptomatic O
individuals O
. O

Putin O
and O
the O
Security O
Council O
discussed O
ensuring O
security O
without O
the O
INF O
Treaty O

The O
meeting O
also B-TERM
discussed O
peace O
- O
making O
in O
Syria O
after O
the O
formation B-TERM
of O
the O
Constitutional O
Committee O

Russian O
President O
Vladimir O
Putin O
and O
the O
Russian O
Security O
Council O
discussed O
issues O
related O
to O
security O
guarantees O
after O
the O
end B-TERM
of O
the O
Intermediate O
- O
Range O
Nuclear O
Forces O
Treaty B-TERM
, O
including O
with O
consideration O
of O
the O
proposal O
made O
to O
some O
NATO O
member O
countries O
for O
a O
moratorium O
on O
deploying O
intermediate O
- O
range O
and O
shorter O
- O
range O
missiles O
. O

This O
was O
stated O
by O
the O
Russian O
leader B-TERM
's O
press O
secretary O
Dmitry O
Peskov O
. O

The O
Kremlin O
representative O
noted O
that O
the O
meeting O
also B-TERM
discussed O
current B-TERM
issues O
concerning O
the O
country O
's O
socio O
- O
economic O
development O
, O
as O
well O
as O
ongoing O
prospects O
for O
settlement O
in O
Syria O
after O
the O
formation B-TERM
of O
the O
Constitutional O
Committee O
. O

Prime O
Minister O
Dmitry O
Medvedev O
, O
Federation O
Council O
Chair O
Valentina O
Matviyenko O
, O
Security O
Council O
Secretary O
Nikolai O
Patrushev O
, O
FSB O
Director O
Alexander O
Bortnikov O
, O
Defense O
Minister O
Sergei O
Shoigu O
, O
and O
Foreign O
Intelligence O
Service O
Director O
Sergei O
Naryshkin O
also O
took B-TERM
part O
in O
the O
meeting O
. O

As O
the O
kp.ru O
site O
reported O
, O
on O
25 O
September O
the O
Russian O
leader B-TERM
sent O
a O
number O
of O
NATO O
member O
countries O
a O
proposal O
to O
introduce O
a O
moratorium O
on O
deploying O
intermediate- O
and O
shorter O
- O
range O
missiles O
in O
Europe O
. O

However O
, O
the O
secretary O
- O
general O
of O
the O
alliance O
Jens O
Stoltenberg O
said O
Putin O
's O
proposal O
was O
not O
credible O
. O

A O
dump O
truck O
brought O
down O
an O
overpass O
on O
a O
highway O
under O
construction O
in O
Crimea O

A O
dump O
truck O
with O
a O
raised O
dump O
body O
knocked O
down O
two B-TERM
beams O
of O
an O
overpass O
that O
was O
under O
construction O
on O
the O
Tavrida O
Highway O
in O
Crimea O
. O

The O
driver O
managed O
to O
save O
his O
life O
by O
leaping O
from O
the O
cabin O
. O

The O
incident B-TERM
took O
place O
on O
the O
morning O
of O
September O
27 O
in O
the O
Bakhchisarai O
region O
of O
the O
peninsula O
. O

The O
man O
driving O
the O
heavy O
vehicle B-TERM
forgot O
to O
lower O
the O
dump O
body O
and O
by O
the O
time O
he O
remembered O
, O
it O
was O
already O
too O
late O
to O
stop O
. O

The O
driver O
leaped O
from O
the O
cabin O
and O
the O
dump O
truck O
collided O
with O
the O
overpass O
at O
speed B-TERM
. O

The O
collapsing O
beams O
crushed O
the O
cabin O
and O
blocked O
the O
roadway O
, O
which O
is O
still O
not O
open O
. O

The O
sum O
of O
the O
total O
damage B-TERM
still O
has O
yet O
to O
be O
determined O
, O
the O
losses O
are O
planned O
to O
be O
recovered O
from O
the O
highway O
's O
building O
subcontractor O
, O
the O
driver O
of O
which O
was O
responsible O
for O
the O
accident O
. O

Medvedev O
congratulated O
pre O
- O
school O
teachers O
on O
their O
professional B-TERM
holiday O

Russian O
Prime O
Minister O
Dmitry O
Medvedev O
congratulated O
kindergarten O
teachers O
and O
all O
pre O
- O
school O
employees B-TERM
on O
their O
professional B-TERM
holiday O
. O

In O
his O
words O
, O
children O
's O
future O
depends O
on O
them O
. O

This O
is O
stated O
in O
a O
telegram O
published B-TERM
on O
the O
Government O
website O
. O

Medvedev O
noted O
that O
the O
kindergarten O
teacher O
's O
profession O
is O
special O
, O
demanding O
great O
love O
for O
one O
's O
work O
, O
patience O
and O
up O
- O
to O
- O
date O
knowledge B-TERM
. O

Parents O
are O
entrusting O
you O
with O
their O
child O
. O

And O
you O
do O
everything O
to O
make O
kindergarten O
a O
second O
home B-TERM
for O
children O
, O
where O
it O
is O
cozy O
, O
interesting O
and O
safe O
. O

" O
Together B-TERM
with O
you O
they O
get O
to O
know O
the O
surrounding O
world O
, O
the O
beauty O
of O
nature B-TERM
, O
music O
, O
poetry O
, O
learn O
independence B-TERM
, O
the O
ability O
to O
communicate O
and O
make O
friends O
, O
" O
said O
the O
Government O
Chairman O
. O

In O
the O
words O
of O
the O
prime O
minister O
, O
it O
is O
thanks O
to O
pre O
- O
school O
teachers O
that O
children O
's O
character O
develops O
and O
abilities O
blossom O
. O

Medvedev O
is O
certain O
that O
children O
's O
future O
depends O
precisely B-TERM
on O
kindergarten O
teachers O
. O

" O
This O
is O
why O
developing O
pre O
- O
school O
education O
, O
raising O
its O
quality B-TERM
, O
building O
modern B-TERM
kindergartens O
, O
and O
providing O
material O
support O
for O
pre O
- O
school O
employees B-TERM
are O
priority O
tasks O
of O
state O
social O
policy O
, O
and O
the O
national O
Demography O
project B-TERM
is O
aimed B-TERM
at O
achieving O
them O
, O
" O
said O
the O
head B-TERM
of O
the O
Government O
. O

Rooms O
in O
the O
center O
of O
Moscow O
are O
being O
rented O
out O
for O
the O
cost O
of O
apartments O
on O
the O
outskirts O

Despite O
a O
reduction B-TERM
in O
the O
number B-TERM
of O
communal O
apartments O
in O
Moscow O
, O
demand O
for O
them O
has O
not O
fallen O
. O

Offers O
are O
meeting O
demand O
as O
a O
result O
of O
apartments O
being O
rented O
out O
room O
by O
room O
. O

Room O
rentals O
in O
the O
center O
of O
Moscow O
are O
rising O
in O
price O
faster O
than O
on O
the O
outskirts O
, O
on O
the O
whole O
, O
due O
to O
high O
demand O
. O

What O
's O
more O
, O
rooms O
in O
the O
center O
cost O
as O
much O
as O
apartments O
on O
the O
outskirts O
. O

The O
average O
rental O
cost O
of O
a O
room O
in O
Khamovniki O
is O
28,000 O
rubles O
according O
to O
research O
from O
the O
Apartment O
World O
portal O
. O

A O
one O
- O
room O
apartment O
can O
be O
rented O
for O
the O
same O
sum O
not O
far O
from O
the O
Moscow O
Ring O
Road O
. O

A O
room O
on O
Arbat O
rents O
for O
27,300 O
rubles O
on O
average O
, O
however O
, O
in O
individual O
cases O
offers O
can O
equal O
not O
only O
the O
rental O
prices O
for O
one O
- O
room O
apartments O
, O
but O
even O
for O
two O
- O
room O
apartments O
in O
dormitory O
suburbs O
. O

The O
very O
cheapest O
rooms O
in O
Moscow O
can O
be O
found O
in O
Kapotnya O
- O
the O
average O
rate O
for O
the O
area B-TERM
is O
13,600 O
rubles O
. O

The O
second O
most O
affordable O
area B-TERM
is O
West O
Biryulevo O
( O
13,800 O
) O
. O

Rooms O
in O
East O
Biryulevo O
and O
Veshnyaki O
cost O
14,100 O
to O
rent O
. O

The O
most O
expensive O
area B-TERM
outside O
of O
the O
Moscow O
Ring O
Road O
was O
Solntsevo O
where O
rooms O
cost O
almost O
16,000 O
rubles O
a O
month O
. O

Rooms O
in O
North O
and O
South O
Butovo O
and O
Novo O
- O
Peredelkino O
cost O
slightly O
less O
. O

How O
to O
increase O
your O
future O
pension O
and O
not O
overwork O

Pension O
payments O
can O
be O
made O
by O
the O
Russian O
Pension O
Fund O
as O
well O
as O
by O
non O
- O
state O
pension O
funds O
. O

NSPFs O
are O
private O
companies B-TERM
, O
reports O
Volgogradskaya O
pravda.ru. O

They O
work O
like B-TERM
a O
deposit B-TERM
: O
you O
contribute O
money O
, O
the O
fund O
invests O
it O
and O
later O
returns O
it O
to O
you O
with O
interest O
. O

If O
you O
are O
interested O
in O
this O
method B-TERM
, O
first O
study O
the O
information B-TERM
about O
NSPFs O
on O
the O
Central O
Bank O
of O
Russia O
website O
. O

All O
funds O
operate O
under O
the O
same O
rules O
, O
which O
are O
established O
by O
federal O
laws O
. O

Pension O
points O
can O
be O
purchased O
according O
to O
the O
law O
. O

A O
shortfall O
in O
points O
is O
determined O
by O
how O
many O
years O
in O
the O
workforce O
you O
are O
lacking O
for O
pension O
eligibility O
. O

This O
way B-TERM
suits O
those O
who O
worked O
unofficially O
. O

Also O
, O
it O
is O
possible O
to O
make O
a O
contribution O
for O
a O
relative O
, O
for O
example O
, O
a O
homemaker O
wife B-TERM
. O

Recommendations O
for O
those O
who O
start O
thinking O
about O
the O
pension O
at O
the O
start O
of O
their O
working O
life O
. O

Larger O
pension O
payments O
are O
awarded O
to O
civil O
servants O
, O
doctors B-TERM
, O
teachers B-TERM
, O
agricultural O
workers O
and O
people O
who O
spent O
a O
certain O
number B-TERM
of O
years O
working O
in O
the O
Far O
North O
. O

So O
that O
you O
don O
't O
have O
to O
refuse O
yourself O
anything O
when O
you O
reach O
pension O
age O
, O
provide O
for O
it O
in O
advance O
. O

Purchase O
real O
estate O
, O
currency O
, O
securities O
, O
save O
money O
in O
deposits B-TERM
. O

Most O
importantly O
- O
constantly O
raise O
your O
financial O
knowledge O
. O

Media O
representatives O
visit O
the O
fourth O
reactor O
of O
the O
Chernobyl O
Nuclear O
Power O
Plant O

Video O
recordings O
taken O
from O
the O
control O
room O
of O
the O
fourth O
reactor O
of O
the O
Chernobyl O
Nuclear O
Power O
Plant O
have O
emerged O
on O
the O
internet O
, O
published B-TERM
first O
on O
YouTube O
by O
the O
video O
news O
agency O
Ruptly O
. O

A O
group O
of O
15 O
media O
representatives O
were O
reported O
to O
have O
been O
granted O
access O
to O
the O
fourth O
reactor O
control O
room O
of O
the O
Chernobyl O
Nuclear O
Power O
Plant O
as O
part O
of O
a O
presentation O
for O
a O
guidebook O
through O
the O
exclusion O
zone O
. O

According O
to O
the O
RT O
Telegram O
channel O
, O
the O
journalists O
wore O
special O
protective O
gear O
and O
were O
there O
for O
less O
than O
five O
minutes B-TERM
, O
since O
the O
ruins O
of O
the O
reactor O
that O
was O
destroyed O
by O
the O
explosion O
still O
emit O
40 O
thousand O
times O
more O
radiation O
than O
normal O
. O

The O
disaster B-TERM
at O
the O
Chernobyl O
Nuclear O
Power O
Plant O
occurred O
the O
night O
of O
April O
26 O
, O
1986 O
. O

12 O
regions B-TERM
of O
Ukraine O
and O
23 O
% O
of O
Belarus O
were O
subject O
to O
radiation O
pollution O
. O

19 O
regions B-TERM
in O
Russia O
were O
affected O
. O

This O
July O
, O
Ukrainian O
leader B-TERM
Volodymyr O
Zelensky O
signed O
an O
order O
that O
led O
to O
the O
creation O
of O
a O
green O
corridor O
in O
Chernobyl O
, O
which O
is O
open B-TERM
to O
tourists O
. O

The O
ban O
on O
photography O
in O
the O
exclusion O
zone O
has O
also B-TERM
been O
lifted O
. O

It O
had O
been O
previously O
reported O
that O
the O
Chernobyl O
Nuclear O
Power O
Plant O
exclusion O
zone O
was O
open O
to O
tourists O
on O
the O
Belorussian O
side O
. O

The O
tour O
organizers O
pointed O
out O
that O
you O
could O
receive B-TERM
less O
radiation O
from O
one O
day O
in O
the O
zone O
than O
during O
an O
airplane O
flight O
. O

Tarasov O
repeated O
Ibrahimovic O
's O
trick O

The O
former B-TERM
Moscow O
team O
" O
Lokomotiv O
" O
midfielder B-TERM
took B-TERM
on O
a O
challenge O
put O
forward O
by O
the O
US O
team O
LA O
Galaxy O
's O
Swedish O
forward O
Zlatan O
Ibrahimovic O
. O

Tarasov O
posted O
the O
footage O
of O
the O
trick O
on O
his O
Instagram O
account O
. O

Afterwards B-TERM
, O
Tarasov O
put O
forward O
a O
challenge O
to O
" O
Zeleznodorozhnik O
" O
halfbacks O
Aleksei O
and O
Anton O
Miranchuk O
, O
rapper O
T O
- O
Killah O
and O
even O
bloggers O
from O
the O
YouTube O
channel O
2DROTS O
. O

Posting O
a O
video O
with O
the O
# O
matrixchallenge O
hashtag O
, O
the O
Swede O
catches O
the O
ball O
on O
his O
chest O
, O
leaning O
back O
while O
motioning O
with O
his O
arms O
in O
a O
similar B-TERM
fashion O
to O
the O
hero O
of O
the O
Matrix O
film B-TERM
Neo O
, O
who O
dodges O
flying O
bullets O
in O
such O
a O
manner O
in O
one O
scene O
. O

Ibrahimovic O
challenged O
Manchester O
United O
halfback O
Paul O
Pogba O
, O
tennis O
player O
Novak O
Djokovic O
, O
Russian O
UFC O
champion O
Khabib O
Nurmagomedov O
and O
his O
agent O
, O
Mino O
Raiola O
, O
to O
repeat O
the O
trick O
in O
a O
comment O
under O
the O
post O
. O

It O
was O
earlier O
reported O
that O
the O
wife B-TERM
of O
a O
Ukrainian O
football O
player O
took B-TERM
up O
Ibrahimovic O
's O
challenge O
. O

Trade O
turnover O
between O
Russia O
and O
Slovakia O
may O
reach O
$ O
6 O
bln O
at O
year O
- O
end B-TERM
2019 O

Under O
the O
emergent O
positive O
dynamics O
, O
trade O
turnover O
between O
Russia O
and O
Slovakia O
may O
reach O
6 O
billion O
rubles O
at O
the O
end B-TERM
of O
2019 O
, O
the O
Slovakian O
Minister O
of O
Economy O
Peter O
≈Ωiga O
announced B-TERM
. O

At O
a O
meeting O
of O
the O
intergovernmental O
commission O
on O
economic O
and O
scientific O
- O
technological O
cooperation B-TERM
between O
Russia O
and O
Slovakia O
, O
the O
minister O
noted O
the O
growth B-TERM
in O
trade O
turnover O
between O
the O
two B-TERM
countries O
. O

At O
the O
end B-TERM
of O
last O
year O
it O
stood O
at O
13 O
percent O
, O
and O
reached O
the O
indicator B-TERM
of O
$ O
5.5 O
billion O
. O

In O
the O
first O
half O
of O
2019 O
the O
states B-TERM
achieved O
3 O
billion O
dollars O
in O
mutual O
trade O
, O
≈Ωiga O
said O
. O

According O
to O
the O
head B-TERM
of O
the O
Ministry O
of O
Industry O
and O
Trade O
Denis O
Manturov O
, O
increased O
mutual O
cooperation B-TERM
in O
the O
industrial O
sector O
is O
needed O
to O
reinforce O
this O
positive O
tendency O
. O

Earlier O
it O
became O
known O
that O
Russian O
and O
Slovakian O
parliamentarians O
intend O
to O
hold O
joint B-TERM
events O
to O
develop O
tourism O
between O
the O
countries O
, O
as O
well O
as O
cooperation B-TERM
in O
the O
areas B-TERM
of O
health O
care O
and O
education O
. O

TNT O
decides O
rapper O
Guf O
not O
good O
enough B-TERM
for O
the O
Bachelor O

People O
spent O
several O
days O
online O
discussing O
whether O
the O
rapper O
Guf O
is O
good O
enough O
to O
be O
the O
new O
Bachelor O
. O

They O
remembered O
him O
for O
his O
numerous O
infidelities O
and O
antics O
with O
escorts O
, O
and O
they O
even O
decided O
that O
the O
musician O
wanted B-TERM
to O
thereby O
rehabilitate O
himself O
after O
the O
scandalous O
Moscow O
clip O
that O
received B-TERM
a O
record O
number B-TERM
of O
dislikes O
from O
listeners O
. O

But O
the O
TNT O
management B-TERM
decided O
to O
put O
a O
stop O
to O
all O
the O
gossip O
at O
once O
. O

Guf O
will O
not O
be O
the O
new O
bachelor O
on O
the O
show O
. O

In O
an O
official O
statement O
, O
the O
press O
service O
said O
that O
he O
was O
considered O
for O
the O
role B-TERM
, O
but O
in O
the O
end B-TERM
they O
chose B-TERM
another B-TERM
candidate O
. O

Who O
could O
be O
better O
than O
Guf O
? O

Basically O
, O
anyone O
... O

" O
At O
the O
least O
the O
producers O
were O
able B-TERM
to O
somehow O
figure O
out O
that O
he O
isn O
't O
right O
for O
the O
program O
, O
" O
" O
Yeah O
, O
they O
just O
couldn O
't O
find O
any O
willing O
girls B-TERM
to O
recruit O
for O
him O
, O
" O
" O
They O
're O
going O
to O
foist O
another O
pretty O
boy B-TERM
onto O
the O
screen O
, O
" O
users O
said O
online O
, O
commenting O
on O
the O
news B-TERM
. O

Magomed O
Ismailov O
: O
" O
When O
I O
hear O
such O
fan O
support O
, O
I O
become O
possessed O
in O
the O
cage O
. O
" O

Russian O
mixed O
martial O
arts O
( O
MMA O
) O
fighter O
Magomed O
Ismailov O
commented O
on O
his O
victory O
over O
Artem O
Frolov O
in O
the O
ACA O
99 O
competition O
in O
Moscow O
. O

This O
fellow O
is O
simply O
a O
cannon O
. O

His O
strikes O
are O
like O
cannon O
blows O
. O

And O
when O
I O
looked O
him O
in O
the O
eye B-TERM
, O
I O
saw B-TERM
character O
and O
the O
will O
. O

This O
is O
a O
real O
man O
. O

Great O
respect O
to O
him O
. O

I O
wish B-TERM
him O
success O
in O
the O
future O
. O

He O
is O
a O
real O
man O
. O

When O
I O
hear O
such O
fan O
support O
, O
I O
become O
possessed O
in O
the O
cage O
. O

It O
was O
really O
difficult B-TERM
. O

I O
tried B-TERM
. O

I O
spoke B-TERM
of O
a O
show O
. O

Did O
I O
promise O
a O
show O
? O

Was O
there O
a O
show O
? O

Thank O
you O
. O

And O
to O
those O
who O
said O
that O
I O
would O
choke O
in O
the O
third O
round O
... O

Ismailov O
finished B-TERM
his O
speech B-TERM
with O
a O
victorious O
wave O
. O

Deutsche O
Welle O
could O
lose O
accreditation O
, O
be O
recognized O
as O
foreign O
agent O

The O
State O
Duma O
Commission O
concluded B-TERM
that O
the O
German B-TERM
television O
- O
radio O
company O
Deutsche O
Welle O
broke O
the O
law O
, O
reports O
RIA O
Novosti O
. O

Documents O
for O
the O
recognition O
of O
Deutsche O
Welle O
as O
a O
foreign O
agent O
will O
be O
sent O
to O
the O
Ministry O
of O
Justice O
. O

Materials B-TERM
for O
the O
loss O
of O
accreditation O
in O
Russia O
will O
be O
submitted O
to O
the O
Russian O
Ministry O
of O
Foreign O
Affairs O
. O

Earlier O
, O
Deutsche O
Welle O
representatives O
refused B-TERM
to O
participate O
in O
the O
session O
of O
the O
State O
Duma O
Commission O
for O
investigating O
the O
interference O
of O
other O
countries O
in O
Russian O
internal O
affairs O
. O

Large O
- O
scale O
Facebook O
crash O
hits O
Europe O
. O

Ukraine O
hit O
as O
well O

A O
large O
- O
scale O
malfunction O
occurred O
in O
the O
Facebook O
social O
network O
in O
Europe O
. O

Recall O
that O
before O
that O
, O
the O
social O
network O
" O
fell O
" O
on O
September O
23 O
. O

As O
the O
Downdetector O
network O
monitoring O
resource O
informs B-TERM
, O
the O
biggest B-TERM
problems B-TERM
with O
access O
to O
the O
social O
network O
are O
being O
experienced O
in O
Belgium O
, O
the O
Netherlands O
, O
Luxembourg O
, O
and O
nearly O
all O
of O
Great O
Britain O
. O

Large O
- O
scale O
failures O
are O
observed O
on O
the O
border B-TERM
of O
Romania O
and O
Bulgaria O
, O
and O
in O
Hungary O
, O
Slovakia O
, O
Germany O
, O
France O
, O
Italy O
, O
Spain O
, O
and O
Portugal O
. O

Facebook O
is O
also B-TERM
inaccessible O
in O
practically B-TERM
all O
of O
Poland O
, O
and O
in O
certain O
places B-TERM
in O
Belarus O
and O
the O
Baltic O
states O
. O

In O
Ukraine O
, O
judging O
by O
the O
map B-TERM
of O
crashes O
compiled O
, O
Facebook O
is O
unavailable O
in O
the O
Kiev O
Oblast O
, O
and O
partially O
so O
in O
the O
Kharkiv O
and O
Vinnytsia O
Oblasts O
. O

Note O
that O
users O
also B-TERM
experienced O
problems B-TERM
with O
Wikipedia O
in O
early O
September O
. O

SARS O
- O
CoV O
- O
2 O
surpasses O
one O
million O
infections O
worldwide O

On O
Thursday O
, O
the O
total O
number B-TERM
of O
cases O
of O
the O
SARS O
- O
CoV O
- O
2 O
coronavirus O
infections O
surpassed O
one O
million O
worldwide O
, O
Johns O
Hopkins O
University O
data B-TERM
indicated O
. O

At O
least O
52 O
thousand O
deaths O
were O
linked O
to O
COVID O
- O
19 O
, O
the O
disease O
caused O
by O
the O
coronavirus O
. O

The O
milestone O
came O
the O
same O
day O
Malawi O
confirmed O
its O
first O
coronavirus O
infections O
and O
Zambia O
had O
its O
first O
coronavirus O
- O
related O
death O
. O

North O
Korea O
claimed O
, O
as O
of O
Thursday O
, O
it O
was O
one O
of O
the O
few O
countries O
remaining O
free O
of O
coronavirus O
infections O
. O

By O
yesterday O
, O
the O
World O
Health O
Organization B-TERM
reported O
1,051,635 O
confirmed O
cases O
, O
including O
79,332 O
cases O
in O
the O
twenty O
four O
hours O
preceding O
10 O
a.m. O
Central O
European O
Time O
( O
0800 O
UTC O
) O
on O
April O
4 O
. O

In O
the O
United O
States O
, O
over O
244 O
thousand O
coronavirus O
cases O
were O
recorded O
, O
linking O
to O
at O
least O
5,900 O
deaths O
. O

CBS O
News O
reported O
, O
citing O
Johns O
Hopkins O
University O
data B-TERM
, O
there O
were O
over O
1,000 O
US O
deaths O
on O
Wednesday O
caused B-TERM
by O
coronavirus O
infections O
. O

Around O
the O
world O
, O
countries O
announced B-TERM
stricter O
measures B-TERM
to O
inhibit O
the O
disease B-TERM
from O
spreading O
. O

On O
Thursday O
, O
Sergei O
Sobyanin O
, O
the O
mayor O
of O
Moscow O
, O
extended O
the O
city O
lockdown O
to O
May O
1 O
. O

Nationally O
, O
President O
Vladimir O
Putin O
declared B-TERM
Russians B-TERM
would O
continue O
to O
be O
paid O
without O
going O
to O
work O
until O
April O
30 O
. O

The O
parliament O
of O
Portugal O
voted O
to O
extend O
the O
national O
state O
of O
emergency O
by O
15 O
days O
; O
the O
vote O
passed O
with O
215 O
votes O
in O
favor O
, O
ten O
abstentions O
, O
and O
one O
vote O
against O
. O

Saudi O
Arabia O
extended O
curfews O
in O
the O
holy O
cities O
of O
Mecca O
and O
Medina O
to O
last O
the O
entire O
day O
; O
previously O
, O
the O
curfew O
was O
only O
in O
effect O
between O
3 O
p.m. O
and O
6 O
a.m. O

Thailand O
planned O
to O
implement O
a O
curfew O
between O
10 O
p.m. O
and O
4 O
a.m. O

The O
governor O
of O
Ohio O
, O
Mike O
DeWine O
, O
announced B-TERM
the O
state O
had O
extended O
its O
stay O
- O
at O
- O
home O
order O
until O
May O
1 O
. O

Which O
club O
will O
take O
the O
released O
- O
on O
- O
parole O
Pavel O
Mamaev O

Football O
player O
Pavel O
Mamaev O
, O
released O
from O
prison O
last O
week O
on O
parole O
, O
will O
not O
return O
to O
the O
Krasnodar O
football O
club O
. O

The O
club O
's O
former B-TERM
midfielder B-TERM
could O
sign O
a O
contract B-TERM
with O
the O
Rostov O
football O
club O
in O
the O
near O
future O
, O
reports O
Chempionat O
. O

According O
to O
the O
publication O
, O
negotiations O
between O
Rostov O
representatives O
and O
Mamaev O
are O
now O
in O
the O
final O
stage B-TERM
. O

Presumably O
, O
the O
contract B-TERM
with O
the O
31 O
- O
year O
- O
old O
will O
be O
signed O
for O
two B-TERM
years O
with O
the O
possibility B-TERM
of O
extending O
it O
for O
another O
season O
. O

Sport O
- O
Express O
writes O
that O
a O
day O
earlier O
, O
Pavel O
Mamaev O
was O
supposed O
to O
undergo O
a O
medical O
examination O
at O
the O
Moscow O
Dinamo O
, O
but O
the O
check O
- O
up O
didn O
't O
happen O
because O
of O
the O
" O
uncertain O
situation B-TERM
in O
the O
club O
. O
" O

Krasnodar O
terminated O
its O
contract B-TERM
with O
Mamaev O
last O
week O
by O
agreement B-TERM
of O
both O
parties O
. O

The O
midfielder B-TERM
had O
played O
for O
Krasnodar O
since O
2014 O
. O

He O
took O
bronze O
with O
the O
team O
twice O
in O
the O
Russian O
championships O
. O

Mamaev O
previously O
played O
for O
Torpedo O
Moscow O
and O
CSKA O
Moscow O
. O

From O
2009 O
to O
2016 O
, O
Mamaev O
played O
15 O
matches O
for O
the O
Russian O
national O
team O
. O

Mamaev O
was O
serving O
a O
sentence O
together B-TERM
with O
Zenit O
player O
Alexander O
Kokorin O
for O
participating O
in O
fights O
in O
the O
center O
of O
Moscow O
in O
October O
of O
last O
year O
. O

They O
were O
released O
from O
prison O
on O
parole O
in O
mid O
- O
September O
. O

Zenit O
signed O
a O
new O
contract B-TERM
with O
Kokorin O
. O

Man O
with O
samurai O
sword O
tried O
to O
fight O
for O
cart O
found B-TERM
in O
trash O
pile O

A O
resident O
of O
the O
American O
town O
Oakland O
Park O
, O
Florida O
, O
was O
arrested O
on O
charges O
of O
attempted O
murder O
after O
he O
waved O
a O
samurai O
sword O
at O
his O
opponent O
in O
a O
dispute B-TERM
over O
a O
cart O
found B-TERM
in O
trash O
. O

54 O
- O
year O
- O
old O
Curtis O
Miller O
was O
rummaging O
in O
a O
trash O
pile O
near O
an O
uninhabited O
house B-TERM
. O

This O
was O
noticed O
by O
Todd O
Beavers O
who O
had O
come O
out O
for O
an O
evening O
walk O
. O

The O
latter O
decided O
to O
join O
the O
search O
and O
found B-TERM
a O
black O
cart O
in O
the O
trash O
. O

Miller O
saw O
Beavers O
' O
find O
and O
got O
upset O
. O

He O
considered B-TERM
that O
he O
had O
a O
right O
to O
the O
cart O
, O
since O
he O
started O
rummaging O
in O
the O
trash O
first O
. O

The O
men O
began O
to O
argue O
. O

Suddenly B-TERM
Beavers O
seized O
the O
cart O
and O
ran O
away O
with O
it O
in O
the O
direction O
of O
his O
home B-TERM
. O

Then O
Miller O
took O
a O
samurai O
sword O
that O
he O
had O
found B-TERM
in O
the O
same O
trash O
pile O
and O
began O
to O
pursue O
his O
opponent O
. O

He O
caught O
up O
with O
Beavers O
near O
his O
house B-TERM
. O

Miller O
withdrew O
the O
sword O
from O
its O
sheath O
and O
began O
to O
wave O
it O
at O
the O
cart O
snatcher O
. O

Beavers O
told O
Miller O
that O
the O
scene O
was O
being O
videoed O
. O

After O
noticing O
the O
video O
camera O
, O
Miller O
ran O
away O
, O
but O
threatened B-TERM
to O
return O
. O

Beavers O
left B-TERM
the O
cart O
in O
the O
yard O
and O
went O
inside O
. O

Soon B-TERM
afterwards B-TERM
he O
saw O
an O
unfamiliar O
woman O
enter O
the O
yard O
and O
take O
the O
cart O
, O
shouting O
insults O
. O

Police B-TERM
had O
already O
been O
searching O
for O
Miller O
for O
driving O
without O
a O
license O
. O

The O
man O
was O
apprehended O
, O
and O
he O
was O
charged O
with O
attempted O
murder O
. O

In O
September O
it O
was O
reported O
that O
in O
the O
American O
town O
Hardyston O
, O
New O
Jersey O
, O
a O
hedge O
fund O
manager O
attacked O
a O
female O
stranger O
and O
injured O
her O
with O
a O
sword O
. O

This O
was O
how O
he O
reacted O
when O
guests O
at O
a O
wedding O
, O
in O
the O
hotel B-TERM
where O
he O
was O
staying O
, O
would O
not O
let O
him O
smoke O
. O

A O
riot O
of O
three O

The O
longer O
the O
Moscow O
Case O
against O
participants O
of O
summer O
's O
protests O
proceeds O
, O
the O
more O
noticeably O
it O
splinters O
into O
separate O
fragments O
and O
loses O
its O
political O
scope O
. O

The O
evidence O
confirming O
the O
" O
riots O
" O
does O
not O
stand O
up O
to O
scrutiny O
, O
but O
in O
the O
absence O
of O
a O
political O
decision B-TERM
to O
halt O
the O
case O
, O
a O
weak B-TERM
body O
of O
evidence O
does O
not O
necessarily B-TERM
lead O
to O
the O
accusations O
being O
withdrawn O
. O

The O
collapse O
of O
the O
case O
should O
hearten O
society O
, O
but O
it O
will O
certainly B-TERM
leave B-TERM
the O
security O
services O
very O
exasperated O
- O
their O
efforts O
to O
bolster O
the O
case O
with O
defendants O
and O
evidence O
were O
in O
vain B-TERM
. O

On O
Thursday O
, O
September O
26 O
, O
one O
of O
the O
case O
's O
three O
remaining O
defendants O
accused O
under O
Article O
212 O
of O
the O
criminal O
code O
( O
rioting O
) O
- O
Alexei O
Minyailo O
- O
was O
unexpectedly O
released O
from O
custody O
without O
any O
conditions O
and O
in O
several O
hours O
" O
time O
was O
exonerated O
: O
the O
Russian O
Investigative O
Committee O
withdrew O
the O
charges O
against O
him O
. O

Minyailo O
had O
been O
under O
arrest O
for O
almost O
two B-TERM
months O
- O
several O
professional B-TERM
communities O
came O
to O
his O
defense O
: O
historians O
, O
priests O
, O
literary O
artists O
. O

As O
a O
result O
, O
only O
two O
of O
those O
accused O
of O
taking O
part O
in O
a O
riot O
remain O
( O
at O
first O
there O
were O
13 O
defendants O
) O
: O
Sergei O
Fomin O
, O
transferred O
on O
September O
3 O
to O
house O
arrest O
and O
Samariddin O
Radzhabov O
, O
who O
the O
day O
before O
had O
his O
arrest O
extended O
till O
the O
end B-TERM
of O
December O
( O
he O
is O
also B-TERM
accused O
of O
using O
force O
against O
government O
authorities O
, O
Article O
318 O
of O
the O
criminal O
code O
) O
. O

b O
'Coronavirus O
disease B-TERM
2019 O
( O
COVID O
- O
19 O
) O
is O
an O
infectious O
disease B-TERM
caused O
by O
severe O
acute O
respiratory O
syndrome O
coronavirus O
2 O
( O
SARS O
- O
CoV O
- O
2 O
) O
. O

Common O
symptoms O
include O
fever O
, O
cough O
, O
and O
shortness O
of O
breath O
. O

Other O
symptoms O
may O
include O
fatigue O
, O
muscle O
pain B-TERM
, O
diarrhea O
, O
sore O
throat O
, O
loss O
of O
smell O
, O
and O
abdominal O
pain B-TERM
. O

The O
time O
from O
exposure O
to O
onset O
of O
symptoms O
is O
typically O
around B-TERM
five O
days O
but O
may O
range O
from O
two B-TERM
to O
fourteen O
days O
. O

While O
the O
majority O
of O
cases O
result O
in O
mild O
symptoms O
, O
some O
progress O
to O
viral O
pneumonia O
and O
multi O
- O
organ O
failure O
. O

As O
of O
17 O
April O
2020 O
, O
more O
than O
2.24 O
million O
cases O
have O
been O
reported O
across O
210 O
countries O
and O
territories O
, O
resulting O
in O
more O
than O
153,000 O
deaths O
. O

More O
than O
568,000 O
people O
have O
recovered.The O
virus O
is O
primarily O
spread O
between O
people O
during O
close O
contact O
, O
often B-TERM
via B-TERM
small O
droplets O
produced O
by O
coughing O
, O
sneezing O
, O
or O
talking O
. O

While O
these O
droplets O
are O
produced O
when O
breathing O
out O
, O
they O
usually O
fall O
to O
the O
ground B-TERM
or O
onto O
surfaces O
rather O
than O
being O
infectious O
over O
long O
distances B-TERM
. O

People O
may O
also B-TERM
become O
infected O
by O
touching O
a O
contaminated O
surface O
and O
then O
touching O
their O
eyes B-TERM
, O
nose O
, O
or O
mouth B-TERM
. O

The O
virus O
can O
survive O
on O
surfaces O
up O
to O
72 O
hours O
. O

It O
is O
most O
contagious O
during O
the O
first O
three O
days O
after O
the O
onset O
of O
symptoms O
, O
although B-TERM
spread O
may O
be O
possible B-TERM
before O
symptoms O
appear O
and O
in O
later O
stages B-TERM
of O
the O
disease.The O
standard O
method B-TERM
of O
diagnosis O
is O
by O
real O
- O
time O
reverse O
transcription O
polymerase O
chain O
reaction O
( O
rRT O
- O
PCR O
) O
from O
a O
nasopharyngeal O
swab O
. O

The O
use O
of O
masks O
is O
recommended O
for O
those O
who O
suspect O
they O
have O
the O
virus O
and O
their O
caregivers O
. O

Recommendations O
for O
mask O
use O
by O
the O
general O
public O
vary O
, O
with O
some O
authorities O
recommending O
against O
their O
use B-TERM
, O
some O
recommending O
their O
use O
, O
and O
others O
requiring O
their O
use O
. O

Currently O
, O
there O
is O
no O
vaccine B-TERM
or O
specific O
antiviral O
treatment O
for O
COVID O
- O
19 O
. O

Local B-TERM
transmission O
of O
the O
disease B-TERM
has O
been O
recorded O
in O
most O
countries O
across O
all O
six O
WHO O
regions B-TERM
. O

Those O
infected O
with O
the O
virus O
may O
be O
asymptomatic O
or O
develop O
flu O
- O
like B-TERM
symptoms O
such O
as O
fever O
, O
cough O
, O
fatigue O
, O
and O
shortness O
of O
breath O
. O

Emergency O
symptoms O
include O
difficulty O
breathing O
, O
persistent O
chest O
pain B-TERM
or O
pressure O
, O
confusion O
, O
difficulty O
waking O
, O
and O
bluish O
face B-TERM
or O
lips O
; O
immediate O
medical O
attention O
is O
advised O
if O
these O
symptoms O
are O
present O
. O

Less O
commonly O
, O
upper O
respiratory O
symptoms O
such O
as O
sneezing O
, O
runny O
nose O
or O
sore O
throat O
may O
be O
seen O
. O

Gastrointestinal O
symptoms O
such O
as O
nausea O
, O
vomiting O
and O
diarrhoea O
have O
been O
observed O
in O
varying O
percentages O
. O

Some O
cases O
in O
China O
initially B-TERM
presented O
only O
with O
chest O
tightness O
and O
palpitations O
. O

In O
some O
, O
the O
disease B-TERM
may O
progress O
to O
pneumonia O
, O
multi O
- O
organ O
failure O
, O
and O
death O
. O

This O
is O
called O
the O
incubation O
period O
. O

The O
incubation O
period O
for O
COVID O
- O
19 O
is O
typically O
five O
to O
six O
days O
but O
may O
range O
from O
two B-TERM
to O
14 O
days O
. O

97.5 O
% O
of O
people O
who O
develop O
symptoms O
will O
do O
so O
within O
11.5 O
days O
of O
infection.Reports O
indicate O
that O
not O
all O
who O
are O
infected O
develop O
symptoms O
. O

The O
role B-TERM
of O
these O
asymptomatic O
carriers O
in O
transmission O
is O
not O
yet O
fully O
known O
; O
however O
, O
preliminary O
evidence O
suggests O
that O
they O
may O
contribute B-TERM
to O
the O
spread O
of O
the O
disease B-TERM
. O

The O
proportion O
of O
infected O
people O
who O
do O
not O
display O
symptoms O
is O
currently O
unknown B-TERM
and O
being O
studied O
, O
with O
the O
Korea O
Centers O
for O
Disease B-TERM
Control O
and O
Prevention O
( O
KCDC O
) O
reporting O
that O
20 O
% O
of O
all O
confirmed O
cases O
remained O
asymptomatic O
during O
their O
hospital O
stay O
. O

China O
's O
National O
Health O
Commission O
began O
including O
asymptomatic O
cases O
in O
its O
daily B-TERM
cases O
on O
1 O
April O
; O
of O
the O
166 O
infections O
on O
that O
day O
, O
130 O
( O
78 O
% O
) O
were O
asymptomatic O
at O
the O
time O
of O
testing O
. O

Both O
sputum O
and O
saliva O
can O
carry O
large O
viral O
loads O
. O

Loud O
talking O
releases O
more O
droplets O
than O
normal B-TERM
talking O
. O

A O
study B-TERM
in O
Singapore O
found O
that O
an O
uncovered O
cough O
can O
lead O
to O
droplets O
travelling O
up O
to O
4.5 O
meters O
( O
15 O
feet O
) O
. O

Though O
the O
virus O
is O
not O
generally O
airborne O
, O
the O
National O
Academy O
of O
Science O
has O
suggested O
that O
bioaerosol O
transmission O
may O
be O
possible B-TERM
and O
air B-TERM
collectors O
positioned O
in O
the O
hallway O
outside O
of O
people O
's O
rooms O
yielded O
samples O
positive O
for O
viral O
RNA O
. O

Some O
medical O
procedures O
such O
as O
intubation O
and O
cardiopulmonary O
resuscitation O
( O
CPR O
) O
may O
cause O
respiratory O
secretions O
to O
be O
aerosolised O
and O
thus O
result O
in O
airborne O
spread O
. O

While O
there O
are O
concerns O
it O
may O
spread O
via B-TERM
feces O
, O
this O
risk O
is O
believed O
to O
be O
low.The O
virus O
is O
most O
contagious O
when O
people O
are O
symptomatic O
; O
while O
spread O
may O
be O
possible O
before O
symptoms O
emerge O
, O
the O
risk O
is O
low O
. O

The O
European O
Centre O
for O
Disease B-TERM
Prevention O
and O
Control O
( O
ECDC O
) O
says O
while O
it O
is O
not O
entirely O
clear B-TERM
how O
easily O
the O
disease O
spreads O
, O
one O
person O
generally O
infects O
two O
to O
three O
others.The O
virus O
survives O
for O
hours O
to O
days O
on O
surfaces O
. O

Specifically O
, O
the O
virus O
was O
found O
to O
be O
detectable O
for O
one O
day O
on O
cardboard O
, O
for O
up O
to O
three O
days O
on O
plastic O
( O
polypropylene O
) O
and O
stainless O
steel O
( O
AISI O
304 O
) O
, O
and O
for O
up O
to O
four O
hours O
on O
99 O
% O
copper O
. O

This O
, O
however O
, O
varies O
depending O
on O
the O
humidity O
and O
temperature O
. O

Soap O
and O
detergent O
are O
also B-TERM
effective O
if O
correctly O
used O
; O
soap O
products O
degrade O
the O
virus O
' O
fatty O
protective O
layer O
, O
deactivating O
it O
, O
as O
well O
as O
freeing O
them O
from O
skin O
and O
other O
surfaces O
. O

Other O
solutions O
, O
such O
as O
benzalkonium O
chloride O
and O
chlorhexidine O
gluconate O
( O
a O
surgical O
disinfectant O
) O
, O
are O
less O
effective.In B-TERM
a O
Hong O
Kong O
study B-TERM
, O
saliva O
samples O
were O
taken O
a O
median O
of O
two B-TERM
days O
after O
the O
start O
of O
hospitalization O
. O

In O
five O
of O
six O
patients B-TERM
, O
the O
first O
sample O
showed O
the O
highest O
viral O
load O
, O
and O
the O
sixth O
patient B-TERM
showed O
the O
highest O
viral O
load O
on O
the O
second O
day O
tested O
. O

Severe O
acute O
respiratory O
syndrome O
coronavirus O
2 O
( O
SARS O
- O
CoV O
- O
2 O
) O
is O
a O
novel O
severe O
acute O
respiratory O
syndrome O
coronavirus O
, O
first O
isolated O
from O
three O
people O
with O
pneumonia O
connected O
to O
the O
cluster O
of O
acute O
respiratory O
illness B-TERM
cases O
in O
Wuhan O
. O

All O
features O
of O
the O
novel O
SARS O
- O
CoV O
- O
2 O
virus O
occur O
in O
related O
coronaviruses O
in O
nature B-TERM
. O

Outside O
the O
human O
body O
, O
the O
virus O
is O
killed O
by O
household O
soap O
, O
which O
bursts O
its O
protective O
bubble.SARS O
- O
CoV O
- O
2 O
is O
closely O
related O
to O
the O
original O
SARS O
- O
CoV O
. O

The O
lungs O
are O
the O
organs O
most O
affected O
by O
COVID O
- O
19 O
because O
the O
virus O
accesses O
host O
cells O
via B-TERM
the O
enzyme O
angiotensin O
- O
converting O
enzyme O
2 O
( O
ACE2 O
) O
, O
which O
is O
most O
abundant O
in O
the O
type B-TERM
II O
alveolar O
cells O
of O
the O
lungs O
. O

The O
virus O
uses O
a O
special O
surface O
glycoprotein O
called O
a O
" O
spike O
" O
( O
peplomer O
) O
to O
connect O
to O
ACE2 O
and O
enter O
the O
host O
cell O
. O

Acute O
cardiac O
injury O
was O
found O
in O
12 O
% O
of O
infected O
people O
admitted O
in O
hospital O
in O
Wuhan O
, O
China O
, O
and O
is O
more O
frequent O
in O
severe O
disease B-TERM
. O

Rates O
of O
cardiovascular O
symptoms O
is O
high O
, O
owing O
to O
the O
systemic O
inflammatory O
response B-TERM
and O
immune O
system O
disorders O
during O
disease B-TERM
progression O
, O
but O
acute O
myocardial O
injury O
may O
also B-TERM
be O
related O
to O
ACE2 O
receptors O
in O
the O
heart B-TERM
. O

ACE2 O
receptors O
are O
highly O
expressed O
in O
the O
heart B-TERM
and O
are O
involved O
in O
heart O
function O
. O

A O
high O
incidence O
of O
thrombosis O
( O
31 O
% O
) O
and O
venous O
thromboembolism O
( O
25 O
% O
) O
have O
been O
found O
in O
ICU O
patients B-TERM
with O
COVID O
- O
19 O
infections O
and O
may O
be O
related O
to O
poor O
prognosis.Autopsies O
of O
people O
who O
died O
of O
COVID O
- O
19 O
have O
found O
diffuse O
alveolar O
damage O
( O
DAD O
) O
, O
and O
lymphocyte O
- O
containing O
inflammatory O
infiltrates O
within O
the O
lung O
. O

Although O
SARS O
- O
COV O
- O
2 O
has O
a O
tropism O
for O
ACE2 O
- O
expressing O
epithelial O
cells O
of O
the O
respiratory O
tract O
, O
patients B-TERM
with O
severe O
COVID O
- O
19 O
have O
symptoms O
of O
systemic O
hyperinflammation O
. O

In O
particular O
, O
pathogenic O
GM O
- O
CSF O
- O
secreting O
T O
- O
cells O
were O
shown O
to O
correlate O
with O
the O
recruitment O
of O
inflammatory O
IL O
- O
6 O
- O
secreting O
monocytes O
and O
severe O
lung O
pathology O
in O
COVID O
- O
19 O
patients B-TERM
. O

Lymphocytic O
infiltrates O
have O
also B-TERM
been O
reported O
at O
autopsy B-TERM
. O

The O
WHO O
has O
published B-TERM
several O
testing O
protocols O
for O
the O
disease B-TERM
. O

The O
standard O
method B-TERM
of O
testing O
is O
real O
- O
time O
reverse O
transcription O
polymerase O
chain O
reaction O
( O
rRT O
- O
PCR O
) O
. O

The O
test O
is O
typically O
done O
on O
respiratory O
samples O
obtained O
by O
a O
nasopharyngeal O
swab O
; O
however O
, O
a O
nasal O
swab O
or O
sputum O
sample O
may O
also B-TERM
be O
used B-TERM
. O

Results B-TERM
are O
generally O
available O
within O
a O
few O
hours O
to O
two B-TERM
days O
. O

Blood O
tests O
can O
be O
used O
, O
but O
these O
require O
two B-TERM
blood B-TERM
samples O
taken O
two B-TERM
weeks O
apart O
and O
the O
results B-TERM
have O
little O
immediate O
value O
. O

Chinese O
scientists O
were O
able O
to O
isolate O
a O
strain O
of O
the O
coronavirus O
and O
publish B-TERM
the O
genetic O
sequence B-TERM
so O
laboratories O
across O
the O
world O
could O
independently O
develop O
polymerase O
chain O
reaction O
( O
PCR O
) O
tests O
to O
detect O
infection O
by O
the O
virus O
. O

As O
of O
4 O
April O
2020 O
, O
antibody O
tests O
( O
which O
may O
detect O
active O
infections O
and O
whether O
a O
person O
had O
been O
infected O
in O
the O
past O
) O
were O
in O
development O
, O
but O
not O
yet O
widely O
used O
. O

The O
Chinese O
experience O
with O
testing O
has O
shown B-TERM
the O
accuracy O
is O
only O
60 O
to O
70 O
% O
. O

The O
FDA O
in O
the O
United O
States O
approved O
the O
first O
point O
- O
of O
- O
care O
test O
on O
21 O
March O
2020 O
for O
use O
at O
the O
end B-TERM
of O
that O
month.Diagnostic O
guidelines O
released O
by O
Zhongnan O
Hospital O
of O
Wuhan O
University O
suggested O
methods B-TERM
for O
detecting O
infections O
based O
upon O
clinical O
features B-TERM
and O
epidemiological O
risk O
. O

Bilateral O
multilobar O
ground O
- O
glass O
opacities O
with O
a O
peripheral O
, O
asymmetric O
and O
posterior O
distribution O
are O
common O
in O
early O
infection O
. O

Subpleural O
dominance B-TERM
, O
crazy O
paving O
( O
lobular O
septal O
thickening O
with O
variable B-TERM
alveolar O
filling O
) O
, O
and O
consolidation O
may O
appear O
as O
the O
disease B-TERM
progresses O
. O

Few O
data B-TERM
are O
available O
about O
microscopic O
lesions O
and O
the O
pathophysiology O
of O
COVID O
- O
19 O
. O

The O
main B-TERM
pathological O
findings B-TERM
at O
autopsy B-TERM
are O
: O

Macroscopy O
: O
pleurisy O
, O
pericarditis O
, O
lung O
consolidation O
and O
pulmonary O
oedema O

Four O
types B-TERM
of O
severity O
of O
viral O
pneumonia O
can O
be O
observed O
: O

mild O
pneumonia O
: O
pulmonary O
oedema O
, O
pneumocyte O
hyperplasia O
, O
large O
atypical O
pneumocytes O
, O
interstitial O
inflammation O
with O
lymphocytic O
infiltration O
and O
multinucleated O
giant O
cell O
formation B-TERM

severe O
pneumonia O
: O
diffuse O
alveolar O
damage O
( O
DAD O
) O
with O
diffuse O
alveolar O
exudates O
. O

DAD O
is O
the O
cause O
of O
acute O
respiratory O
distress O
syndrome O
( O
ARDS O
) O
and O
severe O
hypoxemia O
. O

healing O
pneumonia O
: O
organisation B-TERM
of O
exudates O
in O
alveolar O
cavities O
and O
pulmonary O
interstitial O
fibrosis O

Blood B-TERM
: O
disseminated O
intravascular O
coagulation O
( O
DIC O
) O
; O
leukoerythroblastic O
reaction O

Preventive O
measures B-TERM
to O
reduce O
the O
chances O
of O
infection O
include O
staying O
at O
home B-TERM
, O
avoiding O
crowded O
places B-TERM
, O
washing O
hands O
with O
soap O
and O
water O
often O
and O
for O
at O
least O
20 O
seconds O
, O
practising O
good O
respiratory O
hygiene O
and O
avoiding O
touching O
the O
eyes B-TERM
, O
nose O
or O
mouth B-TERM
with O
unwashed O
hands O
. O

The O
CDC O
recommends O
covering O
the O
mouth B-TERM
and O
nose O
with O
a O
tissue O
when O
coughing O
or O
sneezing O
and O
recommends O
using O
the O
inside O
of O
the O
elbow O
if O
no O
tissue O
is O
available O
. O

Proper O
hand O
hygiene O
after O
any O
cough O
or O
sneeze O
is O
encouraged O
. O

The O
CDC O
has O
recommended O
the O
use B-TERM
of O
cloth O
face B-TERM
coverings O
in O
public O
settings O
, O
in O
part O
to O
limit O
transmission O
by O
asymptomatic O
individuals.Social O
distancing O
strategies O
aim B-TERM
to O
reduce O
contact O
of O
infected O
persons O
with O
large O
groups O
by O
closing O
schools O
and O
workplaces O
, O
restricting O
travel O
and O
cancelling O
large O
public O
gatherings O
. O

Distancing B-TERM
guidelines O
also B-TERM
include O
that O
people O
stay O
at O
least O
6 O
feet O
( O
1.8 O
m O
) O
apart O
. O

There O
is O
no O
medication O
known O
to O
be O
effective O
at O
preventing O
COVID O
- O
19.As O
a O
vaccine B-TERM
is O
not O
expected O
until O
2021 O
at O
the O
earliest O
, O
a O
key O
part O
of O
managing O
COVID O
- O
19 O
is O
trying O
to O
decrease B-TERM
the O
epidemic O
peak O
, O
known O
as O
" O
flattening O
the O
curve O
. O
" O

The O
CDC O
also B-TERM
recommends O
that O
individuals O
wash O
hands O
often B-TERM
with O
soap O
and O
water O
for O
at O
least O
20 O
seconds O
, O
especially B-TERM
after O
going O
to O
the O
toilet B-TERM
or O
when O
hands O
are O
visibly O
dirty O
, O
before O
eating O
and O
after O
blowing O
one O
's O
nose O
, O
coughing O
or O
sneezing O
. O

It O
further O
recommends O
using B-TERM
an O
alcohol B-TERM
- O
based O
hand O
sanitiser O
with O
at O
least O
60 O
% O
alcohol O
, O
but O
only O
when O
soap O
and O
water O
are O
not O
readily O
available.For O
areas O
where O
commercial O
hand O
sanitisers O
are O
not O
readily O
available O
, O
the O
WHO O
provides O
two B-TERM
formulations O
for O
local B-TERM
production O
. O

In O
these O
formulations O
, O
the O
antimicrobial O
activity B-TERM
arises O
from O
ethanol O
or O
isopropanol O
. O

Hydrogen O
peroxide O
is O
used O
to O
help O
eliminate O
bacterial O
spores O
in O
the O
alcohol B-TERM
; O
it O
is O
" O
not O
an O
active O
substance O
for O
hand O
antisepsis O
. O
" O

Glycerol O
is O
added O
as O
a O
humectant O
. O

People O
are O
managed O
with O
supportive O
care O
, O
which O
may O
include O
fluid O
therapy O
, O
oxygen O
support O
, O
and O
supporting O
other O
affected O
vital B-TERM
organs O
. O

The O
CDC O
recommends O
that O
those O
who O
suspect O
they O
carry O
the O
virus O
wear O
a O
simple O
face O
mask O
. O

Extracorporeal O
membrane O
oxygenation O
( O
ECMO O
) O
has O
been O
used O
to O
address B-TERM
the O
issue O
of O
respiratory O
failure O
, O
but O
its O
benefits O
are O
still O
under O
consideration O
. O

Personal B-TERM
hygiene O
and O
a O
healthy O
lifestyle O
and O
diet O
have O
been O
recommended O
to O
improve O
immunity O
. O

Supportive O
treatments O
may O
be O
useful O
in O
those O
with O
mild O
symptoms O
at O
the O
early O
stage B-TERM
of O
infection.The O
WHO O
and O
Chinese O
National O
Health O
Commission O
have O
published B-TERM
recommendations O
for O
taking O
care O
of O
people O
who O
are O
hospitalised O
with O
COVID O
- O
19 O
. O

Intensivists O
and O
pulmonologists O
in O
the O
U.S. O
have O
compiled O
treatment O
recommendations O
from O
various O
agencies O
into O
a O
free O
resource O
, O
the O
IBCC O
. O

As O
of O
April O
2020 O
, O
there O
is O
no O
specific O
treatment O
for O
COVID O
- O
19 O
. O

For O
symptoms O
, O
some O
medical O
professionals O
recommend O
paracetamol O
( O
acetaminophen O
) O
over O
ibuprofen O
for O
first O
- O
line B-TERM
use O
. O

Precautions O
must O
be O
taken B-TERM
to O
minimise O
the O
risk O
of O
virus O
transmission O
, O
especially B-TERM
in O
healthcare O
settings O
when O
performing O
procedures O
that O
can O
generate O
aerosols O
, O
such O
as O
intubation O
or O
hand O
ventilation O
. O

For O
healthcare O
professionals O
caring O
for O
people O
with O
COVID O
- O
19 O
, O
the O
CDC O
recommends O
placing O
the O
person O
in O
an O
Airborne O
Infection O
Isolation O
Room O
( O
AIIR O
) O
in O
addition O
to O
using O
standard O
precautions O
, O
contact O
precautions O
and O
airborne O
precautions.The O
CDC O
outlines O
the O
guidelines O
for O
the O
use O
of O
personal O
protective O
equipment O
( O
PPE O
) O
during O
the O
pandemic O
. O

The O
recommended O
gear O
is O
: O
PPE O
gown O
, O
respirator O
or O
facemask O
, O
eye B-TERM
protection O
, O
and O
medical O
gloves.When O
available O
, O
respirators O
( O
instead O
of O
facemasks O
) O
are O
preferred O
. O

N95 O
respirators O
are O
approved O
for O
industrial O
settings O
but O
the O
FDA O
has O
authorised O
the O
masks O
for O
use O
under O
an O
Emergency O
Use O
Authorisation O
( O
EUA O
) O
. O

They O
are O
designed O
to O
protect O
from O
airborne O
particles O
like B-TERM
dust O
but O
effectiveness B-TERM
against O
a O
specific O
biological O
agent O
is O
not O
guaranteed O
for O
off O
- O
label O
uses O
. O

When O
masks O
are O
not O
available O
, O
the O
CDC O
recommends O
using B-TERM
face O
shields O
or O
, O
as O
a O
last O
resort O
, O
homemade O
masks O
. O

Most O
cases O
of O
COVID O
- O
19 O
are O
not O
severe O
enough O
to O
require O
mechanical O
ventilation O
or O
alternatives O
, O
but O
a O
percentage O
of O
cases O
are O
. O

The O
type B-TERM
of O
respiratory O
support O
for O
individuals O
with O
COVID O
- O
19 O
related O
respiratory O
failure O
is O
being O
actively O
studied O
for O
people O
in O
hospital O
, O
with O
some O
evidence O
that O
intubation O
can O
be O
avoided O
with O
a O
high O
flow B-TERM
nasal O
cannula O
or O
bi O
- O
level O
positive O
airway O
pressure B-TERM
. O

Whether O
either B-TERM
of O
these O
two B-TERM
leads O
to O
the O
same O
benefit O
for O
people O
who O
are O
critically O
ill O
is O
not O
known O
. O

Some O
doctors O
prefer O
staying O
with O
invasive O
mechanical O
ventilation O
when O
available O
because O
this O
technique O
limits O
the O
spread O
of O
aerosol O
particles O
compared O
to O
a O
high O
flow O
nasal O
cannula.Severe O
cases O
are O
most O
common O
in O
older B-TERM
adults O
( O
those O
older O
than O
60 O
years O
, O
and O
especially O
those O
older O
than O
80 O
years O
) O
. O

Many O
developed O
countries O
do O
not O
have O
enough O
hospital O
beds O
per O
capita O
, O
which O
limits O
a O
health O
system O
's O
capacity O
to O
handle O
a O
sudden O
spike O
in O
the O
number B-TERM
of O
COVID O
- O
19 O
cases O
severe O
enough O
to O
require O
hospitalisation O
. O

One O
study B-TERM
in O
China O
found O
5 O
% O
were O
admitted O
to O
intensive O
care O
units O
, O
2.3 O
% O
needed O
mechanical O
support O
of O
ventilation O
, O
and O
1.4 O
% O
died O
. O

In O
China O
, O
approximately B-TERM
30 O
% O
of O
people O
in O
hospital O
with O
COVID O
- O
19 O
are O
eventually B-TERM
admitted O
to O
ICU O
. O

Mechanical O
ventilation O
becomes O
more O
complex O
as O
acute O
respiratory O
distress O
syndrome O
( O
ARDS O
) O
develops O
in O
COVID O
- O
19 O
and O
oxygenation O
becomes O
increasingly O
difficult O
. O

Ventilators O
capable O
of O
pressure B-TERM
control O
modes O
and O
high O
PEEP O
are O
needed B-TERM
to O
maximise O
oxygen O
delivery O
while O
minimising O
the O
risk O
of O
ventilator O
- O
associated O
lung O
injury O
and O
pneumothorax O
. O

High O
PEEP O
may O
not O
be O
available O
on O
older O
ventilators O
. O

Research O
into O
potential O
treatments O
started O
in O
January O
2020 O
, O
and O
several O
antiviral O
drugs O
are O
in O
clinical O
trials O
. O

Remdesivir O
appears O
to O
be O
the O
most O
promising O
. O

Although O
new O
medications O
may O
take O
until O
2021 O
to O
develop O
, O
several O
of O
the O
medications O
being O
tested O
are O
already O
approved O
for O
other O
uses O
or O
are O
already O
in O
advanced O
testing O
. O

Antiviral O
medication O
may O
be O
tried O
in O
people O
with O
severe O
disease B-TERM
. O

The O
WHO O
recommended O
volunteers O
take B-TERM
part O
in O
trials O
of O
the O
effectiveness B-TERM
and O
safety O
of O
potential O
treatments.The O
FDA O
has O
granted O
temporary O
authorisation O
to O
convalescent O
plasma O
as O
an O
experimental O
treatment O
in O
cases O
where O
the O
person O
's O
life O
is O
seriously O
or O
immediately O
threatened B-TERM
. O

It O
has O
not O
undergone O
the O
clinical O
studies B-TERM
needed O
to O
show O
it O
is O
safe O
and O
effective O
for O
the O
disease O
. O

In O
February O
2020 O
, O
China O
launched O
a O
mobile B-TERM
app O
to O
deal O
with O
the O
disease B-TERM
outbreak O
. O

Users O
are O
asked O
to O
enter O
their O
name B-TERM
and O
ID O
number O
. O

The O
app O
is O
able O
to O
detect O
' O
close O
contact O
' O
using O
surveillance B-TERM
data B-TERM
and O
therefore O
a O
potential O
risk O
of O
infection O
. O

Every O
user O
can O
also B-TERM
check O
the O
status B-TERM
of O
three O
other O
users O
. O

If O
a O
potential O
risk O
is O
detected O
, O
the O
app O
not O
only O
recommends O
self O
- O
quarantine O
, O
it O
also O
alerts O
local B-TERM
health O
officials.Big B-TERM
data B-TERM
analytics O
on O
cellphone O
data O
, O
facial O
recognition O
technology O
, O
mobile B-TERM
phone O
tracking O
and O
artificial O
intelligence O
are O
used O
to O
track O
infected O
people O
and O
people O
whom O
they O
contacted O
in O
South O
Korea O
, O
Taiwan O
and O
Singapore O
. O

In O
March O
2020 O
, O
the O
Israeli O
government O
enabled O
security O
agencies O
to O
track O
mobile B-TERM
phone O
data B-TERM
of O
people O
supposed O
to O
have O
coronavirus O
. O

The O
measure B-TERM
was O
taken B-TERM
to O
enforce O
quarantine O
and O
protect O
those O
who O
may O
come O
into O
contact O
with O
infected O
citizens O
. O

Also B-TERM
in O
March O
2020 O
, O
Deutsche O
Telekom O
shared O
aggregated O
phone O
location O
data B-TERM
with O
the O
German O
federal O
government O
agency O
, O
Robert O
Koch O
Institute O
, O
in O
order O
to O
research O
and O
prevent O
the O
spread O
of O
the O
virus O
. O

Russia O
deployed O
facial O
recognition O
technology O
to O
detect O
quarantine O
breakers O
. O

Italian O
regional B-TERM
health O
commissioner O
Giulio O
Gallera O
said O
he O
has O
been O
informed B-TERM
by O
mobile O
phone O
operators O
that O
" O
40 O
% O
of O
people O
are O
continuing O
to O
move B-TERM
around O
anyway O
. O
" O

German O
government O
conducted O
a O
48 O
hours O
weekend O
hackathon O
with O
more O
than O
42.000 O
participants O
. O

Also B-TERM
the O
president O
of O
Estonia O
, O
Kersti O
Kaljulaid O
, O
made O
a O
global O
call O
for O
creative O
solutions O
against O
the O
spread O
of O
coronavirus O
. O

Individuals O
may O
experience O
distress O
from O
quarantine O
, O
travel B-TERM
restrictions O
, O
side O
effects O
of O
treatment O
or O
fear B-TERM
of O
the O
infection O
itself O
. O

BBC O
quoted O
Rory O
O O
'Connor O
in O
saying O
, O
" O
Increased O
social O
isolation O
, O
loneliness O
, O
health O
anxiety B-TERM
, O
stress O
and O
an O
economic O
downturn O
are O
a O
perfect B-TERM
storm O
to O
harm O
people O
's O
mental O
health O
and O
wellbeing O
. O
" O

The O
disease O
may O
take O
a O
mild O
course O
with O
few O
or O
no O
symptoms O
, O
resembling O
other O
common O
upper O
respiratory O
diseases B-TERM
such O
as O
the O
common O
cold O
. O

Mild O
cases O
typically O
recover O
within O
two B-TERM
weeks O
, O
while O
those O
with O
severe O
or O
critical O
diseases B-TERM
may O
take O
three O
to O
six O
weeks O
to O
recover O
. O

Pregnant O
women O
may O
be O
at O
higher O
risk O
for O
severe O
infection O
with O
COVID O
- O
19 O
based O
on O
data B-TERM
from O
other O
similar O
viruses O
, O
like O
SARS O
and O
MERS O
, O
but O
data B-TERM
for O
COVID O
- O
19 O
is O
lacking.In O
some O
people O
, O
COVID O
- O
19 O
may O
affect O
the O
lungs O
causing O
pneumonia O
. O

In O
those O
most O
severely O
affected O
, O
COVID O
- O
19 O
may O
rapidly O
progress O
to O
acute O
respiratory O
distress O
syndrome O
( O
ARDS O
) O
causing O
respiratory O
failure O
, O
septic O
shock O
or O
multi O
- O
organ O
failure O
. O

Complications B-TERM
associated O
with O
COVID O
- O
19 O
include O
sepsis O
, O
abnormal B-TERM
clotting O
and O
damage O
to O
the O
heart B-TERM
, O
kidneys O
and O
liver O
. O

Clotting O
abnormalities O
, O
specifically O
an O
increase B-TERM
in O
prothrombin O
time O
, O
have O
been O
described O
in O
6 O
% O
of O
those O
admitted O
to O
hospital O
with O
COVID O
- O
19 O
, O
while O
abnormal O
kidney O
function B-TERM
is O
seen O
in O
4 O
% O
of O
this O
group O
. O

Approximately B-TERM
20 O
- O
30 O
% O
of O
people O
who O
present O
with O
COVID O
- O
19 O
demonstrate O
elevated O
liver O
enzymes O
( O
transaminases O
) O
. O

According O
to O
the O
same O
report O
, O
the O
median O
time O
between O
onset O
of O
symptoms O
and O
death O
was O
ten O
days O
, O
with O
five O
being O
spent O
hospitalised O
. O

However O
, O
patients B-TERM
transferred O
to O
an O
ICU O
had O
a O
median O
time O
of O
seven O
days O
between O
hospitalisation O
and O
death O
. O

In O
a O
study B-TERM
of O
early O
cases O
, O
the O
median O
time O
from O
exhibiting O
initial O
symptoms O
to O
death O
was O
14 O
days O
, O
with O
a O
full O
range O
of O
six O
to O
41 O
days O
. O

In O
a O
study B-TERM
by O
the O
National O
Health O
Commission O
( O
NHC O
) O
of O
China O
, O
men O
had O
a O
death O
rate O
of O
2.8 O
% O
while O
women O
had O
a O
death O
rate O
of O
1.7 O
% O
. O

Histopathological O
examinations B-TERM
of O
post O
- O
mortem O
lung O
samples O
show O
diffuse O
alveolar O
damage O
with O
cellular O
fibromyxoid O
exudates O
in O
both O
lungs O
. O

Viral O
cytopathic O
changes B-TERM
were O
observed O
in O
the O
pneumocytes O
. O

The O
lung O
picture O
resembled B-TERM
acute O
respiratory O
distress O
syndrome O
( O
ARDS O
) O
. O

In O
11.8 O
% O
of O
the O
deaths O
reported O
by O
the O
National O
Health O
Commission O
of O
China O
, O
heart B-TERM
damage O
was O
noted O
by O
elevated O
levels O
of O
troponin O
or O
cardiac O
arrest O
. O

According O
to O
March O
data B-TERM
from O
the O
United B-TERM
States O
, O
89 O
% O
of O
those O
hospitalised O
had O
preexisting O
conditions.Availability O
of O
medical O
resources O
and O
the O
socioeconomics O
of O
a O
region B-TERM
may O
also B-TERM
affect O
mortality O
. O

Estimates O
of O
the O
mortality O
from O
the O
condition O
vary O
because O
of O
those O
regional B-TERM
differences B-TERM
, O
but O
also B-TERM
because O
of O
methodological O
difficulties O
. O

The O
under O
- O
counting O
of O
mild O
cases O
can O
cause O
the O
mortality O
rate O
to O
be O
overestimated O
. O

However O
, O
the O
fact O
that O
deaths O
are O
the O
result B-TERM
of O
cases O
contracted O
in O
the O
past O
can O
mean B-TERM
the O
current B-TERM
mortality O
rate O
is O
underestimated O
. O

Smokers O
were O
1.4 O
times O
more O
likely O
to O
have O
severe O
symptoms O
of O
COVID O
- O
19 O
and O
approximately O
2.4 O
times O
more O
likely O
to O
require O
intensive O
care O
or O
die O
compared O
to O
non O
- O
smokers.Concerns O
have O
been O
raised O
about O
long O
- O
term O
sequelae O
of O
the O
disease O
. O

The O
Hong O
Kong O
Hospital O
Authority O
found O
a O
drop O
of O
20 O
% O
to O
30 O
% O
in O
lung O
capacity O
in O
some O
people O
who O
recovered O
from O
the O
disease B-TERM
, O
and O
lung O
scans O
suggested O
organ O
damage O
. O

This O
may O
also B-TERM
lead O
to O
post O
- O
intensive O
care O
syndrome O
following B-TERM
recovery O
. O

As O
of O
March O
2020 O
, O
it O
was O
unknown O
if O
past O
infection O
provides O
effective O
and O
long O
- O
term O
immunity O
in O
people O
who O
recover O
from O
the O
disease O
. O

Immunity O
is O
seen O
as O
likely O
, O
based O
on O
the O
behaviour O
of O
other O
coronaviruses O
, O
but O
cases O
in O
which O
recovery O
from O
COVID O
- O
19 O
have O
been O
followed B-TERM
by O
positive O
tests O
for O
coronavirus O
at O
a O
later O
date O
have O
been O
reported O
. O

These O
cases O
are O
believed O
to O
be O
worsening O
of O
a O
lingering O
infection O
rather O
than O
re O
- O
infection O
. O

The O
virus O
is O
thought O
to O
be O
natural B-TERM
and O
have O
an O
animal O
origin O
, O
through O
spillover O
infection O
. O

The O
actual O
origin O
is O
unknown O
, O
but O
by O
December O
2019 O
the O
spread O
of O
infection O
was O
almost O
entirely O
driven O
by O
human O
- O
to O
- O
human O
transmission O
. O

A O
study B-TERM
of O
the O
first O
41 O
cases O
of O
confirmed O
COVID O
- O
19 O
, O
published B-TERM
in O
January O
2020 O
in O
The O
Lancet O
, O
revealed O
the O
earliest O
date O
of O
onset O
of O
symptoms O
as O
1 O
December O
2019 O
. O

Official O
publications O
from O
the O
WHO O
reported O
the O
earliest O
onset O
of O
symptoms O
as O
8 O
December O
2019 O
. O

Several O
measures O
are O
commonly O
used O
to O
quantify O
mortality O
. O

These O
numbers O
vary O
by O
region B-TERM
and O
over O
time O
and O
are O
influenced O
by O
the O
volume O
of O
testing O
, O
healthcare O
system O
quality B-TERM
, O
treatment O
options O
, O
time O
since O
initial O
outbreak O
and O
population O
characteristics O
such O
as O
age O
, O
sex O
and O
overall O
health O
. O

In O
late O
2019 O
, O
WHO O
assigned O
the O
emergency O
ICD O
- O
10 O
disease B-TERM
codes O
U07.1 O
for O
deaths O
from O
lab O
- O
confirmed O
SARS O
- O
CoV O
- O
2 O
infection O
and O
U07.2 O
for O
deaths O
from O
clinically O
or O
epidemiologically O
diagnosed O
COVID O
- O
19 O
without O
lab O
- O
confirmed O
SARS O
- O
CoV O
- O
2 O
infection.The O
death O
- O
to O
- O
case O
ratio O
reflects O
the O
number B-TERM
of O
deaths O
divided B-TERM
by O
the O
number B-TERM
of O
diagnosed O
cases O
within O
a O
given O
time O
interval O
. O

Based O
on O
Johns O
Hopkins O
University O
statistics O
, O
the O
global O
death O
- O
to O
- O
case O
ratio O
is O
6.9 O
% O
( O
153,822 O
/ O
2,240,191 O
) O
as O
of O
17 O
April O
2020 O
. O

The O
number O
varies O
by O
region.Other O
measures O
include O
the O
case O
fatality O
rate O
( O
CFR O
) O
, O
which O
reflects O
the O
percent O
of O
diagnosed O
individuals O
who O
die O
from O
a O
disease B-TERM
, O
and O
the O
infection O
fatality O
rate O
( O
IFR O
) O
, O
which O
reflects O
the O
percent O
of O
infected O
individuals O
( O
diagnosed O
and O
undiagnosed O
) O
who O
die O
from O
a O
disease B-TERM
. O

These O
statistics O
are O
not O
time O
bound O
and O
follow O
a O
specific O
population O
from O
infection O
through O
case O
resolution O
. O

While O
not O
all O
infected O
people O
develop O
antibodies O
, O
the O
presence B-TERM
of O
antibodies O
may O
provide O
information O
about O
how O
many O
people O
have O
been O
infected O
. O

In O
the O
epicentre O
of O
the O
outbreak O
in O
Italy O
, O
Castiglione O
d O
'Adda O
, O
a O
small B-TERM
village O
of O
4600 O
, O
80 O
( O
1.7 O
% O
) O
are O
already O
dead O
. O

In O
Gangelt O
, O
the O
disease B-TERM
was O
spread O
by O
Carnival O
festivals O
, O
and O
spread O
to O
younger O
people O
, O
causing B-TERM
a O
relatively O
lower O
mortality O
, O
and O
not O
all O
COVID O
- O
19 O
deaths O
may O
have O
been O
formally O
classified O
as O
such O
. O

Furthermore O
, O
the O
German O
health O
system O
has O
not O
been O
overwhelmed O
. O

In O
the O
Netherlands O
, O
about O
3 O
% O
may O
have O
antibodies O
, O
as O
assessed O
from O
blood B-TERM
donors O
. O

69 O
( O
0.004 O
% O
of O
the O
population O
) O
have O
been O
confirmed O
to O
have O
died O
from O
COVID O
- O
19 O
. O

The O
impact B-TERM
of O
the O
pandemic O
and O
its O
mortality O
rate O
are O
different O
for O
men O
and O
women O
. O

Mortality O
is O
higher O
in O
men O
in O
studies B-TERM
conducted O
in O
China O
and O
Italy O
. O

The O
highest O
risk O
for O
men O
is O
in O
their O
50s O
, O
with O
the O
gap O
between O
men O
and O
women O
closing O
only O
at O
90 O
. O

In O
China O
, O
the O
death O
rate O
was O
2.8 O
percent O
for O
men O
and O
1.7 O
percent O
for O
women O
. O

The O
exact O
reasons O
for O
this O
sex O
- O
difference O
is O
not O
known O
, O
but O
genetic O
and O
behavioural O
factors O
could O
be O
a O
reason O
. O

Sex O
- O
based O
immunological O
differences B-TERM
, O
lesser O
prevalence O
of O
smoking O
in O
women O
and O
men O
developing O
co O
- O
morbid O
conditions O
such O
as O
hypertension O
at O
a O
younger O
age O
than O
women O
could O
have O
contributed O
to O
the O
higher O
mortality O
in O
men O
. O

In O
Europe O
, O
57 O
% O
of O
the O
infected O
individuals O
were O
men O
and O
72 O
% O
of O
those O
died O
with O
COVID O
- O
19 O
were O
men O
. O

As O
of O
April O
2020 O
, O
the O
US O
government O
is O
not O
tracking O
sex O
- O
related O
data O
of O
COVID O
- O
19 O
infections O
. O

Research O
has O
shown B-TERM
that O
viral O
illnesses B-TERM
like B-TERM
Ebola O
, O
HIV O
, O
influenza O
and O
SARS O
affect O
men O
and O
women O
differently O
. O

A O
higher O
percentage O
of O
health O
workers O
, O
particularly B-TERM
nurses O
, O
are O
women O
, O
and O
they O
have O
a O
higher O
chance O
of O
being O
exposed O
to O
the O
virus O
. O

The O
World O
Health O
Organization B-TERM
announced B-TERM
on O
11 O
February O
2020 O
that O
the O
official O
name B-TERM
of O
the O
disease B-TERM
would O
be O
" O
COVID O
- O
19 O
. O
" O

WHO O
chief O
Tedros O
Adhanom O
Ghebreyesus O
explained O
that O
CO O
stands O
for O
corona O
, O
VI O
for O
virus O
, O
D O
for O
disease B-TERM
, O
and O
19 O
for O
when O
the O
outbreak O
was O
first O
identified O
: O
31 O
December O
2019 O
. O

The O
name B-TERM
had O
been O
chosen B-TERM
to O
avoid O
references O
to O
a O
specific O
geographical O
location B-TERM
( O
e.g. O
China O
) O
, O
animal B-TERM
species O
or O
group O
of O
people O
, O
in O
line O
with O
international O
recommendations O
for O
naming O
aimed O
at O
preventing O
stigmatisation.The O
virus O
that O
causes B-TERM
COVID O
- O
19 O
is O
named O
severe O
acute O
respiratory O
syndrome O
coronavirus O
2 O
( O
SARS O
- O
CoV O
- O
2 O
) O
. O

The O
WHO O
additionally O
uses B-TERM
" O
the O
COVID O
- O
19 O
virus O
" O
and O
" O
the O
virus O
responsible O
for O
COVID O
- O
19 O
" O
in O
public O
communications O
. O

Both O
the O
disease B-TERM
and O
virus O
are O
commonly O
referred B-TERM
to O
as O
" O
coronavirus O
. O
" O

During O
the O
initial O
outbreak O
in O
Wuhan O
, O
China O
, O
the O
virus O
and O
disease B-TERM
were O
commonly O
referred B-TERM
to O
as O
" O
coronavirus O
" O
and O
" O
Wuhan O
coronavirus O
. O
" O

In O
January O
2020 O
, O
WHO O
recommended O
2019 O
- O
nCov O
and O
2019 O
- O
nCoV O
acute O
respiratory O
disease B-TERM
as O
interim O
names O
for O
the O
virus O
and O
disease B-TERM
in O
accordance O
with O
2015 O
guidance O
against O
using B-TERM
locations O
in O
disease B-TERM
and O
virus O
names B-TERM
. O

The O
official O
names B-TERM
COVID O
- O
19 O
and O
SARS O
- O
CoV O
- O
2 O
were O
issued O
on O
11 O
February O
2020 O
. O

Due O
to O
capacity O
limitations O
in O
the O
standard O
supply O
chains O
, O
some O
digital O
manufacturers O
are O
printing O
healthcare O
material B-TERM
such O
as O
nasal O
swabs O
and O
ventilator O
parts O
. O

In O
one O
example O
, O
when O
an O
Italian O
hospital O
urgently O
required O
a O
ventilator O
valve O
, O
and O
the O
supplier O
was O
unable O
to O
deliver O
in O
the O
timescale O
required O
, O
a O
local B-TERM
startup O
reverse O
- O
engineered O
and O
printed O
the O
required O
100 O
valves O
overnight O
. O

After O
the O
initial O
outbreak O
of O
COVID O
- O
19 O
, O
conspiracy O
theories O
, O
misinformation O
and O
disinformation O
emerged O
regarding O
the O
origin O
, O
scale O
, O
prevention O
, O
treatment O
and O
other O
aspects O
of O
the O
disease O
and O
rapidly O
spread O
online O
. O

Humans O
appear O
to O
be O
capable O
of O
spreading O
the O
virus O
to O
some O
other O
animals B-TERM
. O

The O
study B-TERM
failed O
to O
find O
evidence O
of O
viral O
replication O
in O
pigs O
, O
ducks O
, O
and O
chickens O
. O

No O
medications O
or O
vaccine B-TERM
is O
approved O
to O
treat O
the O
disease O
. O

International O
research O
on O
vaccines B-TERM
and O
medicines O
in O
COVID O
- O
19 O
are O
underway O
by O
government O
organisations B-TERM
, O
academic O
groups O
and O
industry O
researchers O
. O

In O
March O
, O
the O
World O
Health O
Organization O
initiated O
the O
" O
SOLIDARITY O
Trial O
" O
to O
assess O
treatment O
effects O
of O
four O
existing O
antiviral O
compounds O
with O
the O
most O
promise O
of O
efficacy O
. O

There O
is O
no O
available O
vaccine B-TERM
, O
but O
various O
agencies O
are O
actively O
developing O
vaccine B-TERM
candidates O
. O

Previous B-TERM
work O
on O
SARS O
- O
CoV O
is O
being O
utilised O
because O
SARS O
- O
CoV O
and O
SARS O
- O
CoV O
- O
2 O
both O
use O
the O
ACE2 O
receptor O
to O
enter O
human O
cells O
. O

There O
are O
three O
vaccination B-TERM
strategies O
being O
investigated O
. O

First O
, O
researchers O
aim O
to O
build O
a O
whole O
virus O
vaccine B-TERM
. O

The O
use O
of O
such O
a O
virus O
, O
be O
it O
inactive O
or O
dead O
, O
aims O
to O
elicit O
a O
prompt O
immune O
response B-TERM
of O
the O
human O
body O
to O
a O
new O
infection O
with O
COVID O
- O
19 O
. O

A O
second O
strategy O
, O
subunit O
vaccines B-TERM
, O
aims O
to O
create O
a O
vaccine B-TERM
that O
sensitises O
the O
immune O
system O
to O
certain O
subunits O
of O
the O
virus O
. O

In O
the O
case O
of O
SARS O
- O
CoV O
- O
2 O
, O
such O
research O
focuses O
on O
the O
S O
- O
spike O
protein B-TERM
that O
helps B-TERM
the O
virus O
intrude O
the O
ACE2 O
enzyme O
receptor O
. O

A O
third O
strategy O
is O
that O
of O
the O
nucleic O
acid O
vaccines B-TERM
( O
DNA O
or O
RNA O
vaccines B-TERM
, O
a O
novel O
technique O
for O
creating O
a O
vaccination O
) O
. O

Experimental O
vaccines B-TERM
from O
any O
of O
these O
strategies O
would O
have O
to O
be O
tested O
for O
safety O
and O
efficacy.On O
16 O
March O
2020 O
, O
the O
first O
clinical O
trial O
of O
a O
vaccine B-TERM
started O
with O
four O
volunteers O
in O
Seattle O
. O

The O
vaccine B-TERM
contains O
a O
harmless O
genetic O
code O
copied O
from O
the O
virus O
that O
causes B-TERM
the O
disease.Antibody B-TERM
dependent O
enhancement O
has O
been O
suggested O
as O
a O
potential O
challenge B-TERM
for O
vaccine O
development O
for O
SARS O
- O
COV O
- O
2 O
, O
but O
this O
is O
controversial O
. O

There O
are O
more O
than O
300 O
active B-TERM
clinical O
trials O
underway O
as O
of O
April O
2020 O
. O

Seven O
trials O
were O
evaluating O
already O
approved O
treatments O
for O
malaria O
, O
including O
four O
studies B-TERM
on O
hydroxychloroquine O
or O
chloroquine O
. O

Repurposed O
antiviral O
drugs O
make O
up O
most O
of O
the O
Chinese O
research O
, O
with O
nine O
phase O
III O
trials O
on O
remdesivir O
across O
several O
countries O
due O
to O
report O
by O
the O
end B-TERM
of O
April O
. O

A O
dynamic O
review O
of O
clinical O
development O
for O
COVID O
- O
19 O
vaccine B-TERM
and O
drug O
candidates O
was O
in O
place O
, O
as O
of O
April O
2020.Several O
existing O
antiviral O
medications O
are O
being O
evaluated O
for O
treatment O
of O
COVID O
- O
19 O
, O
including O
remdesivir O
, O
chloroquine O
and O
hydroxychloroquine O
, O
lopinavir O
/ O
ritonavir O
and O
lopinavir O
/ O
ritonavir O
combined B-TERM
with O
interferon O
beta O
. O

There O
is O
tentative O
evidence O
for O
efficacy O
by O
remdesivir O
, O
as O
of O
March O
2020 O
. O

Clinical O
improvement B-TERM
was O
observed O
in O
patients B-TERM
treated O
with O
compassionate O
- O
use O
remdesivir O
. O

Phase O
III O
clinical O
trials O
are O
being O
conducted O
in O
the O
US O
, O
China O
and O
Italy.Chloroquine O
, O
previously O
used O
to O
treat O
malaria O
, O
was O
studied O
in O
China O
in O
February O
2020 O
, O
with O
preliminary O
results B-TERM
. O

However O
, O
there O
are O
calls O
for O
peer O
review O
of O
the O
research O
. O

Korean O
and O
Chinese O
Health O
Authorities O
recommend O
the O
use B-TERM
of O
chloroquine O
. O

However O
, O
the O
Wuhan O
Institute O
of O
Virology O
, O
while O
recommending O
a O
daily O
dose O
of O
one O
gram O
, O
notes O
that O
twice O
that O
dose O
is O
highly B-TERM
dangerous O
and O
could O
be O
lethal B-TERM
. O

On O
28 O
March O
2020 O
, O
the O
FDA O
issued O
an O
emergency O
use O
authorisation O
for O
hydroxychloroquine O
and O
chloroquine O
at O
the O
discretion O
of O
physicians O
treating O
people O
with O
COVID O
- O
19.The O
Chinese O
7th O
edition O
guidelines O
also B-TERM
include O
interferon O
, O
ribavirin O
or O
umifenovir O
for O
use O
against O
COVID O
- O
19 O
. O

Preliminary O
data B-TERM
indicate B-TERM
that O
high O
doses O
of O
ribavirin O
are O
necessary B-TERM
to O
inhibit O
SARS O
- O
CoV O
- O
2 O
in O
vitro O
. O

Nitazoxanide O
has O
been O
recommended O
for O
further O
in O
vivo O
study B-TERM
after O
demonstrating O
low O
concentration O
inhibition O
of O
SARS O
- O
CoV O
- O
2.Studies O
have O
demonstrated O
that O
initial O
spike O
protein O
priming O
by O
transmembrane O
protease O
serine O
2 O
( O
TMPRSS2 O
) O
is O
essential O
for O
entry O
of O
SARS O
- O
CoV O
- O
2 O
via B-TERM
interaction O
with O
the O
ACE2 O
receptor O
. O

The O
studies O
of O
chloroquine O
and O
hydroxychloroquine O
with O
or O
without O
azithromycin O
have O
major O
limitations O
that O
have O
prevented O
the O
medical O
community O
from O
embracing O
these O
therapies O
without O
further O
study.Oseltamivir O
does O
not O
inhibit O
SARS O
- O
CoV O
- O
2 O
in O
vitro O
and O
has O
no O
known O
role O
in O
COVID O
- O
19 O
treatment O
. O

Cytokine O
storm O
can O
be O
a O
complication B-TERM
in O
the O
later O
stages B-TERM
of O
severe O
COVID O
- O
19 O
. O

There O
is O
evidence O
that O
hydroxychloroquine O
may O
have O
anti O
- O
cytokine O
storm O
properties.Tocilizumab O
has O
been O
included O
in O
treatment O
guidelines O
by O
China O
's O
National O
Health O
Commission O
after O
a O
small B-TERM
study B-TERM
was O
completed O
. O

It O
is O
undergoing O
a O
phase O
2 O
non O
randomised O
test O
at O
the O
national O
level O
in O
Italy O
after O
showing O
positive O
results B-TERM
in O
people O
with O
severe O
disease B-TERM
. O

Combined B-TERM
with O
a O
serum O
ferritin O
blood B-TERM
test O
to O
identify O
cytokine O
storms B-TERM
, O
it O
is O
meant O
to O
counter O
such O
developments O
, O
which O
are O
thought O
to O
be O
the O
cause O
of O
death O
in O
some O
affected O
people O
. O

The O
interleukin O
- O
6 O
receptor O
antagonist O
was O
approved O
by O
the O
FDA O
based O
on O
retrospective O
case O
studies B-TERM
for O
treatment O
of O
steroid O
refractory O
cytokine O
release O
syndrome O
induced O
by O
a O
different O
cause B-TERM
, O
CAR O
T O
cell O
therapy O
, O
in O
2017 O
. O

To O
date O
, O
there O
is O
no O
randomised O
, O
controlled O
evidence O
that O
tocilizumab O
is O
an O
efficacious O
treatment O
for O
CRS O
. O

Transferring O
purified O
and O
concentrated O
antibodies O
produced O
by O
the O
immune O
systems O
of O
those O
who O
have O
recovered O
from O
COVID O
- O
19 O
to O
people O
who O
need O
them O
is O
being O
investigated O
as O
a O
non O
- O
vaccine O
method B-TERM
of O
passive O
immunisation O
. O

This O
strategy O
was O
tried O
for O
SARS O
with O
inconclusive O
results B-TERM
. O

Viral O
neutralisation O
is O
the O
anticipated O
mechanism O
of O
action O
by O
which O
passive O
antibody O
therapy O
can O
mediate O
defence B-TERM
against O
SARS O
- O
CoV O
- O
2 O
. O

Other O
mechanisms O
however O
, O
such O
as O
antibody O
- O
dependent O
cellular O
cytotoxicity O
and O
/ O
or O
phagocytosis O
, O
may O
be O
possible O
. O

Other O
forms O
of O
passive O
antibody O
therapy O
, O
for O
example O
, O
using O
manufactured O
monoclonal O
antibodies O
, O
are O
in O
development O
. O

Production O
of O
convalescent O
serum O
, O
which O
consists O
of O
the O
liquid O
portion B-TERM
of O
the O
blood B-TERM
from O
recovered O
patients B-TERM
and O
contains O
antibodies O
specific O
to O
this O
virus O
, O
could O
be O
increased O
for O
quicker O
deployment O
. O

Coronavirus O
diseases B-TERM
, O
a O
group O
of O
closely O
related O
syndromes O

Li O
Wenliang O
, O
a O
doctor B-TERM
at O
Central O
Hospital O
of O
Wuhan O
, O
who O
later O
contracted O
and O
died O
of O
COVID O
- O
19 O
after O
raising O
awareness O
of O
the O
spread O
of O
the O
virus O
. O

Court O
sentences O
author O
of O
joke O
petition O
on O
accession O
of O
Latvia O
to O
US O

The O
court O
of O
the O
Vidzeme O
Suburb O
of O
Riga O
has O
sentenced O
the O
author O
of O
a O
joke O
petition O
on O
the O
accession O
of O
Latvia O
to O
the O
United O
States O
of O
America O
, O
Denis O
Bartetsky O
. O

The O
man O
was O
given O
80 O
hours O
of O
correctional O
labor O
and O
one O
year O
of O
probation O
. O

" O
Common O
sense O
isn O
't O
the O
strongest B-TERM
side O
of O
our O
system O
, O
" O
Bartetsky O
commmented O
on O
the O
court O
's O
decision B-TERM
. O

He O
also B-TERM
added B-TERM
that O
the O
punishment O
is O
usually O
less O
than O
requested O
. O

The O
collection O
of O
signatures O
on O
the O
accession O
of O
Latvia O
to O
the O
US O
was O
organized O
in O
2016 O
. O

Meanwhile O
, O
simultaneously O
with O
this O
petition O
, O
the O
site O
also O
collected O
signatures O
on O
the O
accession O
of O
Latvia O
to O
the O
" O
Galactic O
Empire O
" O
and O
on O
the O
country O
's O
exit O
from O
the O
solar O
system O
and O
the O
Milky O
Way O
. O

A O
criminal O
case O
was O
initiated O
against O
Batetsky O
article O
82 O
, O
paragraph O
1 O
of O
the O
country O
's O
criminal B-TERM
code O
- O
" O
A O
public O
apeal O
to O
undermine O
the O
territorial O
integrity O
of O
the O
Latvian O
Republic O
. O
" O

Previously O
, O
the O
author O
of O
an O
internet O
petition O
on O
the O
accession O
of O
Latvia O
to O
Russia O
received B-TERM
half O
a O
year O
in O
prison O
in O
2016 O
. O

A O
Japanese O
airliner O
has O
made O
an O
emergency O
landing O
in O
Khabarovsk O

TASS O
is O
reporting O
that O
a O
Boeing O
flying O
from O
Austria O
to O
Japan O
has O
made O
an O
emergency O
landing O
at O
Khabarovsk O
airport O
. O

There O
were O
206 O
people O
, O
including O
12 O
crew B-TERM
members O
, O
on O
board O
the O
airliner O
owned O
by O
the O
Japanese O
company B-TERM
ANA–ù O
. O

It O
has O
been O
reported O
that O
nobody O
was O
hurt O
. O

Another B-TERM
aircraft O
has O
taken O
off O
from O
Tokyo O
to O
collect O
the O
people O
. O

A O
spokesperson O
for O
Khabarovsk O
airport O
told O
the O
agency O
that O
the O
incident O
was O
caused O
by O
a O
drop O
in O
oil O
pressure B-TERM
in O
one O
of O
the O
aircraft O
's O
engines B-TERM
. O

It O
was O
previously O
reported O
that O
an O
airplane O
flying O
from O
Zhukovsky O
airport O
outside O
Moscow O
to O
Kyrgyzstan O
made O
an O
emergency O
landing O
at O
Samara O
airport O
due O
to O
a O
sick O
child O
on O
board O
. O

Russian O
Ministry O
of O
Internal O
Affairs O
proposes O
punishment O
for O
insulting O
the O
police O
online O

The O
Russian O
Ministry O
of O
Internal O
Affairs O
has O
prepared O
amendments O
to O
the O
law O
" O
On O
the O
Police B-TERM
, O
" O
aimed B-TERM
at O
protecting B-TERM
officers O
from O
the O
spread O
of O
slanderous O
and O
defamatory O
information B-TERM
on O
the O
internet O
. O

On O
Friday O
, O
an O
application O
for O
public O
discussion B-TERM
of O
the O
bill O
appeared O
on O
the O
federal O
portal O
of O
normative O
legal B-TERM
acts O
, O
while O
the O
draft B-TERM
document O
itself O
has O
not O
yet O
been O
published B-TERM
. O

The O
document O
's O
explanatory O
memo O
notes O
that O
it O
is O
being O
developed O
in O
connection O
with O
the O
need O
to O
protect O
the O
honor B-TERM
and O
dignity O
of O
police O
officers O
from O
" O
the O
spread O
of O
information O
of O
a O
defamatory O
nature O
, O
including O
that O
of O
a O
discrediting O
nature O
, O
in O
information O
and O
communication O
networks O
, O
including O
on O
the O
internet O
. O
" O

It O
is O
not O
specified O
how O
exactly B-TERM
it O
intends O
to O
protect B-TERM
the O
police O
from O
slander O
online O
. O

At O
the O
same O
time O
, O
the O
explanation O
on O
the O
document O
notes O
that O
the O
provisions O
of O
the O
amendments O
will O
be O
applied O
" O
by O
individualizing O
the O
mechanism O
" O
already O
provided O
for O
by O
the O
law O
on O
blocking O
posts O
offending O
government O
officials O
and O
the O
law O
on O
fines O
for O
such O
posts O
. O

Both O
laws O
came O
into O
effect O
in O
March O
of O
this O
year O
. O

The O
final O
text O
of O
the O
bill O
will O
be O
published B-TERM
after O
the O
public O
discussions B-TERM
and O
an O
independent O
anti O
- O
corruption O
review O
. O

According O
to O
the O
explanatory O
memo O
, O
the O
amendments O
to O
the O
law O
" O
On O
the O
Police B-TERM
" O
should O
come O
into O
force O
in O
January O
2020 O
. O

On O
March O
18 O
, O
President O
Vladimir O
Putin O
signed O
a O
law O
on O
punishment O
for O
" O
explicit B-TERM
disrespect O
for O
the O
government O
" O
on O
the O
internet O
. O

According O
to O
this O
document O
, O
Roskomnadzor O
( O
the O
Federal O
Service O
for O
Supervision O
of O
Communications O
, O
Information O
Technology O
and O
Mass O
Media O
) O
warns O
the O
resource O
about O
the O
violation O
and O
gives O
it O
a O
day O
to O
remove O
it O
. O

A O
fine O
of O
30 O
to O
30,000 O
rubles O
is O
stipulated O
for O
the O
first O
violation O
, O
and O
repeated O
violations O
incur O
administrative O
arrest O
for O
up O
to O
15 O
days O
. O

Roskomnadzor O
applied B-TERM
this O
rule O
with O
regard O
to O
the O
media O
for O
the O
first O
time O
on O
April O
12 O
, O
blocking O
the O
Yaroslavl O
outlet O
76.ru. O

Soon O
thereafter O
, O
the O
Chudovo O
regional O
court O
of O
the O
Novgorod O
Oblast O
fined O
a O
local O
resident O
30,000 O
rubles O
for O
publishing O
online O
" O
two O
notes O
with O
information O
in O
an O
unseemly O
form O
that O
offend O
human O
dignity O
and O
public O
morality O
and O
express O
clear O
disrespect O
for O
society O
, O
the O
state O
, O
and O
the O
bodies O
of O
executive O
state O
power O
in O
the O
Russian O
Federation O
. O
" O

Timeframe O
announced O
for O
lowering O
mortgage O
rate O

Interest O
rates O
on O
housing O
loans B-TERM
in O
Russia O
will O
fall O
by O
the O
end B-TERM
of O
2019 O
. O

This O
was O
announced B-TERM
by O
the O
CEO O
of O
the O
credit O
organization B-TERM
Dom.rf O
Alexander O
Plutnik O
, O
Interfax O
reports O
. O

As O
Plutnik O
noted O
at O
the O
Russian O
Construction O
Ministry O
collegium O
, O
most O
banks O
will O
lower O
mortgage O
rates O
once O
more O
in O
the O
remaining O
months O
of O
the O
year O
, O
and O
the O
average O
market O
indicator B-TERM
will O
reach O
8.9 O
percent O
- O
the O
level O
envisaged O
in O
the O
Housing O
and O
Urban O
Environment O
national O
project B-TERM
. O

According O
to O
the O
passport O
of O
the O
project B-TERM
, O
in O
2019 O
the O
average O
mortgage O
interest O
rate O
in O
2019 O
should O
be O
8.9 O
percent O
, O
in O
2021 O
- O
8.5 O
percent O
, O
by O
2024 O
- O
7.9 O
percent O
. O

The O
program O
provides O
for O
" O
ensuring O
affordable O
housing O
for O
average O
- O
income O
families B-TERM
, O
including O
by O
creating O
the O
possibility O
of O
acquisition O
( O
construction B-TERM
of O
housing O
by O
them O
using O
mortgage O
credit O
, O
the O
interest O
rate O
of O
which O
should O
be O
below O
8 O
percent O
) O
. O
" O

Earlier O
in O
September O
it O
became O
known O
that O
one O
of O
the O
largest O
players O
in O
the O
Russian O
mortgage O
market O
- O
Sberbank O
- O
plans O
one O
more O
housing O
loan B-TERM
interest O
rate O
cut B-TERM
by O
the O
end B-TERM
of O
2019 O
. O

Stores B-TERM
in O
Australia O
lower O
toilet O
paper O
limits O
per O
transaction O

On O
Sunday O
and O
Saturday O
evening O
, O
Australian O
store B-TERM
chains O
Woolworths O
and O
Coles O
lowered O
their O
purchase O
restrictions O
on O
toilet O
paper O
to O
two B-TERM
and O
one O
package O
per O
transaction O
in O
all O
stores B-TERM
on O
national O
level O
, O
respectively O
. O

ALDI O
also B-TERM
introduced O
a O
one O
- O
pack O
limit O
, O
on O
Monday O
. O

These O
limitations O
were O
posted O
as O
messages O
on O
the O
checkouts O
, O
and O
on O
the O
chains O
' O
Facebook O
pages O
. O

Buyers O
were O
reportedly O
stocking O
up O
due O
to O
fears B-TERM
of O
COVID O
- O
19 O
in O
case O
people O
need O
to O
self O
- O
isolate O
. O

On O
Wednesday O
, O
Woolworths O
also B-TERM
limited O
toilet O
paper O
purchases O
for O
home O
delivery O
to O
one O
pack O
per O
order O
. O

These O
changes O
followed O
the O
previous O
four O
- O
pack O
per O
transaction O
restriction O
introduced O
by O
Woolworths O
and O
Coles O
on O
March O
4 O
and O
5 O
respectively O
. O

Coles O
, O
in O
its O
March O
8 O
media O
release O
, O
reported O
that O
with O
the O
four O
- O
pack O
restriction O
in O
place O
, O
" O
many O
stores B-TERM
are O
still O
selling O
out O
within O
an O
hour O
of O
delivery O
, O
" O
and O
called O
the O
demand O
" O
unprecedented B-TERM
, O
" O
while O
ALDI O
, O
in O
a O
Facebook O
post O
on O
Tuesday O
, O
called O
it O
" O
unexpected B-TERM
. O
" O

Sales O
went O
up O
in O
a O
" O
sharp O
increase B-TERM
" O
last O
week O
, O
according O
to O
a O
Woolworths O
spokesperson O
. O

Costco O
's O
store B-TERM
in O
Canberra O
also B-TERM
limited O
the O
allowed O
amount B-TERM
to O
two B-TERM
packs O
last O
week O
. O

To O
further O
alleviate O
the O
shortage O
, O
Coles O
ordered O
bigger O
packages O
from O
suppliers O
and O
increased O
delivery O
frequency O
, O
Woolworths O
ordered O
extra O
stock O
, O
while O
ALDI O
made O
stocks O
for O
a O
planned O
Wednesday O
special O
available O
early O
. O

Russell O
Zimmerman O
, O
executive O
director O
of O
the O
Australian O
Retailers O
Association O
, O
said O
that O
retailers O
try B-TERM
to O
raise O
stock O
, O
but O
local B-TERM
council O
restrictions O
on O
the O
timing O
of O
truck O
- O
deliveries O
make O
it O
hard O
. O

He O
expects B-TERM
rising O
production O
costs O
, O
as O
suppliers O
try B-TERM
to O
meet O
demand O
, O
and O
fewer O
specials O
. O

On O
Tuesday O
, O
ALDI O
announced B-TERM
that O
following O
the O
early O
release O
of O
stock O
, O
some O
stores B-TERM
can O
't O
run O
the O
Wednesday O
special O
. O

In O
a O
News.com.au O
report B-TERM
, O
Dr O
Gary O
Mortimer O
, O
retail O
expert B-TERM
from O
Queensland O
University O
of O
Technology O
, O
said O
the O
stores B-TERM
fill O
the O
stock O
every O
night O
. O

He O
remarked O
toilet O
paper O
is O
a O
bulky O
item O
, O
leading O
to O
low O
quantity O
of O
stocks O
in O
numbers B-TERM
, O
and O
, O
when O
sold O
out O
, O
leaves O
vast O
shelf O
spaces O
empty O
, O
hardening O
the O
feeling O
of O
a O
shortage B-TERM
. O

Coles O
and O
Woolworths O
have O
a O
view O
[ O
that O
] O
if O
there O
was O
plenty O
of O
stuff O
on O
the O
shelf O
, O
if O
product O
like B-TERM
toilet O
rolls O
and O
sanitiser O
could O
be O
[ O
bought O
] O
and O
are O
there O
in O
quantities O
, O
you O
would O
probably B-TERM
minimise O
the O
panic O
said O
Russell O
Zimmerman O
per O
ABC O
News O
. O

Recycled O
toilet O
paper O
producer O
Who O
Gives O
a O
Crap O
said O
on O
last O
Wednesday O
they O
'd O
run O
out O
of O
stock O
. O

Kimberly O
- O
Clark O
, O
which O
makes O
Kleenex O
Toilet O
Tissue O
, O
and O
Solaris O
Paper O
which O
makes O
Sorbent O
, O
emphasized O
they O
were O
working O
24 O
/ O
7 O
to O
maintain O
the O
supply O
, O
according O
to O
the O
News.com.au B-TERM
report O
. O

Domain.com O
, O
a O
real O
estate O
site O
, O
reported O
some O
property O
sellers O
offering O
free O
toilet O
paper O
to O
the O
first O
bidder O
on O
auctions O
in O
Melbourne O
, O
when O
fewer O
auctions O
were O
held O
because O
of O
buyers O
having O
time O
off O
on O
the O
long O
weekend O
of O
Labour O
Day O
. O

The O
Thursday O
edition O
of O
NT O
News O
, O
a O
daily B-TERM
printed O
in O
Darwin O
, O
included O
an O
eight O
- O
page O
insert O
meant O
to O
be O
cut O
up O
and O
used O
as O
toilet O
paper O
. O

The O
stores B-TERM
were O
originally O
reluctant O
to O
impose O
restrictions O
, O
according O
to O
a O
report O
from O
ABC O
Australia O
on O
March O
3 O
in O
which O
they O
said O
they O
had O
no O
plans O
to O
introduce O
restrictions O
on O
the O
purchases O
. O

Russell O
Zimmerman O
added B-TERM
that O
other O
products B-TERM
are O
also B-TERM
in O
high O
demand O
, O
including O
masks O
, O
sanitiser O
, O
dried O
goods O
, O
handwash O
and O
flour O
. O

Similarly B-TERM
, O
outside O
of O
Australia O
, O
on O
Sunday O
evening O
online O
British O
supermarket O
Ocado O
was O
observed O
limiting O
purchases O
of O
Andres O
toilet O
paper O
to O
two B-TERM
12 O
- O
roll O
packs O
. O

Will O
phytoestrogens O
and O
phytoandrogens O
prolong O
youth O
? O

Phytoandrogens O
have O
hardly O
been O
studied O
. O

The O
most O
well O
- O
known O
is O
pine O
pollen O
. O

But O
phytoestrogens O
have O
been O
studied O
quite O
thoroughly O
and O
demonstrate O
positive O
effects O
on O
the O
body O
. O

They O
lower O
the O
risk O
of O
certain O
age O
- O
related O
diseases B-TERM
( O
including O
cardiovascular O
disease O
and O
several O
forms O
of O
cancer O
) O
. O

Well O
known O
sources O
of O
phytoestrogens O
include O
all O
types O
of O
beans O
( O
the O
most O
popular O
being O
soy O
) O
, O
hops O
, O
and O
flax O
seed O
. O

However O
, O
many O
professionals O
believe B-TERM
such O
dietary O
supplements O
can O
't O
entirely O
replace O
natural B-TERM
hormones O
. O

Don O
't O
dismiss O
the O
potential O
danger O
of O
such O
supplements O
. O

For O
example O
, O
taking O
them O
can O
lower O
the O
production O
of O
natural O
hormones O
because O
too O
many O
substitutes O
enter O
the O
body O
externally O
. O

Veretennikov O
called O
for O
the O
revival O
of O
Kazakhstan O
's O
Zhenis O
. O

The O
former B-TERM
Rotor O
striker O
and O
Russian O
national O
team O
member O
Oleg O
Veretennikov O
has O
joined O
calls O
for O
the O
return O
of O
Kazakhstan O
's O
Zhenis O
. O

The O
Astana O
club O
, O
which O
was O
in O
previous O
years O
called O
Dinamo O
, O
Tselinnik O
, O
Astana O
and O
Zhenis O
, O
was O
disbanded O
in O
2014 O
. O

Veretennikov O
played O
for O
the O
team O
in O
2004 O
and O
2008 O
. O

" O
I O
heard O
how O
fans O
organized O
a O
movement O
to O
revive B-TERM
the O
Zhenis O
football O
club O
. O

And O
I O
could O
not O
ignore O
it O
! O

I O
spent O
1 O
1 O
/ O
2 O
seasons O
with O
the O
club O
. O

This O
was O
not O
the O
best O
time O
in O
terms O
of O
results B-TERM
or O
financing O
, O
but O
I O
will O
never O
forget O
this O
club O
and O
its O
loyal O
fans O
, O
who O
always B-TERM
stuck O
by O
the O
team O
! O

I O
will O
always O
remember O
the O
Munaitpasov O
Stadium O
at O
which O
I O
scored O
my O
200th O
career O
goal O
. O

Zhenis O
should O
return O
! O

It O
has O
a O
rich O
history O
and O
wonderful B-TERM
fans O
. O

I O
wish B-TERM
them O
the O
very O
best O
and O
believe O
that O
the O
authorities O
will O
return O
their O
hometown O
club O
, O
" O
wrote O
Veretennikov O
on O
Instagram O
. O

The O
Bastion O
missile O
system O
launched O
an O
Oniks O
missile O
in O
Chukotka O

The O
Ministry O
of O
Defense O
has O
launched O
a O
cruise O
missile O
from O
the O
Bastion O
missile O
system O
for O
the O
first O
time O
in O
Chukotka O
. O

The O
Oniks O
was O
launched O
350 O
kilometers O
from O
its O
target O
, O
200 O
kilometers O
of O
which O
was O
above O
land O
, O
which O
is O
a O
record O
for O
this O
type B-TERM
of O
missile O
. O

Security O
for O
the O
launch O
was O
provided O
by O
about O
10 O
warships O
from O
the O
Pacific O
Ocean O
fleet O
as O
well O
as O
naval O
- O
aviation O
aircraft O
, O
Russia O
's O
Ministry O
of O
Defense O
press O
service O
announced B-TERM
. O

The O
Bastion O
missile O
system O
has O
not O
previously O
been O
used O
in O
Chukotka O
. O

Hydrometcenter O
of O
Russia O
lists O
examples O
of O
folk O
wisdom O
that O
are O
correct B-TERM

Russia O
has O
a O
lot B-TERM
of O
folk O
sayings O
that O
people O
use O
to O
predict B-TERM
the O
weather O
. O

Unfortunately O
, O
they O
do O
not O
all O
work O
. O

Hydrometcenter O
of O
Russia O
checked O
all O
the O
examples O
of O
folk O
wisdom O
that O
supposedly O
work O
. O

The O
meteorologists O
concluded B-TERM
that O
only O
two B-TERM
of O
them O
can O
be O
genuinely O
trusted O
and O
only O
when O
it O
concerns O
the O
near O
future O
. O

Roman O
Vilfand O
, O
scientific O
director O
at O
Hydrometcenter O
of O
Russia O
, O
said O
that O
if O
the O
sun O
is O
red O
during O
sunset O
, O
then O
the O
next O
day O
will O
really O
be O
fair O
, O
as O
our O
ancestors O
observed O
. O

And O
if O
the O
heavens O
shine O
with O
a O
pale O
light O
, O
then O
the O
next B-TERM
day O
will O
be O
rainy O
. O

The O
second O
functioning O
piece O
of O
wisdom O
is O
based O
on O
bird O
observations O
. O

People O
often B-TERM
say O
of O
swallows O
that O
if O
they O
are O
flying O
low O
that O
usually O
means O
rain O
. O

This O
can O
be O
explained O
simply O
- O
when O
there O
is O
high O
humidity O
the O
gnats O
' O
wings O
become O
wet O
and O
the O
birds O
are O
forced O
to O
fly O
lower O
in O
order O
to O
catch O
them O
, O
TASS O
reported O
. O

Different O
continents B-TERM
have O
their O
own O
folk O
wisdom O
. O

Groundhog O
Day O
is O
a O
traditional O
folk O
holiday O
in O
the O
US O
and O
Canada O
, O
where O
it O
is O
marked O
every O
February O
2 O
. O

On O
this O
day O
, O
the O
groundhog O
should O
be O
observed O
as O
it O
crawls O
out O
of O
its O
burrow O
to O
determine O
when O
spring O
will O
arrive O
. O

Mystery O
oil O
spill O
discovered O
on O
the O
beaches O
of O
northeastern O
Brazil O

An O
oil O
spill O
of O
unknown B-TERM
origin O
has O
been O
discovered O
on O
99 O
beaches O
in O
northeast O
Brazil O
. O

Polluted O
areas O
stretch O
2,000 O
kilometers O
along O
the O
shoreline O
. O

Reports O
of O
oil O
spills O
first O
began O
appearing O
on O
September O
2 O
. O

The O
number B-TERM
of O
reports O
, O
as O
well O
as O
the O
area O
affected O
, O
has O
continued O
to O
grow O
with O
each O
day O
through O
to O
Thursday O
. O

The O
Brazilian O
Institute O
of O
Environment O
and O
Renewable O
Natural O
Resources O
conducted O
an O
analysis B-TERM
of O
the O
samples O
that O
have O
been O
found O
. O

The O
samples O
were O
all O
revealed O
to O
be O
identical B-TERM
' O
- O
crude O
oil O
. O

State O
- O
run O
oil O
firm O
Petrobras O
, O
which O
analyzed O
the O
samples O
, O
announced B-TERM
that O
their O
composition O
did O
not O
correspond O
to O
oil O
recovered O
from O
deposits O
on O
Brazilian O
territory O
. O

" O
This O
is O
heavy O
oil O
. O

It O
could O
have O
been O
released O
by O
a O
ship B-TERM
after O
its O
tanks O
were O
cleaned O
. O

Many O
continue O
to O
do O
this O
. O

Most O
likely O
it O
found O
its O
way O
into O
the O
ocean O
currents O
, O
" O
Rog√©rio O
Almeida O
, O
coordinator O
for O
the O
oil O
workers O
union O
in O
the O
states O
of O
Pernambuco O
and O
Para√≠ba O
, O
told O
the O
Brazilian O
news O
portal O
G1 O
. O

He O
added B-TERM
that O
despite O
a O
ban O
on O
the O
practice O
, O
many O
ships B-TERM
continue O
to O
dump O
waste O
into O
the O
open B-TERM
sea O
. O

Nine O
sea O
turtles O
completely O
covered O
in O
a O
layer O
of O
oil O
were O
discovered O
by O
environmental O
workers O
on O
beaches O
in O
four O
out O
of O
eight O
states O
in O
the O
northeast O
of O
the O
country O
. O

Only O
two B-TERM
of O
them O
could O
be O
saved O
. O

The O
Brazilian O
Institute O
of O
Environment O
and O
Renewable O
Natural O
Resources O
together B-TERM
with O
Petrobras O
is O
set O
to O
begin O
cleaning O
the O
polluted O
beaches O
in O
the O
coming O
days O
. O

Meanwhile O
, O
the O
institute O
's O
specialists O
recommend O
that O
tourists O
and O
local B-TERM
residents O
avoid O
the O
oil O
spills O
and O
report O
any O
pollution O
discovered O
. O

Medvedev O
ordered O
a O
review O
of O
the O
regulations O
for O
food O
service O
enterprises B-TERM

Prime O
Minister O
Dmitry O
Medvedev O
instructed O
Rospotrebnadzor O
, O
the O
Justice O
Ministry O
, O
the O
Economics O
Ministry O
and O
the O
Industry O
and O
Trade O
Ministry O
together B-TERM
with O
the O
business O
ombudsmen O
and O
the O
entrepreneurial O
community O
to O
revise O
the O
sanitary O
- O
epidemiological O
rules O
and O
regulations O
for O
food O
service O
organizations B-TERM
. O

Also B-TERM
they O
must O
look O
into O
the O
issue O
of O
switching O
to O
applying O
the O
requirements B-TERM
of O
the O
Eurasian O
Economic O
Union B-TERM
's O
technical O
regulations O
to O
the O
organization B-TERM
of O
food O
service O
. O

The O
agencies O
must O
present O
their O
proposals O
to O
the O
government O
no O
later O
than O
15 O
October O
, O
as O
stated O
in O
the O
list B-TERM
of O
Mr. O
Medvedev O
's O
orders O
according O
to O
the O
Dialog O
program O
which O
screened O
on O
11 O
September O
on O
the O
TV O
channel O
Rossiya O
24 O
. O

By O
that O
deadline O
Mr. O
Medvedev O
ordered O
all O
the O
aforementioned O
agencies O
, O
except O
the O
Justice O
Ministry O
, O
to O
present O
proposals O
for O
conducting O
an O
experiment O
in O
restricting O
monitoring O
activities O
for O
food O
service O
organizations B-TERM
in O
a O
number O
of O
regions B-TERM
, O
including O
Moscow O
, O
Tatarstan O
and O
Kaliningrad O
region B-TERM
, O
starting O
from O
1 O
January O
2020 O
. O

The O
Justice O
Ministry O
and O
Economics O
Ministry O
have O
been O
ordered O
to O
submit O
a O
draft O
law O
to O
the O
government O
with O
amendments O
to O
the O
Administrative O
Code O
on O
applying O
an O
administrative O
suspension O
of O
activity B-TERM
for O
food O
service O
rule O
violations O
that O
harmed O
health O
. O

Also O
, O
the O
Labor O
Ministry O
, O
Economics O
Ministry O
, O
Rospotrebnadzor O
and O
the O
Finance O
Ministry O
must O
work O
on O
the O
issue O
of O
gradually O
switching O
to O
forming O
the O
consumer O
basket O
based O
on O
a O
basic B-TERM
set O
of O
foodstuffs O
needed O
for O
a O
balanced O
diet O
, O
starting O
from O
2021 O
. O

To O
recap O
, O
the O
business O
community O
raised O
the O
issue O
of O
outdated O
regulations O
after O
the O
closure O
of O
a O
cafe O
in O
the O
AnderSon O
chain O
. O

The O
business O
community O
demanded O
that O
the O
sanitary O
rules O
be O
overturned O
, O
and O
Rospotrebnadzor O
announced B-TERM
that O
new O
ones O
would O
be O
jointly O
developed O
. O

33 O
agencies O
were O
included O
in O
the O
list B-TERM

In O
addition O
Rospotrebnazor O
intends O
to O
reduce B-TERM
the O
number O
of O
sanitary O
regulations O
and O
rules O
to O
a O
40th O
of O
their O
current O
number B-TERM
. O

Investigators O
currently O
have O
information B-TERM
about O
three O
thefts B-TERM
involving O
the O
detainee O

The O
man O
operated O
in O
the O
Skuratovsky O
neighborhood O
of O
Tula O
. O

He O
stole B-TERM
batteries O
and O
vehicle B-TERM
audio O
equipment O
from O
cars B-TERM
. O

From O
two B-TERM
vehicles B-TERM
- O
a O
VAZ O
- O
2106 O
and O
a O
VAZ O
- O
2107 O
- O
he O
took O
the O
batteries O
, O
presumably O
for O
the O
purpose B-TERM
of O
selling O
them O
. O

" O
And O
from O
one O
other O
VAZ O
- O
2107 O
car B-TERM
with O
the O
same O
intent O
the O
perpetrator O
took O
an O
audio O
player O
and O
subwoofer O
, O
" O
said O
the O
Tula O
region B-TERM
Interior O
Ministry O
directorate O
. O

The O
thief O
probably B-TERM
intended B-TERM
to O
sell O
the O
stolen O
items O
. O

A O
26 O
- O
year O
- O
old O
unemployed O
person O
is O
in O
custody O
. O

Russians B-TERM
have O
nothing O
to O
save O
for O
retirement O
according O
to O
V. O
Matvienko O

Federation O
Council O
Speaker O
Valentina O
Matvienko O
believes B-TERM
Russians B-TERM
don O
't O
have O
enough O
savings O
for O
the O
bill O
on O
guaranteed O
pension O
product B-TERM
to O
fully O
work O
in O
the O
country O
. O

The O
practice O
of O
supplementing O
pensions O
through O
personal B-TERM
savings O
is O
quite B-TERM
popular O
throughout O
the O
world O
. O

How O
timely B-TERM
its O
introduction O
is O
here O
is O
another B-TERM
matter O
. O

" O
In O
my O
view O
, O
a O
considerable B-TERM
part O
of O
the O
population O
has O
an O
income O
now O
that O
simply O
leaves O
them O
nothing O
to O
set O
aside O
for O
increasing B-TERM
their O
pensions O
in O
the O
future O
, O
" O
stated O
V. O
Matvienko O
. O

The O
Speaker O
believes O
that O
Russians B-TERM
can O
't O
understand B-TERM
how O
pensions O
are O
formed O
and O
calculated O
, O
because O
" O
constant B-TERM
changes B-TERM
in O
this O
area O
have O
completely O
confused O
them O
. O
" O

" O
That O
doesn O
't O
mean B-TERM
I O
'm O
against O
improving O
the O
pension O
system O
and O
its O
regulatory O
legislation O
. O

" O
Russia O
is O
a O
social O
state B-TERM
, O
and O
we O
must O
do O
everything O
to O
improve O
pension O
sizes B-TERM
and O
citizens O
' O
social O
security O
. O

" O
But O
our O
steps B-TERM
in O
this O
direction B-TERM
should O
be O
thoughtful O
and O
responsible O
, O
taking O
domestic O
realities O
into O
account O
, O
" O
V. O
Matvienko O
told O
RIA O
Novosti O
. O

The O
head B-TERM
of O
the O
Federation O
Council O
emphasized O
that O
if O
this O
initiative O
( O
the O
bill O
on O
guaranteed O
pension O
product B-TERM
) O
develops O
, O
then O
several O
basic B-TERM
principles O
must O
be O
specified O
, O
including O
voluntariness O
, O
tax O
preferences O
for O
citizens O
and O
employers O
, O
and O
strict O
guarantees O
and O
state B-TERM
responsibility O
for O
ensuring O
the O
safety O
of O
pension O
savings O
. O

On O
September O
6 O
, O
the O
Russian O
Ministry O
of O
Finance O
announced B-TERM
the O
submission O
of O
the O
bill O
on O
guaranteed O
pension O
product B-TERM
( O
GPP O
) O
for O
approval O
. O

Its O
basic B-TERM
elements O
include O
the O
exclusively O
voluntary O
procedure O
for O
citizens O
to O
join O
the O
savings O
system O
, O
the O
guarantee O
by O
the O
state B-TERM
of O
the O
safety O
of O
citizens O
' O
long O
- O
term O
pension O
savings O
, O
the O
registration O
of O
citizens O
' O
savings O
accounts O
by O
a O
central B-TERM
administrator O
, O
tax O
exemptions O
for O
businesses O
, O
and O
tax O
deductions O
for O
citizens O
. O

Spider O
- O
Man O
remaining O
in O
the O
Marvel O
movie O
universe O
. O

Sony O
and O
Disney O
come O
to O
agreement O

News B-TERM
of O
the O
beloved O
superhero O
's O
departure O
from O
the O
Marvel O
movie O
universe O
angered B-TERM
many O
loyal O
fans O
. O

Spider O
- O
Man O
, O
one O
of O
the O
most O
famous B-TERM
comic O
book O
characters O
, O
will O
remain O
in O
the O
Marvel O
movie O
universe O
. O

Disney O
and O
Sony O
Pictures B-TERM
have O
managed O
to O
reach O
an O
agreement O
on O
the O
rights O
to O
use O
him O
in O
the O
franchise O
's O
films B-TERM
. O

This O
was O
announced O
in O
a O
Sony O
press O
release O
stating O
that O
the O
third O
Spider O
- O
Man O
film O
with O
Tom O
Holland O
will O
be O
released O
on O
July O
16 O
, O
2021 O
. O

Earlier O
it O
was O
reported O
that O
Spider O
- O
Man O
would O
leave B-TERM
the O
Marvel O
movie O
universe O
because O
Disney O
and O
Sony O
Pictures O
couldn O
't O
come O
to O
an O
agreement O
on O
the O
division B-TERM
of O
revenue O
. O

Sony O
owns O
the O
rights O
to O
the O
movie O
hero O
. O

It O
leased O
them O
out O
for O
Marvel O
films B-TERM
, O
which O
belong O
to O
Disney O
. O

As O
a O
result B-TERM
, O
Sony O
received B-TERM
revenue O
from O
the O
box O
office O
, O
and O
Disney O
collected O
revenue O
from O
souvenirs O
and O
toys O
. O

As O
reported O
, O
at O
some O
point O
this O
situation B-TERM
was O
no O
longer O
suitable O
for O
Disney O
, O
and O
the O
company B-TERM
wanted O
to O
reexamine O
the O
agreement B-TERM
. O

The O
president O
of O
Marvel O
Studios O
, O
Kevin O
Feige O
, O
said O
that O
he O
's O
excited O
. O

It O
's O
amazing O
that O
Spidey O
's O
journey B-TERM
in O
the O
Marvel O
movie O
universe O
will O
continue O
. O

" O
All O
of O
us O
at O
Marvel O
Studios O
are O
very O
glad O
to O
be O
able B-TERM
to O
continue O
working O
on O
it O
. O

Spider O
- O
Man O
is O
an O
iconic O
figure O
. O

He O
's O
a O
hero O
whose O
story O
touches O
every O
generation O
and O
audiences O
around O
the O
world O
, O
" O
reads O
the O
press O
release O
. O

At O
the O
same O
time O
, O
Feige O
noted O
that O
Sony O
is O
creating O
its O
own O
cinematic O
universe O
built O
around O
Spider O
- O
Man O
. O

" O
He O
also O
happens O
to O
be O
the O
only O
hero O
with O
the O
superpower O
to O
cross O
cinematic O
universes O
. O

As O
Sony O
continues O
to O
develop O
their O
own O
Spidey O
- O
verse O
you O
never O
know O
what O
surprises O
the O
future O
might O
hold O
, O
" O
he O
said O
. O

Tom O
Holland O
, O
who O
has O
played O
Spider O
- O
Man O
in O
five O
films B-TERM
, O
apparently O
commenting O
on O
the O
news B-TERM
, O
posted O
a O
quote O
from O
the O
film O
Wolf O
of O
Wall O
Street O
on O
his O
Instagram O
account O
, O
where O
the O
hero O
Leonardo O
DiCaprio O
shouts O
, O
" O
I O
'm O
not O
leaving B-TERM
! O
" O

Information B-TERM
about O
the O
conflict O
between O
the O
companies B-TERM
appeared O
in O
August O
. O

As O
the O
media O
reported O
, O
Disney O
wanted B-TERM
to O
take B-TERM
half O
of O
the O
box O
office O
revenue O
from O
Spider O
- O
Man O
films B-TERM
, O
provided O
that O
both O
companies B-TERM
would O
pay O
half O
the O
cost O
of O
producing O
the O
pictures B-TERM
. O

But O
this O
did O
not O
suit O
Sony O
. O

News B-TERM
of O
the O
possibility O
of O
the O
beloved O
superhero O
leaving O
the O
Marvel O
movie O
universe O
angered B-TERM
many O
loyal O
fans O
. O

Details B-TERM
of O
the O
new O
conditions B-TERM
have O
yet O
to O
be O
disclosed O
. O

According O
to O
CNBC O
, O
Sony O
refused B-TERM
to O
comment O
on O
the O
agreement O
, O
but O
said O
: O
" O
We O
have O
worked O
well O
together O
over O
the O
past O
four O
years O
, O
and O
our O
common B-TERM
desire O
to O
continue O
working O
together O
was O
in O
line O
with O
that O
of O
many O
[ O
Spider O
- O
Man O
] O
fans O
. O

We O
are O
glad O
that O
we O
can O
move O
forward O
together B-TERM
. O
" O

The O
film B-TERM
Avengers O
: O
Endgame O
, O
which O
united B-TERM
Spider O
- O
Man O
, O
Thor O
, O
Hulk O
, O
and O
other O
Marvel O
superheroes O
, O
was O
the O
highest O
- O
grossing O
in O
world O
cinematic O
history O
, O
replacing O
Avatar O
. O

The O
President O
of O
Belarus O
is O
invited O
to O
visit O
Crimea O

The O
head B-TERM
of O
the O
Belarusian O
community O
in O
Crimea O
Roman O
Chegrinets O
has O
invited O
the O
president O
of O
Belarus O
Alexander O
Lukashenko O
to O
visit O
the O
peninsula O
. O

The O
main B-TERM
dream B-TERM
is O
the O
transfer O
of O
power B-TERM
by O
inheritance O

How O
Lukashenko O
's O
25 O
- O
year O
rule O
in O
Belarus O
is O
remembered O

In O
his O
opinion O
, O
closer O
economic O
cooperation B-TERM
with O
Belarus O
will O
be O
advantageous O
for O
the O
region B-TERM
. O

Chegrinets O
expressed O
certainty O
that O
Belarusian O
enterprises B-TERM
will O
follow O
Lukashenko O
to O
Crimea O
, O
RIA O
Novosti O
reports O
. O

On O
26 O
September O
the O
president O
of O
Belarus O
gave O
a O
negative O
answer O
to O
a O
Ukrainian O
journalist O
's O
question O
about O
the O
return O
of O
Crimea O
to O
Ukraine O
. O

In O
the O
words O
of O
the O
Belarusian O
leader B-TERM
, O
he O
does O
not O
consider B-TERM
this O
to O
be O
possible B-TERM
in O
the O
foreseeable O
future O
: O
" O
This O
question O
is O
closed O
once O
and O
for O
all O
. O
" O

However O
in O
Kiev O
and O
in O
the O
West O
, O
the O
results B-TERM
of O
the O
vote O
are O
not O
recognized O
. O

Lukashenko O
named O
the O
reasons O
for O
the O
continuation O
of O
conflict O
in O
Donbas O

Famous B-TERM
blogger O
Andrey O
Poltava O
's O
home O
searched O
: O
what O
's O
known O
so O
far O

On O
Friday O
, O
September O
27 O
, O
the O
home B-TERM
of O
the O
relatives O
of O
the O
volunteer O
and O
blogger O
Andrey O
Karpov O
, O
known O
as O
Andrey O
Poltava O
, O
was O
searched O
. O

The O
blogger O
himself O
reported O
about O
it O
on O
Facebook O
, O
noting O
that O
he O
doesn O
't O
live O
at O
this O
address O
. O

Additionally O
, O
Poltava O
writes O
that O
he O
again O
received B-TERM
an O
email O
saying O
, O
" O
We O
report O
that O
on O
the O
territory O
... O
I O
left B-TERM
a O
homemade O
bomb O
. O

The O
second O
such O
explosive O
device B-TERM
, O
planted O
in O
the O
car B-TERM
, O
will O
be O
put O
into O
action O
todya O
near O
the O
home B-TERM
of O
the O
famous B-TERM
Ukrainian O
propagandist O
Karpov O
Andrey O
Anatolievich O
( O
also O
known O
as O
Andrey O
Poltava O
) O
... O

Death O
to O
the O
punishers O
. O
" O

Karpov O
believes B-TERM
the O
Russian O
occupiers O
don O
't O
like B-TERM
this O
activity B-TERM
as O
a O
volunteer O
, O
politician O
, O
and O
blogger O
. O

Poltava O
's O
subscribers O
are O
sure O
that O
his O
reports O
are O
needed B-TERM
and O
wish B-TERM
him O
strength O
and O
patience O
. O

Recall O
that O
Poltava O
talks O
with O
Russians B-TERM
abotu O
the O
war B-TERM
in O
Donbass O
, O
the O
annexation O
of O
Crimea O
, O
peace O
, O
and O
politics O
, O
and O
then O
posts O
the O
videos O
online O
. O

The O
blogger O
ran O
for O
Verkhovna O
Rada O
from O
the O
European O
Solidarity O
Party O
. O

He O
now O
hosts O
a O
show O
on O
the O
channel O
Pryamoy O
, O
where O
he O
harshly O
criticizes O
Russian O
propaganda O
. O

In O
2017 O
, O
Karpov O
was O
recognized O
as O
the O
best O
blogger O
in O
Ukraine O
by O
the O
television O
station O
ICTV O
. O

Riigikogu O
: O
Estonia O
wants B-TERM
to O
make O
its O
2050 O
climate O
target B-TERM
goal B-TERM
even O
more O
ambitious O

Anneli O
Ott O
, O
chairperson O
of O
the O
committee O
, O
noted O
that O
so O
far O
the O
committee O
had O
held O
three O
hearings O
. O

Experts B-TERM
, O
entrepreneurs O
and O
Ministry O
of O
the O
Environment O
representatives O
presented O
their O
vision O
of O
a O
carbon O
- O
neutral O
Estonia O
. O

" O
The O
resulting O
overview O
confirms O
that O
together B-TERM
with O
other O
EU O
member O
states B-TERM
, O
Estonia O
is O
actively O
seeking O
ways B-TERM
of O
making O
2050 O
climate O
goals B-TERM
even O
more O
ambitious O
and O
agree O
on O
methods B-TERM
for O
their O
achievement O
, O
" O
said O
Ott O
. O

The O
chairperson O
added B-TERM
that O
the O
government O
planned O
to O
discuss O
an O
analysis B-TERM
of O
Estonia O
's O
higher O
climate O
goals O
on O
October O
3 O
. O

The O
results B-TERM
of O
the O
discussions O
will O
be O
considered O
further O
at O
the O
Riigikogu O
commissions O
. O

Riina O
Sikkut O
, O
the O
commission O
's O
deputy O
chairperson O
, O
said O
that O
Estonia O
needs O
a O
clear O
plan B-TERM
to O
achieve O
its O
climate O
goals B-TERM
, O
agreed O
to O
by O
all O
interested O
parties O
. O

In O
any O
case O
, O
there O
will O
be O
international O
agreements B-TERM
and O
high O
costs O
for O
carbon O
dioxide O
emissions O
. O

" O
In O
addition B-TERM
to O
energy O
, O
the O
Riigikogu O
may O
focus O
on O
measures B-TERM
in O
the O
agriculture O
, O
transport O
, O
forestry O
and O
housing O
spheres O
as O
part O
of O
national O
discussions B-TERM
. O

The O
socio O
- O
economic O
impact B-TERM
of O
all O
changes B-TERM
needs O
to O
be O
taken O
into O
account O
, O
" O
said O
Sikkut O
. O

This O
autumn O
, O
the O
Riigikogu O
commission O
for O
EU O
Affairs O
launched O
a O
series O
of O
parliamentary O
hearings O
for O
finding O
an O
approach O
with O
which O
Estonia O
can O
take B-TERM
part O
in O
EU O
discussions O
on O
climate O
goals B-TERM
for O
2050 O
. O

FROM O
: O
Katherine O
Maher O
, O
Wikimedia O
Foundation O
CEO O

TO O
: O
All O
Wikimedia O
Foundation O
staff O

SUBJECT O
LINE O
: O
[ O
Covid O
- O
19 O
] O
Lightening O
the O
load O
and O
preparing O
for O
the O
future O

SEND O
DATE O
/ O
TIME O
: O
14 O
March O
, O
2020 O
, O
00 O
: O
24 O
UTC O

LICENSING O
: O
CC0 O
: O
No O
rights O
reserved O

We O
find O
ourselves O
in O
remarkable O
circumstances O
this O
month O
. O

The O
COVID O
- O
19 O
epidemic O
is O
something O
that O
makes O
clear O
our O
global O
human O
interconnectedness O
and O
the O
responsibilities O
we O
have O
to O
one O
another O
. O

We O
don O
't O
have O
precedent O
for O
its O
challenges B-TERM
, O
but O
we O
do O
know O
that O
our O
best O
response O
relies O
on O
the O
sort O
of O
global O
empathy O
, O
cooperation B-TERM
, O
and O
community O
building O
that O
sits O
at O
the O
heart O
of O
this O
organization B-TERM
. O

The O
camaraderie O
and O
care O
we O
have O
seen O
among B-TERM
all O
of O
our O
colleagues O
over O
email O
, O
calls O
, O
and O
chats O
is O
a O
remarkable B-TERM
validation O
of O
the O
incredible O
humans O
we O
are O
fortunate O
enough O
to O
work O
with O
. O

I O
couldn O
't O
be O
more O
grateful O
and O
proud O
to O
count O
you O
all O
as O
colleagues O
. O

Last O
week O
, O
someone O
shared O
with O
me O
their O
appreciation O
for O
our O
work O
. O

They O
reminded O
me O
how O
meaningful O
it O
is O
for O
the O
world O
to O
be O
able O
to O
turn O
to O
Wikipedia O
right O
now O
, O
and O
what O
a O
powerful O
symbol O
it O
is O
for O
this O
critical O
resource O
to O
remain O
online O
and O
available O
to O
all O
. O

Your O
work O
makes O
this O
possible B-TERM
, O
whether O
you O
keep O
the O
sites O
stay O
up O
or O
our O
colleagues O
paid O
or O
our O
communities O
safe O
. O

The O
world O
needs B-TERM
the O
information B-TERM
that O
Wikipedia O
provides O
, O
now O
more O
than O
ever O
. O

This O
is O
a O
moment O
in O
which O
not O
only O
what O
we O
do O
, O
but O
how O
we O
do O
it O
, O
will O
make O
a O
meaningful B-TERM
impact O
on O
the O
world O
. O

Because O
of O
the O
importance B-TERM
of O
this O
mission O
and O
your O
role B-TERM
in O
it O
, O
we O
will O
be O
making O
some O
significant B-TERM
adjustments O
to O
how O
we O
work O
together O
, O
starting O
this O
coming O
week O
. O

Adjustments O
to O
our O
work O
and O
schedules O

As O
Robyn O
mentioned O
previously O
, O
the O
c O
- O
team O
met O
last O
night O
to O
discuss O
our O
approach O
and O
schedule O
for O
the O
coming O
days O
and O
months O
. O

In O
that O
conversation O
, O
we O
considered B-TERM
what O
we O
thought B-TERM
would O
be O
an O
appropriate O
response O
to O
what O
we O
're O
facing O
and O
the O
best O
way B-TERM
to O
keep O
the O
organization B-TERM
sustainable O
during O
this O
time O
. O

Overwhelmingly O
we O
wanted B-TERM
to O
remove O
stress O
and O
support O
our O
mission O
for O
the O
long O
term O
. O

If O
you O
need O
to O
dial O
back O
, O
that O
's O
okay O
. O

For O
all O
staff B-TERM
, O
contractors O
, O
and O
contract O
workers O
: O

our O
daily O
working O
expectations B-TERM
will O
be O
about O
4 O
hours O
a O
day O
, O
or O
20 O
hours O
a O
week O
until O
further O
notice O
. O

We O
're O
not O
declaring B-TERM
a O
holiday O
- O
if O
you O
are O
able O
to O
work O
more O
normal O
hours O
, O
the O
mission O
can O
use O
you O
. O

However O
, O
the O
world O
is O
unpredictable O
right O
now O
, O
and O
whether O
you O
need O
to O
care O
for O
loved O
ones O
, O
get O
groceries O
, O
or O
go O
to O
the O
doctor B-TERM
, O
your O
well O
- O
being O
is O
our O
priority O
. O

We O
are O
not O
tracking O
your O
time O
. O

If O
you O
are O
sick O
, O
do O
not O
work O
. O

This O
should O
go O
without O
saying O
, O
but O
we O
're O
saying O
it O
. O

No O
sick O
days O
or O
PTO O
required O
- O
just O
tell O
your O
manager O
and O
help B-TERM
your O
team O
revise O
calendars O
and O
schedules O
to O
make O
sure O
key O
areas B-TERM
of O
work O
are O
covered O
. O

( O
If O
you O
are O
diagnosed O
positive O
for O
COVID O
- O
19 O
, O
please O
let O
Bryan O
within O
T O
& O
C O
Ops O
know O
so O
T O
& O
C O
can O
help O
with O
support O
and O
make O
sure O
your O
situation B-TERM
gets O
appropriate O
attention O
from O
management B-TERM
) O
. O

Hourly O
folks O
will O
be O
fully O
paid O
. O

We O
have O
already O
said O
, O
and O
are O
recommitting O
to O
honor O
our O
commitments O
to O
our O
contractors O
and O
hourly O
staff B-TERM
colleagues O
. O

Everyone O
will O
be O
paid O
on O
the O
basis O
of O
their O
usual B-TERM
hours O
worked O
during O
normal B-TERM
circumstances O
. O

This O
includes O
if O
you O
are O
sick O
and O
unable O
to O
work O
. O

If O
you O
want O
to O
work O
, O
we O
support O
you O
. O

Many O
people O
use B-TERM
work O
as O
a O
way B-TERM
of O
channeling O
their O
stress O
with O
the O
world O
around O
us O
. O

What O
we O
do O
can O
be O
incredibly O
rewarding O
, O
especially B-TERM
during O
times O
like O
this O
. O

Again O
, O
this O
is O
about O
your O
self O
- O
care O
. O

Our O
ask O
is O
that O
you O
communicate O
with O
your O
manager O
, O
so O
we O
know O
what O
to O
expect B-TERM
and O
can O
adjust O
accordingly O
. O

Some O
work O
is O
considered O
essential O
. O

There O
are O
some O
things O
that O
we O
must O
keep O
doing O
. O

The O
SRE O
, O
HR O
Ops O
, O
Trust O
& O
Safety O
, O
and O
Fundraising O
teams O
( O
among O
others O
) O
do O
critical O
work O
that O
may O
need O
additional O
support O
. O

We O
'll O
begin O
a O
process O
with O
all O
departments O
to O
assess O
current B-TERM
objectives B-TERM
and O
shift O
our O
focus O
to O
supporting O
what O
's O
essential O
for O
our O
mission O
. O

There O
's O
plenty B-TERM
to O
do O
for O
all O
of O
us O
, O
we O
just O
will O
all O
focus O
on O
the O
most O
essential O
projects B-TERM
. O

Slowing O
now O
won O
't O
hurt O
later O
. O

We O
do O
not O
plan O
to O
go O
" O
double O
- O
time O
to O
catch O
up O
" O
once O
the O
pandemic O
has O
passed O
. O

You O
will O
not O
be O
expected O
to O
work O
extra O
hours O
to O
meet O
deadlines O
which O
are O
now O
unrealistic O
. O

We O
accept O
that O
circumstances O
have O
changed O
, O
and O
will O
work O
to O
set O
new O
targets B-TERM
and O
timelines O
where O
appropriate O
. O

What O
happens O
with O
the O
APP O
( O
Annual O
Planning B-TERM
) O
? O

To O
adjust O
to O
our O
new O
reality B-TERM
and O
daily B-TERM
working O
hour O
expectations B-TERM
, O
we O
intend B-TERM
to O
adjust O
the O
timeline O
for O
the O
delivery O
of O
our O
2020 O
- O
2021 O
Annual O
Plan B-TERM
. O

Our O
intention O
is O
to O
propose O
an O
extension O
of O
our O
2019 O
- O
2020 O
plan O
that O
allows O
more O
time O
for O
budgeting O
to O
allow B-TERM
employees O
to O
prioritize O
critical O
work O
, O
self O
- O
care O
, O
and O
care O
for O
loved O
ones O
while O
accommodating O
those O
who O
need O
or O
wish O
to O
work O
a O
reduced B-TERM
schedule O
over O
the O
next O
few O
weeks O
. O

This O
timeline O
extension O
greatly B-TERM
reduces B-TERM
current B-TERM
planning O
workloads O
and O
pressure O
across O
the O
whole B-TERM
organization B-TERM
. O

We O
will O
introduce O
our O
proposal O
to O
the O
Board O
next O
week O
and O
will O
update O
delegates O
and O
teams O
on O
the O
next B-TERM
steps B-TERM
as O
soon O
as O
we O
have O
confirmation O
. O

Thank O
you O
to O
the O
APP O
team O
for O
your O
leadership O
in O
this O
. O

Office B-TERM
status O
, O
exposure O
, O
and O
cleaning O

Last O
week O
, O
we O
learned O
that O
one O
of O
our O
SF O
- O
based O
colleagues O
may O
have O
been O
exposed O
to O
the O
COVID O
- O
19 O
virus O
. O

However O
, O
out O
of O
an O
abundance O
of O
caution O
, O
we O
employed O
an O
antiviral O
cleaning O
crew B-TERM
to O
disinfect O
all O
surfaces O
in O
the O
San O
Francisco O
office B-TERM
. O

They O
utilized O
a O
hospital O
- O
grade O
anti O
- O
viral O
solution O
to O
disinfect O
every O
surface O
, O
as O
well O
as O
the O
lobby O
and O
elevator O
banks O
accessing O
our O
floor O
. O

The O
building O
is O
employing O
its O
own O
duty O
- O
of O
- O
care O
protocol O
utilizing O
products B-TERM
that O
support O
the O
safety O
of O
their O
tenants O
. O

We O
feel B-TERM
comfortable O
that O
the O
office B-TERM
will O
be O
well O
- O
prepared O
for O
when O
we O
decide O
to O
return O
. O

Our O
DC O
office B-TERM
is O
located O
in O
a O
WeWork O
, O
which O
has O
shared O
its O
COVID O
- O
19 O
protocol O
with O
us O
and O
all O
DC O
- O
based O
staff O
members O
. O

As O
of O
last O
week O
, O
our O
DC O
office B-TERM
moved O
to O
a O
fully O
remote O
setup O
in O
line O
with O
the O
guidance O
shared O
with O
San O
Francisco O
. O

As O
some O
of O
our O
NYC O
- O
based O
colleagues O
know O
, O
we O
have O
also B-TERM
been O
in O
discussion O
about O
leasing O
a O
location O
in O
Brooklyn O
. O

These O
discussions B-TERM
are O
continuing O
but O
may O
be O
delayed O
. O

Some O
of O
our O
colleagues O
are O
working O
remotely O
for O
the O
first O
time O
. O

Our O
long O
- O
time O
remote O
colleagues O
know O
that O
it O
can O
be O
an O
adjustment O
, O
and O
wanted B-TERM
to O
offer O
you O
some O
advice B-TERM
: O

Limit O
the O
length O
of O
meetings O
to O
at O
most O
one O
or O
two B-TERM
hour O
increments O
. O

If O
longer O
sessions O
are O
required O
, O
consider B-TERM
how O
they O
can O
be O
broken O
up O
over O
the O
course O
of O
several O
days O
. O

Clearly O
define O
the O
meeting O
, O
have O
an O
agenda O
, O
and O
send O
reading O
materials B-TERM
in O
advance O
. O

Make O
video O
the O
default O
, O
with O
tools O
like B-TERM
Google O
Docs O
and O
Zoom O
to O
facilitate O
live O
collaboration O
and O
connection O
. O

Have O
a O
lead O
to O
facilitate O
every O
meeting O
, O
someone O
to O
monitor O
the O
chat O
for O
questions O
and O
track O
the O
speaker O
list O
, O
and O
someone O
to O
help O
take O
notes O
( O
or O
do O
collaborative O
note O
- O
taking O
) O
. O

Send O
an O
email O
to O
tech O
support O
if O
you O
need O
a O
comfortable B-TERM
headset O
. O

Use B-TERM
your O
wellness O
reimbursement O
for O
snacks O
. O

Join O
the O
# O
remoties O
channel O
in O
Slack O
to O
talk O
with O
your O
colleagues O
about O
distributed O
work O

The O
HR O
Operations O
team O
is O
looking O
into O
webinar O
- O
based O
ergonomics O
guidance O
to O
support O
the O
increase O
in O
distributed O
work O
across O
the O
Foundation O
. O

This O
past O
week O
we O
asked O
all O
community O
grant O
recipients O
to O
cancel O
Wikimedia O
- O
funded O
public O
events O
, O
such O
as O
editathons O
, O
until O
the O
WHO O
declares B-TERM
the O
pandemic O
to O
be O
over O
. O

We O
let O
them O
know O
that O
we O
understood B-TERM
that O
our O
request O
for O
cancellations B-TERM
and O
other O
restrictions O
could O
make O
it O
impossible O
to O
complete O
their O
agreed O
- O
upon O
grant O
activities O
and O
that O
no O
one O
would O
be O
penalized O
for O
having O
to O
delay B-TERM
or O
modify O
those O
goals B-TERM
. O

This O
coming O
week O
we O
will O
follow O
up O
with O
additional O
guidance O
on O
Wikimania O
and O
other O
regional B-TERM
and O
thematic O
community O
conferences B-TERM
. O

The O
general O
sentiment O
from O
around O
the O
global O
community O
seems O
to O
be O
both O
sadness O
at O
the O
disruption O
but O
relief O
at O
the O
clarity O
and O
ability O
to O
focus O
on O
their O
own O
communities O
, O
Wikimedia O
and O
otherwise O
. O

Going O
forward O
, O
the O
CRT O
is O
working O
to O
set O
up O
a O
page O
on O
Meta O
- O
Wiki O
to O
provide O
a O
space O
for O
the O
community O
to O
monitor O
the O
impact B-TERM
and O
follow O
our O
communications O
with O
them O
. O

Staying O
in O
touch O
around O
COVID O
- O
19 O
related O
issues O

We O
'll O
be O
sending O
an O
invitation O
to O
your O
calendars O
for O
next B-TERM
Thursday O
, O
14 O
: O
00 O
UTC O
/ O
07 O
: O
00 O
PT O
for O
a O
special O
staff O
meeting O
. O

We O
'll O
use O
this O
time O
to O
share O
additional O
updates O
, O
answer O
your O
questions O
and O
spend O
some O
time O
connecting O
with O
each O
other O
. O

We O
're O
in O
this O
together B-TERM
and O
here O
to O
help B-TERM
however O
we O
can O
. O

In O
the O
meantime O
, O
you O
can O
continue O
to O
find O
the O
information B-TERM
from O
this O
email O
, O
and O
all O
other O
essential O
COVID O
- O
19 O
related O
information O
, O
on O
Office O
Wiki O
. O

The O
CRT O
will O
keep O
these O
pages O
updated O
and O
all O
the O
information B-TERM
in O
one O
place B-TERM
. O

We O
are O
also B-TERM
working O
to O
maintain O
regular O
communications O
with O
staff O
who O
reside O
in O
countries O
that O
are O
currently O
significantly B-TERM
affected O
. O

If O
you O
have O
any O
questions O
about O
travel B-TERM
, O
events O
, O
a O
major O
workstream O
, O
or O
coverage O
challenge B-TERM
, O
or O
anything O
else O
you O
may O
need O
help O
with O
, O
please O
don O
't O
hesitate O
to O
notify O
and O
work O
with O
the O
CRT O
. O

We O
're O
here O
to O
help O
provide O
support O
and O
liaise O
as O
needed O
. O

If O
you O
have O
a O
confidential O
or O
sensitive O
matter O
, O
please O
email O
Bryan O
Judan O
- O
Director O
of O
HR O
International O
Global O
Operations O
. O

None O
of O
these O
changes B-TERM
should O
be O
seen O
as O
an O
abandonment O
of O
our O
work O
and O
obligations O
. O

Rather O
, O
they O
are O
a O
recognition O
that O
at O
this O
moment O
, O
our O
work O
and O
obligations O
will O
likely O
need O
to O
adapt O
in O
a O
way O
we O
have O
not O
in O
the O
past O
. O

These O
are O
the O
steps B-TERM
we O
believe O
are O
necessary B-TERM
to O
support O
this O
one O
another O
so O
that O
we O
can O
continue O
to O
work O
, O
provide O
our O
movement B-TERM
with O
the O
support O
they O
need B-TERM
, O
and O
the O
world O
with O
the O
service O
they O
rely O
on O
. O

Our O
planned O
work O
will O
be O
there O
waiting O
for O
us O
when O
the O
time O
comes O
. O

For O
now O
, O
it O
is O
time O
to O
support O
one O
another O
and O
create O
space O
for O
the O
important B-TERM
work O
that O
will O
be O
coming O
in O
the O
weeks O
and O
potentially O
months O
ahead O
. O

We O
need O
all O
of O
you O
to O
make O
that O
happen O
, O
and O
so O
we O
need O
you O
all O
to O
take O
care O
of O
yourself O
and O
your O
families B-TERM
so O
that O
you O
can O
be O
at O
your O
best O
when O
the O
need O
arises O
. O

Now O
, O
please O
-- O
wash O
your O
hands O
and O
don O
't O
touch O
your O
face B-TERM
! O

Katherine O
, O
the O
CRT O
( O
Amanda O
K O
, O
Amy O
V O
, O
Bryan O
J O
, O
Doreen O
D O
, O
Gregory O
V O
, O
Jaime O
V O
, O
Joel O
L O
, O
Lynette O
L O
, O
Ryan O
M O
, O
and O
Tony O
S O
) O
, O
and O
the O
rest B-TERM
of O
the O
Leadership O
Team O
( O
Grant O
I O
, O
Heather O
W O
, O
Jaime O
V O
, O
Janeen O
U O
, O
Lisa O
S O
, O
Robyn O
A O
, O
Ryan O
M O
, O
and O
Toby O
N O
) O
. O

Chelsea O
luring O
Neymar O
with O
record O
salary B-TERM

The O
leadership B-TERM
of O
English O
Chelsea O
has O
expressed O
a O
desire O
to O
acquire O
the O
French O
PSG O
team O
's O
forward O
Neymar O
. O

This O
is O
reported O
by O
El O
Desmarque O
. O

According O
to O
the O
publication O
's O
information B-TERM
, O
the O
London O
club O
will O
make O
the O
Parisians O
an O
offer O
in O
the O
summer O
transfer O
window O
. O

It O
is O
noted O
that O
Chelsea O
plans O
to O
pay O
PSG O
300 O
million O
euros O
, O
and O
offer O
Neymar O
a O
contract B-TERM
with O
a O
salary B-TERM
of O
42 O
million O
euros O
, O
which O
would O
make O
him O
the O
world O
's O
highest O
- O
paid O
player O
. O

This O
summer O
the O
Brazilian O
said O
he O
would O
like O
to O
rejoin O
Barcelona O
. O

According O
to O
press O
reports O
, O
Neymar O
did O
not O
want B-TERM
to O
stay O
in O
PSG O
, O
but O
did O
not O
manage O
to O
switch O
to O
a O
different O
club O
in O
the O
last O
transfer O
window O
. O

After O
that O
, O
fans O
of O
the O
Parisians O
publicly O
addressed O
the O
footballer O
, O
expressing O
dissatisfaction O
with O
his O
actions O
. O

Child O
's O
Arm O
Amputated O
Because O
Of O
Doctor B-TERM
's O
Mistake O
In O
Rostov O
Oblast O

In O
Rostov O
Oblast O
, O
an O
11 O
- O
year O
- O
old O
boy B-TERM
lost O
an O
arm O
due O
to O
a O
doctor B-TERM
's O
mistake O
. O

This O
was O
reported O
on O
the O
pages O
of O
online O
media O
. O

Regnum O
News O
Agency O
wrote O
that O
the O
child O
was O
brought O
to O
a O
hospital O
in O
Zernograd O
with O
a O
broken O
arm O
. O

The O
boy B-TERM
was O
put O
in O
a O
cast O
, O
and O
afterwards B-TERM
developed O
gangrene O
. O

In O
the O
end B-TERM
, O
the O
appendage O
had O
to O
be O
amputated O
. O

It O
was O
reported O
in O
the O
cited O
article O
that O
employees B-TERM
of O
the O
Federal O
Service O
for O
Supervision O
of O
Healthcare O
found O
the O
medical O
facility O
" O
failed O
to O
timely O
and O
properly O
diagnose O
the O
child O
, O
as O
well O
as O
violations O
in O
the O
standards O
and O
scope O
of O
aid O
provided O
at O
the O
first O
stage B-TERM
of O
treatment O
. O
" O

Investigators O
are O
looking O
into O
the O
incident B-TERM
. O

Updating O
the O
diagnostic O
criteria O
of O
COVID O
- O
19 O
" O
suspected O
case O
" O
and O
" O
confirmed O
case O
" O
is O
necessary B-TERM

On O
6 O
February O
2020 O
, O
our O
team O
had O
published B-TERM
a O
rapid O
advice B-TERM
guideline O
for O
diagnosis O
and O
treatment O
of O
2019 O
novel O
coronavirus O
( O
2019 O
- O
nCoV O
) O
infection O
, O
and O
this O
guideline O
provided O
our O
experience O
and O
make O
well O
reference O
for O
fighting O
against O
this O
pandemic O
worldwide O
. O

However O
, O
the O
coronavirus O
disease O
2019 O
( O
COVID O
- O
19 O
) O
is O
a O
new O
disease B-TERM
, O
our O
awareness O
and O
knowledge O
are O
gradually O
increasing O
based O
on O
the O
ongoing O
research O
findings O
and O
clinical O
practice O
experience O
; O
hence O
, O
the O
strategies O
of O
diagnosis O
and O
treatment O
are O
also B-TERM
continually O
updated O
. O

In O
this O
letter O
, O
we O
answered O
one O
comment O
on O
our O
guideline O
and O
provided O
the O
newest O
diagnostic O
criteria O
of O
" O
suspected O
case O
" O
and O
" O
confirmed O
case O
" O
according O
to O
the O
latest O
Diagnosis O
and O
Treatment O
Guidelines O
for O
COVID O
- O
19 O
( O
seventh O
version O
) O
that O
issued O
by O
the O
National O
Health O
Committee O
of O
the O
People O
's O
Republic O
of O
China O
. O

In O
December O
2019 O
, O
the O
2019 O
novel O
coronavirus O
( O
2019 O
- O
nCoV O
) O
has O
caused O
an O
outbreak O
, O
which O
is O
now O
officially O
named O
as O
the O
coronavirus O
disease B-TERM
2019 O
( O
COVID O
- O
19 O
) O
and O
the O
virus O
has O
been O
named O
severe O
acute O
respiratory O
syndrome O
coronavirus O
2 O
( O
SARS O
- O
CoV O
- O
2 O
) O
. O

On O
11 O
March O
2020 O
, O
WHO O
characterized O
COVID O
- O
19 O
as O
a O
pandemic O
. O

In O
order O
to O
fight O
against O
the O
SARS O
- O
CoV O
- O
2 O
infection O
, O
our O
team O
has O
developed O
a O
rapid O
advice O
guideline O
and O
that O
has O
been O
published B-TERM
online O
in O
Military O
Medical O
Research O
on O
06 O
February O
2020 O
. O

It O
has O
attracted O
a O
great O
attention O
since O
published O
. O

Note O
however O
that O
COVID O
- O
19 O
is O
a O
new O
disease B-TERM
, O
our O
awareness O
and O
knowledge B-TERM
is O
gradually O
increasing O
based O
on O
the O
ongoing O
research O
findings B-TERM
and O
clinical O
practice O
experience O
; O
hence O
, O
the O
strategies O
of O
diagnosis O
and O
treatment O
are O
also B-TERM
continually B-TERM
updated O
. O

For O
instance O
the O
Diagnosis O
and O
Treatment O
Guidelines O
for O
COVID O
- O
19 O
issued O
by O
the O
National O
Health O
Committee O
of O
the O
People O
's O
Republic O
of O
China O
( O
http O
: O
/ O
/ O
www.nhc.gov.cn O
/ O
) O
, O
among O
16 O
January O
2020 O
to O
3 O
March O
2020 O
, O
has O
issued O
a O
total O
of O
seven O
editions O
with O
some O
contexts O
being O
substantively O
changed O
. O

Now O
our O
guideline O
received O
a O
comment O
by O
Zhou O
et O
al O
. O
, O
they O
introduced O
a O
simple B-TERM
scoring O
proposal O
based O
on O
their O
clinical O
experience O
. O

Their O
work O
added B-TERM
new O
evidence O
for O
our O
guideline O
and O
also B-TERM
make O
valuable B-TERM
reference O
for O
this O
pandemic O
worldwide O
. O

We O
endorse O
their O
significant O
work O
and O
express O
our O
thanks O
. O

However O
, O
their O
work O
also O
needs O
update O
according O
to O
the O
latest O
Diagnosis O
and O
Treatment O
Guidelines O
for O
COVID O
- O
19 O
( O
Trial O
seventh O
version O
) O
and O
recently O
studies B-TERM
. O

According O
to O
the O
seventh O
edition O
( O
3 O
March O
2020 O
) O
, O
to O
confirm O
the O
suspected O
case O
needs O
to O
combine O
any O
one O
item O
of O
epidemiological O
history O
features O
with O
two B-TERM
items O
of O
clinical O
manifestations O
to O
make O
a O
comprehensive O
analysis B-TERM
, O
or O
needs O
to O
meet O
three O
items O
of O
clinical O
manifestations O
if O
without O
clear O
epidemiological O
history O
: O

Epidemiological O
history O
: O
( O
1 O
) O
a O
history O
of O
travel O
or O
residence B-TERM
in O
Wuhan O
city O
and O
surrounding O
areas O
, O
or O
other O
communities O
where O
COVID O
- O
19 O
cases O
had O
been O
reported O
in O
the O
last O
14 O
days O
before O
symptom O
onset O
; O
( O
2 O
) O
a O
history O
of O
contact O
with O
SARS O
- O
CoV O
- O
2 O
infectious O
cases O
( O
with O
positive O
nucleic O
acid O
test O
) O
; O
( O
3 O
) O
a O
history O
of O
contacting O
with O
patients B-TERM
with O
fever O
or O
respiratory O
symptoms O
from O
Wuhan O
city O
and O
surrounding O
areas O
, O
or O
other O
communities O
where O
COVID O
- O
19 O
had O
been O
reported O
in O
the O
last O
14 O
days O
before O
symptom O
onset O
; O
( O
4 O
) O
a O
history O
of O
contacting O
with O
cluster O
of O
confirmed O
cases O
( O
‚â• O
2 O
cases O
with O
fever O
and O
/ O
or O
respiratory O
symptoms O
occurred O
within O
2 O
weeks O
in O
small B-TERM
areas O
, O
such O
as O
home B-TERM
, O
office B-TERM
, O
class O
of O
school O
, O
etc O
) O
. O

Clinical O
manifestations O
: O
( O
1 O
) O
fever O
and O
/ O
or O
respiratory O
symptoms O
; O
( O
2 O
) O
with O
imaging O
features O
of O
COVID O
- O
19 O
infection O
; O
( O
3 O
) O
total O
white O
blood O
cell O
counts O
showing O
normal B-TERM
, O
decreased O
, O
or O
reduced B-TERM
lymphocyte O
count O
in O
the O
early O
onset O
stage B-TERM
. O

Diagnosing O
the O
confirmed O
case O
should O
base O
on O
suspected O
case O
with O
any O
one O
item O
of O
pathogenic O
or O
serological O
evidence O
as O
following O
: O
( O
1 O
) O
real O
- O
time O
PCR O
test O
positive O
for O
SARS O
- O
CoV O
- O
2 O
; O
( O
2 O
) O
viral O
whole O
genome O
sequencing O
showing B-TERM
high O
homogeneity O
to O
the O
known O
novel O
coronaviruses O
; O
( O
3 O
) O
positive O
for O
the O
specific O
IgM O
antibody O
and O
IgG O
antibody O
to O
SARS O
- O
CoV O
- O
2 O
in O
serum O
test O
; O
or O
a O
change B-TERM
of O
the O
SARS O
- O
CoV O
- O
2 O
- O
specific O
IgG O
antibody O
from O
negative O
to O
positive O
, O
or O
titer O
rising O
‚â• O
4 O
times O
in O
the O
recovery O
phase O
above O
that O
in O
the O
acute O
phase O
. O

We O
can O
see O
that O
the O
real O
- O
time O
PCR O
test O
for O
nucleic O
acid O
in O
respiratory O
tract O
or O
blood B-TERM
samples O
was O
added B-TERM
to O
the O
second O
( O
18 O
January O
2020 O
) O
and O
third O
( O
22 O
January O
2020 O
) O
editions O
. O

The O
pathogenic O
detection O
of O
blood O
sample O
was O
added B-TERM
to O
the O
fourth O
( O
27 O
January O
2020 O
) O
and O
fifth O
( O
8 O
February O
2020 O
) O
editions O
; O
and O
then O
the O
serological O
evidence O
was O
added B-TERM
to O
the O
seventh O
edition O
. O

These O
modifications O
based O
on O
the O
researchers O
continued O
work O
that O
to O
search O
for O
an O
optimal O
nucleic O
acid O
detection O
kit O
for O
rapid B-TERM
diagnosis O
, O
as O
well O
as O
the O
samples O
from O
respiratory O
tract O
including O
blood B-TERM
sampling O
, O
which O
increased O
the O
availability O
of O
different O
specimens O
, O
and O
supported O
bringing O
the O
specific O
antibody O
positive O
result B-TERM
into O
the O
confirmed O
criteria O
. O

Besides O
, O
there O
are O
more O
and O
more O
evidence O
that O
remind O
us O
to O
caution O
with O
the O
atypical O
symptomatic O
and O
asymptomatic O
patients B-TERM
. O

Hence O
, O
the O
flow O
chart O
of O
Zhou O
et O
al. O
should O
be O
updated O
, O
as O
they O
classified O
the O
person O
without O
clinical O
symptoms O
as O
" O
low O
risk O
. O
" O

The O
score O
system O
also B-TERM
needs O
to O
be O
verified O
in O
further O
clinical O
practice O
and O
studies B-TERM
. O

To O
conclude B-TERM
, O
we O
hope O
more O
direct O
evidence O
coming O
up O
and O
call O
for O
readers O
to O
provide O
their O
comments O
. O

For O
the O
diagnosis O
of O
" O
suspected O
case O
" O
and O
" O
confirmed O
case O
, O
" O
we O
suggest O
to O
trace O
and O
obey O
the O
newest O
guidelines O
of O
their O
home O
countries O
. O

Our O
team O
will O
also B-TERM
timely B-TERM
update O
our O
guideline O
to O
offer O
help O
. O

Car B-TERM
strikes O
woman O
with O
two B-TERM
children O
in O
Penza O
Oblast O

A O
car B-TERM
struck O
a O
woman O
with O
an O
infant B-TERM
in O
a O
stroller O
and O
a O
three O
- O
year O
- O
old O
son O
in O
the O
Penza O
Oblast O
, O
killing O
one O
child O
. O

The O
head B-TERM
of O
the O
Regional O
Office O
of O
the O
Ministry O
of O
Internal O
Affairs O
press O
service O
Olga O
Evdokimova O
reported O
about O
it O
to O
Interfax O
. O

The O
accident O
occurred O
in O
the O
Serdobsk O
Region O
on O
Friday O
evening O
. O

The O
agency O
's O
interlocutor O
specified O
that O
the O
woman O
was O
walking O
with O
traffic O
on O
the O
roadside O
with O
a O
stroller O
with O
a O
child O
born O
in O
2019 O
, O
and O
her O
son O
, O
born O
in O
2016 O
. O

The O
driver O
of O
the O
Ford O
Focus O
struck O
all O
three O
of O
them O
. O

The O
older O
boy B-TERM
died O
as O
a O
result B-TERM
. O

The O
younger O
child O
was O
delivered O
to O
the O
hospital O
unconscious O
. O

THe O
woman O
suffered O
no O
trauma O
and O
was O
released O
after O
being O
examined O
. O

According O
to O
Evdokimova O
, O
the O
perpetrator O
of O
the O
accident B-TERM
tried B-TERM
to O
flee O
the O
scene O
, O
but O
was O
quickly O
detained O
. O

According O
to O
preliminary O
information B-TERM
, O
the O
driver O
was O
drunk O
and O
was O
sent O
for O
a O
medical O
examination O
. O

The O
accident B-TERM
is O
being O
investigated O
. O

A O
former O
high O
- O
ranking O
police O
officer O
from O
Kabardino O
- O
Balkaria O
was O
arrested O
in O
Karsnodar O

Law O
enforcement O
officials O
arrested O
Sergey O
Rybnikov O
, O
the O
former B-TERM
head B-TERM
of O
the O
Investigative O
Unit O
of O
the O
Internal O
Security O
Division O
of O
the O
Ministry O
of O
Internal O
Affairs O
of O
Kabardino O
- O
Balkaria O
, O
in O
a O
rented O
apartment O
in O
Krasnodar O
. O

Citing O
representatives O
from O
the O
Russian O
Ministry O
of O
Foreign O
Affairs O
and O
the O
Russian O
Investigative O
Committee O
, O
RIA O
News B-TERM
reported O
that O
he O
had O
been O
wanted O
since O
May O
for O
corruption O
. O

The O
man O
has O
been O
turned O
over O
to O
the O
investigation O
department O
. O

The O
detainee O
was O
taken O
into O
custody O
, O
but O
had O
been O
charged O
in O
absence O
beforehand O
. O

According O
to O
law O
enforcement O
, O
from O
2017 O
- O
2018 O
, O
officials O
from O
the O
Ministry O
of O
Internal O
Affairs O
of O
the O
Kabardino O
- O
Balkar O
Republic O
received B-TERM
42 O
million O
rubles O
in O
bribes O
. O

In O
exchange O
, O
they O
allowed O
alcoholic O
beverages O
to O
be O
illegally O
transported O
through O
the O
region B-TERM
. O

16 O
individuals O
are O
involved O
in O
the O
case O
. O

14 O
of O
them O
were O
detained O
during O
the O
initial O
stage B-TERM
of O
the O
investigation O
. O

Oleg O
Vinnik O
lands O
in O
Mirotvorets O
database O
: O
what O
happened O

Popular O
Ukrainian O
singer O
Oleg O
Vinnik O
, O
who O
starred O
in O
the O
project B-TERM
# O
VsemMir O
( O
# O
PeaceToAll O
) O
with O
Russian O
stars O
who O
support O
the O
Kremlin O
's O
policies O
towards O
Ukraine O
and O
the O
annexation O
of O
Crimea O
, O
has O
landed O
in O
the O
Mirotvorets O
( O
Peacemaer O
) O
database O
. O

A O
message B-TERM
about O
it O
appeared O
on O
the O
database O
's O
official O
site O
. O

The O
description O
talks O
about O
how O
Vinnik O
participated O
in O
the O
Russian O
anti O
- O
Ukrainian O
propaganda O
campaign O
# O
VsemMir O
, O
aimed O
at O
shifting O
responsibility O
for O
the O
war B-TERM
unleashed O
by O
Russia O
( O
an O
aggressor O
country O
) O
to O
Ukraine O
. O

Recall O
that O
the O
clip O
included O
Vladimir O
Pozner O
, O
Mireille O
Mathieu O
( O
France O
) O
, O
Alessandro O
Safina O
( O
Italy O
) O
, O
Valeria O
, O
Soso O
Pavliashvili O
, O
Igor O
Krutoy O
, O
Zara O
, O
Tamara O
Gverdtsiteli O
, O
Denis O
Klyaver O
, O
Valery O
Syutkin O
, O
Dmitry O
Malikov O
, O
Maxim O
Pokrovsky O
, O
Yana O
Poplavskaya O
, O
Maxim O
Averin O
, O
Ksenia O
Alferova O
, O
Nonna O
Grishaeva O
, O
and O
others O
. O

The O
majority O
of O
the O
participants O
in O
the O
flashmob O
pubicly O
support O
the O
aggressive O
policy O
of O
the O
Kremlin O
. O

Vinnik O
was O
the O
only O
Ukrainian O
participant O
in O
the O
project B-TERM
. O

The O
singer O
's O
press O
service O
previously O
explained O
that O
the O
artist O
took B-TERM
part O
in O
the O
project B-TERM
in O
support O
of O
the O
International O
Day O
of O
Peace O
, O
which O
is O
celebrated O
on O
September O
21 O
, O
and O
that O
his O
patriotic O
position O
has O
not O
changed O
. O

Recall O
that O
a O
wave O
of O
indignation B-TERM
arose O
online O
. O

The O
clip O
itself O
was O
called B-TERM
derisive O
. O

How O
can O
artists O
who O
have O
visited O
occupied O
Crimea O
and O
support O
the O
policies O
of O
Putin O
, O
who O
launched O
the O
war B-TERM
in O
Donbass O
, O
where O
people O
are O
dying O
almost O
daily O
, O
speak B-TERM
about O
peace O
? O

Four O
people O
sentenced O
for O
a O
series O
of O
dacha O
robberies O
in O
Khabarovsk O

In O
Khabarovsk O
a O
court O
sentenced O
four O
residents O
of O
the O
village O
Druzhba O
, O
who O
over O
the O
course O
of O
two B-TERM
years O
burgled O
dachas O
in O
the O
Kosmos O
and O
Raduga O
communities O
in O
the O
Chernaya O
Rechka O
area B-TERM
. O

IA O
Khabarovsky O
Kray O
Segodnya O
reports O
this O
on O
27 O
September O
. O

The O
criminal B-TERM
group O
consisted O
of O
previously O
unconvicted O
men O
aged O
31 O
and O
37 O
years O
and O
two B-TERM
brothers O
aged O
21 O
and O
24 O
years O
. O

It O
was O
established O
that O
the O
instigator O
of O
the O
crimes B-TERM
was O
the O
elder O
of O
the O
brothers O
who O
had O
spent O
time O
in O
a O
juvenile O
detention O
facility O
in O
his O
youth O
. O

On O
his O
own O
he O
robbed O
nine O
houses B-TERM
, O
the O
others O
joined O
in O
later O
. O

The O
damage B-TERM
from O
each O
theft B-TERM
was O
from O
three O
to O
21 O
thousand O
rubles O
. O

The O
criminals O
took O
away O
stoves O
, O
refrigerators O
, O
curtains O
, O
buckets O
, O
gas O
canisters O
, O
chairs O
, O
cabinets O
and O
many O
other O
objects B-TERM
. O

They O
were O
caught O
thanks O
to O
an O
alarm O
signalling O
in O
the O
last O
house B-TERM
. O

The O
defendants O
were O
found O
guilty B-TERM
of O
theft B-TERM
carried O
out O
with O
illegal B-TERM
entry O
into O
a O
residence B-TERM
causing O
significant B-TERM
damage B-TERM
by O
a O
group O
in O
a O
prior O
conspiracy O
. O

" O
The O
brothers O
are O
sentenced O
to O
3 O
years O
6 O
months O
' O
imprisonment O
in O
a O
general O
regime O
penal O
colony O
, O
and O
the O
two O
other O
defendants O
- O
to O
two O
years O
10 O
months O
' O
and O
1 O
year O
6 O
months O
' O
suspended O
prison O
sentence O
, O
" O
the O
Khabarovsk O
region O
prosecutor B-TERM
's O
senior O
assistant O
Yulia O
Vasilyeva O
was O
quoted O
by O
the O
agency O
. O

Medvedev O
: O
Kokorin O
continues O
individual O
training O
program O

Petersburg O
Zenit O
forward O
Alexander O
Kokorin O
is O
continuing O
to O
train O
under O
an O
individual O
program O
after O
his O
release O
on O
parole O
, O
TASS O
reports O
citing O
the O
team O
's O
general O
director O
Alexander O
Medvedev O
. O

Last O
Thursday O
, O
26 O
September O
, O
the O
striker O
started O
training O
with O
Zenit O
- O
2 O
. O

The O
trainer O
of O
the O
second O
dark O
blue O
- O
white O
- O
sky O
blue O
team O
Vladislav O
Radimov O
posted O
a O
photo B-TERM
of O
Kokorin O
on O
his O
Instagram O
page O
. O

Earlier O
Medvedev O
said O
that O
Kokorin O
, O
possibly B-TERM
, O
will O
play O
for O
Zenit O
in O
a O
friendly O
game O
in O
the O
autumn O
. O

The O
forward O
can O
only O
appear O
in O
official O
meetings O
after O
22 O
January O
2020 O
, O
he O
must O
be O
registered O
in O
the O
nearest O
transfer O
window O
. O

To O
recap O
, O
on O
8 O
October O
2018 O
Kokorin O
, O
his O
younger O
brother O
Kirill O
, O
Krasnodar O
halfback O
Pavel O
Mamayev O
and O
children O
's O
trainer O
Alexander O
Protasovitsky O
participated O
in O
a O
series O
of O
fights O
in O
the O
center O
of O
Moscow O
. O

The O
inebriated O
sportsmen O
beat O
up O
three O
people O
. O

They O
spent O
a O
long O
time O
in O
pretrial O
detention O
. O

In O
May O
2019 O
a O
court O
sentenced O
them O
to O
real O
jail O
terms O
. O

The O
Kokorin O
brothers O
were O
sentenced O
to O
one O
- O
and O
- O
a O
- O
half O
years O
behind O
bars O
, O
Mamayev O
and O
Protasovitsky O
- O
to O
1 O
year O
and O
5 O
months O
. O

In O
September O
2019 O
a O
court O
granted O
the O
request O
of O
the O
sportsmen O
, O
with O
the O
exclusion O
of O
Protasovitsky O
, O
for O
early O
release O
on O
parole O
. O

The O
first O
fight O
under O
Alexander O
Emelianenko O
's O
rules O
is O
set O
to O
take O
place O
on O
November O
29 O
. O

The O
first O
MMA O
bout O
under O
Alexander O
Emelianenko O
's O
rules O
is O
to O
take O
place O
in O
Moscow O
on O
November O
29 O
- O
on O
the O
undercard O
boxing O
match O
between O
Emelianenko O
and O
strongman O
Mikhail O
Koklyaev O
. O

Fights O
have O
been O
lost O
in O
the O
spectacle O
, O
said O
Emelianenko O
in O
an O
interview O
with O
SE O
. O

There O
is O
nothing O
to O
look O
at O
. O

That O
is O
why O
I O
have O
thought O
up O
a O
new O
mixed O
martial O
art O
- O
Universal O
World O
Fight O
. O

The O
rules O
call O
for O
three O
different O
rounds O
. O

MMA O
is O
the O
type O
of O
sport O
where O
all O
types O
of O
martial O
arts O
come O
together O
. O

A O
mixed O
- O
style O
fighter O
should O
be O
able O
to O
do O
it O
all O
- O
work O
standing O
, O
wrestle O
, O
and O
work O
on O
the O
ground O
. O

The O
first O
round O
consists O
of O
only O
striking O
while O
standing O
. O

The O
second O
round O
is O
only O
wrestling O
, O
furthermore O
, O
holds O
on O
the O
ground O
are O
only O
permitted O
for O
30 O
seconds O
. O

Everything O
is O
permitted B-TERM
in O
the O
third O
round O
. O

When O
will O
the O
first O
tournament O
using O
your O
rules O
take O
place O
? O

November O
29 O
. O

With O
the O
undercard O
bout O
with O
Koklyaev O
. O

But O
it O
is O
still O
not O
known O
how O
many O
bouts O
there O
will O
be O
. O

A O
veteran O
and O
his O
spouse O
were O
killed O
in O
a O
Russian O
city O

A O
WWII O
veteran O
and O
his O
wife B-TERM
were O
killed O
in O
Ryazan O
. O

This O
is O
reported O
on O
the O
regional B-TERM
Investigative O
Committee O
's O
website O
. O

The O
bodies O
of O
a O
man O
and O
woman O
born O
in O
1928 O
and O
1930 O
were O
found B-TERM
in O
their O
apartment O
. O

It O
is O
noted O
that O
signs O
of O
violent O
death O
were O
found O
on O
them O
. O

A O
criminal B-TERM
case O
has O
been O
opened O
into O
what O
happened O
. O

The O
investigation O
is O
following O
different O
leads O
, O
including O
mercenary O
motives O
for O
murder O
. O

The O
investigation O
is O
currently O
under O
way O
. O

On O
24 O
August O
it O
was O
reported O
that O
in O
Kaluga O
a O
man O
was O
detained O
, O
who O
had O
killed O
a O
92 O
- O
year O
- O
old O
veteran O
to O
get O
money O
for O
drugs O
. O

It O
is O
noted O
that O
the O
elderly O
man O
was O
beaten O
at O
least O
10 O
times O
. O

A O
criminal O
case O
was O
opened O
under O
part O
4 O
of O
article O
111 O
of O
the O
Russian O
Criminal O
Code O
( O
" O
Intentional O
infliction O
of O
a O
grave O
injury O
, O
causing O
the O
death O
of O
the O
victim O
by O
negligence O
" O
) O
. O

Later O
the O
Telegram O
channel O
Mash O
reported O
that O
the O
suspect O
in O
the O
killing O
glazed O
the O
veteran O
's O
balcony O
five O
years O
ago O
. O

KAMAZ O
- O
master O
is O
sending O
four O
teams O
to O
Dakar O
Rally O
2020 O

At O
a O
KAMAZ O
- O
master O
press O
conference B-TERM
on O
Friday O
, O
September O
27 O
, O
in O
Naberezhniye O
Chelny O
, O
the O
team O
's O
leader B-TERM
, O
Vladimir O
Chagin O
, O
named B-TERM
the O
racers O
who O
would O
be O
taking B-TERM
part O
in O
rally O
raid O
Dakar O
Rally O
2020 O
. O

The O
Russian O
team O
will O
be O
represented O
at O
the O
marathon O
rally O
by O
four O
crew B-TERM
members O
who O
will O
be O
driving O
KAMAZ O
- O
43509 O
: O
current O
Dakar O
champion O
Eduard O
Nikolaev O
, O
the O
winner O
of O
the O
Silk O
Way O
2019 O
rally O
, O
Anton O
Shibalov O
, O
as O
well O
as O
Andrei O
Karginov O
and O
Dmitry O
Sotnikov O
. O

The O
team O
's O
preparations O
for O
the O
Dakar O
Rally O
2020 O
are O
currently O
in O
their O
final O
stage B-TERM
. O

This O
was O
announced B-TERM
by O
the O
team O
's O
press O
service O
. O

The O
first O
technical O
inspections O
and O
ferry O
loading O
of O
the O
race O
participants O
' O
equipment O
to O
be O
sent O
to O
the O
Arab O
Peninsula O
will O
take O
place O
in O
the O
French O
city O
of O
Marseille O
on O
December O
5 O
- O
6 O
. O

Starting O
from O
2020 O
, O
the O
Dakar O
marathon O
rally O
will O
be O
taking O
place O
in O
a O
new O
location O
. O

Having O
taken O
place O
for O
the O
last O
10 O
years O
on O
routes O
in O
South O
America O
, O
the O
race O
's O
organizers O
have O
signed O
a O
five O
- O
year O
contract B-TERM
with O
Saudi O
Arabia O
. O

The O
42nd O
Dakar O
kicks O
off O
on O
January O
5 O
, O
starting O
from O
the O
Red O
Sea O
shores B-TERM
in O
Jeddah O
. O

The O
participants O
will O
have O
a O
rest O
day O
in O
the O
kingdom O
's O
capital O
, O
Riyadh O
, O
on O
January O
11 O
and O
the O
race O
is O
planned O
to O
finish O
in O
Qiddiya O
on O
January O
17 O
. O

Trading O
with O
Russia O
- O
it O
's O
not O
just O
tanks B-TERM

Trade O
turnover O
between O
Russia O
and O
India O
could O
double O
thanks O
to O
the O
geopolitical O
situation B-TERM

The O
deputy O
director O
of O
the O
Confederation O
of O
Indian O
Industry B-TERM
Manish O
Kumar O
spoke O
of O
this O
at O
the O
5th O
Anniversary O
Small B-TERM
and O
Medium O
- O
Sized O
Businesses O
Forum O
of O
the O
SCO O
and O
BRICS O
Regions B-TERM
. O

It O
's O
important O
for O
us O
to O
learn O
from O
the O
SCO O
and O
BRICS O
countries O
, O
including O
Russia O
, O
emphasized O
the O
guest O
from O
Delhi O
. O

- O
In O
our O
confederation O
there O
are O
9000 O
direct O
members O
and O
300,000 O
partner O
companies B-TERM
from O
130 O
countries O
. O

This O
is O
all O
small B-TERM
and O
medium O
- O
sized O
business O
cooperating O
with O
Shanghai O
organization B-TERM
countries O
. O

And O
we O
aren O
't O
standing O
still O
, O
but O
developing O
, O
while O
at O
the O
same O
time O
all O
these O
sanctions O
against O
Russia O
and O
the O
geopolitical O
situation B-TERM
only O
help B-TERM
us O
grow O
. O

Now O
our O
bilateral O
trade O
exceeds O
$ O
10 O
bln O
, O
but O
these O
figures O
could O
double O
. O

Firstly O
, O
on O
account O
of O
new O
technologies O
in O
the O
area O
of O
healthcare O
, O
artificial O
intelligence O
and O
robotics O
. O

Our O
trade O
is O
more O
than O
just O
tanks B-TERM
and O
heavy O
industry B-TERM
. O

According O
to O
Manish O
Kumar O
, O
India O
has O
already O
established O
initial O
contacts O
with O
contemporary O
centers O
of O
Russia O
. O

As O
such O
, O
the O
delegation O
from O
Delhi O
and O
other O
cities O
recently O
visited O
Skolkovo O
and O
Innopolis O
. O

We O
signed O
a O
memorandum O
on O
creating O
a O
system O
in O
which O
we O
will O
be O
able O
to O
build O
our O
modern B-TERM
business O
. O

After O
all O
, O
entrepreneurship O
is O
not O
a O
whim B-TERM
, O
but O
a O
necessity B-TERM
. O

A O
necessary B-TERM
step B-TERM
for O
us O
towards O
economic O
well O
- O
being O
. O

We O
need O
to O
expand O
, O
attract O
small B-TERM
and O
medium O
- O
sized O
business O
, O
and O
together B-TERM
with O
Russia O
, O
China O
and O
other O
countries O
we O
will O
definitely O
do O
this O
, O
stressed O
the O
Indian O
entrepreneur O
. O

To O
recap O
, O
Ufa O
is O
hosting O
the O
Small B-TERM
and O
Medium O
- O
Sized O
Businesses O
Forum O
of O
the O
SCO O
and O
BRICS O
Regions B-TERM
for O
the O
fifth O
consecutive O
time O
. O

From O
25 O
- O
27 O
September O
more O
than O
2800 O
people O
from O
Russia O
and O
another O
31 O
countries O
took B-TERM
part O
in O
the O
forum O
. O

As O
part O
of O
a O
working O
tour O
to O
Tobolsk O
, O
Tyumen O
region B-TERM
Governor O
Alexander O
Moor O
took B-TERM
part O
in O
the O
formal O
opening O
of O
the O
Sokolovsky O
Water O
Intake O
following B-TERM
its O
reconstruction O
. O

It O
can O
now O
process O
25,000 O
cubic O
meters O
a O
day O
. O

The O
water O
intake O
's O
reconstruction O
took O
place O
as O
part O
of O
the O
Clean O
Water O
federal O
project B-TERM
under O
the O
auspices O
of O
the O
Ecology O
national O
project O
. O

Investors O
provided O
the O
authorities O
with O
assistance O
: O
the O
Sokolovsky O
Water O
Intake O
was O
one O
example O
of O
the O
public O
- O
private O
partnership O
at O
work O
. O

The O
Tyumen O
region B-TERM
provides O
the O
country O
with O
a O
unique B-TERM
example O
of O
cooperation B-TERM
in O
this O
field O
between O
federal O
structures O
, O
regional B-TERM
authorities O
, O
local B-TERM
administration O
and O
private O
investors O
. O

New O
artesian O
wells O
appeared O
at O
the O
site O
. O

Pumping O
stations O
were O
built O
above O
them O
. O

Purification O
and O
sanification O
facilities O
were O
reconstructed O
. O

As O
a O
result B-TERM
, O
the O
Sokolovsky O
Water O
Intake O
provides O
the O
residents O
of O
Tobolsk O
with O
quality O
drinking O
water O
. O

Plans B-TERM
call O
for O
Sokolovsky O
and O
Zhukovsky O
water O
intakes O
to O
be O
connected O
. O

After O
which O
, O
Tobolsk O
will O
be O
able B-TERM
to O
fully O
switch O
to O
subterranean O
water O
sources O
. O

Water O
purification O
facilities O
are O
to O
be O
expanded O
in O
Vagai O

Bangladesh O
reports O
five O
new O
deaths O
due O
to O
COVID O
- O
19 O
, O
a O
daily O
highest O

Yesterday O
, O
Bangladesh O
has O
confirmed O
five O
new O
deaths O
due O
to O
COVID O
- O
19 O
on O
the O
day O
. O

This O
is O
the O
highest O
number B-TERM
of O
fatalities O
in O
a O
day O
due O
to O
the O
virus O
. O

As O
of O
yesterday O
, O
Bangladesh O
's O
Institute O
of O
Epidemiology O
, O
Disease B-TERM
Control O
and O
Research O
( O
IEDCR O
) O
reported O
the O
number B-TERM
of O
recorded O
infected O
cases O
included O
114 O
active O
cases O
and O
33 O
recovered O
cases O
who O
were O
staying O
home O
. O

A O
total O
of O
17 O
deaths O
have O
been O
recorded O
. O

In O
an O
online O
news O
briefing O
, O
the O
director O
of O
IEDCR O
, O
Dr O
Meerjady O
Sabrina O
Flora O
, O
said O
the O
fatalities O
included O
four O
males O
and O
one O
female O
. O

According O
to O
Dr O
Meerjady O
, O
two B-TERM
cases O
were O
aged O
above O
60 O
, O
two B-TERM
between O
51 O
and O
60 O
, O
and O
one O
41 O
- O
50 O
years O
old O
. O

She O
also B-TERM
said O
two O
of O
the O
victims O
were O
from O
Dhaka O
. O

The O
World O
Health O
Organization B-TERM
( O
WHO O
) O
declared B-TERM
COVID O
- O
19 O
a O
pandemic O
on O
March O
11 O
. O

A O
hospital O
official O
told O
Anadolu O
Agency O
, O
a O
local B-TERM
news O
outlet O
, O
that O
one O
of O
the O
deceased O
was O
Jalal O
Saifur O
Rahman O
, O
a O
director O
of O
Bengali O
Anti O
- O
Corruption O
Commission O
, O
who O
was O
cared O
for O
at O
the O
Kuwait O
Maitree O
Hospital O
. O

On O
Saturday O
, O
in O
an O
online O
video O
announcement O
, O
Bangladeshi O
Road O
Transport O
and O
Bridges O
Minister O
Obaidul O
Quader O
said O
public O
transport O
would O
be O
shut O
down O
for O
longer O
than O
initially B-TERM
planned O
, O
until O
this O
coming O
Saturday O
. O

This O
public O
transport O
shutdown O
had O
initially O
started O
on O
March O
26 O
and O
was O
planned O
to O
end O
on O
Saturday O
, O
April O
4 O
. O

Transport O
of O
essential O
goods O
-- O
medical O
, O
fuel B-TERM
and O
food O
-- O
was O
still O
allowed B-TERM
. O

The O
first O
recorded O
incidents O
of O
COVID O
- O
19 O
infection O
in O
Bangladesh O
were O
on O
March O
8 O
, O
in O
two B-TERM
people O
who O
returned O
from O
Italy O
and O
also B-TERM
the O
wife B-TERM
of O
one O
of O
them O
. O

As O
of O
March O
19 O
, O
these O
three O
had O
already O
recovered O
. O

Congress O
sees B-TERM
" O
Russian O
influence O
" O
in O
Trump O
's O
talks O
with O
Zelensky O

The O
lower O
house B-TERM
of O
the O
US O
Congress O
has O
accused O
Russia O
of O
involvement O
in O
a O
scandal O
arising O
from O
a O
telephone O
conversation B-TERM
between O
White O
House O
head B-TERM
Donald O
Trump O
and O
Ukrainian O
President O
Volodymyr O
Zelensky O
. O

MSNBC O
News O
reports O
that O
House O
of O
Representatives O
Speaker O
Nancy O
Pelosi O
said O
that O
" O
Russians B-TERM
" O
may O
somehow O
be O
behind O
the O
episode O
. O

" O
I O
think B-TERM
that O
Russia O
had O
a O
hand O
in O
this O
, O
" O
said O
the O
Democrat O
, O
while O
refraining O
from O
further O
comment O
. O

Headed O
by O
Pelosi O
, O
the O
Democrats O
, O
who O
hold O
a O
majority O
in O
the O
house O
, O
earlier O
announced B-TERM
the O
launch O
of O
impeachment O
proceeding O
against O
the O
president O
. O

This O
comes O
after O
a O
complaint O
by O
an O
intelligence O
informer O
against O
Trump O
. O

The O
informer O
suspected O
that O
during O
a O
conversation B-TERM
with O
Zelensky O
in O
July O
, O
Trump O
pressured B-TERM
Zelensky O
to O
have O
Ukraine O
open O
a O
case O
against O
the O
son O
of O
former B-TERM
Vice O
President O
Joseph O
Biden O
, O
who O
may O
become O
Trump O
's O
adversary O
in O
the O
elections O
scheduled O
for O
one O
year O
's O
time O
. O

The O
White O
House B-TERM
had O
to O
provide O
congress O
members O
and O
the O
general O
public O
with O
a O
transcript O
of O
the O
controversial O
conversation B-TERM
. O

Nornikel O
to O
allocate O
139.8 O
billion O
rubles O
for O
dividends O
per O
results B-TERM
of O
first O
half O
of O
year O

Norilsky O
Nikel O
will O
allocate O
139.88 O
billion O
rubles O
( O
about O
$ O
2.1 O
billion O
) O
for O
dividends O
, O
according O
to O
the O
results B-TERM
of O
the O
first O
half O
of O
2019 O
. O

The O
decision B-TERM
was O
made O
at O
an O
extraordinary O
shareholders O
' O
meeting O
. O

It O
is O
noted O
that O
the O
payment O
per O
share O
will O
be O
883.93 O
rubles O
. O

" O
The O
shareholders O
confirmed O
October O
7 O
, O
2019 O
as O
the O
date O
for O
determining O
who O
will O
be O
entitled O
to O
receive O
dividends O
, O
" O
the O
company B-TERM
's O
press O
service O
said O
. O

According O
to O
data B-TERM
from O
the O
Moscow O
Stock O
Exchange O
at O
18 O
: O
03 O
, O
the O
value B-TERM
of O
one O
Nornikel O
share O
rose O
1.04 O
% O
to O
16,500 O
rubles O
. O

Wang O
Yi O
met O
with O
Secretary O
- O
General O
of O
the O
United O
Nations O
A. O
Guterres O

Chinese O
State O
Counselor O
and O
Minister O
of O
Foreign B-TERM
Affairs O
Wang O
Yi O
met O
with O
Secretary O
- O
General O
of O
the O
United O
Nations O
Ant√≥nio O
Guterres O
in O
the O
United O
Nations O
Headquarters O
in O
New O
York O
on O
Thursday O
. O

A. O
Guterres O
announced B-TERM
at O
the O
meeting O
that O
China O
is O
playing O
an O
extremely B-TERM
important B-TERM
role B-TERM
in O
the O
creation B-TERM
of O
a O
multipolar O
world O
. O

The O
UN O
thanked O
the O
Chinese O
government O
for O
its O
huge O
support O
and O
fruitful B-TERM
cooperation B-TERM
, O
it O
highly O
valued O
as O
well O
China O
's O
important B-TERM
contribution O
to O
the O
international O
struggle O
against O
poverty O
and O
climate O
change B-TERM
as O
well O
as O
its O
creation B-TERM
of O
a O
green O
Belt B-TERM
and O
Road O
Initiative O
. O

He O
would O
like O
to O
see O
cooperation B-TERM
increase O
with O
China O
in O
efforts O
to O
protect O
peace O
and O
security O
and O
sustainable B-TERM
development O
as O
well O
as O
expecting B-TERM
that O
China O
continue O
to O
play O
a O
leading B-TERM
role B-TERM
in O
fighting O
climate O
change B-TERM
and O
other O
areas B-TERM
. O

Wang O
Yi O
responded O
that O
a O
multipolar O
world O
was O
an O
inevitable B-TERM
trend B-TERM
and O
every O
country O
had O
a O
right O
to O
development O
. O

The O
creation O
of O
a O
multipolar O
world O
was O
not O
possible O
without O
multilateralism O
- O
a O
symbol O
of O
which O
was O
the O
main B-TERM
goals B-TERM
and O
principles O
established O
in O
the O
UN O
Charter O
. O

According O
to O
the O
minister O
, O
China O
supports O
a O
more O
active B-TERM
role B-TERM
for O
the O
UN O
, O
supporting O
the O
work O
of O
the O
secretary O
- O
general O
at O
the O
international O
organization B-TERM
and O
strongly O
supporting O
the O
basic O
ideas B-TERM
and O
principles O
of O
the O
UN O
Charter O
. O

Next B-TERM
year O
the O
UN O
will O
mark O
the O
75th O
anniversary O
of O
its O
founding O
and O
China O
intends B-TERM
to O
use B-TERM
this O
opportunity O
to O
strengthen O
its O
cooperation B-TERM
with O
the O
international O
organization B-TERM
in O
order O
that O
combined O
efforts O
will O
create O
a O
bright O
future O
for O
the O
entire B-TERM
world O
. O

President O
Duterte O
of O
the O
Philippines O
to O
Visit O
Russia O
for O
Five O
Days O

Citing O
the O
spokesperson O
of O
the O
Department O
of O
Foreign B-TERM
Affairs O
of O
the O
Philippines O
, O
Amelita O
Aquino O
, O
TASS O
has O
reported O
that O
President O
Rodrigo O
Duterte O
of O
the O
Philippines O
will O
visit O
Russia O
in O
October O
. O

Specifically O
, O
Duterte O
will O
arrive O
in O
Russia O
on O
October O
1 O
. O

His O
visit O
to O
Russia O
will O
last O
until O
October O
5 O
. O

Aquino O
said O
that O
the O
Philippine O
President O
will O
travel O
to O
Russia O
by O
invitation O
from O
Russian O
leader B-TERM
Vladimir O
Putin O
. O

Duterte O
will O
take O
part O
in O
the O
Valdai O
Discussion O
Club O
forum O
in O
Sochi O
. O

The O
Philippine O
leader B-TERM
will O
also B-TERM
visit O
Moscow O
. O

In O
the O
capital O
, O
Duterte O
will O
take B-TERM
part O
in O
the O
Philippines O
- O
Russia O
Business O
Forum O
and O
give O
a O
lecture O
at O
the O
Moscow O
State O
Institute O
of O
International O
Relations O
( O
MGIMO O
) O
. O

According O
to O
Aquino O
, O
the O
main B-TERM
event O
of O
the O
trip B-TERM
is O
a O
meeting O
between O
the O
two B-TERM
presidents O
. O

The O
leaders B-TERM
are O
slated O
to O
discuss O
the O
state O
of O
their O
bilateral O
relationship O
and O
how O
the O
countries O
can O
continue O
to O
expand O
collaboration O
in O
various O
fields O
. O

It O
was O
noted O
that O
the O
meeting O
between O
the O
Philippine O
and O
Russian O
leader B-TERM
will O
be O
their O
fourth O
overall O
. O

The O
first O
time O
the O
presidents O
met O
was O
in O
2016 O
at O
the O
APEC O
summit O
in O
Peru O
. O

The O
head B-TERM
of O
the O
Philippines O
visited O
Russia O
in O
May O
2017 O
, O
and O
the O
leaders B-TERM
met O
again O
in O
November O
2017 O
during O
the O
APEC O
summit O
in O
Vietnam O
. O

It O
was O
previously O
reported O
that O
President O
Rodrigo O
Duterte O
allowed B-TERM
citizens O
to O
shoot O
corrupt O
officials O
. O

Elon O
Musk O
responded O
in O
Russian O
to O
an O
" O
unusual B-TERM
invitation O
" O
to O
a O
business O
forum O
in O
Krasnodar O

Elon O
Musk O
, O
the O
founder O
of O
Tesla O
and O
SpaceX O
, O
reacted O
to O
an O
invitation O
from O
the O
organizers O
of O
a O
Krasnodar O
business O
forum O
to O
attend O
their O
event O
. O

The O
billionaire O
commented O
under O
one O
of O
the O
uploaded O
photos B-TERM
of O
the O
" O
inviting O
billboard O
" O
near O
his O
company B-TERM
's O
office B-TERM
. O

One O
of O
the O
organizers O
of O
the O
" O
Act O
small O
! O
" O
forum O
had O
placed O
a O
billboard O
in O
the O
city O
of O
Horton O
, O
California O
with O
the O
words O
" O
Kak O
tebe O
takoe O
? O
" O
and O
the O
site O
welcomeelon.com O
on O
the O
other O
side O
. O

There O
was O
also B-TERM
a O
special O
QR O
code O
, O
which O
would O
help B-TERM
people O
open O
the O
forum O
website O
and O
find O
information B-TERM
. O

Telegramma.pro O
reported O
that O
the O
inventor O
wrote O
" O
Well O
said O
" O
in O
Russian O
in O
response B-TERM
to O
the O
invitation O
. O

While O
it O
's O
uncertain O
what O
Musk O
meant O
by O
his O
response B-TERM
, O
many O
Russians B-TERM
, O
including O
the O
forum O
speakers O
, O
are O
hoping O
the O
billionaire O
will O
present O
. O

At O
the O
same O
time O
on O
the O
program O
" O
Evening O
Urgant O
, O
" O
they O
've O
already O
imagined B-TERM
how O
the O
billionaire O
would O
be O
outfitted O
in O
Krasnodar O
. O

They O
dressed O
the O
businessman O
in O
a O
Cossak O
outfit O
and O
proposed O
that O
in O
Kuban O
, O
Musk O
would O
be O
presented O
with O
an O
electric O
saber O
, O
electric O
crop O
, O
and O
electric O
saddle O
for O
a O
horse O
. O

Famous B-TERM
land O
artist O
created O
portrait O
of O
Greta O
Thunberg O

It O
had O
to O
happen O
sooner O
or O
later O
. O

The O
image O
of O
Greta O
Thunberg O
has O
been O
immortalized O
by O
a O
tractor O
on O
a O
field O
. O

The O
activist O
's O
portrait O
was O
created O
by O
the O
renowned B-TERM
land O
artist O
Dario O
Gambarin O
. O

The O
16 O
- O
year O
- O
old O
schoolgirl O
from O
Sweden O
, O
who O
suffers O
from O
Asperger O
syndrome O
, O
became O
famous B-TERM
after O
her O
speech B-TERM
at O
the O
UN O
assembly O
. O

The O
activist O
accused O
all O
adults O
of O
robbing O
the O
young O
generation O
of O
their O
childhood O
and O
dreams B-TERM
, O
polluting O
the O
planet O
and O
depriving O
them O
of O
their O
future O
under O
the O
pretense O
of O
economic O
development O
. O

Greta O
is O
nominated O
for O
the O
alternative O
Nobel O
Peace O
Prize O
, O
she O
may O
become O
its O
youngest O
- O
ever O
holder O
, O
and O
mass O
media O
vie O
to O
call B-TERM
the O
schoolgirl O
the O
most O
influential O
teenager B-TERM
in O
the O
world O
. O

US O
Congress O
gives O
approval O
to O
sell O
F O
- O
35 O
fighter O
aircraft O
to O
Poland O

Warsaw O
also B-TERM
plans O
to O
get B-TERM
F O
- O
135 O
engines B-TERM
and O
associated O
equipment B-TERM

The O
United B-TERM
States O
Congress O
approved O
the O
sale O
of O
32 O
fifth O
- O
generation O
F O
- O
35 O
fighter O
- O
bomber O
aircraft O
to O
the O
Poland O
. O

This O
was O
announced B-TERM
by O
the O
republic O
's O
Minister O
of O
National O
Defense B-TERM
Mariusz O
B≈Çaszczak O
. O

According O
to O
his O
information B-TERM
, O
in O
addition O
to O
the O
aircraft O
Warsaw O
will O
receive B-TERM
33 O
Pratt O
& O
Whitney O
two O
- O
spool O
afterburning O
turbofan O
engines B-TERM
, O
and O
also B-TERM
auxiliary O
equipment B-TERM
. O

The O
reservation O
price O
of O
the O
contract B-TERM
is O
$ O
6.5 O
billion O
. O

" O
This O
is O
one O
of O
the O
last O
steps B-TERM
before O
signing O
the O
contract B-TERM
, O
but O
it O
is O
not O
the O
end B-TERM
of O
our O
work O
. O

We O
will O
do O
everything O
possible B-TERM
to O
get O
the O
best O
possible O
price O
, O
" O
B≈Çaszczak O
wrote O
on O
his O
Twitter O
page O
. O

The O
kp.ru O
website O
wrote O
that O
the O
American O
F O
- O
35s O
are O
to O
replace B-TERM
the O
Soviet O
- O
produced O
MiG O
- O
29s O
and O
Su O
- O
22s O
that O
Poland O
currently O
has O
in O
service O
. O

The O
bilateral O
deal B-TERM
is O
expected O
to O
raise O
the O
republic O
's O
security O
. O

Russian O
Defense O
Ministry O
publishes B-TERM
video O
of O
launch O
of O
supersonic O
Onyx O
missile O
in O
Chukotka O

The O
Bastion O
coastal O
complex O
of O
the O
Pacific O
fleet O
has O
launched O
the O
supersonic O
Onyx O
cruise O
missle O
for O
the O
first O
time O
. O

The O
Russian O
Defense O
Ministry O
published B-TERM
a O
video O
of O
the O
launch O
on O
Twitter O
. O

As O
the O
television O
channel O
Star O
reports O
, O
the O
missile O
flew O
in O
standard O
mode O
. O

The O
missile O
successfully B-TERM
hit O
the O
target O
, O
which O
was O
located O
over O
the O
Chukchi O
Sea O
at O
a O
distance B-TERM
of O
more O
than O
200 O
km O
. O

About O
10 O
combat O
ships B-TERM
, O
as O
well O
as O
marine O
aicraft O
provided O
for O
the O
safety O
of O
the O
maneuvers O
. O

Equipment O
and O
military O
personnel O
were O
delivered O
to O
the O
place B-TERM
of O
training O
on O
a O
landing O
craft O
. O

The O
combat O
crew O
fired O
at O
the O
sea O
target B-TERM
, O
located O
at O
a O
distance B-TERM
of O
more O
than O
200 O
kilometers O

World O
Health O
Organization B-TERM
declares B-TERM
COVID O
- O
19 O
pandemic O

On O
Wednesday O
, O
the O
World O
Health O
Organization B-TERM
( O
WHO O
) O
declared B-TERM
the O
ongoing O
outbreak O
of O
COVID O
- O
19 O
- O
the O
disease B-TERM
caused B-TERM
by O
coronavirus O
SARS O
- O
CoV O
- O
2 O
- O
to O
be O
a O
pandemic O
. O

Although O
the O
word O
" O
pandemic O
" O
only O
refers O
to O
how O
widely O
a O
disease B-TERM
has O
spread O
, O
not O
how O
dangerous O
specific O
cases O
are O
, O
the O
WHO O
noted O
the O
need O
to O
drive O
governments O
to O
action O
: O

All O
countries O
can O
still O
change O
the O
course O
of O
this O
pandemic O
. O

If O
countries O
detect O
, O
test O
, O
treat O
, O
isolate O
, O
trace O
and O
mobilize O
their O
people O
in O
the O
response O
, O
said O
Tedros O
Adhanom O
Ghebreyesus O
, O
the O
Director O
- O
General O
of O
the O
WHO O
. O

We O
are O
deeply O
concerned O
both O
by O
the O
alarming O
levels O
of O
spread O
and O
severity O
and O
by O
the O
alarming O
levels O
of O
inaction O
. O

According O
to O
Dr. O
Tom O
Frieden O
, O
formerly O
the O
director O
of O
the O
United O
States O
' O
Centers O
for O
Disease B-TERM
Control O
and O
Prevention O
, O
the O
pandemic O
is O
" O
unprecedented B-TERM
. O
" O

He O
said O
, O
in O
remarks O
published O
by O
CNN O
in O
February O
, O
" O
other O
than O
influenza O
, O
no O
other O
respiratory O
virus O
has O
been O
tracked O
from O
emergence B-TERM
to O
continuous O
global O
spread O
. O
" O

Ghebreyesus O
expressed O
a O
similar B-TERM
view O
, O
saying O
" O
we O
have O
never O
before O
seen O
a O
pandemic O
sparked O
by O
a O
coronavirus O
. O
" O

He O
continued O
, O
" O
and O
we O
have O
never O
before O
seen B-TERM
a O
pandemic O
that O
can O
be O
controlled O
at O
the O
same O
time O
. O
" O

The O
new O
status B-TERM
as O
a O
pandemic O
follows B-TERM
the O
WHO O
's O
decision O
in O
January O
to O
declare B-TERM
the O
outbreak O
a O
public O
health O
emergency O
of O
international O
concern O
. O

The O
United O
States O
' O
National O
Institute O
of O
Allergy O
and O
Infectious O
Disease B-TERM
's O
director O
, O
Dr. O
Anthony O
Fauci O
, O
said O
of O
the O
outbreak O
, O
" O
bottom O
line O
, O
it O
's O
going O
to O
get O
worse O
. O
" O

As O
of O
Thursday O
, O
Associated O
Press O
reported O
there O
were O
at O
least O
126,000 O
cases O
of O
COVID O
- O
19 O
worldwide O
, O
resulting O
in O
over O
4,600 O
deaths O
. O

The O
Federal O
Service O
for O
Surveillance O
on O
Consumer O
Rights O
Protection O
and O
Human O
Wellbeing O
is O
adamantly O
opposed O
to O
the O
return O
of O
smoking O
rooms O
in O
airports O

The O
Federal O
Service O
for O
Surveillance O
on O
Consumer O
Rights O
Protection O
and O
Human O
Wellbeing O
is O
adamantly O
opposed O
to O
the O
revival O
of O
smoking O
rooms O
in O
airports O
. O

" O
Neither O
ventilation O
, O
nor O
filters O
, O
or O
even O
both O
combined O
, O
can O
reduce B-TERM
the O
effects O
of O
tobacco O
smoke O
to O
a O
level O
that O
can O
be O
considered O
acceptable O
, O
" O
the O
service O
announced O
. O

Izvestia O
reported O
on O
Friday O
that O
the O
Ministry O
of O
Health O
had O
introduced O
amendments O
to O
legislation O
currently O
in O
its O
second O
reading O
, O
according O
to O
which O
, O
two B-TERM
smoking O
rooms O
would O
be O
set O
up O
per O
airport O
. O

An O
expert B-TERM
told O
why O
it O
's O
worth O
giving O
up O
teabags O

A O
group O
of O
scientists O
from O
Canada O
, O
representing O
McGill O
University O
, O
found O
out O
that O
when O
a O
teabag O
steeps O
in O
a O
cup O
more O
than O
10 O
billion O
microplastic O
particles O
are O
released O
in O
five O
minutes B-TERM
. O

Dust O
particles O
may O
also B-TERM
be O
added B-TERM
to O
the O
packaged O
drink O
, O
food O
safety O
expert B-TERM
Elizaveta O
Tikhonova O
told O
Nation O
News O
. O

According O
to O
the O
agronomist O
, O
a O
consumer O
cannot O
get B-TERM
reliable O
information B-TERM
about O
the O
composition O
of O
packaged O
tea O
- O
the O
producer O
can O
add B-TERM
ingredients B-TERM
that O
will O
not O
be O
shown O
on O
the O
packaging O
. O

The O
dust O
is O
not O
thrown O
away O
at O
the O
end B-TERM
of O
the O
season O
, O
so O
it O
may O
end O
up O
in O
the O
tea O
. O

" O
Furthermore O
, O
teabags O
don O
't O
always B-TERM
contain O
specifically O
tea O
plants O
, O
" O
Tikhonova O
said O
. O

In O
her O
words O
, O
it O
is O
best O
to O
reject B-TERM
that O
drink O
in O
favor B-TERM
of O
tea O
by O
weight O
, O
which O
is O
sold O
in O
specialized O
stores B-TERM
. O

Also O
, O
she O
emphasized O
that O
in O
addition B-TERM
to O
its O
composition O
, O
the O
danger B-TERM
of O
packaged O
tea O
is O
also O
in O
how O
it O
is O
made O
- O
microparticles O
are O
heated O
to O
high O
temperatures O
, O
causing O
them O
to O
start O
to O
release O
harmful O
substances O
. O

" O
It O
is O
best O
to O
buy O
pure O
green O
or O
black O
tea O
- O
this O
drink O
will O
have O
less O
additives O
, O
" O
the O
expert B-TERM
recommended O
. O

Problems B-TERM
associated O
with O
the O
colonization O
of O
the O
Arctic O
are O
being O
discussed O
at O
an O
international O
conference B-TERM
in O
Norilsk O

Problems B-TERM
associated O
with O
the O
colonization O
of O
the O
Arctic O
are O
being O
discussed O
at O
an O
international O
conference B-TERM
in O
Norilsk O
. O

The O
forum O
was O
organized O
by O
the O
Norilsk O
Development O
Agency O
and O
the O
Taimyr O
Researchers O
Club O
, O
the O
Krasnoyarsk O
State O
TV O
and O
Radio O
Broadcasting O
Company O
reported O
. O

Papers O
are O
being O
presented O
by O
academics O
from O
Moscow O
, O
St. O
Petersburg O
, O
Krasnoyarsk O
, O
Salekhard O
, O
Arkhangelsk O
, O
Norilsk O
and O
Dudinka O
. O

Foreign B-TERM
participants O
have O
come O
from O
the O
Netherlands O
and O
Canada O
. O

One O
of O
the O
forum O
's O
main O
topics O
is O
how O
to O
develop O
an O
urban O
environment O
in O
Arctic O
conditions B-TERM
while O
avoiding O
ecological O
damage O
. O

The O
forum O
's O
participants O
are O
also B-TERM
able B-TERM
to O
visit O
interactive O
venues O
at O
the O
Norilsk O
State O
Industrial O
Institute O
. O

The O
Rodina O
cinema B-TERM
is O
welcoming O
movie B-TERM
lovers O
with O
showings O
of O
science O
fiction O
films B-TERM
about O
the O
arctic O
region B-TERM
. O

Explorers O
and O
scientists O
are O
speaking O
on O
their O
Arctic O
experiences O
at O
a O
meet O
- O
and O
- O
greet O
event O
. O

The O
forum O
is O
continuing O
for O
three O
days O
. O

Festival O
of O
Nordic O
walking O
will O
take O
place O
in O
Ulyanovsk O

Residents O
of O
Ulyanovsk O
region B-TERM
will O
take B-TERM
part O
in O
a O
festival O
of O
Nordic O
walking O
. O

The O
mass O
start O
will O
take O
place O
in O
Pribrezhny O
park O
. O

The O
participants O
of O
the O
festival O
will O
be O
teams O
from O
different O
towns O
and O
districts B-TERM
of O
Ulyanovsk O
region B-TERM
, O
who O
won O
in O
the O
municipal O
stages B-TERM
. O

Their O
members O
are O
mainly O
residents O
of O
the O
region B-TERM
older B-TERM
than O
50 O
years O
. O

The O
project B-TERM
is O
intended O
to O
attract O
the O
older O
generation O
to O
actively O
spend O
their O
time O
, O
1ul.ru O
reports O
. O

The O
town O
stage B-TERM
of O
the O
festival O
took O
place O
on O
7 O
September O
in O
six O
parks O
at O
once O
. O

Participants O
had O
to O
overcome O
a O
distance B-TERM
of O
3 O
km O
by O
Nordic O
walking O
. O

The O
winner O
was O
determined O
by O
the O
total O
age O
of O
participants O
in O
a O
team O
. O

The O
regional B-TERM
festival O
will O
take O
place O
on O
28 O
September O
. O

Regions B-TERM
asked O
to O
share O
business O
support O
secrets B-TERM

According O
to O
Parlamentskaya O
Gazeta O
, O
on O
27 O
September O
the O
Chair O
of O
the O
Federation O
Council O
Committee O
on O
Economic O
Policy O
Andrey O
Kutepov O
wrote O
to O
the O
Minister O
for O
Economic O
Development O
Maxim O
Oreshkin O
and O
Finance O
Minister O
Anton O
Siluanov O
with O
a O
proposal O
to O
state O
a O
position O
in O
regard O
to O
the O
federal O
subjects O
' O
initiative O
for O
improving O
legislation O
in O
the O
sphere O
of O
support O
for O
small B-TERM
and O
medium O
- O
sized O
entreprises O
( O
SMEs O
) O
. O

Time O
to O
establish O
interregional O
ties O

The O
Federation O
Council O
Committee O
on O
Economic O
Policy O
has O
collated O
all O
the O
information B-TERM
received O
from O
the O
regions B-TERM
about O
current O
programs O
to O
develop O
business O
and O
legalize O
the O
self O
- O
employed O
, O
as O
well O
as O
the O
results B-TERM
of O
such O
programs O
. O

In O
their O
correspondence O
the O
regions B-TERM
told O
the O
senators O
about O
SME O
development O
problems B-TERM
and O
submitted O
proposals O
for O
the O
improvement B-TERM
of O
current O
legislation O
. O

" O
At O
present O
communications O
between O
regions O
is O
insufficiently O
developed O
, O
as O
a O
result B-TERM
of O
which O
the O
entrepreneur O
community O
in O
all O
regions B-TERM
visited O
by O
senators O
emphasized O
the O
issue O
of O
the O
lack B-TERM
of O
information B-TERM
about O
regional B-TERM
development O
programs O
for O
entrepreneurship O
in O
the O
country O
as O
a O
whole B-TERM
, O
" O
stated O
Andrey O
Kutepov O
. O

In O
a O
supplement O
to O
the O
letter O
, O
which O
was O
sent O
to O
the O
Government O
, O
he O
presented O
a O
summary O
of O
positive O
work O
by O
the O
regions B-TERM
in O
legalizing O
self O
- O
employment O
, O
and O
combined O
data B-TERM
from O
the O
regions B-TERM
with O
proposals O
and O
problematics O
( O
at O
the O
editorial O
office O
's O
disposal O
) O
. O

In O
addition B-TERM
to O
the O
relevant O
ministries O
, O
the O
combined O
data B-TERM
from O
the O
regions B-TERM
was O
sent O
to O
regional B-TERM
government O
leaders B-TERM
. O

The O
exchange O
of O
information B-TERM
about O
positive O
initiatives O
implemented O
in O
the O
regions B-TERM
could O
stimulate O
the O
development O
of O
entrepreneurship O
overall O
. O

The O
first O
step B-TERM
towards O
such O
an O
exchange O
will O
be O
sharing O
the O
information B-TERM
that O
the O
Council O
of O
Economic O
Policy O
has O
, O
" O
the O
senator O
told O
Parlamentskaya O
Gazeta O
. O

Useful O
experience O

Support O
programs O
for O
small B-TERM
and O
medium O
- O
sized O
business O
have O
been O
adopted O
and O
are O
successfully B-TERM
functioning O
in O
many O
regions B-TERM
of O
the O
country O
at O
present O
. O

For O
example O
, O
the O
Center O
of O
Entrepreneurship O
Support O
is O
operating O
in O
Vologda O
region B-TERM
, O
providing O
financial O
support O
and O
assisting O
businesspeople O
with O
product O
certification O
. O

In O
Ivanov O
region B-TERM
a O
business O
support O
system O
has O
been O
developed O
, O
providing O
for O
the O
implementation O
of O
the O
single O
- O
window O
principle O
through O
a O
multifunctional O
center O
. O

In O
Krasnodar O
Krai O
, O
new O
agricultural B-TERM
consumer O
cooperatives O
are O
offered O
grants O
from O
the O
krai O
budget O
. O

A O
cluster O
development O
center O
is O
functioning O
in O
Oryol O
region B-TERM
. O

As O
part O
of O
the O
" O
Acceleration O
of O
SMEs O
" O
federal O
project B-TERM
, O
Amur O
region B-TERM
is O
providing O
for O
the O
possibility B-TERM
to O
subsidize O
business O
incubators O
created O
on O
the O
foundation B-TERM
of O
non O
- O
state O
co O
- O
working O
centers O
, O
with O
funding O
from O
the O
federal O
budget O
. O

Special O
measures B-TERM
to O
support O
youth O
entrepreneurship O
are O
being O
adopted O
in O
a O
number O
of O
other O
regions B-TERM
. O

The O
self O
- O
employed O
are O
continuing O
to O
come O
out O
of O
the O
shadows O

In O
the O
opinion O
of O
regional B-TERM
governments O
, O
a O
number O
of O
changes B-TERM
should O
be O
made O
to O
current O
legislation O
in O
order O
to O
provide O
more O
effective B-TERM
support O
for O
small B-TERM
and O
medium O
- O
sized O
business O
. O

For O
example O
, O
Arkhangelsk O
region B-TERM
proposed O
changing O
the O
term O
" O
self O
- O
employment O
" O
to O
" O
entrepreneurial O
activity B-TERM
, O
" O
since O
it O
" O
best O
corresponds O
to O
the O
content O
of O
state O
services O
promoting O
self O
- O
employment O
to O
unemployed O
citizens O
. O
" O

Ivanovo O
region O
considers B-TERM
it O
necessary O
to O
introduce O
amendments O
providing O
for O
expanding O
the O
list O
of O
types B-TERM
of O
activity B-TERM
performed O
by O
self O
- O
employed O
citizens O
, O
including O
types B-TERM
of O
activity B-TERM
in O
fitting O
out O
and O
renovating O
residential O
properties O
, O
dacha O
construction O
, O
fitness O
training O
. O

Bryansk O
region B-TERM
believes B-TERM
it O
is O
important B-TERM
to O
tighten O
control O
over O
unscrupulous O
producers O
of O
dairy O
products O
, O
using O
the O
Mercury O
veterinary O
system O
. O

And O
Kostroma O
and O
Magadan O
regions B-TERM
are O
advocating O
for O
legal B-TERM
and O
statutory O
recognition O
of O
the O
concept B-TERM
of O
" O
social O
entrepreneurship O
" O
and O
efforts O
to O
support O
social O
entrepreneurship O
. O

All O
the O
proposals O
from O
the O
regions B-TERM
will O
be O
considered O
in O
the O
preparation O
of O
state O
programs O
to O
support O
SMEs O
, O
and O
the O
most O
important B-TERM
ones O
will O
be O
developed O
in O
the O
form O
of O
draft O
legislation O
. O

" O
All O
proposals O
from O
the O
regions B-TERM
will O
be O
considered O
in O
the O
preparation O
of O
state O
programs O
to O
support O
SMEs O
, O
and O
the O
most O
important B-TERM
ones O
will O
be O
developed O
in O
the O
form O
of O
draft O
legislation O
, O
" O
Andrey O
Kutepov O
said O
. O

An O
airline O
has O
helped B-TERM
passengers O
avoid O
being O
seated O
next O
to O
crying O
babies O

Air O
carrier O
Japan O
Airlines O
( O
JAL O
) O
has O
unveiled O
a O
new O
service O
: O
passengers O
can O
find O
out O
where O
small B-TERM
children O
will O
be O
seated O
when O
booking O
tickets O
. O

If O
desired O
, O
passengers O
can O
now O
avoid O
being O
seated O
next O
to O
them O
. O

Japan O
Airlines O
( O
JAL O
) O
passengers O
now O
can O
use O
the O
new O
service O
to O
avoid O
these O
undesirable O
seats O
next O
to O
small B-TERM
children O
. O

The O
air O
carrier O
unveiled O
a O
service O
that O
tracks O
which O
spots O
will O
seat O
children O
. O

Passengers O
will O
be O
shown O
an O
image O
of O
a O
child O
's O
head O
on O
seats O
that O
are O
occupied O
by O
children O
aged O
from O
eight O
days O
to O
two B-TERM
years O
when O
selecting O
a O
place B-TERM
in O
the O
cabin O
while O
booking O
a O
ticket O
. O

As O
a O
result O
, O
people O
who O
do O
not O
want O
to O
fly O
next O
to O
kids O
because O
of O
the O
possible B-TERM
inconvenience O
due O
to O
their O
crying O
can O
be O
seated O
as O
far O
away O
as O
possible O
from O
them O
. O

Internet O
users O
who O
use B-TERM
the O
airline O
's O
services O
were O
overjoyed O
at O
the O
new O
option O
. O

Several O
of O
them O
thanked O
the O
air O
carrier O
, O
remarking O
that O
other O
airlines O
should O
follow O
suit O
. O

One O
user O
complained O
that O
several O
weeks O
ago O
while O
flying O
from O
New O
York O
to O
Doha O
three O
crying O
babies O
were O
seated O
directly O
next O
to O
them O
. O

Another O
person O
suggested O
that O
" O
adult O
- O
only O
flights O
" O
should O
be O
introduced O
, O
adding O
that O
they O
would O
be O
prepared O
to O
pay O
more O
for O
such O
a O
flight O
. O

Many O
tourists O
noted O
that O
they O
would O
always B-TERM
try O
to O
choose B-TERM
Japan O
Airlines O
for O
their O
journeys O
, O
as O
they O
could O
see B-TERM
no O
good O
coming O
from O
being O
seated O
next O
to O
a O
crying O
baby O
in O
an O
enclosed O
space O
. O

Previously O
, O
a O
woman O
traveling O
with O
an O
infant O
tried O
to O
win O
over O
her O
fellow O
passengers O
during O
a O
flight O
from O
Seoul O
to O
San O
Francisco O
. O

She O
prepared O
small O
bags O
of O
sweets O
with O
apology O
notes O
for O
every O
one O
of O
the O
200 O
passengers O
. O

Oleg O
Tabakov O
's O
train O
in O
the O
capital O
's O
metro O
? O

If O
you O
often O
use B-TERM
the O
Kaluga O
- O
Riga O
line B-TERM
( O
as O
do O
most O
residents O
of O
Konkov O
) O
, O
then O
you O
're O
in O
for O
a O
surprise O
. O

A O
new O
thematic O
train O
, O
" O
The O
Great O
Russian O
Artist O
Oleg O
Tabakov O
, O
" O
has O
been O
launched O
in O
the O
subway O
. O

This O
train O
carries O
10 O
thousand O
people O
every O
day O
. O

It O
runs O
on O
the O
orange O
line B-TERM
and O
shares O
information O
about O
the O
director O
, O
actor O
, O
and O
founder O
of O
the O
Tabakerka O
Theater O
. O

Incidentally O
, O
from O
Konkov O
it O
's O
convenient O
to O
get O
to O
the O
shows O
on O
the O
theater O
's O
new O
stage O
( O
located O
on O
Malaya O
Sukharevskaya O
Square O
, O
near O
Sukharevskaya O
metro O
station O
) O
. O

As O
the O
press O
service O
of O
the O
Moscow O
Metropolitan O
explained O
to O
us O
, O
" O
the O
external O
design O
of O
the O
thematic O
train O
uses B-TERM
images O
of O
fragments O
of O
stained O
glass O
of O
the O
new O
stage O
and O
portraits O
of O
Oleg O
Tabakov O
in O
iconic O
images O
he O
created O
in O
the O
theater O
, O
cinema B-TERM
, O
and O
animation O
. O
" O

The O
inside O
of O
the O
train O
tells O
about O
his O
family B-TERM
, O
the O
play O
" O
The O
Sailor O
's O
Silence B-TERM
, O
" O
which O
began O
the O
great O
life O
of O
the O
theater O
, O
the O
Tabakerka O
itself O
, O
and O
the O
director O
's O
work O
. O

Rare O
archival O
photos B-TERM
and O
scenes O
from O
his O
films O
can O
be O
seen O
on O
the O
walls O
of O
the O
train O
cars O
. O

Russian O
gays O
with O
adopted O
children O
request O
asylum O
in O
the O
US O

A O
single O
- O
sex O
Russian O
couple B-TERM
with O
two B-TERM
adopted O
children O
have O
requested O
asylum O
in O
the O
US O
, O
RIA O
Novosti O
has O
reported O
. O

According O
to O
the O
report O
, O
the O
men O
left O
Russia O
for O
Ukraine O
, O
they O
then O
traveled O
to O
the O
United O
States O
, O
where O
they O
applied O
for O
asylum O
. O

According O
to O
an O
announcement O
from O
the O
Stimul O
group O
, O
" O
constant O
attention O
from O
law O
enforcement O
authorities O
" O
led O
to O
the O
family B-TERM
's O
actions O
. O

According O
to O
reports O
, O
the O
men O
do O
not O
plan O
on O
returning O
to O
Russia O
. O

The O
children O
have O
been O
adapting B-TERM
to O
local O
conditions B-TERM
and O
attending O
an O
American O
school O
since O
the O
beginning O
of O
the O
school O
year O
. O

It O
has O
been O
previously O
reported O
that O
proceedings O
have O
been O
launched O
against O
a O
social O
worker O
from O
the O
Marino O
district B-TERM
in O
regard O
to O
the O
adoption O
of O
the O
young O
boys B-TERM
by O
the O
single O
- O
sex O
family B-TERM
. O

Meanwhile O
, O
the O
Human O
Rights O
Council O
stated O
that O
the O
raising O
of O
children O
by O
single O
- O
sex O
couples B-TERM
is O
not O
a O
reason O
in O
itself O
for O
proceedings O
to O
be O
launched O
. O

The O
MITs O
Izvestia O
press O
center O
will O
host O
the O
press O
conference B-TERM
of O
the O
MKhAT O
project B-TERM
" O
SEASON O
OF O
VERSE O
Third O
stage O
. O
Poetry O
" O

A O
press O
conference B-TERM
will O
be O
held O
on O
3 O
October O
at O
11 O
: O
00 O
in O
the O
MITs O
Izvestia O
press O
center O
to O
announce O
the O
start O
of O
the O
project B-TERM
" O
SEASON O
OF O
VERSE O
Third O
stage O
. O
Poetry O
" O
at O
the O
M. O
Gorky O
MKhAT O
. O

Eduard O
Boyakov O
, O
artistic O
director O
of O
the O
M. O
Gorky O
MKhAT O
, O
director O
- O
producer O
of O
the O
project B-TERM
. O

Ivan O
Kupreyanov O
, O
poet O
, O
producer O
of O
the O
project B-TERM
. O

Dmitry O
Vodennikov O
, O
poet O
. O

Irina O
Lindt O
, O
theater O
and O
film B-TERM
actress O
. O

Alexei O
Shmelev O
, O
poet O
. O

In O
its O
new O
season O
the O
Third O
stage O
of O
the O
M. O
Gorky O
MKhAT O
will O
become O
a O
total O
poetry O
territory O
. O

Performances O
based O
on O
verse O
by O
leading B-TERM
contemporary O
poets O
will O
be O
presented O
within O
the O
framework O
of O
a O
wide O
- O
reaching O
program O
. O

The O
project B-TERM
team O
will O
create O
for O
viewers O
a O
unique B-TERM
poetic O
world O
of O
verse O
, O
music O
and O
multimedia O
images O
. O

The O
artistic O
director O
of O
MKhAT O
Eduard O
Boyakov O
and O
the O
curator O
of O
the O
project B-TERM
, O
poet O
and O
producer O
Ivan O
Kupreyanov O
will O
present O
the O
first O
and O
currently O
only O
theatrical O
anthology O
of O
contemporary O
fine O
literature O
- O
the O
project B-TERM
" O
SEASON O
OF O
VERSE O
Third O
stage O
. O
Poetry O
. O
" O

The O
season O
opens O
on O
5 O
October O
at O
19 O
: O
00 O
on O
the O
Third O
stage O
of O
the O
M. O
Gorky O
MKhAT O
with O
a O
production O
of O
a O
legendary O
poet O
whose O
every O
performance O
becomes O
a O
significant B-TERM
event O
for O
appreciators O
of O
fine O
literature O
, O
Dmitry O
Vodennikov O
. O

The O
shows O
will O
take O
place O
in O
October O
and O
November O
. O

Every O
production O
has O
its O
own O
author O
, O
curator O
and O
actor O
. O

MKhAT O
artists O
and O
invited O
stars O
will O
take B-TERM
part O
in O
the O
performances O
: O
Irina O
Lindt O
, O
Agniya O
Kuznetsova O
, O
Olga O
Kabo O
, O
Alisa O
Grebenshchikova O
. O

Musical O
concept B-TERM
of O
the O
project B-TERM
- O
Sergei O
Letov O
. O

Curators O
of O
the O
shows O
: O
Pavel O
Kryuchkov O
, O
Mariya O
Golovanivskaya O
, O
Eduart O
Boyakov O
, O
Ivan O
Kupreyanov O
et O
al O
. O

The O
project B-TERM
is O
being O
implemented O
with O
the O
support O
of O
the O
Ministry O
of O
Culture O
of O
Russia O
. O

Pavel O
Ustinov O
joins O
pickets O
in O
support O
of O
defendants O
in O
" O
Moscow O
Case O
" O

Actor O
Pavel O
Ustinov O
joined O
a O
series O
of O
individual O
" O
Freedom O
For O
All O
" O
pickets O
held O
on O
Friday O
at O
the O
Russian O
presidential O
administration O
building O
on O
the O
Old B-TERM
Square O
in O
Moscow O
, O
reports O
an O
Interfax O
correspondent O
. O

The O
series O
of O
pickets O
began O
on O
September O
18 O
in O
support O
of O
Ustinov O
himself O
and O
has O
continued O
every O
day O
since O
. O

The O
protesters O
are O
currently O
taking O
turns O
standing O
and O
holding O
posters O
with O
the O
inscription O
" O
Freedom O
For O
All O
" O
and O
the O
last O
names O
of O
those O
convicted O
and O
arrested O
after O
uncoordinated O
rallies O
in O
Moscow O
in O
the O
summer O
of O
2019 O
. O

Besides B-TERM
Ustinov O
, O
the O
posters O
had O
the O
names B-TERM
of O
Egor O
Zhukov O
, O
Kirill O
Zhukov O
, O
Daniel O
Beglets O
, O
Evgeny O
Kovalenko O
, O
Konstantine O
Kotov O
, O
Ivan O
Podkopaev O
, O
Aidar O
Gubaidulin O
, O
Alexei O
Minyailo O
, O
Sergei O
Fomin O
, O
Samariddin O
Radzhabov O
, O
Nikita O
Chirtsov O
, O
Edward O
Malyshevsky O
, O
and O
Vladislav O
Sinitsa O
. O

On O
September O
16 O
, O
the O
Tver O
Court O
of O
Moscow O
sentenced O
the O
24 O
- O
year O
- O
old O
Ustinov O
to O
3.5 O
years O
in O
a O
penal O
colony O
on O
charges O
of O
violence O
against O
a O
riot O
police O
officer O
at O
an O
uncoordinated O
rally O
on O
August O
3 O
in O
the O
center O
of O
Moscow O
( O
part O
2 O
, O
article O
318 O
of O
the O
Russian O
criminal O
code O
) O
. O

Then O
, O
on O
September O
20 O
, O
by O
request O
of O
the O
Prosecutor O
General O
, O
the O
court O
changed O
Ustinov O
's O
sentence O
from O
detention O
in O
custody O
to O
recognizance O
. O

The O
petition O
for O
Ustinov O
's O
release O
gathered O
more O
than O
112 O
thousand O
signatures O
in O
a O
day O
. O

Theater O
and O
film B-TERM
artists O
started O
a O
flash O
mob O
in O
support O
of O
their O
colleague O
. O

People O
lined O
up O
to O
participate O
in O
the O
picket O
as O
a O
sign O
of O
solidarity O
with O
the O
actor O
on O
September O
18 O
on O
the O
Old B-TERM
Square O
. O

Human O
rights O
activists O
, O
journalists O
, O
scholars O
, O
teachers B-TERM
, O
doctors B-TERM
, O
and O
Orthodox O
priests O
demanded O
that O
the O
case O
be O
reviewed O
. O

As O
Ustinov O
's O
sister O
Julia O
reported O
to O
Interfax O
, O
her O
brother O
does O
not O
plan O
to O
speak O
at O
the O
meeting O
in O
support O
of O
the O
defendants O
of O
the O
" O
Moscow O
Case O
" O
on O
September O
29 O
in O
the O
capital O
. O

Deliveries O
of O
sanctioned O
foodstuffs O
to O
Russia O
fall O
to O
1 O
percent O
of O
previous O
levels O
. O

The O
Russian O
government O
has O
calculated O
that O
the O
deliveries O
to O
Russia O
of O
agricultural O
produce O
and O
foodstuffs O
from O
countries O
falling O
under O
Russia O
's O
food O
embargo O
have O
shrunk O
to O
1 O
percent O
of O
their O
2013 O
levels O
. O

According O
to O
the O
report O
provided O
to O
Russian O
President O
Vladimir O
Putin O
, O
in O
the O
first O
half O
of O
2019 O
, O
31,000 O
tons O
of O
foodstuffs O
were O
imported O
from O
sanctioned O
countries O
compared O
with O
3.4422 O
million O
tons O
for O
the O
same O
period O
in O
2013 O
, O
Interfax O
reported O
. O

The O
value B-TERM
of O
imported O
foodstuffs O
fell O
to O
$ O
226.5 O
million O
from O
$ O
4.9755 O
billion O
, O
respectively O
. O

This O
refers O
to O
the O
supply O
of O
goods O
that O
was O
not O
subject O
to O
the O
embargo O
. O

The O
report B-TERM
showed O
that O
the O
falling O
volumes O
of O
prohibited O
foodstuffs O
were O
compensated B-TERM
for O
by O
increased B-TERM
imports O
from O
CIS O
countries O
, O
Africa O
, O
Southeast O
Asia O
and O
Serbia O
. O

At O
the O
end B-TERM
of O
August O
, O
the O
government O
extended O
until O
December O
31 O
, O
2020 O
, O
the O
rule O
dictating O
the O
destruction O
of O
agricultural O
produce O
, O
staples O
and O
foodstuffs O
that O
are O
forbidden O
for O
import O
into O
Russia O
under O
counter O
- O
sanctions O
. O

The O
document O
, O
posted O
on O
the O
official O
legal B-TERM
information B-TERM
portal O
, O
states O
that O
the O
rule O
was O
extended O
for O
a O
further O
year O
- O
from O
December O
31 O
, O
2019 O
, O
until O
December O
31 O
, O
2020 O
. O

At O
first O
, O
the O
regulation O
on O
the O
destruction O
of O
embargoed O
foodstuffs O
applied O
to O
produce O
from O
the O
US O
, O
EU O
, O
Australia O
, O
Norway O
and O
Canada O
. O

Later O
, O
from O
August O
13 O
, O
2015 O
, O
Albania O
, O
Montenegro O
, O
Iceland O
and O
Liechtenstein O
" O
joined O
" O
the O
list B-TERM
- O
from O
January O
1 O
, O
2016 O
, O
Ukraine O
was O
added O
. O

The O
decree B-TERM
signed O
by O
Putin O
on O
the O
destruction O
of O
illegally O
imported O
embargoed O
goods O
( O
products B-TERM
that O
fall O
under O
the O
foodstuffs O
embargo O
put O
in O
place O
by O
Moscow O
in O
response B-TERM
to O
West O
's O
anti O
- O
Russian O
sanctions O
) O
, O
came O
into O
force O
in O
2015 O
. O

Furthermore O
, O
the O
government O
authorized O
the O
destruction O
of O
sanctioned O
goods O
using O
any O
legal O
method B-TERM
. O

In O
response O
to O
the O
West O
's O
continued O
sanctions O
, O
Russia O
also B-TERM
extended O
its O
counter O
measures B-TERM
. O

The O
measures B-TERM
, O
however O
, O
do O
not O
extend O
to O
foodstuffs O
that O
citizens O
import O
for O
their O
own O
personal B-TERM
use O
. O

The O
ban O
does O
not O
apply O
to O
goods O
for O
personal B-TERM
use O
weighing O
under O
5 O
kilograms O
. O

The O
head B-TERM
of O
the O
Presidential O
Council O
for O
Civil O
Society O
and O
Human O
Rights O
, O
Mikhail O
Fedotov O
, O
earlier O
referred B-TERM
to O
the O
destruction O
of O
food O
products B-TERM
as O
" O
simply O
immoral O
" O
and O
by O
his O
account O
, O
it O
negatively O
influenced O
peoples O
' O
development O
. O

Russian O
Federal O
Service O
for O
Surveillance O
on O
Consumer O
Rights O
Protection O
and O
Human O
Wellbeing O
came O
out O
in O
support O
of O
efforts O
to O
destroy O
edible O
foodstuffs O
. O

Following B-TERM
this O
, O
the O
Presidential O
Council O
for O
Civil O
Society O
and O
Human O
Rights O
issued O
an O
equivalent O
recommendation O
to O
the O
government O
. O

Russian O
Deputy O
Prime O
Minister O
Alexei O
Gordeyev O
stated O
that O
the O
destruction O
of O
food O
products B-TERM
was O
incorrect O
and O
that O
thought O
needed O
to O
be O
put O
into O
how O
to O
use B-TERM
them O
once O
their O
quality B-TERM
had O
been O
established O
. O

Laboratory O
testing O
for O
the O
respiratory O
coronavirus O
disease O
2019 O
( O
COVID O
- O
19 O
) O
and O
the O
associated O
SARS O
- O
CoV O
- O
2 O
virus O
includes O
methods B-TERM
that O
detect O
the O
presence B-TERM
of O
virus O
and O
those O
that O
detect O
antibodies O
produced O
in O
response B-TERM
to O
infection O
. O

The O
presence B-TERM
of O
viruses O
in O
samples O
is O
confirmed O
by O
RT O
- O
PCR O
, O
which O
detects O
the O
coronavirus O
' O
RNA O
. O

This O
test O
is O
specific O
and O
is O
designed O
to O
only O
detect O
the O
RNA O
of O
the O
SARS O
- O
CoV O
- O
2 O
virus O
. O

It O
is O
used O
to O
confirm O
very O
recent B-TERM
or O
active B-TERM
infections O
. O

Detection O
of O
antibodies O
( O
serology O
) O
can O
be O
used O
both O
for O
diagnosis O
and O
population O
surveillance O
. O

Antibody O
tests O
show O
how O
many O
people O
have O
had O
the O
disease B-TERM
, O
including O
those O
whose O
symptoms O
were O
too O
minor B-TERM
to O
report O
or O
who O
were O
asymptomatic O
. O

An O
accurate O
mortality O
rate O
of O
the O
disease B-TERM
and O
the O
level O
of O
herd O
immunity O
in O
the O
population O
can O
be O
determined O
from O
the O
results B-TERM
of O
this O
test O
. O

Due O
to O
limited O
testing O
, O
as O
of O
March O
2020 O
no O
countries O
had O
reliable O
data B-TERM
on O
the O
prevalence O
of O
the O
virus O
in O
their O
population O
. O

By O
23 O
March O
, O
no O
country O
had O
tested O
more O
than O
3 O
% O
of O
their O
population O
, O
and O
there O
are O
massive O
variations O
in O
how O
much O
testing O
has O
been O
done O
across O
countries O
. O

This O
variability O
is O
also O
likely O
to O
be O
significantly B-TERM
affecting O
reported O
case O
fatality O
rates O
, O
which O
are O
likely O
to O
be O
significantly B-TERM
over O
- O
estimated O
in O
some O
countries O
. O

Using O
real O
- O
time O
reverse O
transcription O
polymerase O
chain O
reaction O
( O
rRT O
- O
PCR O
) O
the O
test O
can O
be O
done O
on O
respiratory O
samples O
obtained O
by O
various O
methods B-TERM
, O
including O
nasopharyngeal O
swab O
or O
sputum O
sample O
. O

Results B-TERM
are O
generally O
available O
within O
a O
few O
hours O
to O
2 O
days O
. O

The O
RT O
- O
PCR O
test O
performed O
with O
throat O
swabs O
is O
only O
reliable O
in O
the O
first O
week O
of O
the O
disease B-TERM
. O

Later O
on O
the O
virus O
can O
disappear B-TERM
in O
the O
throat O
while O
it O
continues O
to O
multiply O
in O
the O
lungs O
. O

For O
infected O
people O
tested O
in O
the O
second O
week O
, O
alternatively O
sample O
material B-TERM
can O
then O
be O
taken O
from O
the O
deep O
airways O
by O
suction O
catheter O
or O
coughing O
up O
material O
( O
sputum O
) O
can O
be O
used B-TERM
. O

One O
of O
the O
early O
PCR O
tests O
was O
developed O
at O
Charit√© O
in O
Berlin O
in O
January O
2020 O
using O
real O
- O
time O
reverse O
transcription O
polymerase O
chain O
reaction O
( O
rRT O
- O
PCR O
) O
, O
and O
formed O
the O
basis B-TERM
of O
250,000 O
kits O
for O
distribution O
by O
the O
World O
Health O
Organization B-TERM
( O
WHO O
) O
. O

The O
United B-TERM
Kingdom O
had O
also B-TERM
developed O
a O
test O
by O
23 O
January O
2020.The O
South O
Korean O
company B-TERM
Kogenebiotech O
developed O
a O
clinical O
grade O
, O
PCR O
- O
based O
SARS O
- O
CoV O
- O
2 O
detection O
kit O
( O
PowerChek O
Coronavirus O
) O
on O
28 O
January O
2020 O
. O

It O
looks O
for O
the O
" O
E O
" O
gene O
shared O
by O
all O
beta O
coronaviruses O
, O
and O
the O
RdRp O
gene O
specific O
to O
SARS O
- O
CoV O
- O
2.In O
China O
, O
BGI O
Group O
was O
one O
of O
the O
first O
companies B-TERM
to O
receive B-TERM
emergency O
use O
approval O
from O
China O
's O
National O
Medical O
Products O
Administration B-TERM
for O
a O
PCR O
- O
based O
SARS O
- O
CoV O
- O
2 O
detection O
kit.In O
the O
United O
States O
, O
the O
Centers O
for O
Disease B-TERM
Control O
and O
Prevention O
( O
CDC O
) O
is O
distributing O
its O
2019 O
- O
Novel O
Coronavirus O
( O
2019 O
- O
nCoV O
) O
Real O
- O
Time O
RT O
- O
PCR O
Diagnostic O
Panel O
to O
public O
health O
labs O
through O
the O
International O
Reagent O
Resource O
. O

One O
of O
three O
genetic O
tests O
in O
older O
versions O
of O
the O
test O
kits O
caused O
inconclusive O
results B-TERM
due O
to O
faulty O
reagents O
, O
and O
a O
bottleneck O
of O
testing O
at O
the O
CDC O
in O
Atlanta O
; O
this O
resulted B-TERM
in O
an O
average O
of O
fewer O
than O
100 O
samples O
a O
day O
being O
successfully O
processed O
throughout O
the O
whole O
of O
February O
2020 O
. O

Tests O
using O
two B-TERM
components B-TERM
were O
not O
determined O
to O
be O
reliable O
until O
28 O
February O
2020 O
, O
and O
it O
was O
not O
until O
then O
that O
state O
and O
local B-TERM
laboratories O
were O
permitted B-TERM
to O
begin O
testing O
. O

The O
test O
was O
approved O
by O
the O
Food O
and O
Drug O
Administration B-TERM
under O
an O
Emergency O
Use O
Authorization.US O
commercial O
labs O
began O
testing O
in O
early O
March O
2020 O
. O

As O
of O
5 O
March O
2020 O
LabCorp O
announced B-TERM
nationwide O
availability O
of O
COVID O
- O
19 O
testing O
based O
on O
RT O
- O
PCR O
. O

Quest O
Diagnostics O
similarly O
made O
nationwide O
COVID O
- O
19 O
testing O
available O
as O
of O
9 O
March O
2020 O
. O

No O
quantity O
limitations O
were O
announced B-TERM
; O
specimen O
collection O
and O
processing O
must O
be O
performed O
according O
to O
CDC O
requirements B-TERM
. O

In O
Russia O
, O
the O
COVID O
- O
19 O
test O
was O
developed O
and O
produced B-TERM
by O
the O
State O
Research O
Center O
of O
Virology O
and O
Biotechnology O
VECTOR O
. O

On O
11 O
February O
2020 O
the O
test O
was O
registered O
by O
the O
Federal O
Service O
for O
Surveillance B-TERM
in O
Healthcare.On O
12 O
March O
2020 O
, O
Mayo O
Clinic O
was O
reported O
to O
have O
developed O
a O
test O
to O
detect O
COVID O
- O
19 O
infection.On O
13 O
March O
2020 O
, O
Roche O
Diagnostics O
received B-TERM
FDA O
approval O
for O
a O
test O
which O
could O
be O
performed O
within O
3.5 O
hours O
in O
high O
volume O
, O
thus O
allowing B-TERM
one O
machine B-TERM
to O
do O
approximately B-TERM
4,128 O
tests O
in O
a O
24 O
- O
hour O
period O
. O

On O
19 O
March O
2020 O
, O
the O
FDA O
issued O
emergency O
use O
authorization O
( O
EUA O
) O
to O
Abbott O
Laboratories O
for O
a O
test O
on O
Abbott O
's O
m2000 O
system O
; O
the O
FDA O
had O
previously O
issued O
similar B-TERM
authorization O
to O
Hologic O
, O
LabCorp O
, O
and O
Thermo O
Fisher O
Scientific O
. O

On O
21 O
March O
2020 O
, O
Cepheid O
similarly B-TERM
received B-TERM
EUA O
from O
the O
FDA O
for O
a O
test O
that O
takes B-TERM
about O
45 O
minutes B-TERM
. O

The O
FDA O
has O
approved O
a O
test O
that O
uses O
isothermal O
nucleic O
acid O
amplification O
technology O
instead O
of O
PCR O
. O

Since O
this O
does O
not O
require O
a O
series O
of O
alternating O
temperature O
cycles O
this O
method O
can O
deliver O
positive O
results B-TERM
in O
as O
little O
as O
five O
minutes B-TERM
and O
negative O
results O
in O
13 O
minutes B-TERM
. O

There O
are O
currently O
about O
18,000 O
of O
these O
machines B-TERM
in O
the O
U.S. O
and O
Abbott O
expects O
to O
ramp O
up O
manufacturing O
to O
deliver O
50,000 O
tests O
per O
day.A O
test O
which O
uses O
a O
monoclonal O
antibody O
which O
specifically O
binds O
to O
the O
nucleocapsid O
protein O
( O
N O
protein B-TERM
) O
of O
the O
novel O
coronavirus O
is O
being O
developed O
in O
Taiwan O
, O
with O
the O
hope O
that O
it O
can O
provide O
results B-TERM
in O
15 O
to O
20 O
minutes B-TERM
just O
like B-TERM
a O
rapid O
influenza O
test O
. O

A O
March O
2020 O
literature O
review O
concluded B-TERM
that O
" O
chest O
radiographs O
are O
of O
little O
diagnostic O
value B-TERM
in O
early O
stages B-TERM
, O
whereas O
CT O
[ O
computed O
tomography O
] O
findings B-TERM
may O
be O
present O
even O
before O
symptom O
onset O
. O
" O

Typical B-TERM
features O
on O
CT O
include O
bilateral O
multilobar O
ground O
- O
glass O
opacificities O
with O
a O
peripheral O
, O
asymmetric O
and O
posterior O
distribution O
. O

Subpleural O
dominance B-TERM
, O
crazy O
paving O
and O
consolidation O
develop O
as O
the O
disease B-TERM
evolves B-TERM
. O

A O
study B-TERM
comparing O
PCR O
to O
CT O
in O
Wuhan O
at O
the O
point O
of O
origin O
of O
the O
current B-TERM
pandemic O
has O
suggested O
that O
CT O
is O
significantly B-TERM
more O
sensitive O
than O
PCR O
, O
though B-TERM
less O
specific O
, O
with O
many O
of O
its O
imaging O
features O
overlapping O
with O
other O
pneumonias O
and O
disease B-TERM
processes O
. O

As O
of O
March O
2020 O
, O
the O
American O
College O
of O
Radiology O
recommends O
that O
" O
CT O
should O
not O
be O
used B-TERM
to O
screen O
for O
or O
as O
a O
first O
- O
line B-TERM
test O
to O
diagnose O
COVID O
- O
19 O
. O
" O
As O
of O
March O
2020 O
, O
the O
CDC O
recommends O
PCR O
for O
initial O
screening O
. O

Part O
of O
the O
immune O
response B-TERM
to O
infection O
is O
the O
production O
of O
antibodies O
including O
IgM O
and O
IgG O
. O

These O
can O
be O
used B-TERM
to O
detect O
infection O
in O
individuals O
starting O
7 O
days O
or O
so O
after O
the O
onset O
of O
symptoms O
, O
to O
determine O
immunity O
, O
and O
in O
population O
surveillance.Assays O
can O
be O
performed O
in O
central O
laboratories O
( O
CLT O
) O
or O
by O
point O
- O
of O
- O
care O
testing O
( O
PoCT O
) O
. O

The O
high O
- O
throughput O
automated O
systems O
in O
many O
clinical O
laboratories O
will O
be O
able B-TERM
to O
perform B-TERM
these O
assays O
but O
their O
availability O
will O
depend O
on O
the O
rate O
of O
production O
for O
each O
system O
. O

For O
CLT O
a O
single O
specimen O
of O
peripheral O
blood O
is O
commonly O
used O
, O
although O
serial O
specimens O
can O
be O
used O
to O
follow O
the O
immune O
response O
. O

For O
PoCT O
a O
single O
specimen O
of O
blood B-TERM
is O
usually O
obtained O
by O
skin O
puncture O
. O

Unlike O
PCR O
methods B-TERM
an O
extraction O
step B-TERM
is O
not O
needed B-TERM
before O
assay.On O
March O
26 O
, O
2020 O
, O
the O
FDA O
named O
29 O
entities O
that O
provided O
notification O
to O
the O
agency O
as O
required O
and O
are O
now O
therefore O
able O
to O
distribute O
their O
antibody O
tests O
. O

As O
of O
April O
7 O
, O
2020 O
, O
only O
a O
single O
test O
has O
been O
approved O
by O
the O
FDA O
under O
an O
emergency O
use O
authorization.In O
late O
March O
2020 O
, O
Euroimmun O
Medical O
Laboratory O
Diagnostics O
and O
Epitope O
Diagnostics O
received B-TERM
European O
approvals O
for O
their O
test O
kits O
, O
which O
can O
detect O
IgG O
and O
IgA O
antibodies O
against O
the O
virus O
in O
blood B-TERM
samples O
. O

The O
testing O
capacity O
is O
several O
hundred O
samples O
within O
hours O
and O
therefore O
much O
faster O
than O
the O
conventional B-TERM
PCR O
assay O
of O
viral O
RNA O
. O

The O
antibodies O
are O
usually O
detectable O
14 O
days O
after O
the O
onset O
of O
the O
infection.In O
early O
April O
, O
the O
UK O
found O
none O
of O
the O
antibody O
test O
kits O
it O
purchased O
were O
sufficiently O
good O
to O
use O
. O

Hong O
Kong O
has O
set O
up O
a O
scheme O
where O
suspected O
patients B-TERM
can O
stay O
home O
, O
" O
emergency O
department O
will O
give O
a O
specimen O
tube O
to O
the O
patient O
, O
" O
they O
spit O
into O
it O
, O
send O
it O
back O
and O
get O
a O
test O
result B-TERM
a O
while O
after.The O
British O
NHS O
has O
announced O
that O
it O
is O
piloting O
a O
scheme O
to O
test O
suspected O
cases O
at O
home O
, O
which O
removes O
the O
risk O
of O
a O
patient B-TERM
infecting O
others O
if O
they O
come O
to O
a O
hospital O
or O
having O
to O
disinfect O
an O
ambulance O
if O
one O
is O
used.In O
drive O
- O
through O
testing O
for O
COVID O
- O
19 O
for O
suspected O
cases O
, O
a O
healthcare O
professional O
takes O
sample O
using B-TERM
appropriate O
precautions O
. O

Drive O
- O
through O
centers O
have O
helped B-TERM
South O
Korea O
do O
some O
of O
the O
fastest O
, O
most O
- O
extensive O
testing O
of O
any O
country.In O
Germany O
, O
the O
National O
Association O
of O
Statutory O
Health O
Insurance O
Physicians O
said O
on O
2 O
March O
, O
that O
it O
had O
a O
capacity O
for O
about O
12,000 O
tests O
per O
day O
in O
the O
ambulatory O
setting O
and O
10.700 O
had O
been O
tested O
in O
the O
prior O
week O
. O

Costs O
are O
borne O
by O
the O
health O
insurance O
when O
the O
test O
is O
ordered O
by O
a O
physician O
. O

According O
to O
the O
president O
of O
the O
Robert O
Koch O
Institute O
, O
Germany O
has O
an O
overall O
capacity O
for O
160,000 O
tests O
per O
week O
. O

As O
of O
19 O
March O
drive O
in O
tests O
were O
offered O
in O
several O
large O
cities O
. O

As O
of O
26 O
March O
2020 O
the O
total O
number B-TERM
of O
tests O
performed O
in O
Germany O
was O
unknown B-TERM
, O
because O
only O
positive O
results B-TERM
are O
reported O
. O

A O
first O
lab O
survey O
revealed B-TERM
that O
as O
of O
calendar O
week O
12 O
/ O
2020 O
a O
total O
of O
at O
least O
483,295 O
samples O
were O
tested O
up O
to O
and O
including O
week O
12 O
/ O
2020 O
and O
33,491 O
samples O
( O
6.9 O
% O
) O
tested O
positive O
for O
SARS O
- O
CoV O
- O
2.In O
Israel O
, O
researchers O
at O
Technion O
and O
Rambam O
Hospital O
developed O
and O
tested O
a O
method B-TERM
for O
testing O
samples O
from O
64 O
patients B-TERM
simultaneously O
, O
by O
pooling O
the O
samples O
and O
only O
testing O
further O
if O
the O
combined O
sample O
is O
found O
to O
be O
positive.In O
Wuhan O
a O
makeshift O
2000 O
- O
sq O
- O
meter O
emergency O
detection O
laboratory O
named B-TERM
" O
Huo O
- O
Yan O
" O
( O
Chinese O
: O
ÁÅ´ O
Áúº O
, O
or O
" O
Fire O
Eye B-TERM
" O
in O
English O
) O
was O
opened O
on O
5 O
February O
2020 O
by O
BGI O
, O
which O
can O
process O
over O
10,000 O
samples O
a O
day O
. O

With O
the O
construction B-TERM
overseen O
by O
BGI O
- O
founder O
Wang O
Jian O
and O
taking O
5 O
- O
days O
, O
modelling O
has O
show B-TERM
cases O
in O
Hubei O
would O
have O
been O
47 O
% O
higher O
and O
the O
corresponding O
cost O
of O
the O
tackling O
the O
quarantine O
would O
have O
doubled O
if O
this O
testing O
capacity O
hadn O
't O
come O
on O
line O
. O

The O
Wuhan O
Laboratory O
has O
been O
promptly O
followed O
by O
Huo O
- O
Yan O
labs O
in O
Shenzhen O
, O
Tianjin O
, O
Beijing O
, O
and O
Shanghai O
, O
in O
a O
total O
of O
12 O
cities O
across O
China O
. O

By O
4 O
March O
2020 O
the O
daily B-TERM
throughput O
totals O
were O
50,000 O
tests O
per O
day.Open B-TERM
source O
, O
multiplexed O
designs O
released O
by O
Origami O
Assays O
have O
been O
released O
that O
can O
test O
as O
many O
as O
1122 O
patient B-TERM
samples O
for O
COVID19 O
using O
only O
93 O
assays O
. O
These O
balanced O
designs O
can O
be O
run O
in O
small B-TERM
laboratories O
without O
the O
need O
for O
robotic O
liquid O
handlers O
. O

By O
March O
, O
shortages B-TERM
and O
insufficient O
amounts B-TERM
of O
reagent O
has O
become O
a O
bottleneck O
for O
mass O
testing O
in O
the O
EU O
and O
UK O
and O
the O
US O
. O

This O
has O
led O
some O
authors O
to O
explore O
sample O
preparation O
protocols O
that O
involve O
heating O
samples O
at O
98 O
¬∞ O
C O
( O
208 O
¬∞ O
F O
) O
for O
5 O
minutes B-TERM
to O
release O
RNA O
genomes O
for O
further O
testing.On O
31 O
March O
it O
was O
announced B-TERM
United B-TERM
Arab O
Emirates O
was O
now O
testing O
more O
of O
its O
population O
for O
Coronavirus O
per O
head O
than O
any O
other O
country O
, O
and O
was O
on O
track O
to O
scale O
up O
the O
level O
of O
testing O
to O
reach O
the O
bulk O
of O
the O
population O
. O

This O
was O
through O
a O
combination O
of O
drive O
- O
through O
capability O
, O
and O
purchasing B-TERM
a O
population O
- O
scale O
mass O
- O
throughput O
laboratory O
from O
Group O
42 O
and O
BGI O
( O
based O
on O
their O
" O
Huo O
- O
Yan O
" O
emergency O
detection O
laboratories O
in O
China O
) O
. O

Constructed O
in O
14 O
days O
, O
the O
lab O
is O
capable O
of O
conducting O
tens O
of O
thousands O
RT O
- O
PCR O
tests O
per O
day O
and O
is O
the O
first O
in O
the O
world O
of O
this O
scale O
to O
be O
operational O
outside O
of O
China O
. O

Different O
testing O
recipes O
targeting O
different O
parts O
of O
the O
coronavirus O
genetic O
profile O
were O
developed O
in O
China O
, O
France O
, O
Germany O
, O
Hong O
Kong O
, O
Japan O
, O
and O
the O
United O
States O
. O

The O
World O
Health O
Organization B-TERM
adopted O
the O
German B-TERM
recipe O
for O
manufacturing O
kits O
sent O
to O
low O
- O
income O
countries O
without O
the O
resources O
to O
develop O
their O
own O
. O

The O
German B-TERM
recipe O
was O
published O
on O
17 O
January O
2020 O
; O
the O
protocol O
developed O
by O
the O
United O
States O
Centers O
for O
Disease O
Control O
was O
not O
available O
until O
28 O
January O
, O
delaying O
available O
tests O
in O
the O
U.S.China O
and O
the O
United O
States O
had O
problems O
with O
the O
reliability O
of O
test O
kits O
early O
in O
the O
outbreak O
, O
and O
these O
countries O
and O
Australia O
were O
unable O
to O
supply O
enough O
kits O
to O
satisfy O
demand O
and O
recommendations O
for O
testing O
by O
health O
experts O
. O

In O
contrast O
, O
experts B-TERM
say O
South O
Korea O
's O
broad O
availability O
of O
testing O
helped B-TERM
reduce B-TERM
the O
spread O
of O
the O
novel O
coronavirus O
. O

Testing O
capacity O
, O
largely B-TERM
in O
private O
sector O
labs O
, O
was O
built O
up O
over O
several O
years O
by O
the O
South O
Korean O
government O
. O

On O
16 O
March O
, O
the O
World O
Health O
Organization B-TERM
called O
for O
ramping O
up O
the O
testing O
programmes O
as O
the O
best O
way B-TERM
to O
slow O
the O
advance O
of O
COVID O
- O
19 O
pandemic.High O
demand O
for O
testing O
due O
to O
wide O
spread O
of O
the O
virus O
caused O
backlogs O
of O
hundreds O
of O
thousands O
of O
tests O
at O
private O
U.S. O
labs O
, O
and O
supplies O
of O
swabs O
and O
chemical O
reagents O
became O
strained O
. O

In O
March O
2020 O
China O
reported O
problems B-TERM
with O
accuracy O
in O
their O
test O
kits O
. O

In O
the O
United O
States O
, O
the O
test O
kits O
developed O
by O
the O
CDC O
had O
" O
flaws B-TERM
; O
" O
the O
government O
then O
removed B-TERM
the O
bureaucratic O
barriers O
that O
had O
prevented O
private O
testing.Spain O
purchased O
test O
kits O
from O
Chinese O
firm B-TERM
Shenzhen O
Bioeasy O
Biotechnology O
Co O
Ltd O
, O
but O
found O
that O
results B-TERM
were O
inaccurate O
. O

The O
firm B-TERM
explained O
that O
the O
incorrect O
results B-TERM
may O
be O
a O
result O
of O
a O
failure O
to O
collect O
samples O
or O
use O
the O
kits O
correctly O
. O

The O
Spanish O
ministry O
said O
it O
will O
withdraw O
the O
kits O
that O
returned O
incorrect O
results B-TERM
, O
and O
would O
replace B-TERM
them O
with O
a O
different O
testing O
kit O
provided O
by O
Shenzhen O
Bioeasy.80 O
% O
of O
test O
kits O
the O
Czech O
Republic O
purchased O
from O
China O
gave O
wrong O
results.Slovakia O
purchased O
1.2 O
million O
test O
kits O
from O
China O
which O
were O
found O
to O
be O
inaccurate O
. O

Prime O
Minister O
Matoviƒç O
suggested O
these O
be O
dumped O
into O
the O
Danube.Ate≈ü O
Kara O
of O
the O
Turkish O
Health O
Ministry O
said O
the O
test O
kits O
Turkey O
purchased O
from O
China O
had O
a O
" O
high O
error O
rate O
" O
and O
did O
not O
" O
put O
them O
into O
use B-TERM
. O
" O
The O
UK O
purchased O
3.5 O
million O
test O
kits O
from O
China O
but O
in O
early O
April O
2020 O
announced B-TERM
these O
were O
not O
usable O
. O

Testing O
, O
followed O
with O
quarantine O
of O
those O
who O
tested O
positive O
and O
tracing O
of O
those O
with O
whom O
the O
SARS O
- O
CoV O
- O
2 O
positive O
people O
had O
had O
contact O
, O
resulted B-TERM
in O
positive O
outcomes B-TERM
. O

Researchers O
working O
in O
the O
Italian O
town O
of O
V√≤ O
, O
the O
site O
of O
the O
first O
COVID O
- O
19 O
death O
in O
Italy O
, O
conducted O
two B-TERM
rounds O
of O
testing O
on O
the O
entire B-TERM
population O
of O
about O
3,400 O
people O
, O
about O
ten O
days O
apart O
. O

About O
half O
the O
people O
testing O
positive O
had O
no O
symptoms O
, O
and O
all O
discovered O
cases O
were O
quarantined O
. O

With O
travel O
to O
the O
commune O
restricted O
, O
this O
eliminated O
new O
infections O
completely O
. O

With O
aggressive O
contact O
tracing O
, O
inbound O
travel O
restrictions O
, O
testing O
, O
and O
quarantining O
, O
the O
2020 O
coronavirus O
pandemic O
in O
Singapore O
has O
proceeded O
much O
more O
slowly O
than O
in O
other O
developed O
countries O
, O
but O
without O
extreme O
restrictions O
like B-TERM
forced O
closure O
of O
restaurants O
and O
retail O
establishments O
. O

Many O
events O
have O
been O
cancelled O
, O
and O
Singapore O
did O
start O
advising O
residents O
to O
stay O
at O
home O
on O
28 O
March O
, O
but O
schools O
reopened O
on O
time O
after O
holiday O
break O
on O
23 O
March O
. O

Several O
other O
countries O
have O
also B-TERM
managed O
the O
pandemic O
with O
aggressive O
contact O
tracing O
, O
inbound O
travel O
restrictions O
, O
testing O
, O
and O
quarantining O
, O
but O
with O
less O
aggressive O
lock O
- O
downs O
, O
such O
as O
Iceland O
and O
South O
Korea O
. O

A O
statistical O
study B-TERM
has O
found O
that O
countries O
that O
have O
tested O
more O
, O
relative O
to O
the O
number B-TERM
of O
deaths O
, O
have O
much O
lower O
case O
fatality O
rates O
, O
probably B-TERM
because O
these O
countries O
are O
better O
able O
to O
detect O
those O
with O
only O
mild O
or O
no O
symptoms O
. O

WHO O
recommends O
that O
countries O
that O
do O
not O
have O
testing O
capacity O
and O
national O
laboratories O
with O
limited O
experience O
on O
COVID O
- O
19 O
send O
their O
first O
five O
positives O
and O
the O
first O
ten O
negative O
COVID O
- O
19 O
samples O
to O
one O
of O
the O
16 O
WHO O
reference O
laboratories O
for O
confirmatory O
testing O
. O

Out O
of O
the O
16 O
reference O
laboratories O
, O
7 O
are O
in O
Asia O
, O
5 O
in O
Europe O
, O
2 O
in O
Africa O
, O
1 O
in O
North O
America O
and O
1 O
in O
Australia O
. O

In O
the O
following O
chart O
, O
the O
column O
" O
Positive O
as O
% O
of O
tests O
" O
is O
influenced O
by O
the O
country O
's O
testing O
policy O
. O

A O
country O
that O
only O
tests O
people O
admitted O
to O
hospitals O
will O
have O
a O
higher O
positive O
as O
% O
of O
tests O
than O
a O
country O
that O
tests O
all O
citizens O
, O
whether O
or O
not O
they O
are O
showing O
symptoms O
, O
other O
things O
being O
equal B-TERM
. O

Company B-TERM
director O
found O
guilty B-TERM
of O
tax O
evasion O

The O
director O
of O
OOO O
" O
Zemlya O
i O
pravo O
" O
has O
been O
found O
guilty O
by O
Chekoksary O
's O
Leninsky O
district O
court O
of O
crimes B-TERM
under O
p O
. O
" O
b O
" O
pt O
. O
2 O
art O
. O
199 O
of O
the O
Russian O
Criminal O
Code O
( O
evasion O
of O
paying O
an O
organization B-TERM
's O
taxes O
by O
deliberately O
including O
false B-TERM
information B-TERM
in O
a O
tax O
declaration B-TERM
, O
committed O
on O
an O
especially B-TERM
large O
scale O
) O
and O
p O
. O
2 O
art O
. O
327 O
of O
the O
Russian O
Criminal O
Code O
( O
forgery O
of O
an O
official O
document O
that O
gives O
rights O
and O
releases O
from O
duties O
, O
committed O
for O
the O
purpose O
of O
concealing O
another B-TERM
crime O
or O
facilitating O
its O
commitment O
) O
. O
o O

This O
is O
reported O
by O
the O
press O
service O
of O
the O
investigative O
directorate O
of O
the O
ICR O
in O
Chuvashia O
. O

From O
January O
2008 O
through O
December O
2009 O
Vyacheslav O
Morozov O
included O
information B-TERM
about O
non O
- O
existent O
transactions O
in O
company O
tax O
declaration O
documents O
. O

According O
to O
the O
fraudulent O
documents O
the O
company B-TERM
incurred O
additional O
expenses O
, O
and O
, O
consequently O
, O
the O
amount O
of O
value B-TERM
- O
added B-TERM
and O
profit O
taxes O
owed O
by O
the O
organization B-TERM
were O
reduced B-TERM
by O
11.2 O
mln O
rub O
. O

Vyacheslav O
Morozov O
was O
imposed O
a O
penalty O
in O
the O
form O
of O
3.5 O
years O
' O
suspended O
sentence O
. O

The O
first O
new O
- O
format O
school O
is O
set O
to O
open O
in O
the O
center O
of O
the O
capital O
by O
2023 O
. O

A O
new O
- O
format O
school O
is O
opening O
in O
Khamovniki O
. O

According O
to O
the O
head O
of O
the O
Moscow O
City O
Committee O
for O
the O
Implementation O
of O
Investment O
Projects O
in O
Construction O
and O
Supervision O
of O
Participatory O
Construction O
, O
Anastasiya O
Pyatovaya O
, O
all O
the O
necessary O
conditions B-TERM
will O
be O
created O
to O
ensure O
children O
's O
self O
- O
fulfillment O
and O
their O
talents O
are O
developed O
. O

It O
was O
decided O
to O
name O
the O
educational O
institution O
New O
View O
. O

The O
project B-TERM
will O
be O
overseen O
by O
the O
Moscow O
State O
Institute O
of O
International O
Relations O
and O
the O
Foundation O
for O
Economic O
Development O
of O
Higher O
Education O
. O

Work O
on O
the O
design O
of O
the O
approximately O
10,000 O
square O
meter O
institution O
is O
planned O
to O
already O
begin O
next B-TERM
year O
. O

Construction O
is O
to O
be O
completed O
by O
the O
end B-TERM
of O
2022 O
and O
classes O
are O
to O
start O
already O
the O
following O
year O
. O

" O
The O
project O
foresees O
the O
creation B-TERM
of O
a O
public O
, O
non O
- O
commercial O
educational O
space O
based O
on O
the O
traditions B-TERM
of O
classical O
Moscow O
schools O
and O
experimental O
methods O
, O
" O
stated O
the O
Moscow O
City O
Committee O
for O
the O
Implementation O
of O
Investment O
Projects O
in O
Construction O
and O
Supervision O
of O
Participatory O
Construction O
's O
press O
release O
. O

Construction O
of O
billion O
- O
euro O
telescope O
begins O
in O
Chile O

This O
is O
reported O
by O
TASS O
citing O
the O
European O
Southern O
Observatory O
( O
ESO O
) O
press O
service O
. O

ESO O
says O
that O
this O
week O
construction B-TERM
officially O
began O
on O
the O
dome O
of O
the O
building O
that O
is O
to O
house B-TERM
the O
E O
- O
ELT O
( O
European O
Extremely O
Large O
Telescope O
) O
, O
currently O
the O
most O
expensive O
and O
ambitious O
terrestrial O
astronomical O
project B-TERM
. O

Its O
overall O
cost O
, O
according O
to O
ESO O
estimations O
, O
exceeds O
a O
billion O
euros O
. O

A O
large O
part O
of O
this O
money O
will O
be O
spent O
making O
the O
equipment B-TERM
and O
constructing O
the O
observatory O
building O
. O

The O
most O
expensive O
and O
complex O
component B-TERM
of O
the O
telescope O
is O
the O
record O
- O
setting O
large O
mirror O
, O
with O
a O
diameter O
of O
about O
39 O
meters O
. O

It O
will O
consist O
of O
798 O
hexagonal O
1.4 O
- O
meter O
segments O
. O

This O
huge O
mirror O
, O
and O
also B-TERM
two B-TERM
supplementary O
reflective O
surfaces O
4.2 O
and O
3.75 O
meters O
in O
diameter O
, O
will O
help O
the O
E O
- O
ELT O
obtain O
the O
first O
detailed O
photographs O
of O
planets O
outside O
the O
Solar O
System O
, O
stars O
in O
other O
galaxies O
, O
and O
also B-TERM
search O
for O
Earth O
twins O
. O

Researchers O
will O
also O
try O
to O
use B-TERM
this O
observatory O
to O
view O
the O
surroundings O
of O
Sgr O
A O
* O
, O
a O
supermassive O
back O
hole B-TERM
at O
the O
center O
of O
the O
Milky O
Way O
. O

Despite O
the O
fact O
that O
construction O
of O
the O
dome O
has O
only O
just O
begun O
, O
scientists O
, O
engineers O
and O
other O
specialists O
have O
already O
been O
developing O
the O
mirrors O
, O
research O
instruments O
and O
other O
components B-TERM
of O
the O
observatory O
for O
three O
years O
- O
from O
the O
moment B-TERM
when O
the O
first O
plans B-TERM
to O
build O
the O
E O
- O
ELT O
were O
announced O
. O

The O
contract B-TERM
to O
produce O
the O
main O
mirror O
, O
the O
total O
cost O
of O
which O
was O
about O
400 O
million O
euros O
, O
was O
received B-TERM
by O
the O
German O
company B-TERM
SCHOTT O
and O
the O
French O
company B-TERM
Safran O
Reosc O
. O

Rapidly O
increasing O
cumulative O
incidence O
of O
coronavirus O
disease O
( O
COVID O
- O
19 O
) O
in O
the O
European O
Union B-TERM
/ O
European O
Economic O
Area O
and O
the O
United O
Kingdom O
, O
1 O
January O
to O
15 O
March O
2020 O

The O
cumulative O
incidence O
of O
coronavirus O
disease O
( O
COVID O
- O
19 O
) O
cases O
is O
showing O
similar B-TERM
trends B-TERM
in O
European O
Union O
/ O
European O
Economic O
Area O
countries O
and O
the O
United O
Kingdom O
confirming O
that O
, O
while O
at O
a O
different O
stage B-TERM
depending O
on O
the O
country O
, O
the O
COVID O
- O
19 O
pandemic O
is O
progressing O
rapidly O
in O
all O
countries O
. O

Based O
on O
the O
experience O
from O
Italy O
, O
countries O
, O
hospitals O
and O
intensive O
care O
units O
should O
increase O
their O
preparedness O
for O
a O
surge O
of O
patients B-TERM
with O
COVID O
- O
19 O
who O
will O
require O
healthcare O
, O
and O
in O
particular O
intensive O
care O
. O

On O
31 O
December O
2019 O
, O
a O
cluster O
of O
pneumonia O
cases O
of O
unknown B-TERM
aetiology O
was O
reported O
in O
Wuhan O
, O
Hubei O
Province O
, O
China O
. O

On O
9 O
January O
2020 O
, O
the O
China O
Center O
for O
Disease B-TERM
Control O
and O
Prevention O
reported O
the O
causative O
agent O
as O
being O
a O
novel O
coronavirus O
now O
referred O
to O
as O
severe O
acute O
respiratory O
syndrome O
coronavirus O
2 O
( O
SARS O
- O
CoV O
- O
2 O
) O
. O

Since O
, O
the O
illness B-TERM
resulting O
from O
SARS O
- O
CoV O
- O
2 O
infection O
has O
been O
named O
coronavirus O
disease B-TERM
( O
COVID O
- O
19 O
) O
. O

Evidence O
to O
date O
is O
that O
ca O
80 O
% O
of O
individuals O
with O
COVID O
- O
19 O
have O
a O
mild O
disease B-TERM
, O
i.e. O
a O
respiratory O
tract O
infection O
with O
or O
without O
pneumonia O
, O
and O
most O
of O
these O
recover O
. O

In O
ca O
14 O
% O
cases O
, O
COVID O
- O
19 O
develops O
into O
a O
more O
severe O
disease B-TERM
requiring O
hospitalisation O
while O
the O
remaining O
6 O
% O
cases O
experience O
critical O
illness B-TERM
requiring O
intensive O
care O
. O

The O
mortality O
of O
patients B-TERM
hospitalised O
due O
to O
COVID O
- O
19 O
is O
ca O
4 O
% O
. O

In O
this O
study B-TERM
, O
we O
assess O
the O
trends B-TERM
in O
the O
cumulative O
incidence O
of O
COVID O
- O
19 O
in O
each O
European O
Union B-TERM
/ O
European O
Economic O
Area O
( O
EU O
/ O
EEA O
) O
country O
and O
the O
United O
Kingdom O
( O
UK O
) O
and O
compare O
them O
to O
that O
of O
Hubei O
Province O
, O
China O
. O

We O
also B-TERM
compare O
the O
current B-TERM
number B-TERM
of O
COVID O
- O
19 O
cases O
in O
EU O
/ O
EEA O
countries O
and O
the O
UK O
with O
that O
in O
Italy O
during O
31 O
January O
- O
15 O
March O
2020 O
. O

COVID O
- O
19 O
cases O
in O
EU O
/ O
EEA O
countries O
and O
the O
UK O

Subsequent O
to O
China O
, O
COVID O
- O
19 O
underwent O
further O
geographical O
spread O
and O
the O
dynamic O
of O
the O
COVID O
- O
19 O
pandemic O
in O
the O
rest B-TERM
of O
the O
world O
currently O
follows B-TERM
that O
of O
this O
country O
. O

On O
11 O
March O
2020 O
, O
the O
Director O
General O
of O
the O
World O
Health O
Organization B-TERM
( O
WHO O
) O
declared B-TERM
COVID O
- O
19 O
a O
pandemic O
. O

In O
the O
5 O
March O
issue O
of O
Eurosurveillance O
2020 O
, O
Spiteri O
et O
al. O
reported O
on O
the O
first O
European O
confirmed O
COVID O
- O
19 O
cases O
according O
to O
the O
WHO O
case O
definition O
. O

In O
the O
EU O
/ O
EEA O
, O
the O
first O
three O
confirmed O
cases O
were O
reported O
by O
France O
on O
24 O
January O
2020 O
in O
persons O
returning O
from O
Wuhan O
, O
Hubei O
Province O
, O
China O
. O

As O
at O
15 O
March O
2020 O
, O
COVID O
- O
19 O
cases O
had O
been O
detected O
in O
all O
30 O
EU O
/ O
EEA O
countries O
and O
the O
United O
Kingdom O
( O
UK O
) O
, O
whereby O
between O
31 O
December O
2019 O
and O
that O
date O
included O
, O
39,768 O
cases O
and O
1,727 O
deaths O
had O
been O
reported O
, O
with O
17,750 O
cases O
and O
1,441 O
deaths O
from O
Italy O
alone B-TERM
. O

Obtaining O
cumulative O
number B-TERM
and O
cumulative O
incidence O
of O
COVID O
- O
19 O
cases O

At O
the O
European O
Centre O
for O
Disease B-TERM
Prevention O
and O
Control O
( O
ECDC O
) O
, O
the O
notified O
COVID O
- O
19 O
case O
counts O
in O
each O
country O
worldwide O
, O
obtained O
from O
only O
official O
sources O
such O
as O
the O
countries O
" O
Ministry O
of O
Health O
, O
national O
and O
regional B-TERM
health O
authorities O
and O
the O
WHO O
, O
are O
updated O
each O
day O
at O
8 O
: O
00 O
a.m. O

These O
data B-TERM
were O
used O
for O
assessing O
the O
trends B-TERM
of O
COVID O
- O
19 O
in O
EU O
/ O
EEA O
and O
the O
UK O
, O
and O
comparing O
them O
to O
that O
in O
Italy O
. O

As O
a O
proxy O
of O
the O
prevalence O
of O
active B-TERM
COVID O
- O
19 O
cases O
, O
we O
calculated O
the O
14 O
- O
day O
truncated O
cumulative O
incidence O
of O
COVID O
- O
19 O
cases O
, O
thus O
taking O
into O
account O
the O
natural O
course O
of O
COVID O
- O
19 O
, O
in O
each O
EU O
/ O
EEA O
country O
and O
the O
UK O
, O
during O
the O
1 O
January O
- O
15 O
March O
2020 O
period O
. O

We O
also B-TERM
presented O
the O
cumulative O
number B-TERM
of O
notified O
cases O
of O
each O
country O
as O
at O
15 O
March O
2020 O
8 O
: O
00 O
a.m. O
compared O
with O
that O
of O
Italy O
for O
the O
31 O
January O
- O
15 O
March O
2020 O
period O
. O

Trends B-TERM
of O
COVID O
- O
19 O
in O
EU O
/ O
EEA O
countries O
and O
the O
UK O

The O
trends B-TERM
in O
the O
14 O
- O
day O
truncated O
cumulative O
incidence O
of O
COVID O
- O
19 O
cases O
in O
EU O
/ O
EEA O
countries O
and O
the O
UK O
generally O
followed O
that O
of O
Hubei O
Province O
( O
China O
) O
( O
Figure O
1 O
) O
. O

For O
the O
EU O
/ O
EEA O
and O
the O
UK O
overall O
, O
the O
cumulative O
incidence O
of O
COVID O
- O
19 O
started O
to O
increase O
around O
21 O
February O
and O
then O
increased O
sharply O
around O
28 O
February O
2020 O
( O
Supplementary O
material O
) O
. O

This O
was O
mostly B-TERM
driven O
by O
the O
rapid B-TERM
increase B-TERM
in O
the O
number B-TERM
of O
reported O
cases O
from O
Italy O
, O
but O
all O
other O
EU O
/ O
EEA O
countries O
and O
the O
UK O
showed O
similar B-TERM
increasing O
trends B-TERM
of O
the O
cumulative O
incidence O
of O
COVID O
- O
19 O
( O
Supplementary O
material B-TERM
) O
. O

Figure O
2 O
shows B-TERM
the O
cumulative O
number B-TERM
of O
COVID O
- O
19 O
cases O
, O
in O
EU O
/ O
EEA O
countries O
and O
the O
UK O
compared O
with O
that O
in O
Italy O
for O
the O
31 O
January O
- O
15 O
March O
2020 O
period O
. O

It O
highlights O
that O
, O
as O
at O
15 O
March O
8 O
: O
00 O
a.m. O
, O
15 O
other O
EU O
/ O
EEA O
countries O
and O
the O
UK O
had O
already O
reported O
a O
total O
number B-TERM
of O
cases O
comparable O
to O
that O
of O
Italy O
just O
3 O
weeks O
prior O
or O
less O
. O

Our O
results B-TERM
indicate O
that O
the O
number B-TERM
of O
notified O
cases O
of O
COVID O
- O
19 O
is O
rapidly O
increasing B-TERM
in O
the O
EU O
/ O
EEA O
and O
the O
UK O
. O

The O
observed O
trends B-TERM
in O
the O
cumulative O
incidence O
of O
COVID O
- O
19 O
suggest O
that O
the O
pandemic O
is O
progressing O
at O
a O
comparable O
speed B-TERM
in O
all O
countries O
. O

This O
is O
despite O
countries O
being O
at O
different O
stages B-TERM
, O
variations O
in O
national O
public O
health O
responses O
, O
and O
possibly B-TERM
different O
case O
definitions O
in O
countries O
and O
different O
protocols O
for O
selecting O
patients B-TERM
that O
must O
be O
tested O
for O
confirmation O
of O
COVID O
- O
19 O
, O
including O
catch O
- O
up O
testing O
. O

Early O
March O
2020 O
, O
doctors B-TERM
in O
the O
affected O
regions B-TERM
of O
Italy O
described O
a O
situation O
in O
which O
ca O
10 O
% O
of O
patients B-TERM
with O
COVID O
- O
19 O
required O
intensive O
care O
and O
media O
sources O
reported O
that O
hospitals O
and O
intensive O
care O
units O
in O
these O
regions B-TERM
had O
already O
reached O
their O
maximum O
capacity O
. O

Data O
on O
admission O
of O
COVID O
- O
19 O
cases O
in O
a O
hospital O
and O
/ O
or O
an O
intensive O
care O
unit O
are O
currently O
available O
at O
EU O
/ O
EEA O
level O
for O
only O
6 O
% O
and O
1 O
% O
cases O
, O
respectively O
( O
data B-TERM
not O
shown O
) O
. O

They O
should O
, O
however O
, O
be O
collected O
in O
a O
systematic O
fashion O
to O
complement O
current O
surveillance O
data O
that O
focus O
on O
the O
number B-TERM
of O
reported O
cases O
and O
the O
number B-TERM
of O
deaths O
. O

A O
study B-TERM
performed O
in O
2010 O
- O
11 O
showed O
a O
large O
variation O
in O
the O
availability O
of O
intensive O
care O
and O
intermediate O
care O
beds O
in O
Europe O
, O
ranging O
from O
29.2 O
in O
Germany O
to O
4.2 O
beds O
per O
100,000 O
population O
in O
Portugal O
. O

This O
means B-TERM
that O
countries O
may O
have O
more O
or O
less O
resources O
than O
Italy O
( O
12.5 O
intensive O
care O
and O
intermediate O
care O
beds O
per O
100,000 O
population O
in O
2010 O
- O
11 O
) O
. O

Modelling O
scenarios O
related O
to O
healthcare O
capacity O
saturation O
, O
with O
estimates O
for O
each O
EU O
/ O
EEA O
country O
and O
the O
UK O
of O
the O
prevalence O
of O
hospitalised O
COVID O
- O
19 O
cases O
associated O
with O
a O
> O
90 O
% O
risk O
of O
exceeding O
intensive O
care O
bed O
capacity O
, O
are O
provided O
in O
the O
sixth O
update O
of O
the O
ECDC O
rapid O
risk O
assessment O
on O
COVID O
- O
19 O
. O

Since O
cases O
have O
so O
far O
clustered O
in O
certain O
regions O
in O
EU O
/ O
EEA O
countries O
and O
the O
UK O
, O
and O
hospitals O
and O
intensive O
care O
units O
usually O
serve O
a O
defined O
regional O
catchment O
population O
, O
information O
about O
cases O
and O
intensive O
care O
beds O
should O
preferably O
be O
made O
available O
at O
the O
Nomenclature O
of O
territorial O
units O
for O
statistics O
2 O
( O
NUTS O
- O
2 O
) O
level O
. O

The O
experience O
from O
Italy O
and O
the O
current B-TERM
trends B-TERM
in O
other O
countries O
show B-TERM
that O
the O
COVID O
- O
19 O
pandemic O
is O
progressing O
rapidly O
in O
the O
EU O
/ O
EEA O
and O
the O
UK O
. O

Countries O
, O
hospitals O
and O
intensive O
care O
units O
should O
thus O
prepare O
themselves O
for O
a O
scenario O
of O
sustained O
community O
transmission O
of O
SARS O
- O
CoV O
- O
2 O
and O
an O
increase B-TERM
in O
the O
number B-TERM
of O
patients B-TERM
with O
COVID O
- O
19 O
requiring O
healthcare O
, O
and O
in O
particular O
intensive O
care O
, O
such O
as O
the O
one O
occurring O
in O
the O
affected O
regions B-TERM
of O
Italy O
. O

As O
pointed O
out O
in O
the O
recent B-TERM
ECDC O
rapid O
risk O
assessment O
, O
a O
rapid O
, O
proactive O
and O
comprehensive O
approach O
is O
essential O
to O
delay O
the O
spread O
of O
SARS O
- O
COV O
- O
2 O
, O
with O
a O
shift O
from O
a O
containment O
to O
a O
mitigation O
approach O
, O
as O
the O
anticipated O
rapid O
increase B-TERM
in O
the O
number B-TERM
of O
cases O
may O
not O
provide O
decision B-TERM
makers O
and O
hospitals O
enough B-TERM
time O
to O
comprehend O
, O
accept B-TERM
and O
adapt O
their O
response O
accordingly O
if O
not O
implemented O
ahead O
of O
time O
. O

The O
rapid O
risk O
assessment O
also B-TERM
lists O
the O
public O
health O
measures B-TERM
to O
mitigate O
the O
impact B-TERM
of O
the O
pandemic O
. O

There O
is O
a O
short O
window O
of O
opportunity O
during O
which O
countries O
have O
the O
possibility O
to O
further O
increase O
their O
control O
efforts O
to O
slow O
down O
the O
spread O
of O
SARS O
- O
CoV O
- O
2 O
and O
decrease O
the O
pressure O
on O
healthcare O
. O

Failing O
this O
, O
it O
is O
likely O
that O
the O
healthcare O
systems O
of O
other O
EU O
/ O
EEA O
countries O
will O
face O
a O
surge O
of O
patients B-TERM
that O
require O
intensive O
care O
within O
the O
coming O
days O
or O
weeks O
. O

Zoonotic O
origins O
of O
human O
coronaviruses O

Mutation O
and O
adaptation O
have O
driven O
the O
co O
- O
evolution O
of O
coronaviruses O
( O
CoVs O
) O
and O
their O
hosts O
, O
including O
human O
beings O
, O
for O
thousands O
of O
years O
. O

Before O
2003 O
, O
two B-TERM
human O
CoVs O
( O
HCoVs O
) O
were O
known O
to O
cause B-TERM
mild O
illness B-TERM
, O
such O
as O
common O
cold O
. O

The O
outbreaks O
of O
severe O
acute O
respiratory O
syndrome O
( O
SARS O
) O
and O
the O
Middle O
East O
respiratory O
syndrome O
( O
MERS O
) O
have O
flipped O
the O
coin O
to O
reveal O
how O
devastating O
and O
life O
- O
threatening O
an O
HCoV O
infection O
could O
be O
. O

The O
emergence B-TERM
of O
SARS O
- O
CoV O
- O
2 O
in O
central O
China O
at O
the O
end B-TERM
of O
2019 O
has O
thrusted O
CoVs O
into O
the O
spotlight O
again O
and O
surprised O
us O
with O
its O
high O
transmissibility O
but O
reduced O
pathogenicity O
compared O
to O
its O
sister O
SARS O
- O
CoV O
. O

HCoV O
infection O
is O
a O
zoonosis O
and O
understanding O
the O
zoonotic O
origins O
of O
HCoVs O
would O
serve O
us O
well O
. O

Most O
HCoVs O
originated O
from O
bats O
where O
they O
are O
non O
- O
pathogenic O
. O

The O
intermediate O
reservoir O
hosts O
of O
some O
HCoVs O
are O
also B-TERM
known O
. O

Identifying O
the O
animal B-TERM
hosts O
has O
direct O
implications O
in O
the O
prevention B-TERM
of O
human O
diseases B-TERM
. O

Investigating O
CoV O
- O
host O
interactions O
in O
animals B-TERM
might O
also B-TERM
derive O
important O
insight O
on O
CoV O
pathogenesis O
in O
humans O
. O

In O
this O
review O
, O
we O
present O
an O
overview O
of O
the O
existing O
knowledge O
about O
the O
seven O
HCoVs O
, O
with O
a O
focus O
on O
the O
history O
of O
their O
discovery O
as O
well O
as O
their O
zoonotic O
origins O
and O
interspecies O
transmission O
. O

Importantly O
, O
we O
compare O
and O
contrast O
the O
different O
HCoVs O
from O
a O
perspective O
of O
virus O
evolution O
and O
genome O
recombination O
. O

The O
current O
CoV O
disease B-TERM
2019 O
( O
COVID O
- O
19 O
) O
epidemic O
is O
discussed O
in O
this O
context O
. O

In O
addition B-TERM
, O
the O
requirements B-TERM
for O
successful O
host O
switches O
and O
the O
implications O
of O
virus O
evolution O
on O
disease B-TERM
severity O
are O
also O
highlighted O
. O

Coronaviruses O
( O
CoVs O
) O
belong O
to O
the O
family B-TERM
Coronaviridae O
, O
which O
comprises O
a O
group O
of O
enveloped O
, O
positive O
- O
sensed O
, O
single O
- O
stranded O
RNA O
viruses O
. O

These O
viruses O
harbouring O
the O
largest O
genome O
of O
26 O
to O
32 O
kilobases O
amongst O
RNA O
viruses O
were O
termed O
" O
CoVs O
" O
because O
of O
their O
crown O
- O
like O
morphology O
under O
electron O
microscope O
. O

Structurally O
, O
CoVs O
have O
non O
- O
segmented O
genomes O
that O
share O
a O
similar O
organization B-TERM
. O

Approximately O
two O
thirds O
of O
the O
genome O
contain O
two B-TERM
large O
overlapping O
open O
reading O
frames O
( O
ORF1a O
and O
ORF1b O
) O
, O
which O
are O
translated O
into O
the O
pp1a O
and O
pp1ab O
replicase O
polyproteins O
. O

The O
polyproteins O
are O
further O
processed O
to O
generate O
16 O
non O
- O
structural O
proteins B-TERM
, O
designated O
nsp1 O
~ O
16 O
. O

The O
remaining O
portion B-TERM
of O
the O
genome O
contains O
ORFs O
for O
the O
structural O
proteins B-TERM
, O
including O
spike O
( O
S O
) O
, O
envelope O
( O
E O
) O
, O
membrane O
( O
M O
) O
and O
nucleoprotein O
( O
N O
) O
. O

A O
number O
of O
lineage O
- O
specific O
accessory O
proteins B-TERM
are O
also B-TERM
encoded O
by O
different O
lineages O
of O
CoVs O
. O

Based O
on O
the O
difference B-TERM
in O
protein O
sequences B-TERM
, O
CoVs O
are O
classified O
into O
four O
genera O
( O
alpha O
- O
CoV O
, O
beta O
- O
CoV O
, O
gamma O
- O
CoV O
and O
delta O
- O
CoV O
) O
, O
among O
which O
the O
beta O
- O
CoV O
genera O
contains O
most O
HCoVs O
and O
is O
subdivided O
into O
four O
lineages O
( O
A O
, O
B O
, O
C O
and O
D O
) O
. O

Phylogenetic O
evidence O
has O
shown O
that O
bats O
and O
rodents O
serve O
as O
the O
gene O
source O
of O
most O
alpha O
- O
CoVs O
and O
beta O
- O
CoVs O
, O
while O
birds O
are O
the O
main B-TERM
reservoir O
of O
gamma O
- O
CoVs O
and O
delta O
- O
CoVs O
. O

For O
thousands O
of O
years O
, O
CoVs O
have O
constantly O
crossed O
species O
barriers O
and O
some O
have O
emerged O
as O
important O
human O
pathogens O
. O

To O
date O
, O
seven O
human O
CoVs O
( O
HCoVs O
) O
are O
known O
. O

Among O
them O
HCoV O
- O
229E O
and O
HCoV O
- O
NL63 O
are O
alpha O
- O
CoVs O
. O

The O
other O
five O
beta O
- O
CoVs O
include O
HCoV O
- O
OC43 O
, O
HCoV O
- O
HKU1 O
, O
severe O
acute O
respiratory O
syndrome O
coronavirus O
( O
SARS O
- O
CoV O
) O
, O
Middle O
East O
respiratory O
syndrome O
coronavirus O
( O
MERS O
- O
CoV O
) O
and O
SARS O
- O
CoV O
- O
2 O
. O

HCoV O
- O
229E O
, O
HCoV O
- O
OC43 O
, O
HCoV O
- O
HKU1 O
and O
HCoV O
- O
NL63 O
usually O
cause B-TERM
mild O
symptoms O
, O
like O
common O
cold O
and O
/ O
or O
diarrhea O
. O

In O
contrast O
, O
SARS O
- O
CoV O
, O
MERS O
- O
CoV O
and O
the O
newly O
- O
identified O
SARS O
- O
CoV O
- O
2 O
are O
highly B-TERM
pathogenic O
, O
causing B-TERM
severe O
lower O
respiratory O
tract O
infection O
in O
relatively O
more O
patients B-TERM
with O
a O
higher O
chance O
to O
develop O
acute O
respiratory O
distress O
syndrome O
( O
ARDS O
) O
and O
extrapulmonary O
manifestations O
. O

The O
first O
HCoV O
- O
229E O
strain O
, O
B814 O
, O
was O
isolated O
from O
the O
nasal O
discharge O
of O
patients B-TERM
with O
common O
cold O
in O
mid O
- O
1960s O
. O

Since O
then O
, O
more O
knowledge B-TERM
was O
accumulated B-TERM
through O
extensive O
studies B-TERM
on O
HCoV O
- O
229E O
and O
HCoV O
- O
OC43 O
, O
both O
of O
which O
cause B-TERM
self O
- O
limiting O
symptoms O
. O

Indeed B-TERM
, O
the O
concept B-TERM
had O
been O
widely O
accepted O
that O
infection O
with O
HCoVs O
is O
generally O
harmless O
until O
the O
outbreak O
of O
SARS O
. O

The O
SARS O
outbreak O
occurred O
in O
2003 O
is O
one O
of O
the O
most O
devastating O
in O
current B-TERM
history O
, O
infecting O
over O
8,000 O
people O
with O
a O
crude O
case O
fatality O
of O
approximately B-TERM
10 O
% O
. O

Ten O
years O
later O
, O
the O
Middle O
East O
respiratory O
syndrome O
( O
MERS O
) O
outbreak O
resulted O
in O
a O
persistent O
epidemic O
in O
the O
Arabian O
Peninsula O
with O
sporadic O
spreading O
to O
the O
rest B-TERM
of O
the O
world O
. O

The O
2019 O
novel O
HCoV O
( O
2019 O
- O
nCoV O
) O
, O
which O
has O
subsequently B-TERM
been O
renamed O
SARS O
- O
CoV O
- O
2 O
, O
is O
the O
causative O
agent O
of O
the O
ongoing O
epidemic O
of O
coronavirus O
disease B-TERM
2019 O
( O
COVID O
- O
19 O
) O
, O
which O
has O
claimed O
more O
than O
3,120 O
lives O
and O
infected O
more O
than O
91,000 O
people O
as O
of O
March O
3 O
, O
2020 O
. O

The O
alarm O
has O
been O
ringing O
and O
the O
world O
has O
to O
prepare O
for O
the O
coming O
pandemic O
of O
SARS O
- O
CoV O
- O
2 O
. O

All O
seven O
HCoVs O
have O
a O
zoonotic O
origin O
from O
bats O
, O
mice O
or O
domestic O
animals B-TERM
. O

Multiple O
lines O
of O
evidence O
support O
an O
evolutionary O
origin O
of O
all O
HCoVs O
from O
bats O
, O
where O
viruses O
are O
well O
adapted B-TERM
and O
non O
- O
pathogenic O
but O
show B-TERM
great O
genetic O
diversity O
. O

The O
COVID O
- O
19 O
epidemic O
has O
presented O
enormous O
medical O
, O
scientific O
, O
social O
and O
moral B-TERM
challenges O
to O
China O
and O
the O
world O
. O

Tracing O
the O
zoonotic O
origins O
of O
HCoVs O
provides O
a O
framework O
to O
understand B-TERM
the O
natural B-TERM
history O
, O
driving O
force O
and O
restriction O
factors O
of O
species O
jumping O
. O

This O
might O
also B-TERM
guide O
or O
facilitate O
the O
search O
for O
the O
reservoir O
, O
intermediate O
and O
amplifying O
animal O
host O
( O
s O
) O
of O
SARS O
- O
CoV O
- O
2 O
, O
with O
important B-TERM
implications O
in O
the O
prevention B-TERM
of O
future O
spillovers O
. O

In O
this O
review O
we O
present O
an O
overview O
of O
the O
zoonotic O
origins O
, O
interspecies O
transmission O
and O
pathogenesis O
of O
HCoVs O
. O

Particularly O
, O
we O
highlight O
and O
discuss O
the O
common B-TERM
theme O
that O
parental O
viruses O
of O
HCoVs O
are O
typically O
non O
- O
pathogenic O
in O
their O
natural O
reservoir O
hosts O
but O
become O
pathogenic O
after O
interspecies O
transmission O
to O
a O
new O
host O
. O

We O
also B-TERM
review O
the O
trend B-TERM
of O
HCoV O
evolution O
in O
which O
the O
increase O
in O
transmissibility O
often B-TERM
comes O
with O
the O
decrease O
in O
pathogenicity O
. O

The O
outcome B-TERM
of O
the O
ongoing O
SARS O
- O
CoV O
- O
2 O
outbreak O
is O
also O
discussed O
in O
this O
context O
. O

Animal B-TERM
CoVs O
have O
been O
known O
since O
late O
1930s O
. O

Before O
the O
first O
isolation O
of O
HCoV O
- O
229E O
strain O
B814 O
from O
the O
nasal O
discharge O
of O
patients B-TERM
who O
had O
contracted O
common O
cold O
, O
different O
CoVs O
had O
been O
isolated O
in O
various O
infected O
animals B-TERM
, O
including O
turkey O
, O
mouse O
, O
cow O
, O
pig O
, O
cat O
and O
dog O
. O

In O
the O
past O
decades O
, O
seven O
HCoVs O
have O
been O
identified O
. O

A O
brief O
summary O
of O
the O
history O
of O
HCoV O
discovery O
in O
chronological O
order O
( O
Table O
1 O
) O
would O
be O
informative O
and O
instructive O
. O

The O
first O
HCoV O
- O
229E O
strain O
was O
isolated O
from O
the O
respiratory O
tract O
of O
patients B-TERM
with O
upper O
respiratory O
tract O
infection O
in O
the O
year O
of O
1966 O
, O
and O
was O
subsequently O
adapted B-TERM
to O
grow O
in O
WI O
- O
38 O
lung O
cell O
lines B-TERM
. O

Patients B-TERM
infected O
with O
HCoV O
- O
229E O
presented O
with O
common B-TERM
cold O
symptoms O
, O
including O
headache O
, O
sneezing O
, O
malaise B-TERM
and O
sore O
- O
throat O
, O
with O
fever O
and O
cough O
seen O
in O
10 O
~ O
20 O
% O
cases O
. O

Later O
in O
1967 O
, O
HCoV O
- O
OC43 O
was O
isolated O
from O
organ O
culture O
and O
subsequent O
serial O
passage O
in O
brains O
of O
suckling O
mice O
. O

The O
clinical O
features O
of O
HCoV O
- O
OC43 O
infection O
appear B-TERM
to O
be O
similar B-TERM
to O
those O
caused O
by O
HCoV O
- O
229E O
, O
which O
are O
symptomatically O
indistinguishable O
from O
infection O
with O
other O
respiratory O
tract O
pathogens O
such O
as O
influenza O
A O
viruses O
and O
rhinoviruses O
. O

Both O
HCoV O
- O
229E O
and O
HCoV O
- O
OC43 O
are O
distributed O
globally O
, O
and O
they O
tend O
to O
be O
predominantly O
transmitted O
during O
the O
season O
of O
winter O
in O
temperate O
climate O
. O

Generally O
, O
the O
incubation O
time O
of O
these O
two B-TERM
viruses O
is O
less O
than O
one O
week O
, O
followed O
by O
an O
approximately B-TERM
2 O
- O
week O
illness B-TERM
. O

According O
to O
a O
human O
volunteer O
study B-TERM
, O
healthy O
individuals O
infected O
with O
HCoV O
- O
229E O
developed O
mild O
common O
cold O
. O

Only O
a O
few O
immunocompromised O
patients B-TERM
exhibited O
severe O
lower O
respiratory O
tract O
infection O
. O

SARS O
, O
also B-TERM
known O
as O
" O
atypical O
pneumonia O
, O
" O
was O
the O
first O
well O
documented O
HCoV O
- O
caused B-TERM
pandemic O
in O
human O
history O
and O
the O
etiological O
agent O
is O
SARS O
- O
CoV O
, O
the O
third O
HCoV O
discovered O
. O

The O
first O
case O
of O
SARS O
can O
be O
traced O
back O
to O
late O
2002 O
in O
Guangdong O
Province O
of O
China O
. O

The O
SARS O
epidemic O
resulted O
in O
8,096 O
reported O
cases O
with O
774 O
deaths O
, O
spreading O
across O
many O
countries O
and O
continents B-TERM
. O

Apart O
from O
the O
super O
- O
spreaders O
, O
it O
was O
estimated O
that O
each O
case O
could O
give O
rise O
to O
approximately B-TERM
two B-TERM
secondary O
cases O
, O
with O
an O
incubation O
period O
of O
4 O
to O
7 O
days O
and O
the O
peak O
of O
viral O
load O
appearing O
on O
the O
10th O
day O
of O
illness B-TERM
. O

Patients B-TERM
infected O
with O
SARS O
- O
CoV O
initially B-TERM
present O
with O
myalgia O
, O
headache O
, O
fever O
, O
malaise B-TERM
and O
chills O
, O
followed O
by O
dyspnea O
, O
cough O
and O
respiratory O
distress O
as O
late O
symptoms O
. O

Lymphopenia O
, O
deranged O
liver O
function O
tests O
, O
and O
elevated O
creatine O
kinase O
are O
common O
laboratory O
abnormalities O
of O
SARS O
. O

Diffuse O
alveolar O
damage O
, O
epithelial O
cell O
proliferation O
and O
an O
increase O
of O
macrophages O
are O
also B-TERM
observed O
in O
SARS O
patients B-TERM
. O

Approximately B-TERM
20 O
- O
30 O
% O
of O
patients B-TERM
subsequently B-TERM
require O
intensive O
care O
and O
mechanical O
ventilation O
. O

In O
addition B-TERM
to O
lower O
respiratory O
tract O
, O
multiple O
organs O
including O
gastrointestinal O
tract O
, O
liver O
and O
kidney O
can O
also B-TERM
be O
infected O
in O
these O
severe O
cases O
, O
usually O
accompanied O
with O
a O
cytokine O
storm B-TERM
, O
which O
might O
be O
lethal B-TERM
particularly B-TERM
in O
immunocompromised O
patients B-TERM
. O

The O
virus O
was O
first O
isolated O
from O
the O
open B-TERM
lung O
biopsy O
of O
a O
relative O
of O
the O
index O
patient B-TERM
who O
travelled O
to O
Hong O
Kong O
from O
Guangzhou O
. O

Since O
then O
, O
tremendous B-TERM
efforts O
have O
been O
dedicated O
to O
HCoV O
research O
. O

HCoV O
- O
NL63 O
was O
isolated O
from O
a O
7 O
- O
month O
- O
old O
child O
from O
the O
Netherlands O
during O
late O
2004 O
. O

It O
was O
initially B-TERM
found O
to O
be O
prevalent O
in O
young O
children O
, O
the O
elderly O
and O
immunocompromised O
patients B-TERM
with O
respiratory O
illnesses B-TERM
. O

Presentation O
of O
coryza O
, O
conjunctivitis O
, O
fever O
, O
and O
bronchiolitis O
is O
common O
in O
the O
disease B-TERM
caused B-TERM
by O
HCoV O
- O
NL63 O
. O

Another B-TERM
independent O
study B-TERM
described O
the O
isolation O
of O
the O
same O
virus O
from O
a O
nasal O
specimen O
from O
an O
8 O
- O
month O
- O
old O
boy B-TERM
suffering O
from O
pneumonia O
in O
the O
Netherlands O
. O

Although O
it O
was O
identified O
in O
Netherlands O
, O
it O
is O
actually O
distributed O
globally O
. O

It O
has O
been O
estimated O
that O
HCoV O
- O
NL63 O
accounts O
for O
approximately B-TERM
4.7 O
% O
of O
common O
respiratory O
diseases B-TERM
, O
and O
its O
peak O
incidence O
occurs O
during O
early O
summer O
, O
spring O
and O
winter O
. O

HCoV O
- O
NL63 O
is O
associated O
with O
obstructive O
laryngitis O
, O
also B-TERM
known O
as O
croup O
. O

In O
the O
same O
year O
, O
HCoV O
- O
HKU1 O
was O
isolated O
from O
a O
71 O
- O
year O
- O
old O
man O
who O
had O
been O
hospitalized O
with O
pneumonia O
and O
bronchiolitis O
in O
Hong O
Kong O
. O

Besides B-TERM
community O
- O
acquired O
pneumonia O
and O
bronchiolitis O
, O
HCoV O
- O
HKU1 O
was O
reported O
to O
be O
associated O
with O
acute O
asthmatic O
exacerbation O
. O

Similar O
to O
HCoV O
- O
NL63 O
, O
HCoV O
- O
229E O
and O
HCoV O
- O
OC43 O
, O
HCoV O
- O
HKU1 O
was O
found O
worldwide O
, O
causing B-TERM
mild O
respiratory O
diseases B-TERM
. O

All O
these O
four O
community O
- O
acquired O
HCoVs O
have O
been O
well O
adapted B-TERM
to O
humans O
and O
are O
generally O
less O
likely O
to O
mutate O
to O
cause O
highly O
pathogenic O
diseases B-TERM
, O
though B-TERM
accidents O
did O
occur O
for O
unknown B-TERM
reasons O
as O
in O
the O
rare O
case O
of O
a O
more O
virulent O
subtype O
of O
HCoV O
- O
NL63 O
, O
which O
has O
recently O
been O
reported O
to O
cause O
severe O
lower O
respiratory O
tract O
infection O
in O
China O
. O

Generally O
, O
when O
these O
HCoVs O
acquire O
the O
abilities O
to O
transmit O
efficiently O
and O
to O
maintain O
themselves O
continuously O
within O
humans O
, O
they O
also O
become O
less O
virulent O
or O
pathogenic O
. O

MERS O
- O
CoV O
was O
first O
isolated O
in O
2012 O
from O
the O
lung O
of O
a O
60 O
- O
year O
- O
old O
patient B-TERM
who O
developed O
acute O
pneumonia O
and O
renal O
failure O
in O
Saudi O
Arabia O
. O

Whereas O
most O
of O
the O
laboratory O
- O
confirmed O
cases O
originate O
from O
the O
Middle O
East O
, O
imported O
cases O
with O
occasional O
secondary O
spreads O
to O
close O
contacts O
have O
been O
reported O
in O
various O
European O
countries O
and O
Tunisia O
. O

Another O
secondary O
outbreak O
occurred O
in O
South O
Korea O
in O
2015 O
with O
186 O
confirmed O
cases O
. O

Clinical O
manifestations O
of O
MERS O
resemble B-TERM
those O
of O
SARS O
, O
characterized O
by O
progressive O
acute O
pneumonia O
. O

Unlike O
SARS O
, O
many O
patients B-TERM
with O
MERS O
also B-TERM
developed O
acute O
renal O
failure O
, O
which O
is O
thus O
far O
unique O
for O
MERS O
among O
HCoV O
- O
caused B-TERM
diseases B-TERM
. O

More O
than O
30 O
% O
of O
patients B-TERM
present O
with O
gastrointestinal O
symptoms O
, O
such O
as O
diarrhea O
and O
vomiting O
. O

As O
of O
February O
14 O
, O
2020 O
, O
over O
2500 O
laboratory O
confirmed O
cases O
were O
reported O
with O
a O
high O
case O
fatality O
of O
34.4 O
% O
, O
making O
MERS O
- O
CoV O
one O
of O
the O
most O
devastating O
viruses O
known O
to O
humans O
. O

During O
middle O
to O
late O
December O
2019 O
, O
clusters O
of O
pneumonia O
patients B-TERM
retrospectively O
known O
to O
be O
associated O
with O
SARS O
- O
CoV O
- O
2 O
infection O
were O
detected O
in O
Wuhan O
, O
Hubei O
Province O
, O
China O
. O

World O
Health O
Organization B-TERM
declared B-TERM
the O
ongoing O
outbreak O
of O
lower O
respiratory O
tract O
infection O
caused B-TERM
by O
SARS O
- O
CoV O
- O
2 O
a O
Public O
Health O
Emergency O
of O
International O
Concern O
and O
also O
named B-TERM
the O
disease B-TERM
COVID O
- O
19 O
. O

As O
of O
March O
3 O
, O
2020 O
, O
90,053 O
cases O
have O
been O
confirmed O
worldwide O
, O
with O
a O
crude O
case O
fatality O
of O
3.4 O
% O
. O

Notably O
, O
the O
case O
fatality O
in O
Hubei O
, O
China O
is O
4.2 O
% O
, O
whereas O
the O
one O
outside O
of O
it O
is O
1.2 O
% O
. O

SARS O
- O
CoV O
- O
2 O
causes B-TERM
severe O
respiratory O
infection O
like B-TERM
SARS O
- O
CoV O
and O
MERS O
- O
CoV O
, O
presented O
as O
fever O
, O
cough O
and O
dyspnea O
. O

Diarrhea O
is O
also B-TERM
seen O
in O
some O
patients B-TERM
. O

Pneumonia O
is O
one O
of O
the O
most O
severe O
symptoms O
and O
can O
progress O
rapidly O
to O
acute O
respiratory O
distress O
syndrome O
. O

Although O
SARS O
- O
CoV O
and O
SARS O
- O
CoV O
- O
2 O
are O
very O
similar O
due O
to O
high O
nucleotide O
sequence B-TERM
homology O
of O
82 O
% O
, O
they O
cluster O
into O
different O
branches O
in O
the O
phylogenetic O
tree O
. O

SARS O
- O
CoV O
- O
2 O
is O
apparently B-TERM
less O
pathogenic O
but O
more O
transmissible O
compared O
to O
SARS O
- O
CoV O
and O
MERS O
- O
CoV O
. O

Asymptomatic O
subjects O
infected O
with O
SARS O
- O
CoV O
- O
2 O
have O
been O
reported O
and O
might O
contribute O
to O
its O
rapid O
spreading O
around O
the O
world O
. O

Comparing O
and O
contrasting O
SARS O
- O
CoV O
- O
2 O
with O
the O
other O
six O
HCoVs O
reveal O
similarities B-TERM
and O
differences B-TERM
of O
great O
interest O
. O

First O
, O
the O
incubation O
period O
and O
the O
duration O
of O
the O
course O
of O
HCoV O
disease B-TERM
are O
very O
similar B-TERM
. O

In O
this O
regard O
, O
SARS O
- O
CoV O
- O
2 O
follows O
the O
general O
trend B-TERM
of O
the O
other O
six O
HCoVs O
. O

Second O
, O
the O
severity O
of O
symptoms O
of O
COVID O
- O
19 O
lies O
between O
SARS O
- O
CoV O
and O
the O
four O
community O
- O
acquired O
HCoVs O
( O
i.e. O
HCoV O
- O
229E O
, O
HCoV O
- O
OC43 O
, O
HCoV O
- O
HKU1 O
and O
HCoV O
- O
NL63 O
) O
. O

On O
one O
hand O
, O
SARS O
- O
CoV O
- O
2 O
infection O
exhibits O
features O
that O
are O
more O
commonly O
seen O
during O
infection O
with O
community O
- O
acquired O
HCoVs O
, O
including O
the O
presentation O
of O
non O
- O
specific O
, O
mild O
or O
even O
no O
symptoms O
. O

On O
the O
other O
hand O
, O
a O
small B-TERM
subset O
of O
severe O
cases O
of O
COVID O
- O
19 O
can O
also O
be O
seen O
as O
in O
the O
case O
of O
SARS O
- O
CoV O
infection O
, O
although B-TERM
the O
ratio O
is O
a O
bit O
lower O
. O

Third O
, O
the O
transmission O
of O
SARS O
- O
CoV O
- O
2 O
also B-TERM
shows O
interesting O
patterns O
characteristic O
of O
both O
community O
- O
acquired O
HCoVs O
and O
SARS O
- O
CoV O
. O

On O
one O
hand O
, O
the O
transmissibility O
of O
SARS O
- O
CoV O
- O
2 O
is O
at O
least O
as O
high O
as O
that O
of O
community O
- O
acquired O
HCoVs O
. O

On O
the O
other O
hand O
, O
it O
remains O
to O
be O
verified O
whether O
the O
transmissibility O
of O
SARS O
- O
CoV O
- O
2 O
decreases O
after O
passages O
in O
humans O
as O
in O
the O
cases O
of O
SARS O
- O
CoV O
and O
MERS O
- O
CoV O
. O

Finally O
, O
same O
as O
the O
other O
HCoVs O
, O
SARS O
- O
CoV O
- O
2 O
can O
be O
detected O
in O
fecal O
samples O
. O

Whether O
fecal O
- O
oral O
transmission O
of O
SARS O
- O
CoV O
- O
2 O
plays O
an O
important B-TERM
role O
as O
in O
the O
case O
of O
SARS O
- O
CoV O
at O
least O
under O
some O
circumstance O
remains O
to O
be O
clarified O
by O
future O
studies O
. O

It O
is O
also O
of O
particularly O
great O
interest O
to O
see O
whether O
SARS O
- O
CoV O
- O
2 O
might O
exhibit O
seasonality O
as O
in O
the O
cases O
of O
community O
- O
acquired O
HCoVs O
. O

Nevertheless O
, O
the O
features B-TERM
of O
SARS O
- O
CoV O
- O
2 O
including O
its O
transmissibility O
, O
pathogenicity O
and O
sustainable B-TERM
spreading O
after O
passages O
in O
humans O
will O
be O
influential O
on O
the O
ultimate O
fate O
of O
the O
ongoing O
outbreak O
of O
COVID O
- O
19 O
. O

All O
four O
community O
- O
acquired O
HCoVs O
causing B-TERM
mild O
symptoms O
have O
been O
well O
adapted B-TERM
to O
humans O
. O

From O
another B-TERM
perspective O
, O
it O
might O
also O
be O
true O
that O
humans O
have O
been O
well O
adapted B-TERM
to O
these O
four O
HCoVs O
. O

In O
other O
words O
, O
both O
could O
be O
the O
survivors O
of O
ancient O
HCoV O
pandemics O
. O

HCoVs O
that O
cause O
severe O
diseases B-TERM
in O
humans O
and O
humans O
who O
developed O
severe O
HCoV O
diseases B-TERM
have O
been O
eliminated O
. O

For O
this O
to O
happen O
, O
HCoVs O
have O
to O
replicate O
in O
humans O
to O
sufficient O
extent O
to O
allow O
the O
accumulation B-TERM
of O
adaptive O
mutations O
that O
counteract O
host O
restriction O
factors O
. O

In O
this O
sense O
, O
the O
longer O
the O
SARS O
- O
CoV O
- O
2 O
outbreak O
persists O
and O
the O
more O
people O
that O
it O
infects O
, O
the O
greater O
chance O
that O
it O
will O
fully O
adapt B-TERM
to O
humans O
. O

If O
it O
adapts B-TERM
well O
, O
its O
transmission O
in O
humans O
would O
be O
difficult O
to O
stop O
by O
quarantine O
or O
other O
infection O
control O
measures B-TERM
. O

For O
many O
years O
, O
the O
four O
community O
- O
acquired O
CoVs O
circulate O
in O
human O
populations O
, O
triggering O
common O
cold O
in O
immunocompetent O
subjects O
. O

These O
viruses O
do O
not O
need O
an O
animal B-TERM
reservoir O
. O

In O
contrast O
, O
highly O
pathogenic O
SARS O
- O
CoV O
and O
MERS O
- O
CoV O
have O
not O
adapted B-TERM
to O
humans O
well O
and O
their O
transmission O
within O
humans O
cannot O
be O
sustained O
. O

They O
need O
to O
maintain O
and O
propagate O
in O
their O
zoonotic O
reservoirs O
and O
seek O
the O
chance O
to O
spillover O
to O
susceptible O
human O
targets O
, O
possibly B-TERM
via B-TERM
one O
or O
more O
intermediate O
and O
amplifying O
hosts O
. O

SARS O
- O
CoV O
- O
2 O
has O
features B-TERM
that O
are O
similar B-TERM
to O
both O
SARS O
- O
CoV O
/ O
MERS O
- O
CoV O
and O
the O
four O
community O
- O
acquired O
HCoVs O
. O

It O
is O
highly B-TERM
transmissible O
like B-TERM
community O
- O
acquired O
HCoVs O
, O
at O
least O
for O
the O
time O
being O
. O

However O
, O
it O
is O
more O
pathogenic O
than O
community O
- O
acquired O
HCoVs O
and O
less O
pathogenic O
than O
SARS O
- O
CoV O
or O
MERS O
- O
CoV O
. O

It O
remains O
to O
be O
seen O
whether O
it O
will O
adapt B-TERM
fully O
to O
humans O
and O
circulate O
within O
humans O
without O
a O
reservoir O
or O
intermediate O
animal B-TERM
host O
. O

Before O
discussing O
the O
animal B-TERM
origins O
of O
HCoVs O
, O
it O
will O
serve O
us O
well O
to O
discuss O
the O
definitions O
and O
characteristics O
of O
evolutionary O
, O
natural B-TERM
, O
reservoir O
, O
intermediate O
and O
amplifying O
hosts O
of O
HCoVs O
. O

An O
animal B-TERM
serves O
as O
the O
evolutionary O
host O
of O
an O
HCoV O
if O
it O
harbours O
a O
closely O
related O
ancestor O
sharing O
high O
homology O
at O
the O
level O
of O
nucleotide O
sequence B-TERM
. O

The O
ancestral O
virus O
is O
usually O
well O
adapted O
and O
non O
- O
pathogenic O
in O
this O
host O
. O

Likewise O
, O
a O
reservoir O
host O
harbours O
HCoV O
continuously B-TERM
and O
for O
long O
term O
. O

In O
both O
cases O
, O
the O
hosts O
are O
naturally O
infected O
and O
are O
the O
natural B-TERM
hosts O
of O
HCoV O
or O
its O
parental O
virus O
. O

In O
contrast O
, O
if O
the O
HCoV O
is O
newly O
introduced O
to O
an O
intermediate O
host O
right O
before O
or O
around B-TERM
its O
introduction O
to O
humans O
, O
it O
is O
not O
well O
adapted O
to O
the O
new O
host O
and O
is O
often B-TERM
pathogenic O
. O

This O
intermediate O
host O
can O
serve O
as O
the O
zoonotic O
source O
of O
human O
infection O
and O
play O
the O
role B-TERM
of O
an O
amplifying O
host O
by O
allowing B-TERM
the O
virus O
to O
replicate O
transiently O
and O
then O
transmitting O
it O
to O
humans O
to O
amplify O
the O
scale O
of O
human O
infection O
. O

An O
HCoV O
can O
undergo O
a O
dead O
- O
end O
infection O
if O
it O
cannot O
sustain O
its O
transmission O
within O
the O
intermediate O
host O
. O

On O
the O
contrary B-TERM
, O
HCoVs O
can O
also B-TERM
adapt B-TERM
to O
the O
intermediate O
host O
and O
even O
establish O
long O
- O
term O
endemicity O
. O

In O
this O
case O
, O
the O
intermediate O
host O
becomes O
a O
natural B-TERM
reservoir O
host O
. O

Epidemiological O
data B-TERM
revealed B-TERM
retrospectively O
that O
the O
index O
case O
of O
SARS O
had O
a O
contact O
history O
with O
game O
animals B-TERM
. O

Subsequent O
seroprevalence O
investigations O
indicated B-TERM
that O
animal B-TERM
traders B-TERM
had O
a O
higher O
prevalence O
of O
anti O
- O
SARS O
- O
CoV O
IgG O
compared O
with O
that O
of O
the O
general O
population O
. O

Masked O
palm O
civets O
( O
Paguma O
larvata O
) O
and O
a O
racoon O
dog O
in O
live O
animal B-TERM
markets O
were O
first O
identified O
to O
carry O
SARS O
- O
CoV O
- O
like O
viruses O
that O
are O
almost O
identical B-TERM
to O
SARS O
- O
CoV O
. O

This O
was O
indirectly O
supported O
by O
the O
fact O
that O
no O
further O
SARS O
was O
reported O
after O
killing O
all O
civets O
in O
the O
markets O
. O

However O
, O
it O
has O
been O
reported O
that O
masked O
palm O
civets O
from O
the O
wild O
or O
farms O
without O
exposure O
to O
the O
live O
animal O
markets O
were O
largely O
negative O
for O
SARS O
- O
CoV O
, O
suggesting O
that O
masked O
palm O
civets O
might O
only O
serve O
as O
the O
intermediate O
amplifying O
host O
but O
not O
the O
natural B-TERM
reservoir O
of O
SARS O
- O
CoV O
. O

Notably O
, O
since O
80 O
% O
of O
the O
different O
animals B-TERM
in O
the O
markets O
in O
Guangzhou O
have O
anti O
- O
SARS O
- O
CoV O
antibodies O
, O
the O
possibilities B-TERM
that O
multiple O
species O
of O
small O
mammals O
might O
also B-TERM
serve O
as O
intermediate O
amplifying O
hosts O
of O
SARS O
- O
CoV O
cannot B-TERM
be O
excluded O
. O

All O
of O
these O
appear B-TERM
to O
be O
dead O
- O
end O
hosts O
of O
SARS O
- O
CoV O
. O

Subsequent O
search O
for O
the O
natural B-TERM
animal B-TERM
host O
of O
SARS O
- O
CoV O
unveiled O
a O
closely O
related O
bat O
CoV O
, O
termed O
SARS O
- O
related O
Rhinolophus O
bat O
CoV O
HKU3 O
( O
SARSr O
- O
Rh O
- O
BatCoV O
HKU3 O
) O
, O
which O
exists O
in O
Chinese O
horseshoe O
bats O
. O

These O
bats O
are O
positive O
for O
anti O
- O
SARS O
- O
CoV O
antibodies O
and O
genome O
sequence B-TERM
of O
SARSr O
- O
Rh O
- O
BatCoV O
HKU3 O
. O

This O
and O
other O
bat O
CoVs O
share O
88 O
- O
92 O
% O
nucleotide O
sequence B-TERM
homology O
with O
SARS O
- O
CoV O
. O

These O
studies B-TERM
have O
laid O
the O
foundation B-TERM
for O
the O
new O
concept B-TERM
that O
bats O
host O
emerging O
human O
pathogens O
. O

Several O
SARS O
- O
like B-TERM
CoVs O
( O
SL O
- O
CoVs O
) O
have O
also B-TERM
been O
identified O
from O
bats O
, O
but O
none O
except O
for O
one O
designated O
WIV1 O
can O
be O
isolated O
as O
live O
virus O
. O

Human O
angiotensin O
converting O
enzyme O
2 O
( O
ACE2 O
) O
is O
known O
to O
be O
the O
receptor O
of O
SARS O
- O
CoV O
. O

WIV1 O
derived O
from O
fecal O
sample O
of O
bats O
was O
demonstrated B-TERM
to O
use B-TERM
bat O
, O
civet O
and O
human O
ACE2 O
as O
receptor O
for O
cell O
entry O
. O

Intriguingly O
, O
sera O
of O
convalescent O
SARS O
patients B-TERM
were O
capable O
of O
neutralizing O
WIV1 O
. O

Thus O
far O
, O
WIV1 O
represents O
the O
most O
closely O
related O
ancestor O
of O
SARS O
- O
CoV O
in O
bats O
, O
sharing O
95 O
% O
nucleotide O
sequence B-TERM
homology O
. O

Albeit O
the O
high O
homology O
between O
these O
two B-TERM
viruses O
, O
it O
is O
generally O
believed O
that O
WIV1 O
is O
not O
the O
immediate O
parental O
virus O
of O
SARS O
- O
CoV O
and O
bats O
are O
not O
the O
immediate O
reservoir O
host O
of O
SARS O
- O
CoV O
. O

Phylogenetic O
analysis B-TERM
clusters O
MERS O
- O
CoV O
to O
the O
same O
group O
as O
bat O
CoV O
- O
HKU4 O
and O
bat O
CoV O
- O
HKU5 O
. O

Bat O
CoV O
- O
HKU4 O
and O
MERS O
- O
CoV O
utilize O
the O
same O
host O
receptor O
, O
dipeptidyl O
peptidase O
4 O
( O
DPP4 O
) O
, O
for O
virus O
entry O
. O

RNA O
- O
dependent O
RNA O
polymerase O
sequences B-TERM
of O
MERS O
- O
CoV O
are O
phylogenetically O
closer O
to O
counterparts O
in O
bat O
beta O
- O
CoVs O
identified O
from O
Europe O
and O
Africa O
. O

Up O
to O
now O
, O
no O
live O
MERS O
- O
CoV O
can O
be O
found B-TERM
in O
wild O
bats O
. O

MERS O
- O
CoV O
and O
its O
closest O
relative O
bat O
CoV O
- O
HKU25 O
share O
only O
87 O
% O
nucleotide O
sequence B-TERM
homology O
. O

Thus O
, O
bats O
might O
not O
be O
the O
immediate O
reservoir O
host O
of O
MERS O
- O
CoV O
. O

On O
the O
other O
hand O
, O
studies B-TERM
in O
Middle O
East O
have O
shown B-TERM
that O
dromedary O
camels O
are O
seropositive O
for O
MERS O
- O
CoV O
- O
specific O
neutralizing O
antibodies O
, O
same O
as O
camels O
of O
Middle O
East O
origin O
in O
multiple O
African O
countries O
. O

Live O
MERS O
- O
CoV O
identical B-TERM
to O
the O
virus O
found O
in O
humans O
was O
isolated O
from O
the O
nasal O
swabs O
of O
dromedary O
camels O
, O
further O
indicating O
that O
camels O
serve O
as O
the O
bona O
fide O
reservoir O
host O
of O
MERS O
- O
CoV O
. O

It O
is O
also B-TERM
noteworthy O
that O
generally O
mild O
symptoms O
but O
massive O
virus O
shedding O
were O
observed O
in O
camels O
experimentally O
infected O
with O
MERS O
- O
CoV O
. O

Notably O
, O
infected O
camels O
shed O
viruses O
not O
only O
through O
respiratory O
route O
but O
also O
through O
fecal O
- O
oral O
route O
, O
which O
is O
also B-TERM
the O
main O
route O
for O
virus O
shedding O
from O
bats O
. O

However O
, O
questions O
still O
remain O
since O
many O
confirmed O
cases O
of O
MERS O
have O
no O
contact O
history O
with O
camels O
prior O
to O
symptom O
onset O
, O
plausibly O
ascribed O
to O
human O
- O
to O
- O
human O
transmission O
or O
unknown B-TERM
transmission O
routes O
involving O
unrecognized O
animal B-TERM
species O
that O
harbour O
MERS O
- O
CoV O
. O

SARS O
- O
CoV O
- O
2 O
shares O
96.2 O
% O
nucleotide O
homology O
with O
a O
bat O
CoV O
RaTG13 O
isolated O
from O
Rhinolophus O
affinis O
bats O
. O

As O
in O
the O
cases O
of O
SARS O
- O
CoV O
and O
MERS O
- O
CoV O
, O
the O
sequence B-TERM
divergence O
between O
SARS O
- O
CoV O
- O
2 O
and O
RaTG13 O
is O
too O
great O
to O
assign O
parental O
relationship O
. O

That O
is O
to O
say O
, O
bats O
might O
not O
be O
the O
immediate O
reservoir O
host O
( O
s O
) O
of O
SARS O
- O
CoV O
- O
2 O
unless O
almost O
identical B-TERM
bat O
CoVs O
are O
found B-TERM
in O
future O
. O

Presumably O
, O
the O
intermediate O
animal O
hosts O
of O
SARS O
- O
CoV O
- O
2 O
should O
be O
among B-TERM
the O
wildlife O
species O
sold O
and O
killed O
at O
the O
Huanan O
Seafood O
Wholesale O
Market O
, O
with O
which O
many O
of O
the O
initial O
cases O
of O
COVID O
- O
19 O
were O
associated O
, O
indicative O
of O
a O
probable B-TERM
animal O
- O
to O
- O
human O
transmission O
event O
. O

Several O
recent B-TERM
studies B-TERM
based O
on O
metagenomic O
sequencing O
have O
suggested O
that O
a O
group O
of O
endangered O
small O
mammals O
known O
as O
pangolins O
( O
Manis O
javanica O
) O
could O
also B-TERM
harbour O
ancestral O
beta O
- O
CoVs O
related O
to O
SARS O
- O
CoV O
- O
2 O
. O

These O
novel O
pangolin O
CoV O
genomes O
share O
85 O
- O
92 O
% O
nucleotide O
sequence B-TERM
homology O
with O
SARS O
- O
CoV O
- O
2 O
. O

However O
, O
they O
are O
equally O
closely O
related O
to O
RaTG13 O
with O
about O
90 O
% O
identity O
at O
the O
level O
of O
nucleotide O
sequence B-TERM
. O

They O
cluster O
into O
two B-TERM
sub O
- O
lineages O
of O
SARS O
- O
CoV O
- O
2 O
- O
like O
viruses O
in O
the O
phylogenetic O
tree O
, O
one O
of O
which O
share O
a O
more O
similar B-TERM
receptor O
binding O
domain O
( O
RBD O
) O
with O
SARS O
- O
CoV O
- O
2 O
, O
with O
97.4 O
% O
amino O
acid O
sequence B-TERM
identity O
. O

In O
stark O
contrast B-TERM
, O
the O
RBDs O
of O
SARS O
- O
CoV O
- O
2 O
and O
RaTG13 O
are O
more O
divergent O
, O
albeit O
a O
higher O
degree O
of O
sequence B-TERM
homology O
genome O
- O
wide O
. O

An O
earlier O
study B-TERM
on O
diseased O
pangolins O
also B-TERM
reported O
the O
detection O
of O
viral O
contigs O
from O
lung O
samples O
, O
which O
turn O
out O
to O
be O
similarly B-TERM
related O
to O
SARS O
- O
CoV O
- O
2 O
. O

This O
study B-TERM
adopted O
different O
assembly O
methods B-TERM
and O
manual O
curation O
to O
generate O
a O
partial O
genome O
sequence B-TERM
comprising O
about O
86.3 O
% O
of O
the O
full O
- O
length O
viral O
genome O
. O

We O
cannot B-TERM
exclude O
the O
possibility B-TERM
that O
pangolin O
is O
one O
of O
the O
intermediate O
animal B-TERM
hosts O
of O
SARS O
- O
CoV O
- O
2 O
. O

However O
, O
currently O
there O
is O
no O
evidence O
in O
support O
of O
a O
direct O
pangolin O
origin O
of O
SARS O
- O
CoV O
- O
2 O
due B-TERM
to O
the O
sequence B-TERM
divergence O
between O
SARS O
- O
CoV O
- O
2 O
and O
pangolin O
SARS O
- O
CoV O
- O
2 O
- O
related O
beta O
- O
CoVs O
. O

In O
addition B-TERM
, O
the O
distance B-TERM
between O
SARS O
- O
CoV O
- O
2 O
and O
RaTG13 O
is O
even O
shorter O
than O
that O
between O
SARS O
- O
CoV O
- O
2 O
and O
pangolin O
SARS O
- O
CoV O
- O
2 O
- O
related O
beta O
- O
CoVs O
. O

The O
evolutionary O
pathway O
of O
SARS O
- O
CoV O
- O
2 O
in O
bats O
, O
pangolins O
and O
other O
mammals O
remains O
to O
be O
established O
. O

Whereas O
the O
highest O
sequence B-TERM
homology O
has O
been O
found B-TERM
in O
the O
RBDs O
between O
SARS O
- O
CoV O
- O
2 O
and O
pangolin O
, O
SARS O
- O
CoV O
- O
2 O
- O
related O
beta O
- O
CoVs O
, O
SARS O
- O
CoV O
- O
2 O
and O
RaTG13 O
share O
the O
highest O
genome O
- O
wide O
sequence B-TERM
homology O
. O

It O
is O
highly B-TERM
speculative O
that O
the O
high O
degree O
of O
similarity B-TERM
between O
the O
RBDs O
of O
pangolin O
SARS O
- O
CoV O
- O
2 O
- O
related O
beta O
- O
CoVs O
and O
SARS O
- O
CoV O
- O
2 O
is O
driven O
by O
selectivity O
- O
mediated O
convergent O
evolution O
. O

A O
counter O
- O
proposal O
is O
in O
favour O
of O
a O
recombination O
between O
a O
pangolin O
SARS O
- O
CoV O
- O
2 O
- O
related O
beta O
- O
CoV O
and O
RaTG13 O
in O
the O
third O
wild O
animal B-TERM
species O
. O

As O
a O
driving O
force O
in O
evolution O
, O
recombination O
is O
widespread O
among B-TERM
beta O
- O
CoVs O
. O

The O
jury O
is O
still O
out O
on O
the O
immediate O
zoonotic O
origin O
of O
SARS O
- O
CoV O
- O
2 O
. O

Besides B-TERM
the O
highly O
pathogenic O
HCoVs O
, O
the O
zoonotic O
origin O
of O
HCoV O
- O
229E O
, O
HCoV O
- O
OC43 O
, O
HCoV O
- O
NL63 O
and O
HCoV O
- O
HKU1 O
have O
also B-TERM
been O
studied O
. O

Phylogenetic O
evidence O
indicated B-TERM
that O
both O
HCoV O
- O
NL63 O
and O
HCoV O
- O
229E O
might O
have O
originated O
from O
bat O
CoVs O
, O
while O
the O
parental O
viruses O
of O
HCoV O
- O
OC43 O
and O
HCoV O
- O
HKU1 O
have O
been O
found O
in O
rodents O
. O

It O
has O
been O
reported O
that O
a O
bat O
CoV O
termed O
ARCoV.2 O
( O
Appalachian O
Ridge O
CoV O
) O
detected O
in O
North O
American O
tricolored O
bat O
displayed B-TERM
close O
relationship O
with O
HCoV O
- O
NL63 O
. O

On O
the O
other O
hand O
, O
HCoV O
- O
229E O
was O
genetically O
related O
to O
another B-TERM
bat O
CoV O
, O
termed O
Hipposideros O
/ O
GhanaKwam O
/ O
19 O
/ O
2008 O
, O
which O
was O
detected O
in O
Ghana O
, O
while O
camelids O
have O
also O
been O
suspected O
as O
its O
intermediate O
host O
. O

For O
clarity O
, O
the O
current O
knowledge B-TERM
on O
animal O
origins O
of O
known O
HCoVs O
is O
summarized O
in O
Figure O
1 O
and O
Table O
2 O
. O

Phylogenetic O
analysis B-TERM
has O
provided O
evidence O
for O
interspecies O
transmission O
events O
of O
HCoVs O
in O
the O
history O
. O

When O
HCoV O
- O
OC43 O
crossed O
species O
to O
infect O
humans O
from O
domestic O
livestock O
around B-TERM
1890 O
, O
a O
pandemic O
of O
respiratory O
infection O
was O
recorded O
. O

The O
interspecies O
transmission O
history O
of O
HCoV O
- O
229E O
is O
less O
clear B-TERM
. O

Bat O
alpha O
- O
CoVs O
closely O
related O
to O
HCoV O
- O
229E O
have O
been O
found O
. O

Between O
them O
there O
is O
an O
alpaca O
alpha O
- O
CoV O
. O

Several O
lines O
of O
evidence O
support O
the O
transmission O
of O
virus O
from O
bats O
to O
humans O
directly O
. O

First O
, O
humans O
but O
not O
alpacas O
might O
have O
contact O
with O
bats O
in O
a O
shared O
ecological O
niche O
. O

Instead O
, O
humans O
have O
close O
contact O
with O
alpacas O
. O

Second O
, O
HCoV O
- O
229E O
- O
related O
bat O
alpha O
- O
CoVs O
are O
diverse O
and O
non O
- O
pathogenic O
in O
bats O
, O
whereas O
alpaca O
alpha O
- O
CoV O
caused B-TERM
an O
outbreak O
of O
respiratory O
disease B-TERM
in O
infected O
animals B-TERM
. O

Finally O
, O
alpaca O
alpha O
- O
CoV O
has O
not O
been O
found O
in O
feral O
animals B-TERM
. O

Thus O
, O
the O
possibility B-TERM
cannot B-TERM
be O
excluded O
that O
alpacas O
obtain O
the O
HCoV O
- O
229E O
- O
related O
alpha O
- O
CoV O
from O
humans O
. O

In O
fact O
, O
bats O
are O
the O
direct O
source O
of O
human O
pathogenic O
viruses O
including O
rabies O
virus O
, O
Ebola O
virus O
, O
Nipah O
virus O
and O
Hendra O
virus O
. O

It O
is O
therefore B-TERM
not O
too O
surprising O
that O
bats O
might O
transmit O
HCoV O
- O
229E O
to O
humans O
directly B-TERM
. O

Alternatively O
, O
whereas O
bat O
alpha O
- O
CoVs O
serve O
as O
the O
gene O
pool O
of O
HCoV O
- O
229E O
, O
alpacas O
and O
dromedary O
camels O
might O
serve O
as O
intermediate O
hosts O
that O
transmit O
viruses O
to O
humans O
, O
exactly B-TERM
as O
in O
the O
case O
of O
MERS O
- O
CoV O
. O

MERS O
- O
CoV O
serves O
as O
an O
excellent B-TERM
example O
of O
interspecies O
transmission O
from O
bats O
to O
dromedary O
camels O
and O
from O
dromedary O
camels O
to O
humans O
. O

The O
evolutionary O
origin O
of O
MERS O
- O
CoV O
from O
bats O
is O
known O
at O
its O
initial O
identification O
and O
has O
also O
been O
strengthened O
by O
subsequent O
findings O
. O

It O
is O
obvious O
that O
bats O
provide O
a O
rich B-TERM
pool O
of O
virus O
species O
for O
interspecies O
exchange O
of O
genetic O
fragments O
and O
interspecies O
transmission O
. O

Longevity O
, O
densely O
packed O
colonies O
, O
close O
social O
interaction O
and O
strong O
ability O
to O
fly O
are O
all O
favourable O
conditions O
for O
bats O
to O
be O
an O
ideal O
' O
virus O
spreader O
' O
. O

On O
the O
other O
hand O
, O
MERS O
- O
CoV O
has O
been O
introduced O
to O
dromedary O
camels O
for O
decades O
. O

It O
is O
well O
adapted B-TERM
to O
these O
camels O
that O
have O
turned O
from O
an O
intermediate O
host O
to O
a O
stable B-TERM
and O
natural B-TERM
reservoir O
host O
. O

MERS O
- O
CoV O
causes B-TERM
very O
mild O
disease B-TERM
and O
maintains O
a O
relatively O
low O
mutation O
rate O
in O
these O
animals B-TERM
. O

Its O
sporadic O
transmission O
to O
humans O
is O
an O
accident O
and O
humans O
remain O
a O
dead O
- O
end O
host O
of O
MERS O
- O
CoV O
as O
its O
transmission O
cannot O
be O
sustained O
. O

In O
contrast O
to O
the O
role B-TERM
of O
camels O
in O
the O
transmission O
of O
MERS O
- O
CoV O
, O
the O
role B-TERM
of O
pangolins O
, O
if O
there O
is O
any O
, O
in O
the O
transmission O
of O
SARS O
- O
CoV O
- O
2 O
is O
different O
. O

Particularly O
, O
pangolin O
beta O
- O
CoVs O
are O
highly O
pathogenic O
in O
pangolins O
. O

They O
might O
be O
a O
dead O
- O
end O
host O
for O
SARS O
- O
CoV O
- O
2 O
- O
related O
beta O
- O
CoVs O
, O
similar O
to O
civets O
in O
the O
case O
of O
SARS O
- O
CoV O
. O

Several O
possibilities B-TERM
for O
interspecies O
transmission O
of O
SARS O
- O
CoV O
- O
2 O
from O
animals B-TERM
to O
humans O
have O
to O
be O
ruled O
in O
or O
ruled O
out O
in O
future O
studies B-TERM
. O

First O
, O
bats O
could O
be O
the O
reservoir O
host O
of O
a O
SARS O
- O
CoV O
- O
2 O
- O
related O
virus O
almost O
identical B-TERM
to O
SARS O
- O
CoV O
- O
2 O
. O

Humans O
might O
share O
the O
ecological O
niche O
with O
bats O
through O
butchering O
or O
coal O
mining O
. O

Second O
, O
pangolins O
could O
be O
one O
of O
intermediate O
amplifying O
host O
to O
which O
a O
SARS O
- O
CoV O
- O
2 O
- O
related O
virus O
had O
been O
newly O
introduced O
. O

Humans O
contract O
the O
virus O
through O
butchering O
and O
consumption O
of O
game O
meat O
. O

It O
is O
possible O
that O
many O
mammals O
including O
domestic O
animals B-TERM
are O
susceptible O
to O
SARS O
- O
CoV O
- O
2 O
. O

A O
survey O
of O
domestic O
and O
wild O
animals B-TERM
for O
antibodies O
is O
warranted O
. O

Third O
, O
as O
mentioned O
above O
, O
recombination O
and O
adaptation O
of O
SARS O
- O
CoV O
- O
2 O
might O
have O
occurred O
in O
a O
third O
species O
that O
has O
contact O
with O
both O
bats O
and O
pangolins O
. O

The O
search O
for O
the O
animal O
origins O
of O
SARS O
- O
CoV O
- O
2 O
is O
still O
on O
. O

Apart B-TERM
from O
different O
types B-TERM
of O
the O
animal B-TERM
hosts O
, O
three O
major O
factors O
on O
the O
viral O
side O
are O
also B-TERM
important O
in O
facilitating B-TERM
CoVs O
to O
cross O
species O
barriers O
. O

First O
of O
all O
, O
their O
relatively O
high O
mutation O
rates O
in O
RNA O
replication O
. O

In O
comparison O
to O
other O
single O
- O
stranded O
RNA O
viruses O
, O
the O
estimated O
mutation O
rates O
of O
CoVs O
could O
be O
regarded B-TERM
as O
" O
moderate O
" O
to O
" O
high O
" O
with O
an O
average O
substitution O
rate O
being O
~ O
10 O
- O
4 O
substitution O
per O
year O
per O
site O
2 O
, O
depending O
on O
the O
phase O
of O
CoV O
adaptation O
to O
novel O
hosts O
. O

CoVs O
have O
a O
proof O
- O
reading O
exoribonuclease O
, O
deletion O
of O
which O
results O
in O
exceedingly O
high O
mutability O
and O
attenuation O
or O
even O
inviability O
. O

Interestingly O
, O
the O
nucleotide O
analogue O
Remdesivir O
is O
known O
to O
suppress O
CoV O
replication O
through O
inhibition O
of O
this O
exoribonuclease O
and O
the O
RNA O
- O
dependent O
RNA O
polymerase O
. O

Remdesivir O
is O
one O
of O
most O
promising O
anti O
- O
SARS O
- O
CoV O
- O
2 O
agents O
to O
be O
tested O
in O
clinical O
trials O
. O

Nevertheless O
, O
mutation O
rates O
of O
CoVs O
are O
about O
a O
million O
times O
higher O
than O
those O
of O
their O
hosts O
. O

In O
addition B-TERM
, O
mutation O
rate O
is O
often B-TERM
high O
when O
CoVs O
are O
not O
well O
adapted O
to O
the O
host O
. O

Compared O
to O
SARS O
- O
CoV O
with O
a O
high O
mutation O
rate O
, O
the O
mutation O
rate O
of O
SARS O
- O
CoV O
- O
2 O
is O
apparently B-TERM
lower O
, O
suggestive O
of O
a O
higher O
level O
of O
adaptation O
to O
humans O
. O

Presumably O
, O
it O
has O
already O
been O
adapted B-TERM
to O
another B-TERM
host O
close O
to O
humans O
. O

In O
addition B-TERM
to O
SARS O
- O
CoV O
- O
2 O
, O
this O
also B-TERM
applies O
to O
MERS O
- O
CoV O
, O
which O
is O
well O
adapted O
to O
dromedary O
camels O
. O

Theoretically O
, O
it O
is O
unlikely O
that O
genetic O
drift O
would O
render O
vaccines B-TERM
and O
antivirals O
against O
SARS O
- O
CoV O
- O
2 O
ineffective O
quickly O
. O

Second O
, O
the O
large O
RNA O
genome O
in O
CoVs O
exerts O
extra O
plasticity O
in O
genome O
modification O
for O
mutations O
and O
recombination O
, O
thereby O
increasing O
the O
probability B-TERM
for O
interspecies O
co O
- O
evolution O
, O
which O
is O
advantageous O
for O
the O
emergence B-TERM
of O
novel O
CoVs O
when O
the O
conditions B-TERM
become O
appropriate O
. O

This O
is O
supported O
by O
the O
copious O
unique B-TERM
open B-TERM
reading O
frames O
and O
protein B-TERM
functions B-TERM
encoded O
towards O
the O
3 O
‚Ä≤ O
end B-TERM
of O
the O
genome O
. O

Third O
, O
CoVs O
randomly O
and O
frequently B-TERM
switch O
templates O
during O
RNA O
replication O
through O
a O
unique B-TERM
" O
copy O
- O
choice B-TERM
" O
mechanism O
. O

In O
a O
host O
that O
serves O
as O
the O
mixing O
vessel O
, O
strand O
switching O
occurs O
frequently B-TERM
during O
CoV O
RNA O
transcription O
. O

Highly O
homologous O
full O
- O
length O
and O
subgenomic O
RNAs O
could O
recombine O
to O
generate B-TERM
new O
CoVs O
. O

Phylogenetic O
evidence O
of O
natural B-TERM
recombination O
has O
been O
found O
in O
both O
HCoV O
- O
HKU1 O
and O
HCoV O
- O
OC43 O
, O
as O
well O
as O
animal O
CoVs O
such O
as O
bat O
SL O
- O
CoV O
and O
batCoV O
- O
HKU9 O
. O

Virus O
- O
host O
interaction O
in O
relation O
to O
transmission O

Besides O
three O
viral O
factors O
stated O
above O
, O
viral O
interaction O
with O
host O
receptor O
is O
another O
key O
factor O
influential O
on O
interspecies O
transmission O
. O

Herein O
, O
recombination O
of O
SARS O
- O
CoV O
is O
taken O
as O
a O
typical B-TERM
example O
, O
which O
also B-TERM
showed B-TERM
evidence O
of O
positive O
selection O
during O
interspecies O
transmission O
events O
. O

Based O
on O
the O
comparative O
analysis B-TERM
between O
isolates O
of O
human O
and O
civet O
SARS O
- O
CoVs O
, O
SARS O
- O
CoV O
is O
thought O
to O
undergo O
rapid B-TERM
adaptation O
in O
different O
hosts O
, O
particularly B-TERM
with O
mutations O
at O
the O
RBD O
of O
the O
S O
protein O
. O

Generally O
, O
the O
RBD O
in O
the O
S O
protein O
of O
a O
CoV O
interacts O
with O
the O
cellular O
receptor O
and O
is O
intensely O
selected O
by O
the O
host O
antibody O
response B-TERM
. O

In O
SARS O
- O
CoV O
, O
the O
RBD O
is O
in O
the O
318th O
to O
510th O
amino O
acids O
on O
the O
S1 O
fragment O
, O
which O
binds O
to O
the O
human O
ACE2 O
as O
well O
as O
its O
coreceptors O
for O
viral O
entry O
. O

The O
RBD O
of O
SARS O
- O
CoV O
is O
capable O
of O
recognizing O
the O
ACE2 O
receptors O
of O
various O
animals B-TERM
, O
including O
bat O
, O
civet O
, O
mouse O
and O
raccoon O
dog O
, O
allowing O
interspecies O
transmission O
of O
the O
virus O
. O

In O
fact O
, O
only O
6 O
amino O
acid O
residues O
were O
observed O
to O
be O
different O
from O
human O
and O
civet O
viral O
isolates O
in O
the O
RBD O
and O
4 O
of O
them O
locate O
in O
the O
receptor O
- O
binding O
motif O
for O
interaction O
with O
the O
ACE2 O
receptor O
. O

Civet O
SARS O
- O
CoV O
has O
K479N O
and O
S487T O
mutations O
in O
its O
RBD O
, O
which O
might O
increase O
the O
affinity O
of O
the O
interaction O
of O
spike O
protein B-TERM
with O
human O
ACE2 O
receptor O
. O

In O
other O
words O
, O
these O
two B-TERM
amino O
acid O
substitutions O
might O
be O
critical O
to O
viral O
adaption O
to O
humans O
. O

It O
is O
noteworthy O
that O
SARS O
- O
CoV O
- O
2 O
shares O
the O
same O
cellular O
receptor O
with O
SARS O
- O
CoV O
. O

A O
30 O
% O
difference B-TERM
between O
SARS O
- O
CoV O
- O
2 O
and O
SARS O
- O
CoV O
in O
the O
S1 O
unit O
of O
the O
S O
protein O
implicates O
that O
the O
binding O
affinity O
of O
its O
S O
protein B-TERM
with O
human O
ACE2 O
might O
have O
altered O
. O

Indeed B-TERM
, O
a O
cryo O
- O
EM O
study B-TERM
indicates O
a O
10- O
to O
20 O
- O
fold O
higher O
affinity O
of O
this O
binding O
than O
that O
between O
human O
ACE2 O
and O
SARS O
- O
CoV O
S O
protein B-TERM
. O

It O
will O
also B-TERM
be O
of O
interest O
to O
determine O
whether O
any O
other O
coreceptor O
might O
be O
required O
for O
SARS O
- O
CoV O
- O
2 O
transmission O
. O

Intriguingly O
, O
HCoV O
- O
NL63 O
also B-TERM
binds O
to O
ACE2 O
but O
with O
a O
different O
part O
of O
S. O

There O
exist O
many O
other O
HCoV O
receptors O
, O
such O
as O
aminopeptidase O
N O
for O
HCoV O
- O
229E O
, O
and O
9 O
- O
O O
- O
acetylated O
sialic O
acid O
for O
HCoV O
- O
OC43 O
. O

They O
might O
also B-TERM
account O
for O
successful O
adaptation O
of O
these O
CoVs O
in O
humans O
after O
interspecies O
transmission O
from O
their O
animal B-TERM
hosts O
. O

In O
addition B-TERM
to O
cellular O
receptors O
, O
the O
outcome B-TERM
of O
interspecies O
transmission O
of O
HCoVs O
is O
also B-TERM
governed O
by O
other O
host O
dependency O
and O
restriction O
factors O
. O

The O
divergence O
of O
these O
host O
proteins B-TERM
between O
humans O
and O
natural B-TERM
reservoir O
hosts O
of O
HCoVs O
such O
as O
bats O
, O
dromedary O
camels O
and O
rodents O
might O
constitute O
a O
barrier O
to O
interspecies O
transmission O
. O

HCoVs O
have O
to O
usurp O
host O
dependency O
factors O
and O
subvert O
host O
restriction O
factors O
for O
a O
successful O
interspecies O
transmission O
. O

In O
this O
regard O
, O
molecular O
determinants O
in O
this O
important B-TERM
area B-TERM
of O
virus O
- O
host O
interaction O
remain O
to O
be O
identified O
and O
characterized O
. O

An O
unbiased O
genome O
- O
wide O
screening O
of O
host O
dependency O
and O
restriction O
factors O
for O
SARS O
- O
CoV O
- O
2 O
using O
the O
state O
- O
of O
- O
the O
- O
art O
technology O
of O
CRISPR O
might O
be O
fruitful O
. O

Emergence B-TERM
of O
novel O
HCoVs O
: O
back O
to O
ground O
zero O

The O
diversity O
of O
bat O
CoVs O
provides O
ample O
opportunities O
for O
the O
emergence B-TERM
of O
novel O
HCoVs O
. O

In O
this O
sense O
, O
bat O
CoVs O
serve O
as O
the O
gene O
pool O
of O
HCoVs O
. O

In O
addition B-TERM
, O
rapid B-TERM
mutation O
and O
genetic O
recombination O
also B-TERM
drive O
HCoV O
evolution O
and O
serve O
as O
two B-TERM
important B-TERM
steps O
in O
this O
process O
. O

For O
example O
, O
the O
acquisition B-TERM
or O
loss B-TERM
of O
novel O
protein B-TERM
- O
coding O
genes O
has O
the O
potential O
to O
drastically O
modify O
viral O
phenotypes O
. O

Among B-TERM
SARS O
- O
CoV O
accessory O
proteins B-TERM
, O
ORF8 O
has O
been O
thought O
to O
be O
important B-TERM
in O
adaptation O
to O
humans O
, O
as O
SARS O
- O
CoV O
- O
related O
bat O
viruses O
were O
isolated O
but O
found O
to O
encode O
divergent O
ORF8 O
proteins B-TERM
. O

A O
29 O
- O
nucleotide O
deletion O
characteristic O
of O
SARS O
- O
CoVs O
has O
been O
found O
in O
strains O
isolated O
at O
the O
beginning O
of O
the O
human O
epidemic O
. O

This O
deletion O
splits O
ORF8 O
into O
ORF8a O
and O
ORF8b O
and O
is O
thought B-TERM
to O
be O
an O
adaptive O
mutation O
that O
promotes O
the O
switch O
of O
hosts O
. O

Besides B-TERM
, O
SARS O
- O
CoV O
has O
a O
possible B-TERM
recombination O
history O
with O
lineages O
of O
alpha- O
and O
gamma O
- O
CoVs O
, O
where O
a O
large O
number B-TERM
of O
smaller O
recombinant O
regions O
were O
identified O
in O
the O
RNA O
- O
dependent O
RNA O
polymerase O
. O

Recombination O
locations O
were O
also B-TERM
identified O
in O
the O
nsp9 O
, O
most O
of O
nsp10 O
, O
and O
parts O
of O
nsp14 O
. O

Likewise O
, O
it O
has O
been O
shown B-TERM
that O
the O
epidemic O
MERS O
- O
CoV O
experienced O
recombination O
events O
between O
different O
lineages O
, O
which O
occurred O
in O
dromedary O
camels O
in O
Saudi O
Arabia O
. O

Besides B-TERM
SARS O
- O
CoV O
and O
MERS O
- O
CoV O
, O
recombination O
events O
have O
also B-TERM
been O
observed O
in O
other O
HCoVs O
, O
in O
which O
the O
HCoVs O
recombine O
with O
other O
animal O
CoVs O
in O
their O
non O
- O
structural O
genes O
. O

It O
should O
also B-TERM
be O
cautioned O
that O
artificial O
selection O
can O
contribute B-TERM
to O
unintended O
changes B-TERM
in O
viral O
genomes O
, O
most O
likely O
resulting B-TERM
from O
relieving O
viruses O
from O
selection O
pressures B-TERM
exerted O
, O
such O
as O
by O
the O
host O
immune O
system O
. O

An O
example O
of O
these O
effects O
is O
the O
loss B-TERM
of O
a O
full O
- O
length O
ORF4 O
in O
the O
HCoV O
- O
229E O
prototype O
strain O
, O
owing B-TERM
to O
a O
two O
- O
nucleotide O
deletion O
. O

While O
intact O
ORF4 O
could O
be O
observed O
in O
bat O
and O
camel O
viruses O
related O
to O
HCoV O
- O
229E O
, O
the O
alpaca O
alpha O
- O
CoV O
displays B-TERM
a O
single O
nucleotide O
insertion O
, O
resulting O
in O
a O
frameshift O
. O

Last O
but O
not O
least O
, O
the O
evolution O
of O
novel O
HCoVs O
is O
also B-TERM
driven O
by O
the O
selection O
pressure B-TERM
in O
their O
reservoir O
hosts O
. O

Asymptomatic O
or O
only O
mild O
symptoms O
were O
detected O
when O
bats O
were O
infected O
with O
CoVs O
, O
indicating O
the O
mutual O
adaptation O
between O
CoVs O
and O
bats O
. O

It O
appeared O
that O
bats O
are O
well O
adapted O
to O
CoVs O
anatomically O
and O
physiologically O
. O

For O
example O
, O
defects B-TERM
in O
the O
activation O
of O
pro O
- O
inflammatory O
response B-TERM
in O
bats O
efficiently O
reduce B-TERM
the O
pathology O
triggered O
by O
CoVs O
. O

Besides O
, O
the O
natural O
killer B-TERM
cell O
activity B-TERM
in O
bats O
is O
suppressed O
due B-TERM
to O
upregulation O
of O
inhibitory O
natural B-TERM
killer B-TERM
cell O
receptor O
NKG2 O
/ O
CD94 O
and O
low O
expression O
level O
of O
major O
histocompatibility O
complex O
class O
I O
molecules O
. O

Moreover O
, O
the O
high O
level O
of O
reactive O
oxygen O
species O
( O
ROS O
) O
generated B-TERM
from O
high O
metabolic O
activity B-TERM
of O
bats O
could O
both O
suppress O
CoV O
replication O
and O
affects O
proofreading O
by O
exoribonuclease O
, O
thus O
providing O
the O
selection O
pressure B-TERM
for O
the O
generation O
of O
virus O
strains O
highly O
pathogenic O
when O
introduced O
into O
a O
new O
host O
. O

More O
pathogenic O
CoV O
strains O
might O
also B-TERM
evolve B-TERM
by O
recombination O
, O
leading O
to O
the O
acquisition B-TERM
of O
novel O
proteins B-TERM
or O
protein O
features B-TERM
for O
host O
adaptation O
. O

Thus O
, O
it O
is O
not O
by O
chance O
that O
three O
novel O
HCoVs O
have O
emerged O
in O
the O
past O
two O
decades O
. O

CoVs O
are O
non O
- O
pathogenic O
or O
cause B-TERM
mild O
symptoms O
in O
their O
reservoir O
hosts O
such O
as O
bats O
and O
camels O
. O

They O
replicate O
robustly O
without O
eliciting O
a O
strong B-TERM
host O
immune O
response O
. O

Herein O
lie O
the O
secrets B-TERM
of O
why O
asymptomatic O
carriers O
are O
seen B-TERM
and O
what O
causes B-TERM
the O
severe O
cases O
in O
human O
infection O
. O

The O
severe O
symptoms O
are O
mainly O
due O
to O
the O
hyperactivation O
of O
immune O
response O
and O
the O
cytokine O
storm B-TERM
wherein O
the O
stronger O
the O
immune O
response O
, O
the O
more O
severe O
the O
lung O
damage O
. O

In O
contrast B-TERM
, O
in O
asymptomatic O
carriers O
, O
the O
immune O
response O
has O
been O
de O
- O
coupled O
from O
CoV O
replication O
. O

The O
same O
strategy O
of O
delinking O
the O
immune O
response O
might O
have O
beneficial O
effects O
in O
anti O
- O
SARS O
- O
CoV O
- O
2 O
therapy O
. O

The O
interferon O
response B-TERM
is O
particularly B-TERM
strong B-TERM
in O
bats O
. O

Thus O
, O
administration O
of O
type B-TERM
I O
interferon O
at O
least O
in O
the O
early O
phase O
of O
SARS O
- O
CoV O
- O
2 O
infection O
in O
humans O
should O
be O
beneficial O
. O

In O
addition B-TERM
, O
NLRP3 O
inflammasome O
activation O
in O
bats O
is O
defective O
. O

By O
this O
reasoning O
, O
inhibition O
of O
NLRP3 O
inflammasome O
with O
MCC950 O
might O
be O
useful O
in O
the O
treatment O
of O
COVID O
- O
19 O
. O

The O
emergence B-TERM
of O
SARS O
- O
CoV O
- O
2 O
follows O
the O
general O
theme O
by O
which O
SARS O
- O
CoV O
and O
MERS O
- O
CoV O
arose O
. O

Whereas O
a O
bat O
beta O
- O
CoV O
sharing O
95 O
% O
nucleotide O
homology O
with O
SARS O
- O
CoV O
has O
been O
found B-TERM
, O
there O
also B-TERM
exists O
a O
bat O
- O
CoV O
sharing O
96 O
% O
nucleotide O
homology O
with O
SARS O
- O
CoV O
- O
2 O
. O

Whereas O
civets O
and O
other O
animals B-TERM
in O
the O
markets O
have O
been O
found O
to O
harbour O
viruses O
identical B-TERM
to O
SARS O
- O
CoV O
, O
immediate O
intermediate O
hosts O
for O
SARS O
- O
CoV O
- O
2 O
have O
not O
been O
identified O
. O

Pangolin O
beta O
- O
CoVs O
strikingly O
homologous O
to O
SARS O
- O
CoV O
- O
2 O
have O
been O
found O
, O
indicating O
that O
pangolins O
might O
serve O
as O
one O
of O
intermediate O
hosts O
or O
pangolin O
beta O
- O
CoVs O
could O
contribute O
gene O
fragments O
to O
the O
final O
version O
of O
SARS O
- O
CoV O
- O
2 O
. O

Although O
questions O
remain O
, O
there O
is O
no O
evidence O
that O
SARS O
- O
CoV O
- O
2 O
is O
man O
- O
made O
either B-TERM
deliberately B-TERM
or O
accidentally O
. O

CoVs O
have O
returned O
to O
the O
limelight O
due O
to O
the O
recent B-TERM
outbreak O
of O
SARS O
- O
CoV O
- O
2 O
. O

The O
study B-TERM
of O
CoVs O
in O
bats O
and O
other O
animals B-TERM
has O
drastically O
changed O
our O
perception O
of O
the O
importance O
of O
zoonotic O
origins O
and O
animal B-TERM
reservoirs O
of O
HCoVs O
in O
human O
transmission O
. O

Pervasive O
evidence O
has O
shown B-TERM
that O
SARS O
- O
CoV O
, O
MERS O
- O
CoV O
and O
SARS O
- O
CoV O
- O
2 O
have O
a O
bat O
origin O
and O
are O
transmitted O
to O
humans O
via B-TERM
intermediate O
hosts O
. O

Given O
that O
SARS O
- O
CoV O
infection O
originates O
from O
the O
contact O
between O
humans O
and O
civets O
in O
the O
markets O
, O
closing O
wet O
markets O
and O
killing O
civets O
therein O
could O
have O
effectively O
ended B-TERM
the O
SARS O
epidemic O
. O

By O
the O
same O
reasoning O
, O
pangolins O
should O
be O
removed B-TERM
from O
wet O
markets O
to O
prevent O
zoonotic O
transmission O
, O
in O
view O
of O
the O
discovery O
of O
multiple O
lineages O
of O
pangolin O
beta O
- O
CoVs O
closely O
related O
to O
SARS O
- O
CoV O
- O
2 O
. O

However O
, O
whether O
and O
how O
SARS O
- O
CoV O
- O
2 O
is O
transmitted O
to O
humans O
through O
pangolins O
and O
other O
mammals O
remain O
to O
be O
clarified O
in O
future O
investigations O
. O

On O
the O
other O
hand O
, O
MERS O
- O
CoV O
has O
existed O
in O
dromedary O
camels O
for O
a O
long O
time O
. O

These O
camels O
serve O
as O
an O
important B-TERM
tool O
for O
transportation O
as O
well O
as O
a O
main B-TERM
source O
of O
meat O
, O
milk O
, O
leather O
and O
wool O
products B-TERM
for O
the O
local B-TERM
people O
. O

They O
are O
widely O
distributed O
across O
the O
Middle O
East O
and O
Africa O
. O

It O
is O
therefore B-TERM
impossible B-TERM
to O
sacrifice O
all O
camels O
for O
the O
control O
of O
MERS O
, O
as O
what O
was O
done O
in O
wild O
animal B-TERM
markets O
in O
China O
to O
prevent O
the O
spreading O
of O
SARS O
- O
CoV O
and O
SARS O
- O
CoV O
- O
2 O
. O

To O
stop O
the O
recurrent O
outbreaks O
of O
MERS O
, O
a O
comprehensive O
approach O
should O
be O
taken O
to O
develop O
effective B-TERM
vaccines B-TERM
against O
MERS O
- O
CoV O
for O
camels O
, O
in O
combination B-TERM
with O
other O
infection O
control O
measures B-TERM
. O

As O
we O
are O
not O
able O
to O
eliminate B-TERM
these O
viruses O
, O
new O
genotypes O
might O
emerge O
to O
cause O
outbreaks O
. O

A O
variety O
of O
zoonotic O
CoVs O
are O
circulating O
in O
the O
wild O
. O

Particularly O
, O
bat O
CoVs O
with O
zoonotic O
potential O
are O
so O
diverse O
. O

There O
are O
plenty O
of O
opportunities O
that O
these O
zoonotic O
CoVs O
evolve O
and O
recombine O
, O
resulting O
in O
the O
emergence B-TERM
of O
new O
CoVs O
that O
are O
more O
transmissible O
and O
/ O
or O
deadly O
in O
humans O
in O
future O
. O

The O
culture O
of O
eating O
wild O
animals B-TERM
in O
some O
places O
of O
China O
should O
be O
abandoned O
to O
reduce B-TERM
unnecessary O
contact O
between O
humans O
and O
animals B-TERM
. O

With O
the O
ordeals O
of O
SARS O
, O
MERS O
and O
COVID O
- O
19 O
, O
a O
better O
preparedness O
and O
response O
plan B-TERM
should O
be O
in O
place O
. O

In O
fact O
, O
many O
viruses O
have O
existed O
in O
the O
planet O
for O
a O
very O
long O
time O
. O

They O
stay O
in O
their O
own O
natural B-TERM
reservoirs O
until O
there O
is O
a O
chance O
for O
spillover O
. O

Although B-TERM
bats O
have O
many O
features B-TERM
that O
favours O
the O
spreading O
of O
viruses O
, O
the O
chance O
for O
humans O
to O
be O
in O
contact O
with O
bats O
and O
other O
wildlife O
species O
can O
be O
minimized O
if O
people O
are O
educated O
to O
stay O
away O
from O
them O
. O

Continuous O
surveillance B-TERM
in O
mammals O
is O
necessary B-TERM
for O
better O
understanding O
of O
the O
ecology O
of O
CoVs O
and O
their O
natural B-TERM
hosts O
, O
which O
will O
prove O
useful O
in O
preventing O
animal B-TERM
- O
to O
- O
human O
transmission O
and O
future O
outbreaks O
. O

To O
conclude B-TERM
, O
the O
most O
effective B-TERM
way B-TERM
to O
prevent O
viral O
zoonosis O
is O
for O
humans O
to O
stay O
away O
from O
the O
ecological O
niches O
of O
the O
natural B-TERM
reservoirs O
of O
the O
zoonotic O
viruses O
. O

Several O
pieces O
in O
the O
puzzle O
of O
the O
zoonotic O
origin O
of O
SARS O
- O
CoV O
- O
2 O
are O
still O
missing O
. O

First O
, O
if O
bats O
transmit O
an O
ancestral O
virus O
of O
SARS O
- O
CoV O
- O
2 O
to O
pangolins O
, O
it O
will O
be O
of O
interest O
to O
see O
under O
what O
circumstances O
bats O
and O
pangolins O
could O
share O
the O
same O
ecological O
niche O
. O

Second O
, O
if O
bats O
play O
a O
more O
direct O
role B-TERM
in O
human O
transmission O
, O
how O
humans O
get O
into O
contact O
with O
bats O
should O
be O
determined O
. O

Third O
, O
if O
a O
third O
mammal O
acts O
as O
the O
true B-TERM
intermediate O
host O
, O
how O
it O
interacts O
with O
the O
different O
species O
including O
humans O
, O
bats O
and O
pangolins O
has O
to O
be O
clarified O
. O

Finally O
, O
since O
many O
mammals O
including O
domestic O
animals B-TERM
might O
be O
susceptible O
to O
SARS O
- O
CoV O
- O
2 O
, O
both O
surveillance B-TERM
and O
experimental O
infection O
should O
be O
conducted O
. O

Should O
it O
be O
a O
bat O
, O
a O
pangolin O
or O
another B-TERM
mammal O
, O
it O
is O
expected O
that O
SARS O
- O
CoV O
- O
2 O
or O
its O
parental O
viruses O
that O
are O
almost O
identical O
will O
be O
identified O
in O
its O
natural B-TERM
hosts O
in O
future O
. O

Continued O
investigations O
in O
this O
area B-TERM
will O
elucidate O
the O
evolutionary O
pathway O
of O
SARS O
- O
CoV O
- O
2 O
in O
animals B-TERM
, O
with O
important B-TERM
implications B-TERM
in O
the O
prevention O
and O
control O
of O
COVID O
- O
19 O
in O
humans O
. O

